
<html lang="en"     class="pb-page"  data-request-id="d4587d72-6b2c-4f6d-a4a6-120f61759d2a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00053;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria" /></meta><meta name="dc.Creator" content="Shuimu  Lin" /></meta><meta name="dc.Creator" content="Hongxia  Li" /></meta><meta name="dc.Creator" content="Yiwen  Tao" /></meta><meta name="dc.Creator" content="Jiayong  Liu" /></meta><meta name="dc.Creator" content="Wenchang  Yuan" /></meta><meta name="dc.Creator" content="Yongzhi  Chen" /></meta><meta name="dc.Creator" content="Ying  Liu" /></meta><meta name="dc.Creator" content="Shouping  Liu" /></meta><meta name="dc.Description" content="Because of the rapid increase in bacterial resistance, there is an urgent need for developing new antimicrobial agents to combat multidrug-resistant pathogens. In this study, we designed and synthe..." /></meta><meta name="Description" content="Because of the rapid increase in bacterial resistance, there is an urgent need for developing new antimicrobial agents to combat multidrug-resistant pathogens. In this study, we designed and synthe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 13, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00053" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00053" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00053" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00053" /></link>
        
    
    

<title>In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00053" /></meta><meta property="og:title" content="In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0014.jpeg" /></meta><meta property="og:description" content="Because of the rapid increase in bacterial resistance, there is an urgent need for developing new antimicrobial agents to combat multidrug-resistant pathogens. In this study, we designed and synthesized a series of kaempferol derivatives as antimicrobial agents biomimicking the structural properties and biological functions of host defense peptides. After fine-tuning of hydrophobic and cationic hydrophilic moieties linked to the flavone scaffold of kaempferol, we obtained a lead compound (52) that displayed high membrane selectivity (&gt;128), poor hemolytic activity, low cytotoxicity to mammalian cells, and excellent activity against Gram-positive bacteria (minimum inhibitory concentrations = 1.56 μg/mL), including methicillin-resistant Staphylococcus aureus. Compound 52 can kill bacteria quickly by destroying the bacterial membranes and avoid developing bacterial resistance. Moreover, compound 52 exhibited potent in vivo antibacterial activity against S. aureus in a murine corneal infection model. These results indicated that compound 52 had the therapeutic potential as a novel membrane-active antimicrobial to combat Gram-positive bacterial infections." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00053"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00053">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00053&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00053&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00053&amp;href=/doi/10.1021/acs.jmedchem.0c00053" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5797-5815</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b02137" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00075" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Shuimu Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuimu Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuimu++Lin">Shuimu Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongxia Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongxia Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongxia++Li">Hongxia Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yiwen Tao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yiwen Tao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yiwen++Tao">Yiwen Tao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiayong Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiayong Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiayong++Liu">Jiayong Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenchang Yuan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenchang Yuan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenchang++Yuan">Wenchang Yuan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yongzhi Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yongzhi Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yongzhi++Chen">Yongzhi Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ying Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Guangdong Key Laboratory of Optical Fiber Sensing and Communications, Institute of Photonics Technology, Jinan University, Guangzhou, Guangdong 510632, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Liu">Ying Liu</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Shouping Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shouping Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3a56534f4952554f4a53545d080a0b027a0b0c0914595557"><span class="__cf_email__" data-cfemail="4e22273b3d26213b3e2720297c7e7f760e7f787d602d2123">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shouping++Liu">Shouping Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2415-076X" title="Orcid link">http://orcid.org/0000-0003-2415-076X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00053&amp;href=/doi/10.1021%2Facs.jmedchem.0c00053" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5797–5815</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 13, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 January 2020</li><li><span class="item_label"><b>Published</b> online</span>13 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 June 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00053" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00053</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5797%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShuimu%2BLin%252C%2BHongxia%2BLi%252C%2BYiwen%2BTao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D11%26contentID%3Dacs.jmedchem.0c00053%26title%3DIn%2BVitro%2Band%2Bin%2BVivo%2BEvaluation%2Bof%2BMembrane-Active%2BFlavone%2BAmphiphiles%253A%2BSemisynthetic%2BKaempferol-Derived%2BAntimicrobials%2Bagainst%2BDrug-Resistant%2BGram-Positive%2BBacteria%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5815%26publicationDate%3DJune%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00053"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1152</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00053" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shuimu&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Hongxia&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yiwen&quot;,&quot;last_name&quot;:&quot;Tao&quot;},{&quot;first_name&quot;:&quot;Jiayong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Wenchang&quot;,&quot;last_name&quot;:&quot;Yuan&quot;},{&quot;first_name&quot;:&quot;Yongzhi&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Shouping&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5797-5815&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00053&quot;},&quot;abstract&quot;:&quot;Because of the rapid increase in bacterial resistance, there is an urgent need for developing new antimicrobial agents to combat multidrug-resistant pathogens. In this study, we designed and synthesized a series of kaempferol derivatives as antimicrobial agents biomimicking the structural properties and biological functions of host defense peptides. After fine-tuning of hydrophobic and cationic hydrophilic moieties linked to the flavone scaffold of kaempferol, we obtained a lead compound (52) that displayed high membrane selectivity (&gt;128), poor hemolytic activity, low cytotoxicity to mammalian cells, and excellent activity against Gram-positive bacteria (minimum inhibitory concentrations = 1.56 μg/mL), including methicillin-resistant Staphylococcus aureus. Compound 52 can kill bacteria quickly by destroying the bacterial membranes and avoid developing bacterial resistance. Moreover, compound 52 exhibited potent in vivo antibacterial activity against S. aureus in a murine corneal infection model. These result&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00053&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00053" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00053&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00053" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00053&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00053" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00053&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00053&amp;href=/doi/10.1021/acs.jmedchem.0c00053" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00053" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00053" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00053%26sid%3Dliteratum%253Aachs%26pmid%3D32400157%26genre%3Darticle%26aulast%3DLin%26date%3D2020%26atitle%3DIn%2BVitro%2Band%2Bin%2BVivo%2BEvaluation%2Bof%2BMembrane-Active%2BFlavone%2BAmphiphiles%253A%2BSemisynthetic%2BKaempferol-Derived%2BAntimicrobials%2Bagainst%2BDrug-Resistant%2BGram-Positive%2BBacteria%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D11%26spage%3D5797%26epage%3D5815%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a>,</li><li><a href="/action/doSearch?ConceptID=291691" title="Membranes">Membranes</a>,</li><li><a href="/action/doSearch?ConceptID=291676" title="Antibacterial activity">Antibacterial activity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/jmcmar.2020.63.issue-11/20200611/jmcmar.2020.63.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Because of the rapid increase in bacterial resistance, there is an urgent need for developing new antimicrobial agents to combat multidrug-resistant pathogens. In this study, we designed and synthesized a series of kaempferol derivatives as antimicrobial agents biomimicking the structural properties and biological functions of host defense peptides. After fine-tuning of hydrophobic and cationic hydrophilic moieties linked to the flavone scaffold of kaempferol, we obtained a lead compound (<b>52</b>) that displayed high membrane selectivity (>128), poor hemolytic activity, low cytotoxicity to mammalian cells, and excellent activity against Gram-positive bacteria (minimum inhibitory concentrations = 1.56 μg/mL), including methicillin-resistant <i>Staphylococcus aureus</i>. Compound <b>52</b> can kill bacteria quickly by destroying the bacterial membranes and avoid developing bacterial resistance. Moreover, compound <b>52</b> exhibited potent in vivo antibacterial activity against <i>S. aureus</i> in a murine corneal infection model. These results indicated that compound <b>52</b> had the therapeutic potential as a novel membrane-active antimicrobial to combat Gram-positive bacterial infections.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recently, because of the abuse of antimicrobial agents and the lack of new antimicrobial agents, bacterial resistance has risen dramatically, which is seriously endangering public health.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> The pharmaceutical company’s investment in research and development of antimicrobial agents has dropped significantly because antimicrobial agents have a short lifespan and are more prone to developing drug resistance, resulting in reduced profits.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Current treatment options for drug-resistant bacterial infections are inadequate, often accompanied by high medical costs, high morbidity, and high mortality.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Considering this serious situation, the World Health Organization recently issued a global priority pathogen list of antibiotic-resistant bacteria and listed bacterial resistance as one of the top 10 health threats in the world.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> If we do not pay enough attention to the emergence of superbugs, the number of deaths caused by drug-resistant pathogen infections will increase dramatically from about 700,000 patients each year to 10 million patients each year by 2050.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Therefore, it is very urgent to develop novel antimicrobial agents with new antibacterial mechanisms for treating drug-resistant bacterial infections.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Host defense peptides (HDPs), also known as antimicrobial peptides, are a key component of the innate immune system.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> They are generally composed of 10–50 amino acid residues to form a positively charged amphiphilic configuration, showing a great advantage in avoiding bacterial resistance.<a onclick="showRef(event, 'ref12 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref15">(12,15)</a> Unlike conventional antimicrobial agents with specific targets, most HDPs can kill bacteria quickly by destroying the bacterial cell membranes and have nonspecific targets, leading to an effective reduction in the probability of drug resistance.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> However, the clinical application of HDPs is also constrained by several defects such as high toxicity, low in vivo stability, and high manufacturing costs.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> In recent years, in order to solve the inherent defects of HDPs, researchers have developed a series of novel membrane-active small-molecule-based HDP mimics by simulating HDPs in chemical structure and biological functions.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18−22)</a> So far, several small-molecule-based HDP mimics have successfully entered clinical trials, such as brilacidin<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> and LTX109.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Flavone derivatives are widely found in vegetables and fruits, which are generally beneficial to human health and have no side effects.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> Flavone derivatives have been reported to contain a variety of remarkable pharmacological activities such as antibacterial,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> antioxidant,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> antiviral,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> anticancer activities,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and so forth. In our previous work, we used natural icaritin as the starting material to develop membrane-targeting flavone-based antimicrobial agents by biomimicking the chemical structure and biological functions of HDPs.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> One of the optimized compounds showed potent in vitro and in vivo antimicrobial activity against Gram-positive bacteria, which can kill bacteria rapidly by destroying the integrity of the bacterial membranes and avert the development of drug resistance in laboratory assays.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Nevertheless, this strategy for developing flavone-based antimicrobials has some obvious shortcomings, such as the high cost of the starting material icaritin and limited modification sites in chemical synthesis.</div><div class="NLM_p">Kaempferol (3,5,7,4′-tetrahydroxyflavone) is abundantly found in vegetables, fruits, teas, and Chinese herbal medicine.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> It has been reported that kaempferol existed in 80% of plant-based foods and displays a variety of biological activities including anti-inflammatory,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> antioxidant,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> anticancer,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> anticoagulant activities,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and so forth. However, kaempferol is poorly water-soluble, affecting the preparation of intravenous injection and the in vivo absorption.<a onclick="showRef(event, 'ref37 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref37 ref41 ref42">(37,41,42)</a> Moreover, kaempferol contains four phenolic hydroxyl groups, which can be covalently bonded to endogenous molecules such as glucuronic acid, glycine, and sulfuric acid, leading to strong first-pass metabolism and poor pharmacokinetic properties.<a onclick="showRef(event, 'ref37 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref37 ref42 ref43">(37,42,43)</a> This work will improve the water solubility and pharmacokinetic properties of kaempferol derivatives through structural modification to solve the defects of kaempferol in clinical applications.</div><div class="NLM_p">Herein, we designed and synthesized a new class of membrane-active flavone amphiphiles with potent antibacterial activity using kaempferol as a starting material and biomimicking the chemical structure and mode of action of HDPs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). It is well known that two “last-resort” marketed antibiotics, including daptomycin and polymyxin, can associate and interact with bacterial membranes.<a onclick="showRef(event, 'ref44 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46 ref47">(44−47)</a> This design strategy will use cheap kaempferol as a starting material, which can significantly reduce the cost of preparation and provide more alternative modification options as compared to icaritin, resulting in the rapid generation of a new library of flavone amphiphiles as antimicrobial agents (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Kaempferol provides the important flavone scaffold that is small and conformationally rigid hydrophobic core. We hypothesized that the incorporated cationic moieties that provide positive charges and hydrophilicity can promote the interaction between flavone compounds and negatively charged bacterial cell membranes via electrostatic interaction, and then the incorporation of lipid chains together with the flavone core can facilitate the insertion of flavone compounds into bacterial phospholipid bilayer membranes. Because the mammalian cell membranes are zwitterionic,<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> the cationic flavone amphiphiles could greatly enhance the selectivity between bacterial and mammalian cell membranes. Fine-tuning of the hydrophobic and cationic hydrophilic moieties of kaempferol derivatives was performed to obtain membrane-active antimicrobial agents with potent antibacterial activity, high membrane selectivity, and low toxicity. Finally, time-kill kinetics, resistance development, antibacterial mechanism, and in vivo antibacterial efficacy in a murine corneal infection model for selected compounds were further investigated. These findings suggest that this design strategy for kaempferol-based HDP mimics can help to pave a way for the development of novel antimicrobial agents.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design concept for amphiphilic kaempferol-based antimicrobial agents by biomimicking the chemical structure and biological functions of HDPs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis of Kaempferol-Based Antibacterial Analogues</h3><div class="NLM_p">The synthetic routes used to yield various amphiphilic kaempferol analogues are illustrated in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>−<named-content content-type="anchor" rid="sch2" type="simple"></named-content><named-content content-type="anchor" rid="sch3" type="simple"></named-content><named-content content-type="anchor" rid="sch4" type="simple"></named-content><a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The starting material kaempferol was alkylated with about 2 equiv of corresponding 1-iodoalkane or 3,3-dimethylallyl bromide together with K<sub>2</sub>CO<sub>3</sub> to afford compounds <b>1–5</b>. The phenolic hydroxyl group at the C3, C7, and C4′ positions was more active than that at the C5 position because there was stable intramolecular hydrogen bond formation between the C5 phenolic hydroxyl group and C4 carbonyl group.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> The alkylations of compounds <b>1–5</b> with 1,3-dibromopropane in the presence of K<sub>2</sub>CO<sub>3</sub> provided compounds <b>6–10</b>. Compounds <b>6–10</b> were then treated with diethylamine to yield compounds <b>11–15</b>. Compound <b>5</b> was then alkylated with the corresponding α,ω-dibromoalkanes to afford compounds <b>16–21</b>, followed by treating with diethylamine to yield compounds <b>22–27</b>. The treatment of compound <b>10</b> with corresponding amines resulted in compounds <b>28–37</b>. To synthesize compounds <b>38–40</b>, compounds <b>28</b>, <b>15</b>, and <b>30</b> were coupled with iodomethane. Kaempferol was alkylated with 2 or 4 equiv of ethyl bromoacetate in the presence of K<sub>2</sub>CO<sub>3</sub> to provide compounds <b>41–42</b>. Compounds <b>41–42</b> were then hydrolyzed by LiOH to produce acids <b>43–44</b>. The respective acids <b>43–44</b> were then reacted with H-Arg-OMe·2HCl, H-His-OMe·2HCl, <i>N</i>,<i>N</i>-dimethyl-1,3-propanediamine, or <i>N</i>,<i>N</i>-diethyl-1,3-propanediamine in the presence of 2-(3<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate (HATU) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) to yield compounds <b>45–48</b> and <b>52–54</b>. The treatment of compound <b>45</b> with LiOH produced compound <b>49</b>, which was then coupled with H-Arg-OMe·2HCl or <i>N</i>,<i>N</i>-dimethyl-1,3-propanediamine using HATU and DIPEA to afford compounds <b>50–51</b>. All synthesized compounds were characterized by NMR and high-resolution mass spectrometry (HRMS).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>1–15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-iodoalkanes or 3,3-dimethylallyl bromide (2 equiv), K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 1.5–10 h. (b) 1,3-dibromopropanes, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4–6 h. (c) Diethylamine, DMF, 50 °C, 24 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>16–24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) α,ω-dibromoalkanes, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4–6 h. (b) Diethylamine, DMF, 50 °C, 24 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>28–40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) corresponding amines, DMF, 50 °C, 24 h. (b) Iodomethane, CH<sub>3</sub>OH, room temperature (RT), overnight.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>41–48</b> and <b>52–54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ethyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4–12 h. (b) LiOH, THF, H<sub>2</sub>O, RT, 1.5 h. (c) Corresponding aliphatic amines or basic amino acids, HATU, DIPEA, DMF, RT, overnight.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>49–51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiOH, THF, CH<sub>3</sub>OH, H<sub>2</sub>O, RT, 1.5 h. (b) H-Arg-OMe·2HCl or <i>N</i>,<i>N</i>-dimethyl-1,3-propanediamine, HATU, DIPEA, DMF, RT, overnight.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro Antibacterial and Hemolytic Activity</h3><div class="NLM_p">The in vitro antibacterial activities of the kaempferol derivatives were assessed against four Gram-positive pathogens, including methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), by determining their minimum inhibitory concentrations (MICs). The hemolytic activities (HC<sub>50</sub>) toward rabbit erythrocytes were measured to evaluate the membrane selectivity (HC<sub>50</sub>/MICs) of these synthesized compounds.</div><div class="NLM_p">Compounds <b>11–15</b> containing the same cationic moiety were prepared to evaluate the effect of different lipid chains on the biological activity of the kaempferol derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Both compounds <b>11</b> and <b>12</b>, in which the lipid chains consisted of two <i>n</i>-propyl and two <i>n</i>-pentyl groups, respectively, displayed good antimicrobial activities (MICs = 6.25–12.5 μg/mL) and weak hemolytic activities (HC<sub>50</sub> = 58.5 ± 0.6 μg/mL for compound <b>11</b> and HC<sub>50</sub> = 153.4 ± 3.3 μg/mL for compound <b>12</b>). Increasing the lipid chain lengths yielded two more hydrophobic compounds <b>13–14</b>. Both compounds <b>13–14</b> displayed poor antibacterial and hemolytic activities, with MICs >50 μg/mL and HC<sub>50</sub> values >200 μg/mL. Significantly, compound <b>15</b> bearing two isoprenyl groups exhibited the most potent antibacterial activities (MICs = 3.13 μg/mL) among the five compounds. This result is consistent with previous studies where the isoprenyl groups would greatly promote the insertion of cationic amphiphilic compounds into the hydrophobic regions of the Gram-positive bacterial membranes and accelerate their bactericidal action.<a onclick="showRef(event, 'ref21 ref51'); return false;" href="javascript:void(0);" class="ref ref21 ref51">(21,51)</a> Therefore, the isoprenyl groups were selected as the key hydrophobic lipid groups in this study.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Antibacterial and Hemolytic Activities of Kaempferol Derivatives <b>1–40</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">MIC, μg/mL (μM)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>S. aureus</i> ATCC 29213</th><th class="colsep0 rowsep0" align="center">MRSA N315</th><th class="colsep0 rowsep0" align="center">MRSA NCTC10442</th><th class="colsep0 rowsep0" align="center">HC<sub>50</sub>, μg/mL (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>kaempferol</b></td><td class="colsep0 rowsep0" align="left">>50 (>174.7)</td><td class="colsep0 rowsep0" align="left">>50 (>174.7)</td><td class="colsep0 rowsep0" align="left">>50 (>174.7)</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">>50 (>135.0)</td><td class="colsep0 rowsep0" align="left">>50 (>135.0)</td><td class="colsep0 rowsep0" align="left">>50 (>135.0)</td><td class="colsep0 rowsep0" align="left">>200 (>540.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">>50 (>117.2)</td><td class="colsep0 rowsep0" align="left">>50 (>117.2)</td><td class="colsep0 rowsep0" align="left">>50 (>117.2)</td><td class="colsep0 rowsep0" align="left">>200 (>468.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">>50 (>103.6)</td><td class="colsep0 rowsep0" align="left">>50 (>103.6)</td><td class="colsep0 rowsep0" align="left">>50 (>103.6)</td><td class="colsep0 rowsep0" align="left">>200 (>414.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">>50 (>92.8)</td><td class="colsep0 rowsep0" align="left">>50 (>92.8)</td><td class="colsep0 rowsep0" align="left">>50 (>92.8)</td><td class="colsep0 rowsep0" align="left">>200 (>371.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">>50 (>118.3)</td><td class="colsep0 rowsep0" align="left">>50 (>118.3)</td><td class="colsep0 rowsep0" align="left">>50 (>118.3)</td><td class="colsep0 rowsep0" align="left">>200 (>473.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">6.25 (12.9)</td><td class="colsep0 rowsep0" align="left">6.25 (12.9)</td><td class="colsep0 rowsep0" align="left">6.25 (12.9)</td><td class="colsep0 rowsep0" align="left">58.5 ± 0.6(121.0 ± 1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">6.25 (11.6)</td><td class="colsep0 rowsep0" align="left">6.25 (11.6)</td><td class="colsep0 rowsep0" align="left">12.5 (23.2)</td><td class="colsep0 rowsep0" align="left">153.4 ± 3.3 (284.2 ± 6.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">>50 (>83.9)</td><td class="colsep0 rowsep0" align="left">>50 (>83.9)</td><td class="colsep0 rowsep0" align="left">>50 (>83.9)</td><td class="colsep0 rowsep0" align="left">>200 (>335.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">>50 (>76.7)</td><td class="colsep0 rowsep0" align="left">>50 (>76.7)</td><td class="colsep0 rowsep0" align="left">>50 (>76.7)</td><td class="colsep0 rowsep0" align="left">>200 (>306.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">3.125 (5.8)</td><td class="colsep0 rowsep0" align="left">3.125 (5.8)</td><td class="colsep0 rowsep0" align="left">3.125 (5.8)</td><td class="colsep0 rowsep0" align="left">32.1 ± 0.1 (59.9 ± 0.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">50 (95.8)</td><td class="colsep0 rowsep0" align="left">50 (95.8)</td><td class="colsep0 rowsep0" align="left">50 (95.8)</td><td class="colsep0 rowsep0" align="left">>200 (>383.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">3.125 (5.7)</td><td class="colsep0 rowsep0" align="left">3.125 (5.7)</td><td class="colsep0 rowsep0" align="left">3.125 (5.7)</td><td class="colsep0 rowsep0" align="left">17.7 ± 0.9 (32.2 ± 1.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">12.5 (22.2)</td><td class="colsep0 rowsep0" align="left">12.5 (22.2)</td><td class="colsep0 rowsep0" align="left">12.5 (22.2)</td><td class="colsep0 rowsep0" align="left">55.8 ± 1.7 (99.0 ± 3.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">6.25 (10.8)</td><td class="colsep0 rowsep0" align="left">6.25 (10.8)</td><td class="colsep0 rowsep0" align="left">6.25 (10.8)</td><td class="colsep0 rowsep0" align="left">48.4 ± 0.3 (83.8 ± 0.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">50 (82.5)</td><td class="colsep0 rowsep0" align="left">12.5 (20.6)</td><td class="colsep0 rowsep0" align="left">50 (82.5)</td><td class="colsep0 rowsep0" align="left">17.8 ± 1.5 (29.4 ± 2.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">>50 (>78.9)</td><td class="colsep0 rowsep0" align="left">>50 (>78.9)</td><td class="colsep0 rowsep0" align="left">>50 (>78.9)</td><td class="colsep0 rowsep0" align="left">>200 (>315.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">6.25 (12.3)</td><td class="colsep0 rowsep0" align="left">6.25 (12.3)</td><td class="colsep0 rowsep0" align="left">6.25 (12.3)</td><td class="colsep0 rowsep0" align="left">115.8 ± 6.4 (228.1 ± 12.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">>50 (>88.7)</td><td class="colsep0 rowsep0" align="left">>50 (>88.7)</td><td class="colsep0 rowsep0" align="left">>50 (>88.7)</td><td class="colsep0 rowsep0" align="left">>200 (>354.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">>50 (>84.5)</td><td class="colsep0 rowsep0" align="left">>50 (>84.5)</td><td class="colsep0 rowsep0" align="left">>50 (>84.5)</td><td class="colsep0 rowsep0" align="left">>200 (>338.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">12.5 (23.4)</td><td class="colsep0 rowsep0" align="left">6.25 (11.7)</td><td class="colsep0 rowsep0" align="left">12.5 (23.4)</td><td class="colsep0 rowsep0" align="left">>200 (>374.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">12.5 (22.2)</td><td class="colsep0 rowsep0" align="left">6.25 (11.1)</td><td class="colsep0 rowsep0" align="left">12.5 (22.2)</td><td class="colsep0 rowsep0" align="left">46.9 ± 2.3 (83.3 ± 4.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">>50 (>88.4)</td><td class="colsep0 rowsep0" align="left">>50 (>88.4)</td><td class="colsep0 rowsep0" align="left">>50 (>88.4)</td><td class="colsep0 rowsep0" align="left">>200 (>353.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">>50 (>91.0)</td><td class="colsep0 rowsep0" align="left">>50 (>91.0)</td><td class="colsep0 rowsep0" align="left">>50 (>91.0)</td><td class="colsep0 rowsep0" align="left">>200 (>363.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">12.5 (24.0)</td><td class="colsep0 rowsep0" align="left">3.125 (6.0)</td><td class="colsep0 rowsep0" align="left">6.25 (12.0)</td><td class="colsep0 rowsep0" align="left">26.0 ± 0.7 (49.8 ± 1.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">25 (45.5)</td><td class="colsep0 rowsep0" align="left">6.25 (11.4)</td><td class="colsep0 rowsep0" align="left">12.5 (22.7)</td><td class="colsep0 rowsep0" align="left">38.3 ± 1.8 (69.7 ± 3.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">>50 (>84.5)</td><td class="colsep0 rowsep0" align="left">12.5 (21.1)</td><td class="colsep0 rowsep0" align="left">>50 (>84.5)</td><td class="colsep0 rowsep0" align="left">>200 (>338.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">3.125 (4.8)</td><td class="colsep0 rowsep0" align="left">1.56 (2.4)</td><td class="colsep0 rowsep0" align="left">3.125 (4.8)</td><td class="colsep0 rowsep0" align="left">50.2 ± 0.7 (77.3 ± 1.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">3.125 (4.6)</td><td class="colsep0 rowsep0" align="left">1.56 (2.3)</td><td class="colsep0 rowsep0" align="left">3.125 (4.6)</td><td class="colsep0 rowsep0" align="left">59.7 ± 1.6 (88.2 ± 2.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">12.5 (17.1)</td><td class="colsep0 rowsep0" align="left">12.5 (17.1)</td><td class="colsep0 rowsep0" align="left">25 (34.1)</td><td class="colsep0 rowsep0" align="left">34.4 ± 2.1 (46.9 ± 2.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>vancomycin</b></td><td class="colsep0 rowsep0" align="left">0.78 (0.54)</td><td class="colsep0 rowsep0" align="left">1.56 (1.08)</td><td class="colsep0 rowsep0" align="left">1.56 (1.08)</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div></div><div class="NLM_p">To investigate the effect of spacer lengths on the biological activity of the kaempferol derivatives, diethylamine-coupled compounds <b>15</b> and <b>22–27</b> were prepared (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compounds <b>15</b> and <b>23</b> (<i>n</i> = 3 and 4, respectively) displayed significant potency against all tested bacterial strains (MICs = 3.13 μg/mL). Their antibacterial activity was gradually reduced as the spacer lengths of kaempferol derivatives increased, with a spacer length of <i>n</i> > 4. The MIC values for both compounds <b>24</b> (<i>n</i> = 5) and <b>25</b> (<i>n</i> = 6) are in the range of 6.25–12.5 μg/mL. Compound <b>26</b> (<i>n</i> = 8) showed greatly diminished antimicrobial activities, with MICs of 12.5–50 μg/mL. No antibacterial activity (MICs >50 μg/mL) and hemolytic activity (HC<sub>50</sub> > 200 μg/mL) were observed for compound <b>27</b> with the longest spacer length of <i>n</i> = 10. Surprisingly, compound <b>22</b> with a spacer length of <i>n</i> = 2 displayed very poor antibacterial activity (MICs = 50 μg/mL) and very poor hemolytic activity (HC<sub>50</sub> > 200 μg/mL). However, the reason as to why a too short spacer length (<i>n</i> = 2) resulted in poor antimicrobial and hemolytic activities is still unclear. Compounds <b>15</b> and <b>23–26</b> with spacer lengths of <i>n</i> = 3–8 showed moderately hemolytic activities because the membrane selectivity (HC<sub>50</sub>/MIC) of compound <b>15</b> (<i>n</i> = 3) is approximately twice as high as that of compound <b>23</b> (<i>n</i> = 4). Thus, a spacer length of <i>n</i> = 3 was used as the best spacer length in the further structural optimization study.</div><div class="NLM_p">Next, compounds <b>15</b> and <b>28–40</b> were synthesized to explore the effects of different kinds of amine group substitutions on the bioactivity of kaempferol derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). These compounds contained varied cationic amine groups while keeping the same lipid chains of two isoprenyl groups and the same spacer lengths of <i>n</i> = 3. Tertiary amine-substituted flavone compounds <b>15</b> (<i>N</i>,<i>N</i>-diethylamine-coupled) and <b>28</b> (<i>N</i>,<i>N</i>-dimethylamine-coupled) displayed potent antibacterial activity against all tested strains, with MICs of 3.125 and 6.25 μg/mL, respectively. Replacements using <i>N</i>,<i>N</i>-dipropylamine (<b>29</b>) and <i>N</i>,<i>N</i>-dibutylamine (<b>30</b>) instead of <i>N</i>,<i>N</i>-diethylamine (<b>15</b>) resulted in significant loss in antibacterial and hemolytic activities, with MICs >50 μg/mL and HC<sub>50</sub> >200 μg/mL. When incorporating pyrrolidine (<b>31</b>) and 1-methylpiperazine (<b>32</b>), a two-fold reduction in antibacterial activity was observed, with MICs of 6.25–12.5 μg/mL. Owing to the lower pKa values of the introduced amine groups, thiomorpholine-coupled compound <b>33</b> (pKa of free thiomorpholine = 9.0)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and morpholine-coupled compound <b>34</b> (p<i>K</i><sub>a</sub> of free morpholine = 8.36)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> displayed very poor antibacterial activities (MICs > 50 μg/mL) and very poor hemolytic activities (HC<sub>50</sub> > 200 μg/mL). These results suggested that the amine substituents with long carbon chains or lower p<i>K</i><sub>a</sub> values were deleterious to the antimicrobial and hemolytic activities.</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, secondary amine-substituted flavone compounds <b>35</b> (<i>n</i>-propylamine-coupled) and <b>36</b> (<i>n</i>-pentylamine-coupled) showed moderately antibacterial activities (MICs = 3.13–25 μg/mL) and moderately hemolytic activities. A more hydrophobic compound, <b>37</b> (<i>n</i>-octylamine-coupled), displayed dramatically reduced activity (MICs > 50 μg/mL against <i>S. aureus</i> ATCC29213 and MRSA NCTC10442; MICs = 12.5 μg/mL against MRSA N315) and poor hemolytic activities (HC<sub>50</sub> > 200 μg/mL). Tertiary amines <b>28</b>, <b>15</b>, and <b>30</b> were treated with iodomethane to yield quaternary ammonium salts <b>38–40</b>. Both compounds <b>38–39</b> still retained similarly excellent antibacterial activities against Gram-positive bacteria as their precursor compounds <b>28</b> and <b>15</b>. In contrast, compound <b>40</b> showed an obvious enhancement in both antibacterial and hemolytic activities as compared with its precursor compound <b>30</b>, with MICs of 12.5–25 μg/mL and HC<sub>50</sub> of 34.4 ± 2.1 μg/mL. These results suggested that suitable tertiary amine or quaternary ammonium salt substituents can lead to potent anti-Gram-positive bacterial activities for cationic flavone compounds.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Antibacterial and Hemolytic Activities of Kaempferol Derivatives <b>45</b>–<b>54</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">MIC, μg/mL (μM)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>S. aureus</i> ATCC 29213</th><th class="colsep0 rowsep0" align="center">MRSA N315</th><th class="colsep0 rowsep0" align="center">MRSA NCTC10442</th><th class="colsep0 rowsep0" align="center">HC<sub>50</sub>, μg/mL (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">3.125 (4.8)</td><td class="colsep0 rowsep0" align="left">1.56 (2.4)</td><td class="colsep0 rowsep0" align="left">3.125 (4.8)</td><td class="colsep0 rowsep0" align="left">69.8 ± 1.5 (107.3 ± 2.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">>50 (>79.2)</td><td class="colsep0 rowsep0" align="left">>50 (>79.2)</td><td class="colsep0 rowsep0" align="left">>50 (>79.2)</td><td class="colsep0 rowsep0" align="left">>200 (>316.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">6.25 (11.1)</td><td class="colsep0 rowsep0" align="left">6.25 (11.1)</td><td class="colsep0 rowsep0" align="left">12.5 (22.1)</td><td class="colsep0 rowsep0" align="left">162.1 ± 1.6 (287.1 ± 2.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">6.25 (10.5)</td><td class="colsep0 rowsep0" align="left">6.25 (10.5)</td><td class="colsep0 rowsep0" align="left">12.5 (21.1)</td><td class="colsep0 rowsep0" align="left">47.6 ± 0.7 (80.3 ± 1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">3.125 (3.9)</td><td class="colsep0 rowsep0" align="left">3.125 (3.9)</td><td class="colsep0 rowsep0" align="left">3.125 (3.9)</td><td class="colsep0 rowsep0" align="left">66.6 ± 1.5 (82.5 ± 1.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">6.25 (8.7)</td><td class="colsep0 rowsep0" align="left">6.25 (8.7)</td><td class="colsep0 rowsep0" align="left">6.25 (8.7)</td><td class="colsep0 rowsep0" align="left">94.3 ± 1.0 (130.8 ± 1.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">1.56 (1.8)</td><td class="colsep0 rowsep0" align="left">1.56 (1.8)</td><td class="colsep0 rowsep0" align="left">1.56 (1.8)</td><td class="colsep0 rowsep0" align="left">>200 (>227.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">25 (35.4)</td><td class="colsep0 rowsep0" align="left">50 (70.7)</td><td class="colsep0 rowsep0" align="left">50 (70.7)</td><td class="colsep0 rowsep0" align="left">>200 (>282.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">>50 (>65.5)</td><td class="colsep0 rowsep0" align="left">>50 (>65.5)</td><td class="colsep0 rowsep0" align="left">>50 (>65.5)</td><td class="colsep0 rowsep0" align="left">>200 (>262.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>vancomycin</b></td><td class="colsep0 rowsep0" align="left">0.78 (0.54)</td><td class="colsep0 rowsep0" align="left">1.56 (1.08)</td><td class="colsep0 rowsep0" align="left">1.56 (1.08)</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div></div><div class="NLM_p">Inspired by the enhanced antimicrobial activity and membrane selectivity caused by the incorporation of aliphatic amines, we then prepared compounds <b>45–46</b> and <b>50–52</b> to investigate the effect of basic amino acid (e.g., arginine) substituents on the biological activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Basic amino acids are good candidates as cationic groups appending to the flavone scaffold because they can introduce positive charges and increase molecular hydrophilicity and biocompatibility for the flavone compounds. Compound <b>45</b>, with one arginine substitution at the C3 position of the flavone scaffold, displayed potent antibacterial activity (MICs = 1.56–3.13 μg/mL) and weak hemolytic activity (HC<sub>50</sub> = 69.8 ± 1.5 μg/mL). Coupling one more arginine at the same position (compound <b>50</b>) resulted in similar activities, with MICs of 3.13 μg/mL and HC<sub>50</sub> of 66.6 ± 1.5 μg/mL. Compound <b>51</b> containing one arginine residue that was capped with 1,3-propanediamine instead of −OMe (<b>45</b>) displayed a two-fold reduction in antimicrobial activity (MICs = 6.25 μg/mL). The incorporation of low p<i>K</i><sub>a</sub> amino acid (compound <b>46</b>, histidine, p<i>K</i><sub>a</sub> of the side chain of 6.10)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> led to a significant loss in antibacterial and hemolytic activities.</div><div class="NLM_p">Finally, we investigated the effect of biological activity of 3,5-disubstituted flavone derivatives (<b>52–54</b>) with two cationic moieties and 3-monosubstituted flavone derivatives (<b>45</b>, <b>47–48</b>, and <b>50</b>) with one or two cationic moieties. Compounds <b>47–48</b> that included dimethylamine or diethylamine substitution at the C3 position of the flavone scaffold displayed good antibacterial activity (MICs = 6.25 μg/mL) and weak hemolytic activity. Surprisingly, poor antibacterial and hemolytic activities were observed for compounds <b>53–54</b> that contained dimethylamine or diethylamine substitution at the C3 and C5 positions of the flavone scaffold. We also planned to use α,ω-dibromoalkanes or α,ω-diiodoalkanes to prepare 3,5-dihalogenated flavone intermediates that were then reacted with diethylamine to yield bisalkane amine-substituted compounds. However, we failed to obtain 3,5-dihalogenated flavone intermediates. 3,5-Disubstituted flavone compound <b>52</b> containing an arginine group exhibited better antibacterial activity against all the strains tested (MICs = 1.56 μg/mL) than that of 3-monosubstituted flavone compounds <b>45</b> and <b>50</b> containing an arginine group. It should be noted that compound <b>52</b> showed very poor hemolytic activity, with HC<sub>50</sub> >200 μg/mL. Even at the highest tested concentration of 200 μg/mL, compound <b>52</b> caused only 32.8 ± 1.0% hemolysis of red blood cells (RBCs). Therefore, compound <b>52</b> has very high membrane selectivity, with a membrane selectivity index of >128. The incorporation of arginine residue at the C5 position can further increase the hydrophilicity of the flavone compound and make the positive charges be more uniformly dispersed, resulting in a significant decrease in hemolytic activity. We have also screened the activity against Gram-negative bacteria for compounds <b>45</b> and <b>52</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_001.csv" class="ext-link">Table S1</a>). Poor anti-Gram-negative bacterial activity was observed for compound <b>45</b>. Compound <b>52</b> displayed moderate activity (MICs = 12.5–25 μg/mL) against the tested Gram-negative strains, including one <i>Escherichia coli</i> and three <i>Pseudomonas aeruginosa</i> strains. The reason may be that the lipopolysaccharide layer outside the Gram-negative bacterial inner membranes hinders the entry of kaempferol compounds.</div><div class="NLM_p last">From the preliminary structure–activity relationship (SAR) studies, we found that the membrane-targeting properties of flavone compounds are determined by the following distinct structural parameters: lipid chains, spacer lengths, cationic moieties, and the balance of hydrophobic and cationic moieties. The lipid chains are important to provide a driving force to facilitate the insertion of flavone compounds into bacterial phospholipid bilayer membranes. Among these different lipid chains, the isoprenyl groups resulted in the best antibacterial activities. This result is consistent with previous studies where the isoprenyl groups would greatly promote the insertion between cationic amphiphilic compounds and bacterial membranes.<a onclick="showRef(event, 'ref21 ref51'); return false;" href="javascript:void(0);" class="ref ref21 ref51">(21,51)</a> The SAR study indicated that spacer lengths of 4–6 were beneficial to improve the antibacterial activity. The amphiphilic flavone compounds with too short (<i>n</i> = 2) or too long spacer lengths (<i>n</i> ≥ 8) would result in a great reduction or even loss in antibacterial activity. The cationic moieties of flavone compounds played a key role in the interaction with the negatively charged bacterial membranes. The incorporation of high pKa amine groups could enhance the antimicrobial activity of amphiphilic flavone compounds. By contrast, poor antibacterial activity was observed for the incorporation of low pKa amine groups (i.e., thiomorpholine and morpholine). Additionally, the introduced amine groups bearing long hydrophobic side chains (total carbon chains ≥ 6) would result in the loss of antibacterial activity (MIC > 50 μg/mL) for flavone compounds. Compared with flavone compounds substituted by aliphatic amines, arginine-substituted compounds not only maintain excellent antibacterial activity against Gram-positive bacteria but also reduce the hemolytic activity, resulting in the higher membrane selectivity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Time-Kill Kinetics</h3><div class="NLM_p">The bactericidal rate of flavone derivatives was investigated by the time-kill kinetic assay. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, compounds <b>45</b> and <b>52</b> reduced 3.19 and 3.21 log bacteria (killing ≥99.9% of <i>S. aureus</i> ATCC29213) within 1 h at 4× MIC and reduced 3.78 and 3.22 log bacteria within 0.5 h at 8× MIC, as well as no regrowth of bacteria was observed within 24 h. In contrast, traditional vancomycin just reached 1.18 log reduction of bacteria after 8 h at 4× MIC concentration. These results indicated that these two compounds can rapidly kill Gram-positive bacteria, which would shorten the treatment time of bacterial infection and reduce the probability of bacterial resistance development.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time-kill kinetics of <b>45</b>, <b>52</b>, and vancomycin against <i>S. aureus</i> ATCC29213.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Antibacterial Mechanism Studies</h3><div class="NLM_p">The antibacterial mechanism of the selected kaempferol derivatives was first studied using SYTOX Green dye. SYTOX Green is a high-affinity nucleic acid stain that can easily penetrate damaged bacterial cell membranes and bind to nucleic acids in cells, resulting in enhanced fluorescence intensity.<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> shows the effect of compounds <b>45</b> and <b>52</b> at four different concentrations (1×, 2×, 4×, and 8× MIC) against <i>S. aureus</i> ATCC29213 incubated with SYTOX Green. Both potent compounds <b>45</b> and <b>52</b> at the concentrations of 1×, 2×, 4×, and 8× MIC induced an obvious increase in fluorescence intensity, indicating a very strong interaction between compounds <b>45</b> and <b>52</b> and the bacterial cell membranes, leading to the strong cytoplasmic membrane permeabilization. Meanwhile, we carried out the fluorescence experiments without the addition of SYTOX Green as an additional control, showing very weak fluorescence signals (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_001.csv" class="ext-link">Figure S1</a>). This result clearly proved that the measured fluorescence in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> did not come from the antimicrobial compounds themselves. These data demonstrated that compounds <b>45</b> and <b>52</b> can cause the deaths of Gram-positive bacteria by destroying the bacterial cell membranes, resulting in the leakage of internal contents of bacterial cells and the deaths of bacteria.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cytoplasmic membrane permeabilization of compounds <b>45</b> and <b>52</b> at different concentrations (1×, 2×, 4×, and 8× MIC) against <i>S. aureus</i> ATCC29213 and MRSA NCTC10442.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scanning electron microscopy (SEM) is applied to observe the morphological changes of bacteria (<i>S. aureus</i> ATCC29213) treated by compound <b>45</b> or <b>52</b> (8× MIC). As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, without the treatment of flavone compounds, bacterial cells showed a normal smooth surface. In contrast, bacterial cells treated by <b>45</b> or <b>52</b> displayed very obvious cell surface disruption. The loss of structural integrity in bacterial cells exposed to either compound <b>45</b> or compound <b>52</b> was clearly observed with an indication of bacterial cell deaths via lysis.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Differential effects of compounds <b>45</b> and <b>52</b> on the morphologies of <i>S. aureus</i> ATCC29213 (as seen by SEM). The <i>S. aureus</i> ATCC29213 cells were treated with PBS (a), 8× MIC <b>45</b> (b), and 8× MIC <b>52</b> (c), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, the bacterial membrane integrity was determined by using the LIVE/DEAD bacterial viability assay. Propidium iodide (PI) and SYTO 9 are commonly used to measure the bacterial membrane integrity.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> PI cannot penetrate the intact cell membranes but can penetrate the damaged cell membranes and stains the dead bacterial cells red.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> SYTO 9 can penetrate both intact and damaged membranes and stains the cells green.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, after compounds <b>45</b> and <b>52</b> were incubated with <i>S. aureus</i> ATCC29213 for 2 h, only obvious red fluorescence was observed, suggesting that compounds <b>45</b> and <b>52</b> can cause the deaths of bacteria by destroying the bacterial cell membrane integrity. By contrast, only obvious green fluorescence was observed for the phosphate-buffered saline (PBS)-treated group because PBS is unable to destroy bacterial cell membranes and cause the bacterial cell deaths. These results indicated that compounds <b>45</b> and <b>52</b> can effectively kill Gram-positive bacteria by destroying their cell membranes.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Fluorescence microscopy of flavone compounds-induced permeabilization of <i>S. aureus</i> ATCC29213 cells visualized by Syto 9 and PI staining. The <i>S. aureus</i> ATCC29213 cells were treated with PBS (A), 8× MIC <b>45</b> (B), and 8× MIC <b>52</b> (C), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Resistance Development Study</h3><div class="NLM_p">The emergence of bacterial resistance to traditional antimicrobials seriously hinders the effective treatment of infectious diseases.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> Drug resistance development has become a crucial factor in designing and evaluating new antimicrobials.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a> To evaluate the ability of compounds <b>45</b> and <b>52</b> to avoid acute antibacterial resistance, we performed a multipassage resistance selection assay by consecutively passaging <i>S. aureus</i> ATCC29213 in the presence of sublethal concentrations of compounds <b>45</b> and <b>52</b> and norfloxacin for 19 cycles over a period of 19 consecutive days. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, no greater than a 4-fold increase in the MIC values was observed for both compounds <b>45</b> and <b>52</b> after 19 passages. In contrast, norfloxacin induced bacterial resistance rapidly, and the MIC value was increased by 128-fold after 15 passages. The rapid bactericidal activity and membrane-targeting action are very beneficial for compounds <b>45</b> and <b>52</b> to overcome the emergence of drug resistance. The resistance of membrane-targeting antimicrobial agents typically requires large-scale changes in the membrane composition of bacteria, but it is very difficult for the bacteria to maintain viability when remodeling cell membranes.<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a> These results demonstrated that compounds <b>45</b> and <b>52</b> can avoid the development of bacterial resistance.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bacterial resistance studies. (A) Compounds <b>45</b>, <b>52</b>, and norfloxacin against <i>S. aureus</i> ATCC29213. (B) Separated plot for compounds <b>45</b> and <b>52</b> against <i>S. aureus</i> ATCC29213.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vitro Cytotoxicity Evaluation</h3><div class="NLM_p">Based on the in vitro antibacterial and hemolytic activity, two compounds (<b>45</b> and <b>52</b>) were selected for the cytotoxicity evaluation toward mammalian cells (MDA-MB-231 human breast cancer cells or mouse corneal epithelial cells) using the CCK-8 method. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, both compounds showed very low cytotoxicity with a CC<sub>50</sub> value of >50 μg/mL. Even at the highest tested concentration (16× MIC for compound <b>45</b> and 32× MIC for compound <b>52</b>), compounds <b>45</b> and <b>52</b> still retained cell survival rates of 67.3 ± 3.7 and 75.0 ± 4.7% toward MDA-MB-231 human breast cancer cells as well as 62.1 ± 1.7 and 70.1 ± 2.1% toward mouse corneal epithelial cells, indicating that both compounds had high safety toward mammalian cells.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cytotoxicity evaluation of compounds <b>45</b> and <b>52</b> against MDA-MB-231 human breast cancer cells (a) or mouse corneal epithelial cells (b) using CCK-8 assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Antibacterial Efficacy</h3><div class="NLM_p">Compound <b>52</b> exhibited the most excellent in vitro antibacterial activity against Gram-positive bacteria and the highest membrane selectivity among all synthetic kaempferol derivatives. This important finding prompted us to evaluate its in vivo antibacterial efficacy in a murine corneal infection model. Antimicrobial agents, which are used by topical administration for the treatment of ocular infections, can avoid the side effects of systemic administration and greatly increase the drug concentration in the infected area.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In this study, a murine immunosuppression model was prepared by treating cyclophosphamide, and then the murine corneas were infected with <i>S. aureus</i> ATCC29213. One day after bacterial infection, mice were randomly divided into three groups (five mice per group), and each group of mice was topically treated with either 0.5% compound <b>52</b>, 5% vancomycin (positive control), or 5% glucose (negative control). The mice were treated four times a day for 3 days. Vancomycin solution (5%) is commonly applied in the clinical treatment of bacterial keratitis.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Because vancomycin has poor corneal permeability, the concentration required in the treatment of corneal infections is high.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, compound <b>52</b> and vancomycin achieved 3.28 log (<i>p</i> < 0.05) and 3.99 log (<i>p</i> < 0.05) reduction of <i>S. aureus</i> count in the infected cornea, respectively. Compound <b>52</b> exhibited potent in vivo antibacterial activity comparable to that of vancomycin, although its concentration was 10 times lower than that of vancomycin. These results indicate that compound <b>52</b> is very promising in the treatment of murine corneal infection caused by <i>S. aureus</i>.</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo antimicrobial efficacy of <b>52</b> (0.5%) and vancomycin (5%) in a murine <i>S. aureus</i> ATCC29213-induced corneal infection model. (*) <i>P</i> < 0.05 and (**) <i>P</i> < 0.05 compared with the negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have designed and synthesized a novel series of flavone-based antimicrobial agents that were derived from natural kaempferol by biomimicking the chemical structure and biological functions of HDPs. The design strategy can enhance water solubility, drug-like properties, and antibacterial activity of kaempferol-derived compounds, enabling them to overcome multidrug-resistant bacteria. After a series of structural optimization and SAR studies, compound <b>52</b> was identified as the most promising antibacterial agent with low cytotoxicity to mammalian cells (CC<sub>50</sub> > 50 μg/mL), low hemolytic activity (HC<sub>50</sub> > 200 μg/mL), high membrane selectivity (>128), and excellent activity against Gram-positive bacteria (MICs = 1.56 μg/mL), including MRSA. Compound <b>52</b> showed rapid bactericidal properties, reaching > 3 log reduction for <i>S. aureus</i> ATCC29213 within 0.5 h at 8× MIC and within 1 h at 4× MIC. The mode of action studies revealed that there was a strong interaction between compound <b>52</b> and the bacterial cell membranes; compound <b>52</b> can directly destroy the bacterial cell membranes in a concentration-dependent manner, resulting in the deaths of bacterial cells. Remarkably, <b>52</b> showed an excellent antibacterial efficacy in a murine corneal infection model induced by <i>S. aureus</i> ATCC29213. In general, we have developed a new class of kaempferol derivatives as membrane-active antimicrobial agents, providing a promising approach for combating drug-resistant pathogen infections.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Chemistry</h3><div class="NLM_p last">All commercial chemicals and solvents were used without further purification. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a JEOL 400 MHz spectrometer operating at 400 and 100 MHz, respectively. Chemical shifts (δ) are given in parts per million (ppm), and coupling constants (<i>J</i>) are expressed in hertz (Hz). Preparative high-performance liquid chromatography (HPLC) was performed on an Agilent 1260 Infinity system (YMC-Pack, C18 column, 20 × 150 mm, 5 μm, 120 Å) using a proper gradient (20–95%) of methanol and distilled water containing 0.1% HCOOH as the mobile phase. All final compounds possessed a purity of ≥95%. The purity of each final compound was determined by analytical HPLC on a Water 2695 unit with a Water SunFire C18 column (5 μm, 4.6 × 100 mm). HRMS spectra were recorded on a Thermo DFS mass spectrometer.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3,5-Dihydroxy-7-propoxy-2-(4-propoxyphenyl)-4<i>H</i>-chromen-4-one (<b>1</b>)</h3><div class="NLM_p last">To a solution of kaempferol (100 mg, 0.349 mmol) in dimethylformamide (DMF) (15 mL), potassium carbonate (120 mg, 0.873 mmol) was added. After stirring for 0.5 h at RT, 1-iodopropane (70.4 μL, 0.722 mmol) was added to the solution. Then, the mixture was stirred at RT for 10 h. After completion of the reaction, the mixture was diluted with ethyl acetate and washed twice with water. The organic phase was concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 3:1, v/v) to give compound <b>1</b> as a yellow solid (56.5 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.62 (s, 1H), 8.02 (d, <i>J</i> = 7.8 Hz, 2H), 6.98 (d, <i>J</i> = 6.8 Hz, 2H), 6.32 (m, 2H), 3.98 (t, <i>J</i> = 6.6 Hz, 2H), 3.91 (t, <i>J</i> = 6.7 Hz, 2H), 1.89–1.79 (m, 2H), 1.76–1.66 (m, 2H), 1.04 (t, <i>J</i> = 7.5 Hz, 3H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 165.2, 161.8, 157.0, 156.9 (2× C), 137.9, 130.7 (2× CH), 122.5, 115.8 (2× CH), 105.9, 98.5, 92.8, 74.9, 70.3, 23.3, 22.4, 10.5, 10.4. HRMS (ESI+): calcd for C<sub>21</sub>H<sub>23</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 371.1495; found, 371.1484.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3,5-Dihydroxy-7-(pentyloxy)-2-(4-(pentyloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>2</b>)</h3><div class="NLM_p last">Compound <b>2</b> was synthesized from kaempferol (100 mg, 0.349 mmol), potassium carbonate (240 mg, 1.75 mmol), and 1-iodopentane (95.6 μL, 0.73 mmol) according to the procedure used to prepare <b>1</b>. The product was obtained as a yellow solid (68.1 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.63 (s, 1H), 8.02 (d, <i>J</i> = 8.9 Hz, 2H), 6.99 (d, <i>J</i> = 9.0 Hz, 2H), 6.43 (d, <i>J</i> = 2.4 Hz, 1H), 6.34 (d, <i>J</i> = 2.4 Hz, 1H), 4.01 (t, <i>J</i> = 6.9 Hz, 2H), 3.94 (t, <i>J</i> = 7.0 Hz, 2H), 1.96–1.64 (m, 4H), 1.61–1.08 (m, 8H), 0.93 (t, <i>J</i> = 7.3 Hz, 3H), 0.84 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 165.1, 161.7, 158.6, 156.8, 156.7, 137.9, 130.5 (2× CH), 122.6, 115.5 (2× CH), 105.8, 98.3, 92.6, 73.2, 68.7, 29.6, 28.6, 28.0, 27.9, 22.4, 22.4, 14.0, 13.9. HRMS (ESI+): calcd for C<sub>25</sub>H<sub>31</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 427.2121; found, 427.2111.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 7-(Heptyloxy)-2-(4-(heptyloxy)phenyl)-3,5-dihydroxy-4<i>H</i>-chromen-4-one (<b>3</b>)</h3><div class="NLM_p last">Compound <b>3</b> was synthesized by kaempferol (200 mg, 0.699 mmol), potassium carbonate (289.7 mg, 2.1 mmol), and 1-iodoheptane (170.48 μL, 1.05 mmol) according to the procedure used to prepare <b>1</b>. The product was obtained as a brownish yellow solid (88.6 mg, 26%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.66 (s, 1H), 8.15–7.91 (m, 2H), 7.16–6.81 (m, 2H), 6.43 (d, <i>J</i> = 1.6 Hz, 1H), 6.34 (d, <i>J</i> = 1.8 Hz, 1H), 3.99 (dt, <i>J</i> = 19.9, 6.6 Hz, 4H), 1.84–1.66 (m, 4H), 1.39–1.20 (m, 16H), 0.91–0.83 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 165.1, 161.9, 158.4, 156.9, 156.5, 138.0, 130.7, 130.7, 123.0, 115.6, 115.5, 106.0, 98.4, 92.7, 73.2, 68.8, 31.8, 31.8, 30.1, 29.1, 29.1, 29.0, 26.0, 25.90, 22.7, 22.6, 14.2, 14.1. HRMS (ESI+): calcd for C<sub>29</sub>H<sub>39</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 483.2747; found, 483.2737.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3,5-Dihydroxy-7-(nonyloxy)-2-(4-(nonyloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>4</b>)</h3><div class="NLM_p last">Compound <b>4</b> was synthesized from kaempferol (100 mg, 0.349 mmol), potassium carbonate (96.57 mg, 0.699 mmol), and 1-iodononane (112 μL, 0.629 mmol) according to the similar procedure used to prepare <b>1</b>. The reaction mixture was stirred at RT for 4 h. Then, the resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 4:1, v/v). The product was obtained as a yellow solid (34.4 mg, 18%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.67 (s, 1H), 8.02 (d, <i>J</i> = 7.8 Hz, 2H), 6.95 (d, <i>J</i> = 6.2 Hz, 2H), 6.42 (d, <i>J</i> = 2.2 Hz, 1H), 6.34 (d, <i>J</i> = 2.2 Hz, 1H), 3.99 (dt, <i>J</i> = 16.3, 6.7 Hz, 4H), 1.87–1.61 (m, 6H), 1.48–1.40 (m, 2H), 1.35–1.23 (m, 20H), 0.88 (dt, <i>J</i> = 4.7, 3.5 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 165.1, 161.9, 158.6, 156.9, 156.7, 138.0, 130.6 (2× CH), 122.8, 115.6 (2× CH), 105.9, 98.4, 92.7, 73.3, 68.8, 31.9 (2× CH<sub>2</sub>), 30.1, 29.8, 29.6, 29.5, 29.4, 29.3 (2× CH<sub>2</sub>), 29.0, 26.0, 25.9, 22.7 (2× CH<sub>2</sub>), 14.2 (2× CH<sub>3</sub>). HRMS (ESI+): C<sub>33</sub>H<sub>47</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 539.3373; found, 539.3356.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3,5-Dihydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>5</b>)</h3><div class="NLM_p last">Compound <b>5</b> was synthesized from kaempferol (200 mg, 0.699 mmol), potassium carbonate (483 mg, 3.49 mmol), and 3,3-dimethylallyl bromide (170 μL, 1.47 mmol) according to the similar procedure used to prepare <b>1</b>. The reaction mixture was stirred at 50 °C for 1.5 h. Then, the resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 4:1, v/v). The product was obtained as a light yellow solid (142.9 mg, 50%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.68 (s, 1H), 8.03 (d, <i>J</i> = 9.1 Hz, 2H), 6.98 (d, <i>J</i> = 9.2 Hz, 2H), 6.45 (d, <i>J</i> = 2.4 Hz, 1H), 6.36 (d, <i>J</i> = 2.4 Hz, 1H), 5.63–5.21 (m, 2H), 4.57 (d, <i>J</i> = 7.3 Hz, 2H), 4.52 (d, <i>J</i> = 7.8 Hz, 2H), 1.84–1.72 (m, 6H), 1.67–1.54 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.2, 164.9, 161.7, 159.1, 157.5, 156.9, 139.7, 139.4, 137.3, 130.7 (2× CH), 122.6, 119.6, 118.6, 115.8 (2× CH), 105.8, 98.7, 93.0, 69.3, 65.6, 25.9, 25.8, 18.4, 18.0. HRMS (ESI+): calcd for C<sub>25</sub>H<sub>27</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 423.1808; found, 423.1797.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-(3-Bromopropoxy)-5-hydroxy-7-propoxy-2-(4-propoxyphenyl)-4<i>H</i>-chromen-4-one (<b>6</b>)</h3><div class="NLM_p last">To a solution of <b>1</b> (56.5 mg, 0.153 mmol) in acetone (10 mL), potassium carbonate (105.4 mg, 0.76 mmol) and 1,3-dibromopropane (46.43 μL, 0.46 mmol) were added. The mixture was refluxed for 4 h. After completion of the reaction, the mixture was diluted with ethyl acetate and washed twice with water. The organic phase was concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 7:1, v/v) to give compound <b>6</b> as a yellow solid (35.1 mg, 47%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.67 (s, 1H), 8.07 (d, <i>J</i> = 9.2 Hz, 2H), 7.01 (d, <i>J</i> = 9.3 Hz, 2H), 6.42 (d, <i>J</i> = 2.4 Hz, 1H), 6.33 (d, <i>J</i> = 2.4 Hz, 1H), 4.20 (t, <i>J</i> = 6.0 Hz, 2H), 3.96 (dt, <i>J</i> = 11.8, 6.8 Hz, 4H), 3.63 (t, <i>J</i> = 6.5 Hz, 2H), 2.46–2.25 (m, 2H), 1.88–1.61 (m, 4H), 1.04 (t, <i>J</i> = 7.5 Hz, 3H), 0.95 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 165.0, 162.0, 160.7, 156.8, 156.1, 138.1, 130.4 (2× CH), 123.4, 114.4 (2× CH), 106.0, 98.3, 92.6, 74.6, 70.2, 65.5, 32.3, 29.9, 23.4, 22.4, 10.5 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>24</sub>H<sub>28</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 491.1069; found, 491.1055.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-(3-Bromopropoxy)-5-hydroxy-7-(pentyloxy)-2-(4-(pentyloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was synthesized from <b>2</b> (61.2 mg, 0.143 mmol), potassium carbonate (59.5 mg, 0.43 mmol), and 1,3-dibromopropane (43.8 μL, 0.43 mmol) according to the similar procedure used to prepare <b>6</b>. The product was obtained as a yellow solid (40.5 mg, 56%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.67 (s, 1H), 8.06 (d, <i>J</i> = 8.8 Hz, 2H), 7.01 (d, <i>J</i> = 8.9 Hz, 2H), 6.42 (d, <i>J</i> = 2.1 Hz, 1H), 6.33 (d, <i>J</i> = 2.1 Hz, 1H), 4.20 (t, <i>J</i> = 5.8 Hz, 2H), 3.99 (dt, <i>J</i> = 13.4, 6.7 Hz, 4H), 3.63 (t, <i>J</i> = 6.4 Hz, 2H), 2.43–2.31 (m, 2H), 1.85–1.76 (m, 2H), 1.76–1.67 (m, 2H), 1.45–1.27 (m, 8H), 0.94 (t, <i>J</i> = 7.1 Hz, 3H), 0.87 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 165.0, 162.0, 160.7, 156.8, 156.1, 138.2, 130.4 (2× CH), 123.4, 114.4 (2× CH), 106.0, 98.3, 92.6, 73.1, 68.7, 65.5, 32.3, 29.9, 29.8, 28.7, 28.2, 28.1, 22.5 (2× CH<sub>2</sub>), 14.1 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>28</sub>H<sub>36</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 547.1695; found, 547.1679.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-(3-Bromopropoxy)-7-(heptyloxy)-2-(4-(heptyloxy)phenyl)-5-hydroxy-4<i>H</i>-chromen-4-one (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was synthesized from <b>3</b> (88.6 mg, 0.184 mmol), potassium carbonate (63.4 mg, 0.46 mmol), and 1,3-dibromopropane (139.8 μL, 1.38 mmol) according to the similar procedure used to prepare <b>6</b>. The product was obtained as a yellow solid (79.1 mg, 72%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.68 (s, 1H), 8.06 (d, <i>J</i> = 9.0 Hz, 2H), 7.01 (d, <i>J</i> = 9.0 Hz, 2H), 6.42 (d, <i>J</i> = 2.2 Hz, 1H), 6.33 (d, <i>J</i> = 2.2 Hz, 1H), 4.20 (t, <i>J</i> = 5.8 Hz, 2H), 4.00 (dt, <i>J</i> = 12.1, 6.7 Hz, 4H), 3.63 (t, <i>J</i> = 6.4 Hz, 2H), 2.37 (p, <i>J</i> = 6.1 Hz, 2H), 1.85–1.75 (m, 2H), 1.75–1.66 (m, 2H), 1.48–1.24 (m, 16H), 0.91–0.83 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 165.0, 162.0, 160.7, 156.9, 156.1, 138.2, 130.4 (2× CH), 123.4, 114.4 (2× CH), 106.0, 98.3, 92.6, 73.1, 68.7, 65.5, 32.3, 31.9, 31.8, 30.2, 29.9, 29.1 (2× CH<sub>2</sub>), 29.0, 26.0, 25.9, 22.7 (2× CH<sub>2</sub>), 14.2 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>32</sub>H<sub>44</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 603.2321; found, 603.2307.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(3-Bromopropoxy)-5-hydroxy-7-(nonyloxy)-2-(4-(nonyloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> was synthesized from <b>4</b> (98 mg, 0.182 mmol), potassium carbonate (62.9 mg, 0.45 mmol), and 1,3-dibromopropane (138.4 μL, 1.36 mmol) according to the similar procedure used to prepare <b>6</b>. The product was obtained as a yellow solid (69.5 mg, 58%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.68 (s, 1H), 8.07 (d, <i>J</i> = 9.0 Hz, 2H), 7.01 (d, <i>J</i> = 9.0 Hz, 2H), 6.42 (d, <i>J</i> = 2.2 Hz, 1H), 6.33 (d, <i>J</i> = 2.1 Hz, 1H), 4.20 (t, <i>J</i> = 5.8 Hz, 2H), 4.00 (dt, <i>J</i> = 11.6, 6.6 Hz, 4H), 3.63 (t, <i>J</i> = 6.4 Hz, 2H), 2.37 (p, <i>J</i> = 6.1 Hz, 2H), 1.84–1.65 (m, 4H), 1.46–1.24 (m, 24H), 0.87 (dt, <i>J</i> = 4.8, 3.4 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 164.9, 161.9, 160.6, 156.7, 155.9, 138.1, 130.3 (2× CH), 123.3, 114.3 (2× CH), 105.9, 98.2, 92.5, 73.0, 68.6, 65.4, 32.2, 31.9, 31.8, 30.1, 29.7, 29.5 (2× CH<sub>2</sub>), 29.4, 29.3, 29.2 (2× CH<sub>2</sub>), 28.9, 25.90 (2× CH<sub>2</sub>), 22.6 (2× CH<sub>2</sub>), 14.1 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>36</sub>H<sub>52</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 659.2947; found, 659.2933.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(3-Bromopropoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was synthesized from <b>5</b> (30 mg, 0.071 mmol), potassium carbonate (25.1 mg, 0.18 mmol), and 1,3-dibromopropane (54 μL, 0.53 mmol) according to the similar procedure used to prepare <b>6</b>. The reaction mixture was refluxed for 6 h. Then, the resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 6:1, v/v). The product was obtained as a brownish-yellow solid (29.3 mg, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.77–12.67 (m, 1H), 8.22–7.96 (m, 2H), 7.13–6.87 (m, 2H), 6.54–6.40 (m, 1H), 6.38–6.27 (m, 1H), 5.61–5.26 (m, 2H), 4.71–4.43 (m, 4H), 4.19 (t, <i>J</i> = 6.3 Hz, 2H), 3.78–3.48 (m, 2H), 2.52–2.27 (m, 2H), 1.92–1.72 (m, 6H), 1.68 (s, 3H), 1.62 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 178.9, 164.5, 161.9, 160.5, 156.6, 156.2, 139.4, 139.1, 137.4, 130.3 (2× CH), 123.4, 119.7, 118.6, 114.2 (2× CH), 105.8, 98.2, 92.7, 68.8, 65.4, 65.3, 32.1, 29.7, 25.8, 25.7, 18.2, 18.0. HRMS (ESI+): calcd for C<sub>28</sub>H<sub>32</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 543.1382; found, 543.1363.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-(3-(Diethylamino)propoxy)-5-hydroxy-7-propoxy-2-(4-propoxyphenyl)-4<i>H</i>-chromen-4-one (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>6</b> (47.8 mg, 0.097 mmol) in anhydrous DMF (4 mL), diethylamine (1 mL) was added. The mixture was stirred for 24 h at 50 °C. After completion of the reaction, the mixture was diluted with ethyl acetate and washed twice with water. The organic phase was concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (ethyl acetate/ethanol/triethylamine, 1/1/0.1, v/v/v) to give compound <b>11</b> as a yellow gel (27.1 mg, 58%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.04–7.95 (m, 2H), 7.02–6.93 (m, 2H), 6.49–6.40 (m, 1H), 6.26–6.19 (m, 1H), 4.11–4.03 (m, 2H), 4.00–3.94 (m, 2H), 3.90–3.83 (m, 2H), 2.73–2.67 (m, 2H), 2.62 (q, <i>J</i> = 7.2 Hz, 4H), 2.02–1.94 (m, 2H), 1.84–1.66 (m, 4H), 1.10–1.02 (m, 9H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.1, 166.6, 162.8, 162.6, 158.2, 157.7, 139.1, 131.5, 131.4, 124.0, 115.4 (2× CH), 106.8, 99.3, 93.5, 75.5, 71.4, 67.5, 50.4, 47.9 (2× CH<sub>2</sub>), 27.1, 24.4, 23.5, 11.4 (2× CH<sub>3</sub>), 10.9, 10.8. HRMS (ESI+): calcd for C<sub>28</sub>H<sub>38</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 484.2699; found, 484.2676.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(3-(Diethylamino)propoxy)-5-hydroxy-7-(pentyloxy)-2-(4-(pentyloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was synthesized from <b>7</b> (50 mg, 0.091 mmol) and diethylamine (1 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a brownish yellow solid (31.4 mg, 64%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 6.96 (d, <i>J</i> = 8.5 Hz, 2H), 6.41 (s, 1H), 6.19 (d, <i>J</i> = 1.9 Hz, 1H), 4.06 (t, <i>J</i> = 5.9 Hz, 2H), 3.97 (t, <i>J</i> = 6.3 Hz, 2H), 3.89 (t, <i>J</i> = 6.6 Hz, 2H), 2.73–2.66 (m, 2H), 2.61 (q, <i>J</i> = 7.2 Hz, 4H), 2.02–1.92 (m, 2H), 1.80–1.63 (m, 4H), 1.48–1.29 (m, 8H), 1.08 (t, <i>J</i> = 7.2 Hz, 6H), 0.96 (t, <i>J</i> = 7.0 Hz, 3H), 0.88 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.0, 166.4, 162.8, 162.5, 158.0, 157.5, 139.0, 131.4 (2× CH), 123.9, 115.4 (2× CH), 106.7, 99.2, 93.4, 73.8, 69.8, 67.5, 50.3, 47.9 (2× CH<sub>2</sub>), 30.9, 29.9, 29.3 (2× CH<sub>2</sub>), 27.1, 23.6, 23.5, 14.5 (2× CH<sub>3</sub>), 11.5 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>32</sub>H<sub>46</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 540.3325; found, 540.3301.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(3-(Diethylamino)propoxy)-7-(heptyloxy)-2-(4-(heptyloxy)phenyl)-5-hydroxy-4<i>H</i>-chromen-4-one (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was synthesized from <b>8</b> (63.8 mg, 0.106 mmol) and diethylamine (1 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow gel (34.6 mg, 56%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.98 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (d, <i>J</i> = 8.9 Hz, 2H), 6.45 (d, <i>J</i> = 2.0 Hz, 1H), 6.22 (d, <i>J</i> = 2.1 Hz, 1H), 4.08 (t, <i>J</i> = 6.0 Hz, 2H), 3.99 (t, <i>J</i> = 6.4 Hz, 2H), 3.91 (t, <i>J</i> = 6.5 Hz, 2H), 2.80–2.72 (m, 2H), 2.67 (q, <i>J</i> = 7.2 Hz, 4H), 2.05–1.95 (m, 2H), 1.76 (dd, <i>J</i> = 14.4, 6.7 Hz, 2H), 1.69–1.61 (m, 2H), 1.46 (dd, <i>J</i> = 10.2, 5.0 Hz, 2H), 1.38–1.30 (m, 8H), 1.29–1.24 (m, 6H), 1.11 (t, <i>J</i> = 7.2 Hz, 6H), 0.93–0.86 (m, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.1, 166.5, 162.8, 162.5, 158.1, 157.7, 139.0, 131.5 (2× CH), 124.0, 115.4 (2× CH), 106.7, 99.2, 93.5, 73.9, 69.8, 67.4, 50.3, 47.9 (2× CH<sub>2</sub>), 33.0 (2× CH<sub>2</sub>), 31.1 (2× CH<sub>2</sub>), 30.3, 30.2, 27.1 (2× CH<sub>2</sub>), 26.9, 23.7 (2× CH<sub>2</sub>), 14.5 (2× CH<sub>3</sub>), 11.3 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>36</sub>H<sub>54</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 596.3951; found, 596.3923.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-(3-(Diethylamino)propoxy)-5-hydroxy-7-(nonyloxy)-2-(4-(nonyloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was synthesized from <b>9</b> (51.8 mg, 0.079 mmol) and diethylamine (1 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow gel (40.2 mg, 79%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.05 (d, <i>J</i> = 9.3 Hz, 2H), 6.99 (d, <i>J</i> = 9.3 Hz, 2H), 6.41 (d, <i>J</i> = 2.3 Hz, 1H), 6.32 (d, <i>J</i> = 2.3 Hz, 1H), 4.32–3.82 (m, 6H), 3.51–3.14 (m, 2H), 2.68–2.55 (m, 4H), 2.36 (br, 2H), 2.05–1.92 (m, 2H), 1.90–1.16 (m, 26H), 1.05 (t, <i>J</i> = 7.2 Hz, 6H), 0.91–0.79 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 165.0, 162.0, 161.1, 156.9, 156.3, 138.1, 130.3 (2× CH), 123.0, 114.4 (2× CH), 106.0, 98.3, 92.6, 73.1, 68.7, 66.6, 59.2, 49.3, 47.0, 32.0, 31.9, 30.2, 29.6 (2× CH<sub>2</sub>), 29.5, 29.4, 29.3, 29.0, 26.9, 26.0 (2× CH<sub>2</sub>), 22.7 (2× CH<sub>2</sub>), 14.2 (2× CH<sub>3</sub>), 11.6 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>40</sub>H<sub>62</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 652.4577; found, 652.4547.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(3-(Diethylamino)propoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was synthesized from <b>10</b> (94.1 mg, 0.173 mmol) and diethylamine (2 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow gel (90.8 mg, 97%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.09–7.94 (m, 2H), 7.04–6.89 (m, 2H), 6.51–6.38 (m, 1H), 6.29–6.17 (m, 1H), 5.50–5.28 (m, 2H), 4.61–4.52 (m, 2H), 4.47 (d, <i>J</i> = 6.3 Hz, 2H), 4.11–4.00 (m, 2H), 2.74–2.66 (m, 2H), 2.62 (q, <i>J</i> = 7.2 Hz, 4H), 2.07–1.92 (m, 2H), 1.79 (s, 3H), 1.76 (s, 3H), 1.65 (s, 3H), 1.56 (s, 3H), 1.09 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 179.9, 166.0, 162.5, 162.2, 157.8, 157.6, 140.1, 139.3, 138.1, 131.2 (2× CH), 123.8, 120.8, 120.1, 115.1 (2× CH), 106.4, 99.1, 93.5, 69.6, 67.3, 66.4, 50.1, 47.6 (2× CH<sub>2</sub>), 26.8, 25.8, 25.7, 18.2, 18.0, 11.2 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>30</sub>H<sub>38</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 536.3012; found, 536.2986.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-(2-Bromoethoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was synthesized from <b>5</b> (33 mg, 0.078 mmol), potassium carbonate (26.9 mg, 0.195 mmol), and 1,2-dibromoethane (50.5 μL, 0.586 mmol) according to the procedure used to prepare <b>10</b>. The product was obtained as a yellow solid (22.8 mg, 55%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.69 (s, 1H), 8.08 (d, <i>J</i> = 8.4 Hz, 2H), 6.99 (d, <i>J</i> = 8.4 Hz, 2H), 6.38 (d, <i>J</i> = 35.1 Hz, 2H), 5.48 (t, <i>J</i> = 6.2 Hz, 1H), 5.38 (t, <i>J</i> = 7.1 Hz, 1H), 4.56 (d, <i>J</i> = 7.0 Hz, 4H), 4.37 (t, <i>J</i> = 6.0 Hz, 2H), 3.67 (t, <i>J</i> = 5.9 Hz, 2H), 1.81 (s, 3H), 1.76 (s, 3H), 1.68 (s, 3H), 1.62 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 178.9, 164.6, 161.8, 159.8, 156.6, 155.9, 139.3, 139.0, 137.5, 130.3 (2× CH), 123.8, 119.7, 118.6, 114.3 (2× CH), 105.8, 98.2, 92.6, 68.8, 67.7, 65.3, 28.7, 25.7 (2× CH<sub>3</sub>), 18.2, 17.9. HRMS (ESI+): calcd for C<sub>27</sub>H<sub>30</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 529.1226; found, 529.1208.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-(4-Bromobutoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>17</b>)</h3><div class="NLM_p last">Compound <b>17</b> was synthesized from <b>5</b> (40 mg, 0.095 mmol), potassium carbonate (32.7 mg, 0.24 mmol), and 1,4-dibromobutane (79.2 μL, 0.66 mmol) according to the procedure used to prepare <b>10</b>. The product was obtained as a yellow solid (44.8 mg, 85%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.72 (s, 1H), 8.08 (d, <i>J</i> = 9.2 Hz, 2H), 6.98 (d, <i>J</i> = 9.3 Hz, 2H), 6.44 (d, <i>J</i> = 2.4 Hz, 1H), 6.35 (d, <i>J</i> = 2.4 Hz, 1H), 5.60–5.27 (m, 2H), 4.67–4.47 (m, 4H), 4.08 (t, <i>J</i> = 6.2 Hz, 2H), 3.51 (t, <i>J</i> = 6.7 Hz, 2H), 2.25–1.92 (m, 4H), 1.85–1.56 (m, 12H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 164.7, 162.0, 160.9, 156.8, 156.4, 139.5, 139.3, 137.5, 130.4 (2× CH), 123.3, 119.9, 118.7, 114.4 (2× CH), 106.0, 98.4, 92.8, 69.0, 67.1, 65.5, 33.4, 29.5, 27.9, 25.9, 25.9, 18.4, 18.1. HRMS (ESI+): calcd for C<sub>29</sub>H<sub>34</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 557.1539; found, 557.1521.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-((5-Bromopentyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>18</b>)</h3><div class="NLM_p last">Compound <b>18</b> was synthesized from <b>5</b> (78.1 mg, 0.185 mmol), potassium carbonate (63.9 mg, 0.46 mmol), and 1,5-dibromopentane (188 μL, 1.39 mmol) according to the procedure used to prepare <b>10</b>. The product was obtained as a brownish-yellow solid (86.6 mg, 82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.72 (s, 1H), 8.07 (d, <i>J</i> = 8.2 Hz, 2H), 6.97 (d, <i>J</i> = 8.3 Hz, 2H), 6.42 (d, <i>J</i> = 8.2 Hz, 1H), 6.33 (d, <i>J</i> = 10.4 Hz, 1H), 5.48 (t, <i>J</i> = 6.2 Hz, 1H), 5.40 (t, <i>J</i> = 7.0 Hz, 1H), 4.63–4.50 (m, 4H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 3.45 (t, <i>J</i> = 6.6 Hz, 2H), 2.05–1.62 (m, 18H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 164.7, 162.0, 161.0, 156.8, 156.5, 139.5, 139.3, 137.5, 130.4 (2× CH), 123.2, 119.9, 118.7, 114.4 (2× CH), 106.0, 98.4, 92.8, 69.0, 67.8, 65.5, 33.6, 32.5, 28.4, 25.9, 25.9, 24.9, 18.4, 18.1. HRMS (ESI+): calcd for C<sub>30</sub>H<sub>36</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 571.1695; found, 571.1682.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 3-((6-Bromohexyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was synthesized from <b>5</b> (81.8 mg, 0.194 mmol), potassium carbonate (66.9 mg, 0.48 mmol), and 1,6-dibromohexane (224 μL, 1.45 mmol) according to the procedure used to prepare <b>10</b>. The product was obtained as a yellow solid (88.4 mg, 78%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.72 (s, 1H), 8.07 (d, <i>J</i> = 8.2 Hz, 2H), 6.97 (d, <i>J</i> = 8.3 Hz, 2H), 6.42 (d, <i>J</i> = 8.4 Hz, 1H), 6.33 (d, <i>J</i> = 9.8 Hz, 1H), 5.48 (t, <i>J</i> = 6.3 Hz, 1H), 5.40 (t, <i>J</i> = 7.1 Hz, 1H), 4.62–4.49 (m, 4H), 4.04 (t, <i>J</i> = 6.2 Hz, 2H), 3.43 (t, <i>J</i> = 6.7 Hz, 2H), 1.95–1.80 (m, 7H), 1.76 (s, 3H), 1.68 (s, 3H), 1.62 (s, 3H), 1.56–1.44 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 178.9, 164.5, 161.8, 160.9, 156.6, 156.3, 139.3, 139.1, 137.3, 130.2 (2× CH), 123.0, 119.7, 118.6, 114.2 (2× CH), 105.8, 98.2, 92.6, 68.8, 67.8, 65.3, 33.7, 32.6, 28.9, 27.8, 25.8, 25.7, 25.2, 18.2, 17.9. HRMS (ESI+): calcd for C<sub>31</sub>H<sub>38</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 585.1582; found, 585.1534.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-((8-Bromooctyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> was synthesized from <b>5</b> (76.6 mg, 0.18 mmol), potassium carbonate (62.6 mg, 0.45 mmol), and 1,8-dibromooctane (250.5 μL, 1.36 mmol) according to the procedure used to prepare <b>10</b>. The product was obtained as an orange oil (92.9 mg, 83%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.73 (s, 1H), 8.07 (d, <i>J</i> = 8.1 Hz, 2H), 6.97 (d, <i>J</i> = 8.2 Hz, 2H), 6.46–6.30 (m, 2H), 5.48 (t, <i>J</i> = 6.2 Hz, 1H), 5.40 (t, <i>J</i> = 7.2 Hz, 1H), 4.61–4.50 (m, 4H), 4.03 (t, <i>J</i> = 6.3 Hz, 2H), 3.41 (t, <i>J</i> = 6.7 Hz, 2H), 1.91–1.62 (m, 16H), 1.51–1.33 (m, 8H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.0, 164.6, 161.9, 161.1, 156.7, 156.5, 139.4, 139.1, 137.4, 130.3 (2× CH), 123.0, 119.8, 118.7, 114.3 (2× CH), 105.9, 98.3, 92.7, 68.9, 68.1, 65.4, 34.0, 32.8, 29.2, 29.1, 28.7, 28.1, 25.9, 25.8 (2× CH<sub>2</sub>), 18.3, 18.0. HRMS (ESI+): calcd for C<sub>33</sub>H<sub>42</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 613.2165; found, 613.2141.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3-((10-Bromodecyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was synthesized from <b>5</b> (73 mg, 0.173 mmol), potassium carbonate (60.5 mg, 0.44 mmol), and 1,10-dibromodecane (293 μL, 1.3 mmol) according to the procedure used to prepare <b>10</b>. The product was obtained as a brown oil (75.4 mg, 68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.73 (s, 1H), 8.07 (d, <i>J</i> = 9.3 Hz, 2H), 6.98 (d, <i>J</i> = 9.3 Hz, 2H), 6.44 (d, <i>J</i> = 2.4 Hz, 1H), 6.35 (d, <i>J</i> = 2.3 Hz, 1H), 5.69–5.24 (m, 2H), 4.69–4.44 (m, 4H), 4.03 (t, <i>J</i> = 6.8 Hz, 2H), 3.41 (t, <i>J</i> = 7.0 Hz, 2H), 2.02–1.03 (m, 28H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 164.7, 162.0, 161.2, 156.8, 156.6, 139.5, 139.3, 137.5, 130.4 (2× CH), 123.1, 119.9, 118.7, 114.4 (2× CH), 106.0, 98.4, 92.8, 69.0, 68.2, 65.5, 34.1, 32.9, 29.5, 29.4 (2× CH<sub>2</sub>), 29.2, 28.8, 28.2, 26.1, 25.9, 25.8, 18.4, 18.1. HRMS (ESI+): calcd for C<sub>35</sub>H<sub>46</sub>BrO<sub>6</sub> [M + H]<sup>+</sup>, 641.2478; found, 641.2456.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-(2-(Diethylamino)ethoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was synthesized from <b>16</b> (47.7 mg, 0.09 mmol) and diethylamine (0.5 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a brown gel (28.5 mg, 61%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.06 (d, <i>J</i> = 7.4 Hz, 2H), 7.11–6.97 (m, 2H), 6.51 (d, <i>J</i> = 7.7 Hz, 1H), 6.26 (d, <i>J</i> = 6.2 Hz, 1H), 5.52–5.41 (m, 1H), 5.37–5.28 (m, 1H), 4.64–4.56 (m, 2H), 4.53–4.47 (m, 2H), 4.23 (d, <i>J</i> = 2.9 Hz, 2H), 3.15–3.04 (m, 2H), 2.87–2.78 (m, 4H), 1.80 (s, 3H), 1.77 (s, 3H), 1.64 (s, 3H), 1.56 (s, 3H), 1.18 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.3, 162.7, 161.9, 158.1, 157.8, 140.5, 139.6, 138.4, 131.5 (2× CH), 124.6, 120.9, 120.2, 115.4 (2× CH), 106.6, 99.4, 93.8, 69.8, 66.6, 66.2, 52.4, 49.7 (2× CH<sub>2</sub>), 25.9 (2× CH<sub>3</sub>), 18.4, 18.1, 10.9 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>31</sub>H<sub>40</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 522.2856; found, 522.2828.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-(4-(Diethylamino)butoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was synthesized from <b>17</b> (46.3 mg, 0.083 mmol) and diethylamine (2 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as an orange solid (42.2 mg, 92%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.03 (d, <i>J</i> = 4.6 Hz, 2H), 7.05–6.94 (m, 2H), 6.56–6.45 (m, 1H), 6.26 (d, <i>J</i> = 7.6 Hz, 1H), 5.49–5.30 (m, 2H), 4.66–4.54 (m, 2H), 4.49 (d, <i>J</i> = 7.3 Hz, 2H), 4.07 (d, <i>J</i> = 5.9 Hz, 2H), 2.66–2.52 (m, 6H), 1.85–1.67 (m, 10H), 1.65 (s, 3H), 1.56 (s, 3H), 1.07 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.1, 166.2, 162.7, 162.5, 158.0, 157.8, 140.3, 139.4, 138.3, 131.4 (2× CH), 124.0, 121.0, 120.3, 115.3 (2× CH), 106.6, 99.3, 93.7, 69.8, 69.0, 66.6, 58.3, 53.4, 47.7, 28.4, 26.0 (2× CH<sub>3</sub>), 23.8, 18.4, 18.2, 11.3 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>33</sub>H<sub>44</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 550.3169; found, 550.3141.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-((5-(Diethylamino)pentyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>24</b>)</h3><div class="NLM_p last">Compound <b>25</b> was synthesized from <b>18</b> (29.8 mg, 0.052 mmol) and diethylamine (0.5 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as an orange gel (27 mg, 91%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.00 (d, <i>J</i> = 6.7 Hz, 2H), 7.01–6.93 (m, 2H), 6.47 (d, <i>J</i> = 10.8 Hz, 1H), 6.24 (d, <i>J</i> = 7.4 Hz, 1H), 5.49–5.31 (m, 2H), 4.60–4.46 (m, 4H), 4.03 (d, <i>J</i> = 6.1 Hz, 2H), 2.66–2.57 (m, 4H), 2.56–2.51 (m, 2H), 1.88–1.71 (m, 8H), 1.65 (s, 3H), 1.58–1.52 (m, 5H), 1.28–1.25 (m, 2H), 1.09–1.03 (m, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 166.3, 162.8, 162.7, 158.1, 158.0, 140.4, 139.6, 138.4, 131.5 (2× CH), 124.0, 121.0, 120.3, 115.4 (2× CH), 106.7, 99.4, 93.8, 69.8, 69.1, 66.6, 53.7, 47.8 (2× CH<sub>2</sub>), 30.2, 26.9, 26.00, 25.9, 25.3, 18.4, 18.2, 11.2 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>34</sub>H<sub>46</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 564.3325; found, 564.3299.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-((6-(Diethylamino)hexyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>25</b>)</h3><div class="NLM_p last">Compound <b>25</b> was synthesized from <b>19</b> (55.9 mg, 0.095 mmol) and diethylamine (1 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow gel (22.6 mg, 41%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.98 (d, <i>J</i> = 8.7 Hz, 2H), 6.93 (d, <i>J</i> = 8.8 Hz, 2H), 6.44 (d, <i>J</i> = 15.7 Hz, 1H), 6.22 (d, <i>J</i> = 9.7 Hz, 1H), 5.47–5.28 (m, 2H), 4.61–4.52 (m, 2H), 4.47 (d, <i>J</i> = 6.5 Hz, 2H), 4.08–3.91 (m, 2H), 2.64–2.54 (m, 4H), 2.53–2.46 (m, 2H), 1.82–1.72 (m, 8H), 1.65 (s, 3H), 1.57 (s, 3H), 1.39–1.25 (m, 6H), 1.08–1.03 (m, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.3, 162.8, 162.7, 158.1 (2× C), 140.4, 139.6, 138.3, 131.5 (2× CH), 123.9, 121.0, 120.3, 115.4 (2× CH), 106.6, 99.4, 93.7, 69.8, 69.1, 66.6, 53.7, 47.7 (2× CH<sub>2</sub>), 30.3, 28.5, 27.1, 27.0, 26.0, 25.9, 18.4, 18.1, 11.1 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>35</sub>H<sub>48</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 578.3482; found, 578.3454.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-((8-(Diethylamino)octyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was synthesized from <b>20</b> (37.8 mg, 0.062 mmol) and diethylamine (2 mL) according to the similar procedure used to prepare <b>11</b>. The resulting residue was purified by purified by HPLC. The product was obtained as a yellow oil (35.5 mg, 95%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.04 (d, <i>J</i> = 9.0 Hz, 2H), 6.99 (d, <i>J</i> = 9.1 Hz, 2H), 6.51 (d, <i>J</i> = 2.2 Hz, 1H), 6.27 (d, <i>J</i> = 2.2 Hz, 1H), 5.51–5.43 (m, 1H), 5.39–5.30 (m, 1H), 4.60 (d, <i>J</i> = 6.6 Hz, 2H), 4.50 (d, <i>J</i> = 7.5 Hz, 2H), 4.04 (t, <i>J</i> = 6.4 Hz, 2H), 2.59 (q, <i>J</i> = 7.2 Hz, 4H), 2.51–2.44 (m, 2H), 1.84–1.71 (m, 8H), 1.65 (s, 3H), 1.57 (s, 3H), 1.54–1.45 (m, 4H), 1.43–1.32 (m, 6H), 1.06 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 166.4, 162.7, 161.8, 158.1, 157.9, 140.6, 139.8, 138.4, 131.6 (2× CH), 124.7, 120.8, 120.2, 115.4 (2× CH), 106.6, 99.5, 93.8, 69.8, 66.6 (2× CH<sub>2</sub>), 65.8, 62.9, 59.9, 25.9 (4× CH<sub>2</sub>), 25.2 (2× CH<sub>3</sub>), 23.5, 20.7, 18.3, 18.1, 14.0 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>37</sub>H<sub>52</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 606.3795; found, 606.3765.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-((10-(Diethylamino)decyl)oxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was synthesized from <b>21</b> (36 mg, 0.056 mmol) and diethylamine (2 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow solid (11.2 mg, 35%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.72 (s, 1H), 8.07 (s, 1H), 8.05 (s, 1H), 6.97 (d, <i>J</i> = 8.9 Hz, 2H), 6.43 (d, <i>J</i> = 2.2 Hz, 1H), 6.34 (d, <i>J</i> = 2.2 Hz, 1H), 5.47 (t, <i>J</i> = 6.5 Hz, 1H), 5.38 (t, <i>J</i> = 7.3 Hz, 1H), 4.55 (t, <i>J</i> = 7.4 Hz, 4H), 4.02 (t, <i>J</i> = 6.6 Hz, 2H), 2.58 (q, <i>J</i> = 7.1 Hz, 4H), 2.50–2.40 (m, 2H), 2.06–1.89 (m, 4H), 1.83–1.78 (m, 5H), 1.75 (s, 3H), 1.67 (s, 3H), 1.61 (s, 3H), 1.49–1.41 (m, 4H), 1.30–1.28 (m, 6H), 1.04 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 164.7, 162.1, 161.2, 156.8, 156.6, 139.5, 139.3, 137.5, 130.4 (2× CH), 123.1, 119.9, 118.7, 114.4 (2× CH), 106.0, 98.4, 92.8, 69.0, 68.3, 65.5, 46.8 (3× CH<sub>3</sub>), 29.8, 29.6 (3× CH<sub>2</sub>), 29.4, 29.2, 27.7, 26.1, 25.9, 25.8, 18.4, 18.1, 11.3 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>39</sub>H<sub>56</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 634.4108; found, 634.4116.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-(3-(Dimethylamino)propoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was synthesized from <b>10</b> (99.6 mg, 0.183 mmol) and dimethylamine (1 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow solid (79.6 mg, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.73 (s, 1H), 8.07 (d, <i>J</i> = 9.1 Hz, 2H), 6.99 (d, <i>J</i> = 9.3 Hz, 2H), 6.44 (d, <i>J</i> = 2.5 Hz, 1H), 6.35 (d, <i>J</i> = 2.5 Hz, 1H), 5.62–5.30 (m, 2H), 4.65–4.48 (m, 4H), 4.15–4.03 (m, 2H), 2.47 (t, 2H), 2.27 (s, 6H), 2.07–1.92 (m, 2H), 1.85–1.80 (m, 3H), 1.77–1.74 (m, 3H), 1.70–1.64 (m, 3H), 1.63–1.59 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 164.7, 162.0, 161.1, 156.8, 156.5, 139.5, 139.3, 137.5, 130.4 (2× CH), 123.2, 119.9, 118.7, 114.4 (2× CH), 106.0, 98.4, 92.8, 69.0, 66.5, 65.5, 56.3, 45.6 (2× CH<sub>3</sub>), 27.5, 25.9, 25.8, 18.4, 18.1. HRMS (ESI+): calcd for C<sub>30</sub>H<sub>38</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 508.2699; found, 508.2693.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-(3-(Dipropylamino)propoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>29</b>)</h3><div class="NLM_p last">Compound <b>29</b> was synthesized from <b>10</b> (45 mg, 0.083 mmol) and dipropylamine (2 mL) according to the similar procedure used to prepare <b>11</b>. The resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate/triethylamine, 3/1/0.075, v/v/v). The product was obtained as a yellow solid (29.9 mg, 65%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.08 (d, <i>J</i> = 9.1 Hz, 2H), 7.05 (d, <i>J</i> = 9.1 Hz, 2H), 6.56 (s, 1H), 6.30 (d, <i>J</i> = 2.1 Hz, 1H), 5.54–5.42 (m, 1H), 5.35–5.28 (m, 1H), 4.62 (d, <i>J</i> = 6.3 Hz, 2H), 4.52 (d, <i>J</i> = 7.5 Hz, 2H), 4.15 (t, <i>J</i> = 6.0 Hz, 2H), 2.97–2.86 (m, 2H), 2.76–2.65 (m, 4H), 2.11–2.02 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.65–1.56 (m, 10H), 0.96 (t, <i>J</i> = 7.4 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 164.7, 162.0, 161.0, 156.8, 156.5, 139.5, 139.3, 137.5, 130.4 (2× CH), 123.2, 119.9, 118.7, 114.4 (2× CH), 106.0, 98.4, 92.8, 69.0, 66.3, 65.5, 56.0 (2× CH<sub>2</sub>), 50.6, 26.6, 25.9, 25.8, 19.8 (2× CH<sub>2</sub>), 18.3, 18.1, 11.9 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>34</sub>H<sub>46</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 564.3325; found, 564.3298.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-(3-(Dibutylamino)propoxy)-5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4<i>H</i>-chromen-4-one (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was synthesized from <b>10</b> (48.1 mg, 0.089 mmol) and dibutylamine (2 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow solid (42.8 mg, 82%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.01 (d, <i>J</i> = 9.0 Hz, 2H), 6.96 (d, <i>J</i> = 9.0 Hz, 2H), 6.46 (d, <i>J</i> = 2.2 Hz, 1H), 6.23 (d, <i>J</i> = 2.2 Hz, 1H), 5.49–5.41 (m, 1H), 5.37–5.30 (m, 1H), 4.57 (d, <i>J</i> = 6.6 Hz, 2H), 4.48 (d, <i>J</i> = 7.4 Hz, 2H), 4.06 (t, <i>J</i> = 6.1 Hz, 2H), 2.70–2.62 (m, 2H), 2.52–2.44 (m, 4H), 2.02–1.91 (m, 2H), 1.80 (s, 3H), 1.76 (s, 3H), 1.65 (s, 3H), 1.57 (s, 3H), 1.50–1.43 (m, 4H), 1.36–1.29 (m, 4H), 0.93 (t, <i>J</i> = 7.3 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 166.3, 162.8, 162.6, 158.1 (2× C), 140.5, 139.6, 138.3, 131.5 (2× CH), 124.1, 120.9, 120.2, 115.4 (2× CH), 106.6, 99.4, 93.8, 69.8, 67.4, 66.6, 55.0 (2× CH<sub>2</sub>), 51.5, 29.8 (2× CH<sub>2</sub>), 27.3, 25.9 (2× CH<sub>3</sub>), 21.8 (2× CH<sub>2</sub>), 18.3, 18.1, 14.4 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>36</sub>H<sub>50</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 592.3638; found, 592.3609.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-3-(3-(pyrrolidin-1-yl)propoxy)-4<i>H</i>-chromen-4-one (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was synthesized from <b>10</b> (64.2 mg, 0.118 mmol) and tetrahydropyrrole (1.5 mL) according to the similar procedure used to prepare <b>11</b>. The resulting residue was purified by silica gel chromatography (ethyl acetate/ethanol, 3/1/, v/v). The product was obtained as a yellow solid (33 mg, 50%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.97 (d, <i>J</i> = 9.1 Hz, 2H), 6.93 (d, <i>J</i> = 9.1 Hz, 2H), 6.41 (d, <i>J</i> = 2.1 Hz, 1H), 6.19 (d, <i>J</i> = 2.1 Hz, 1H), 5.51–5.39 (m, 1H), 5.39–5.27 (m, 1H), 4.54 (d, <i>J</i> = 6.6 Hz, 2H), 4.46 (d, <i>J</i> = 7.4 Hz, 2H), 4.06 (t, <i>J</i> = 6.1 Hz, 2H), 2.80–2.74 (m, 2H), 2.73–2.67 (m, 4H), 2.10–1.98 (m, 2H), 1.95–1.83 (m, 4H), 1.79 (s, 3H), 1.75 (s, 3H), 1.65 (s, 3H), 1.56 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.4, 166.5, 162.9, 162.6, 158.3, 158.2, 140.7, 139.8, 138.5, 131.7 (2× CH), 124.4, 121.0, 120.4, 115.5 (2× CH), 106.8, 99.6, 93.9, 69.9, 67.3, 66.8, 55.3 (2× CH<sub>2</sub>), 54.3, 29.1, 26.1, 26.0, 24.3 (2× CH<sub>2</sub>), 18.5, 18.2. HRMS (ESI+): calcd for C<sub>32</sub>H<sub>40</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 534.2856; found, 534.2851.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-3-(3-(4-methylpiperazin-1-yl)propoxy)-4<i>H</i>-chromen-4-one (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was synthesized from <b>10</b> (50 mg, 0.092 mmol) and 1-methylpiperazine (2 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a yellow solid (44.9 mg, 86%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.97 (d, <i>J</i> = 8.4 Hz, 2H), 6.93 (d, <i>J</i> = 8.4 Hz, 2H), 6.40 (s, 1H), 6.19 (s, 1H), 5.43 (t, <i>J</i> = 6.0 Hz, 1H), 5.33 (t, <i>J</i> = 7.2 Hz, 1H), 4.54 (d, <i>J</i> = 6.5 Hz, 2H), 4.46 (d, <i>J</i> = 7.3 Hz, 2H), 4.06 (t, <i>J</i> = 6.0 Hz, 2H), 2.97–2.52 (m, 10H), 2.49 (s, 3H), 2.07–1.96 (m, 2H), 1.79 (s, 3H), 1.75 (s, 3H), 1.65 (s, 3H), 1.57 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.2, 162.6, 162.4, 158.0, 157.8, 140.3, 139.5, 138.3, 131.4 (2× CH), 124.1, 121.0, 120.2, 115.3 (2× CH), 106.6, 99.4, 93.7, 69.8, 67.1, 66.6, 55.7, 55.2 (2× CH<sub>2</sub>), 52.8 (2× CH<sub>2</sub>), 45.2, 27.3, 26.0, 25.9, 18.4, 18.2. HRMS (ESI+): calcd for C<sub>33</sub>H<sub>43</sub>N<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 563.3121; found, 563.3114.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-3-(3-thiomorpholinopropoxy)-4<i>H</i>-chromen-4-one (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was synthesized from <b>10</b> (50 mg, 0.092 mmol) and thiomorphol (2 mL) according to the similar procedure used to prepare <b>11</b>. The resulting residue was purified by purified by HPLC. The product was obtained as a yellow gel (37.8 mg, 75%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.02 (d, <i>J</i> = 30.9 Hz, 2H), 7.09–6.95 (m, 2H), 6.59–6.46 (m, 1H), 6.28 (d, <i>J</i> = 2.8 Hz, 1H), 5.51–5.43 (m, 1H), 5.33 (t, <i>J</i> = 7.1 Hz, 1H), 4.60 (s, 2H), 4.51 (d, <i>J</i> = 7.1 Hz, 2H), 4.14 (s, 2H), 3.16–3.05 (m, 4H), 3.00–2.89 (m, 2H), 2.86–2.80 (m, 4H), 2.13 (br, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.65 (s, 3H), 1.57 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.4, 166.4, 162.8, 162.3, 158.2 (2× C), 140.7, 139.8, 138.3, 131.6 (2× CH), 124.4, 120.8, 120.2, 115.4 (2× CH), 106.6, 99.4, 93.8, 69.8, 66.9, 66.6, 56.7, 55.9 (2× CH<sub>2</sub>), 27.3 (2× CH<sub>2</sub>), 26.2, 25.9 (2× CH<sub>3</sub>), 18.3, 18.0. HRMS (ESI+): calcd for C<sub>32</sub>H<sub>40</sub>NO<sub>6</sub>S [M + H]<sup>+</sup>, 566.2576; found, 566.2568.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-3-(3-morpholinopropoxy)-4<i>H</i>-chromen-4-one (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was synthesized from <b>10</b> (46.4 mg, 0.085 mmol) and morpholine (2 mL) according to the similar procedure used to prepare <b>11</b>. The resulting residue was purified by silica gel chromatography (ethyl acetate/ethanol, 1/1/, v/v). The product was obtained as an orange solid (31.1 mg, 70%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.05 (d, <i>J</i> = 9.1 Hz, 2H), 7.01 (d, <i>J</i> = 9.1 Hz, 2H), 6.53 (d, <i>J</i> = 2.2 Hz, 1H), 6.28 (d, <i>J</i> = 2.2 Hz, 1H), 5.52–5.42 (m, 1H), 5.39–5.28 (m, 1H), 4.60 (d, <i>J</i> = 6.6 Hz, 2H), 4.51 (d, <i>J</i> = 7.5 Hz, 2H), 4.12 (t, <i>J</i> = 6.2 Hz, 2H), 3.75–3.68 (m, 4H), 2.61–2.45 (m, 6H), 2.08–1.97 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.65 (s, 3H), 1.57 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.2, 162.7, 162.5, 158.0, 157.9, 140.3, 139.5, 138.3, 131.4 (2× CH), 124.1, 121.0, 120.3, 115.3 (2× CH), 106.6, 99.4, 93.7, 69.8, 67.7 (2× CH<sub>2</sub>), 67.3, 66.6, 56.7, 54.8 (2× CH<sub>2</sub>), 27.2, 26.0, 25.9, 18.4, 18.2. HRMS (ESI+): calcd for C<sub>32</sub>H<sub>40</sub>NO<sub>7</sub> [M + H]<sup>+</sup>, 550.2805; found, 550.2796.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-3-(3-(propylamino)propoxy)-4<i>H</i>-chromen-4-one (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was synthesized from <b>10</b> (42.1 mg, 0.077 mmol) and <i>n</i>-propylamine (2 mL) according to the similar procedure used to prepare <b>11</b>. The resulting residue was purified by silica gel chromatography (ethyl acetate/ethanol/triethylamine, 1/1/0.05, v/v/v). The product was obtained as a yellow solid (31 mg, 75%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.03 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (d, <i>J</i> = 8.9 Hz, 2H), 6.50 (d, <i>J</i> = 1.8 Hz, 1H), 6.25 (d, <i>J</i> = 2.1 Hz, 1H), 5.44 (t, <i>J</i> = 6.2 Hz, 1H), 5.30 (t, <i>J</i> = 7.5 Hz, 1H), 4.57 (d, <i>J</i> = 6.2 Hz, 2H), 4.48 (d, <i>J</i> = 7.5 Hz, 2H), 4.10 (t, <i>J</i> = 5.7 Hz, 2H), 2.79 (t, <i>J</i> = 7.3 Hz, 2H), 2.61–2.53 (m, 2H), 2.06–1.95 (m, 2H), 1.78 (s, 3H), 1.75 (s, 3H), 1.62 (s, 3H), 1.57–1.50 (m, 5H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.2, 162.7, 162.4, 158.0, 157.8, 140.3, 139.5, 138.3, 131.4 (2× CH), 124.1, 121.0, 120.3, 115.3 (2× CH), 106.6, 99.3, 93.7, 69.8, 67.6, 66.6, 52.6, 47.6, 29.9, 26.0, 25.9, 23.4, 18.4, 18.1, 12.1. HRMS (ESI+): calcd for C<sub>31</sub>H<sub>40</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 522.2856; found, 522.2849.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-3-(3-(pentylamino)propoxy)-4<i>H</i>-chromen-4-one (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was synthesized from <b>10</b> (49.8 mg, 0.092 mmol) and <i>n</i>-pentylamine (2 mL) according to the procedure used to prepare <b>11</b>. The product was obtained as a brownish yellow solid (35.4 mg, 71%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.07 (d, <i>J</i> = 8.9 Hz, 2H), 7.03 (d, <i>J</i> = 8.8 Hz, 2H), 6.59–6.44 (m, 1H), 6.29 (d, <i>J</i> = 2.0 Hz, 1H), 5.51–5.43 (m, 1H), 5.37–5.30 (m, 1H), 4.61 (d, <i>J</i> = 6.3 Hz, 2H), 4.51 (d, <i>J</i> = 7.3 Hz, 2H), 4.18–4.02 (m, 2H), 2.82 (t, <i>J</i> = 7.1 Hz, 2H), 2.67–2.58 (m, 2H), 2.10–1.96 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.65 (s, 3H), 1.58–1.52 (m, 5H), 1.38–1.32 (m, 4H), 0.93 (t, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.3, 162.7, 162.4, 158.0, 157.9, 140.4, 139.5, 138.4, 131.5 (2× CH), 124.1, 121.0, 120.3, 115.3 (2× CH), 106.6, 99.4, 93.7, 69.8, 67.6, 66.6, 50.7, 47.7, 30.7, 30.0, 29.9, 26.0 (2× CH<sub>3</sub>), 23.7, 18.4, 18.2, 14.4. HRMS (ESI+): calcd for C<sub>33</sub>H<sub>44</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 550.3169; found, 550.3161.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-3-(3-(octylamino)propoxy)-4<i>H</i>-chromen-4-one (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was synthesized from <b>10</b> (46.1 mg, 0.085 mmol) and <i>n</i>-octylamine (2 mL) according to the similar procedure used to prepare <b>11</b>. The resulting residue was purified by silica gel chromatography (ethyl acetate/ethanol/triethylamine, 1/1/0.05, v/v/v). The product was obtained as an orange oil (36 mg, 72%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.01 (d, <i>J</i> = 4.1 Hz, 2H), 6.97 (d, <i>J</i> = 3.6 Hz, 2H), 6.47 (d, <i>J</i> = 16.8 Hz, 1H), 6.24 (d, <i>J</i> = 11.2 Hz, 1H), 5.51–5.28 (m, 2H), 4.62–4.45 (m, 4H), 4.15–4.03 (m, 2H), 2.85–2.74 (m, 2H), 2.66–2.56 (m, 2H), 2.02 (s, 2H), 1.80 (s, 3H), 1.76 (s, 3H), 1.65 (s, 3H), 1.57 (s, 3H), 1.34–1.27 (m, 12H), 0.89 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.3, 162.8, 162.5, 158.1, 157.9, 140.4, 139.6, 138.4, 131.5 (2× CH), 124.2, 121.0, 120.3, 115.4 (2× CH), 106.6, 99.4, 93.8, 69.8, 67.7, 66.6, 60.2, 50.8, 33.0, 30.7, 30.4 (2× CH<sub>2</sub>), 30.0, 28.5, 26.0 (2× CH<sub>3</sub>), 23.8, 18.4, 18.2, 14.5. HRMS (ESI+): calcd for C<sub>36</sub>H<sub>50</sub>NO<sub>6</sub> [M + H]<sup>+</sup>, 592.3638; found, 592.3611.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-((5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)-<i>N</i>,<i>N</i>,<i>N</i>-trimethylpropan-1-aminium Iodide (<b>38</b>)</h3><div class="NLM_p last">To a solution of <b>28</b> (39.8 mg, 0.078 mmol) in methanol (8 mL), iodomethane (1.5 mL) was added. The reaction mixture was stirred overnight at RT. After completion of the reaction, the mixture was diluted with <i>n</i>-butanol and washed twice with water. The organic phase was concentrated under reduced pressure. The resulting residue was purified by HPLC to yield compound <b>38</b> as a yellow gel (49.2 mg, 71%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.09 (d, <i>J</i> = 8.8 Hz, 2H), 7.08 (d, <i>J</i> = 8.8 Hz, 2H), 6.56 (d, <i>J</i> = 1.9 Hz, 1H), 6.31 (d, <i>J</i> = 2.0 Hz, 1H), 5.51–5.44 (m, 1H), 5.36–5.28 (m, 1H), 4.62 (d, <i>J</i> = 6.5 Hz, 2H), 4.53 (d, <i>J</i> = 7.5 Hz, 2H), 4.22 (t, <i>J</i> = 5.6 Hz, 2H), 3.69–3.55 (m, 2H), 3.22 (s, 9H), 2.42–2.29 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.64 (s, 3H), 1.57 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 166.4, 162.8, 161.9, 158.2, 158.0, 140.6, 139.8, 138.4, 131.6 (2× CH), 124.8, 120.8, 120.2, 115.4 (2× CH), 106.6, 99.5, 93.8, 69.8 (2× CH<sub>2</sub>), 66.6 (2× CH<sub>2</sub>), 53.8, 53.7 (2× CH<sub>3</sub>), 25.9 (2× CH<sub>3</sub>), 24.3, 18.3, 18.0. HRMS (ESI+): calcd for C<sub>31</sub>H<sub>40</sub>INO<sub>6</sub> [M – I]<sup>+</sup>, 522.2850; found, 522.2846.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>,<i>N</i>-Diethyl-3-((5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)-<i>N</i>-methylpropan-1-aminium (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> was synthesized from <b>15</b> (42.7 mg, 0.079 mmol) and iodomethane(1.5 mL) according to the procedure used to prepare <b>38</b>. The product was obtained as a brownish yellow gel (42.3 mg, 76%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.07 (d, <i>J</i> = 8.8 Hz, 2H), 7.06 (d, <i>J</i> = 8.8 Hz, 2H), 6.53 (d, <i>J</i> = 1.8 Hz, 1H), 6.28 (d, <i>J</i> = 1.7 Hz, 1H), 5.52–5.42 (m, 1H), 5.37–5.29 (m, 1H), 4.61 (d, <i>J</i> = 6.5 Hz, 2H), 4.52 (d, <i>J</i> = 7.5 Hz, 2H), 4.21 (t, <i>J</i> = 5.4 Hz, 2H), 3.59–3.42 (m, 6H), 3.08 (s, 3H), 2.35–2.22 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.65 (s, 3H), 1.57 (s, 3H), 1.40 (t, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 166.4, 162.7, 161.9, 158.1, 157.8, 140.6, 139.7, 138.4, 131.6 (2× CH), 124.7, 120.9, 120.2, 115.5 (2× CH), 106.7, 99.5, 93.8, 69.8 (2× CH<sub>2</sub>), 66.7, 65.9, 59.0, 57.9 (2× CH<sub>2</sub>), 26.0, 25.9, 23.5, 18.4, 18.1, 8.2 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>33</sub>H<sub>44</sub>INO<sub>6</sub> [M – I]<sup>+</sup>, 550.3163; found, 550.3156.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-Butyl-<i>N</i>-(3-((5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)propyl)-<i>N</i>-methylbutan-1-aminium (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> was synthesized from <b>30</b> (45.3 mg, 0.079 mmol) and iodomethane(1.5 mL) according to the procedure used to prepare <b>38</b>. The product was obtained as a brown gel (34 mg, 74%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.08 (d, <i>J</i> = 8.4 Hz, 2H), 7.05 (d, <i>J</i> = 8.3 Hz, 2H), 6.60–6.48 (m, 1H), 6.38–6.22 (m, 1H), 5.47 (t, <i>J</i> = 6.5 Hz, 1H), 5.32 (t, <i>J</i> = 7.4 Hz, 1H), 4.61 (d, <i>J</i> = 6.1 Hz, 2H), 4.52 (d, <i>J</i> = 7.4 Hz, 2H), 4.25–4.15 (m, 2H), 3.62–3.48 (m, 2H), 3.38–3.33 (m, 4H), 3.11 (s, 3H), 2.34–2.20 (m, 2H), 1.82–1.72 (m, 10H), 1.65 (s, 3H), 1.57 (s, 3H), 1.47–1.40 (m, 4H), 1.07–1.01 (m, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.2, 166.2, 162.7, 162.7, 158.0, 157.9, 140.3, 139.5, 138.3, 131.4 (2× CH), 123.9, 121.0, 120.3, 115.3 (2× CH), 106.6, 99.3, 93.7, 69.8, 69.2, 66.6, 53.7 (3× CH<sub>2</sub>), 47.7, 30.7, 30.5, 30.3, 28.8, 27.1, 27.0, 26.0, 18.4, 18.2, 11.2 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>37</sub>H<sub>52</sub>INO<sub>6</sub> [M – I]<sup>+</sup>, 606.3789; found, 606.3785.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Ethyl 2-((5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)acetate (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> was synthesized from <b>5</b> (200 mg, 0.473 mmol), ethyl bromoacetate (105 μL, 0.947 mmol), and potassium carbonate (130.8 mg, 0.947 mmol) according to the similar procedure used to prepare <b>6</b>. The reaction mixture was refluxed for 4 h. Then, the resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 4:1, v/v). The product was obtained as a yellow solid (165 mg, 69%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.68 (s, 1H), 8.09 (d, <i>J</i> = 9.3 Hz, 2H), 7.00 (d, <i>J</i> = 9.3 Hz, 2H), 6.43 (d, <i>J</i> = 2.5 Hz, 1H), 6.35 (d, <i>J</i> = 2.4 Hz, 1H), 5.84–5.23 (m, 2H), 4.86–4.42 (m, 6H), 4.36–4.16 (m, 2H), 1.91–1.45 (m, 12H), 1.31 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 179.1, 168.5, 164.8, 162.0, 159.6, 156.8, 156.1, 139.6, 139.3, 137.7, 130.5 (2× CH), 124.4, 119.8, 118.7, 114.5 (2× CH), 106.0, 98.4, 92.8, 69.0, 65.5, 65.3, 61.7, 25.9, 25.8, 18.4, 18.1, 14.3. HRMS (ESI+): calcd for C<sub>29</sub>H<sub>33</sub>O<sub>8</sub> [M + H]<sup>+</sup>, 509.2175; found, 509.2158.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Dimethyl 2,2′-((7-((3-Methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromene-3,5-diyl)bis(oxy))diacetate (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> was synthesized from <b>5</b> (224 mg, 0.53 mmol), ethyl bromoacetate (235.2 μL, 2.12 mmol), and potassium carbonate (293 mg, 2.12 mmol) according to the similar procedure used to prepare <b>6</b>. The reaction mixture was refluxed for 12 h. Then, the resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 2:1, v/v). The product was obtained as a yellow gel (228.8 mg, 72%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.11–8.05 (m, 2H), 7.01–6.99 (m, 1H), 6.99–6.97 (m, 1H), 6.56 (d, <i>J</i> = 2.2 Hz, 1H), 6.28 (d, <i>J</i> = 2.2 Hz, 1H), 5.53–5.39 (m, 2H), 4.78 (s, 2H), 4.69 (s, 2H), 4.60–4.53 (m, 4H), 4.33–4.23 (m, 4H), 1.82 (s, 3H), 1.76 (s, 3H), 1.68 (s, 3H), 1.63 (s, 3H), 1.31 (t, <i>J</i> = 5.2 Hz, 3H), 1.28 (t, <i>J</i> = 5.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 174.0, 168.6, 168.4, 162.8, 159.2, 159.1, 158.8, 153.0, 140.1, 139.7, 139.1, 130.2 (2× CH), 124.7, 120.3, 118.5, 114.4 (2× CH), 110.0, 100.0, 94.7, 68.7, 66.8, 65.5, 65.4, 61.6, 61.5, 25.9, 25.8, 18.3, 18.2, 14.3, 14.2. HRMS (ESI+): calcd for C<sub>33</sub>H<sub>39</sub>O<sub>10</sub> [M + H]<sup>+</sup>, 595.2543; found, 595.2520.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Methyl (2-((5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)acetyl)-<span class="smallcaps smallerCapital">l</span>-argininate (<b>45</b>)</h3><div class="NLM_p last">To a solution of <b>41</b> (60.4 mg, 0.126 mmol) in tetrahydrofuran (THF) (10 mL), an aqueous solution (5 mL) of LiOH (15.1 mg, 0.63 mmol) was added. After stirring for 1.5 h at RT, the reaction mixture was acidified with acetic acid, diluted with <i>n</i>-butanol, and washed twice with water. The organic phase was concentrated under reduced pressure to give crude product <b>43</b> that was used for the next step reaction without further purification. Subsequently, <b>43</b> was dissolved in anhydrous DMF (5 mL), and HATU (95.6 mg, 0.251 mmol), H-Arg-OMe·2HCl (65.6 mg, 0.251 mmol), and DIPEA (83.1 μL, 0.503 mmol) were added. The mixture was stirred at RT for 24 h. After completion of the reaction, the mixture was diluted with n-butanol and washed twice with water. The organic phase was concentrated under reduced pressure. The resulting residue was purified by HPLC to yield compound <b>45</b> as a brown foam (81.8 mg, 74%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.09 (d, <i>J</i> = 6.1 Hz, 2H), 7.12 (d, <i>J</i> = 7.1 Hz, 2H), 6.53 (s, 1H), 6.28 (s, 1H), 5.52–5.42 (m, 1H), 5.33 (t, <i>J</i> = 7.4 Hz, 1H), 4.69 (s, 2H), 4.64–4.56 (m, 3H), 4.53 (d, <i>J</i> = 7.3 Hz, 2H), 3.75 (s, 3H), 3.28–3.15 (m, 2H), 2.06–1.74 (m, 8H), 1.70–1.61 (m, 5H), 1.57 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 173.3, 170.8, 166.4, 162.7, 161.1, 158.7, 158.1, 157.7, 140.7, 139.7, 138.5, 131.5 (2× CH), 125.3, 120.8, 120.2, 115.8 (2× CH), 106.6, 99.4, 93.8, 69.8, 68.0, 66.6, 53.0, 52.9, 41.8, 29.5, 26.3, 25.9 (2× CH<sub>3</sub>), 18.3, 18.1. HRMS (ESI+): calcd for C<sub>34</sub>H<sub>43</sub>N<sub>4</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 651.3030; found, 651.3002.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl (2-((5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)acetyl)-<span class="smallcaps smallerCapital">l</span>-histidinate (<b>46</b>)</h3><div class="NLM_p last">Compound <b>46</b> was synthesized from <b>41</b> (60.4 mg, 0.126 mmol), HATU (95.6 mg, 0.251 mmol), H-His-OMe·2HCl (60.8 mg, 0.251 mmol), and DIPEA (83.1 μL, 0.503 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow foam (59 mg, 86%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.32 (s, 1H), 8.05 (d, <i>J</i> = 7.8 Hz, 2H), 7.16 (d, <i>J</i> = 9.6 Hz, 1H), 7.05 (d, <i>J</i> = 7.6 Hz, 2H), 6.52 (d, <i>J</i> = 20.4 Hz, 1H), 6.27 (d, <i>J</i> = 19.1 Hz, 1H), 5.46 (t, <i>J</i> = 5.7 Hz, 1H), 5.32 (t, <i>J</i> = 7.3 Hz, 1H), 4.87–4.84 (m, 1H), 4.67–4.55 (m, 4H), 4.51 (d, <i>J</i> = 7.3 Hz, 2H), 3.75 (s, 3H), 3.36–3.31 (m, 1H), 3.24–3.13 (m, 1H), 1.80 (s, 3H), 1.77 (s, 3H), 1.64 (s, 3H), 1.56 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 172.2, 170.7, 166.4, 162.7, 161.0, 158.1, 157.7, 140.7 (2× C), 139.7 (2× CH), 138.5, 131.5 (2× CH), 125.4, 120.8 (2× CH), 120.2, 115.8 (2× CH), 106.6, 99.4, 93.8, 69.8, 68.0, 66.6, 53.2, 52.8, 28.3, 25.9 (2× CH<sub>3</sub>), 18.3, 18.1. HRMS (ESI+): calcd for C<sub>34</sub>H<sub>38</sub>N<sub>3</sub>O<sub>9</sub> [M + H]<sup>+</sup>, 632.2608; found, 632.2575.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-(3-(Dimethylamino)propyl)-2-((5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)acetamide (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> was synthesized from <b>41</b> (60 mg, 0.125 mmol), HATU (94.9 mg, 0.25 mmol), <i>N</i>,<i>N</i>-dimethylpropane-1,3-diamine (31.6 μL, 0.25 mmol), and DIPEA (82.6 μL, 0.50 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow solid (61.4 mg, 97%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.10 (d, <i>J</i> = 7.6 Hz, 2H), 7.12 (d, <i>J</i> = 7.7 Hz, 2H), 6.53 (s, 1H), 6.31–6.26 (m, 1H), 5.47 (t, <i>J</i> = 6.5 Hz, 1H), 5.37–5.27 (m, 1H), 4.64 (s, 2H), 4.61 (d, <i>J</i> = 6.5 Hz, 2H), 4.53 (d, <i>J</i> = 7.4 Hz, 2H), 3.40 (t, <i>J</i> = 6.5 Hz, 2H), 3.08–3.00 (m, 2H), 2.79 (s, 6H), 2.00–1.91 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.65 (s, 3H), 1.57 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 171.2, 166.4, 162.8, 161.0, 158.2, 157.7, 140.7, 139.7, 138.6, 131.6 (2× CH), 125.4, 120.9, 120.2, 115.7 (2× CH), 106.7, 99.4, 93.8, 69.8, 68.1, 66.7, 56.8, 43.8 (2× CH<sub>3</sub>), 37.1, 26.3, 25.9 (2× CH<sub>3</sub>), 18.3, 18.1. HRMS (ESI+): calcd for C<sub>32</sub>H<sub>41</sub>N<sub>2</sub>O<sub>7</sub> [M + H]<sup>+</sup>, 565.2914; found, 565.2916.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>-(3-(Diethylamino)propyl)-2-((5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)acetamide (<b>48</b>)</h3><div class="NLM_p last">Compound <b>48</b> was synthesized from <b>41</b> (60 mg, 0.125 mmol), HATU (197.7 mg, 0.25 mmol), <i>N</i>,<i>N</i>-diethylpropane-1,3-diamine (39.3 μL, 0.25 mmol), and DIPEA (82.6 μL, 0.50 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow solid (67.1 mg, 91%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.08 (d, <i>J</i> = 9.0 Hz, 2H), 7.11 (d, <i>J</i> = 8.8 Hz, 2H), 6.54–6.49 (m, 1H), 6.29–6.25 (m, 1H), 5.49–5.41 (m, 1H), 5.35–5.26 (m, 1H), 4.62 (s, 2H), 4.59 (d, <i>J</i> = 6.5 Hz, 2H), 4.52 (d, <i>J</i> = 7.4 Hz, 2H), 3.38 (t, <i>J</i> = 6.4 Hz, 2H), 3.10 (q, <i>J</i> = 7.3 Hz, 4H), 3.06–3.00 (m, 2H), 1.96–1.87 (m, 2H), 1.78 (s, 3H), 1.75 (s, 3H), 1.62 (s, 3H), 1.55 (s, 3H), 1.24 (t, <i>J</i> = 7.3 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 171.2, 166.4, 162.8, 161.0, 158.2, 157.7, 140.7, 139.7, 138.5, 131.6 (2× CH), 125.4, 120.8, 120.2, 115.7 (2× CH), 106.6, 99.4, 93.8, 69.8, 68.1, 66.6, 50.8, 48.2 (2× CH<sub>2</sub>), 37.4, 25.9 (2× CH<sub>3</sub>), 25.5, 18.3, 18.1, 9.3 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>34</sub>H<sub>45</sub>N<sub>2</sub>O<sub>7</sub> [M + H]<sup>+</sup>, 593.3227; found, 593.3233.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Methyl (2-((5-Hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)acetyl)-<span class="smallcaps smallerCapital">l</span>-arginyl-<span class="smallcaps smallerCapital">l</span>-argininate (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> was synthesized from <b>45</b> (68.9 mg, 0.108 mmol), HATU (82.3 mg, 0.216 mmol), H-Arg-OMe·2HCl (50.4 mg, 0.216 mmol), and DIPEA (71.6 μL, 0.433 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow gel (34.5 mg, 40%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.11 (d, <i>J</i> = 8.5 Hz, 2H), 7.13 (d, <i>J</i> = 8.4 Hz, 2H), 6.56 (s, 1H), 6.31 (d, <i>J</i> = 1.6 Hz, 1H), 5.48 (t, <i>J</i> = 6.6 Hz, 1H), 5.33 (t, <i>J</i> = 7.5 Hz, 1H), 4.70 (s, 2H), 4.62 (d, <i>J</i> = 6.4 Hz, 2H), 4.58–4.43 (m, 4H), 3.75–3.72 (m, 3H), 3.25–3.13 (m, 4H), 2.01–1.86 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.77–1.60 (m, 9H), 1.58 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.4, 173.9, 173.5, 170.6, 166.5, 162.8, 161.1, 158.8, 158.7, 158.2, 157.9, 140.8, 139.8, 138.5, 131.6 (2× CH), 125.4, 120.8, 120.1, 115.8, 106.7, 101.3, 99.5, 93.9, 69.8, 67.9, 66.6, 54.1, 53.3, 52.9, 41.9, 41.8, 30.3, 29.5, 26.2, 26.1, 25.9 (2× CH<sub>3</sub>), 18.3, 18.1. HRMS (ESI+): calcd for C<sub>40</sub>H<sub>55</sub>N<sub>8</sub>O<sub>10</sub> [M + H]<sup>+</sup>, 807.4041; found, 807.4003.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>S</i>)-<i>N</i>-(3-(Dimethylamino)propyl)-5-guanidino-2-(2-((5-hydroxy-7-((3-methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromen-3-yl)oxy)acetamido)pentanamide (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> was synthesized from <b>45</b> (58.7 mg, 0.092 mmol), HATU (87.6 mg, 0.23 mmol), <i>N</i>,<i>N</i>-dimethyl-1,3-propanediamine (69.6 μL, 0.553 mmol), and DIPEA (76 μL, 0.46 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow solid (35.1 mg, 53%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.11 (d, <i>J</i> = 8.8 Hz, 2H), 7.15 (d, <i>J</i> = 8.9 Hz, 2H), 6.57 (d, <i>J</i> = 2.0 Hz, 1H), 6.31 (d, <i>J</i> = 2.1 Hz, 1H), 5.48 (t, <i>J</i> = 6.6 Hz, 1H), 5.33 (t, <i>J</i> = 7.5 Hz, 1H), 4.72 (s, 2H), 4.62 (d, <i>J</i> = 6.5 Hz, 2H), 4.55 (d, <i>J</i> = 7.5 Hz, 2H), 4.40–4.31 (m, 1H), 3.31–3.17 (m, 4H), 3.08 (t, <i>J</i> = 7.7 Hz, 2H), 2.81 (s, 6H), 1.99–1.82 (m, 4H), 1.81 (s, 3H), 1.78 (s, 3H), 1.72–1.62 (m, 5H), 1.58 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 180.3, 174.5, 170.9, 166.5, 162.8, 161.1, 158.7, 158.2, 157.8, 140.8, 139.8, 138.5, 131.6 (2× CH), 125.4, 120.8, 120.1, 115.8 (2× CH), 106.6, 99.4, 93.9, 69.8, 67.9, 66.6, 56.4, 54.6, 43.4 (2× CH<sub>3</sub>), 41.9, 37.0, 30.0, 26.4, 25.9 (2× CH<sub>3</sub>), 25.8, 18.3, 18.0. HRMS (ESI+): calcd for C<sub>38</sub>H<sub>53</sub>N<sub>6</sub>O<sub>8</sub> [M + H]<sup>+</sup>, 721.3925; found, 721.3906.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Dimethyl 2,2′-((2,2′-((7-((3-Methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromene-3,5-diyl)bis(oxy))bis(acetyl))bis(azanediyl)) (2<i>S</i>,2′<i>S</i>)-bis(5-guanidinopentanoate) (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> was synthesized from <b>42</b> (189 mg, 0.351 mmol), HATU (533.8 mg, 1.40 mmol), H-Arg-OMe·2HCl (366.6 mg, 1.40 mmol), and DIPEA (464 μL, 2.81 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow gel (146 mg, 47%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.12 (d, <i>J</i> = 8.5 Hz, 2H), 7.15 (d, <i>J</i> = 8.7 Hz, 2H), 6.76 (s, 1H), 6.48 (s, 1H), 5.49 (t, <i>J</i> = 6.4 Hz, 1H), 5.37–5.30 (m, 1H), 4.73–4.63 (m, 6H), 4.60–4.44 (m, 4H), 3.75 (s, 3H), 3.75 (s, 3H), 3.30–3.18 (m, 4H), 2.11–1.76 (m, 12H), 1.69–1.63 (m, 5H), 1.56 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 176.1, 173.5, 173.4, 170.9, 170.8, 169.3, 165.4, 161.1, 159.8, 159.1, 158.7, 155.9, 140.6, 140.4, 140.1, 131.4 (2× CH), 125.3, 120.8, 120.0, 115.9 (2× CH), 109.6, 99.4, 96.0, 69.8, 69.1, 68.0, 66.9, 53.3, 53.1, 53.0 (2× CH<sub>3</sub>), 42.0, 41.8, 29.6, 29.5, 26.3, 26.2, 26.0, 25.9, 18.4, 18.2. HRMS (ESI+): calcd for C<sub>43</sub>H<sub>59</sub>N<sub>8</sub>O<sub>12</sub> [M + H]<sup>+</sup>, 879.4252; found, 879.4223.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2,2′-((7-((3-Methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromene-3,5-diyl)bis(oxy))bis(<i>N</i>-(3-(dimethylamino)propyl)acetamide) (<b>53</b>)</h3><div class="NLM_p last">Compound <b>53</b> was synthesized from <b>42</b> (70 mg, 0.130 mmol), HATU (197.7 mg, 0.52 mmol), <i>N</i>,<i>N</i>-dimethylpropane-1,3-diamine (65.4 μL, 0.52 mmol), and DIPEA (171.8 μL, 1.04 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow gel (69.6 mg, 76%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.10 (d, <i>J</i> = 8.3 Hz, 2H), 7.11 (d, <i>J</i> = 8.3 Hz, 2H), 6.72 (s, 1H), 6.45 (s, 1H), 5.53–5.40 (m, 1H), 5.32 (t, <i>J</i> = 7.2 Hz, 1H), 4.64 (d, <i>J</i> = 5.4 Hz, 2H), 4.59 (s, 4H), 4.50 (d, <i>J</i> = 7.3 Hz, 2H), 3.41 (t, <i>J</i> = 6.7 Hz, 2H), 3.34–3.30 (m, 2H), 2.63–2.54 (m, 2H), 2.40 (t, <i>J</i> = 7.5 Hz, 2H), 2.34 (s, 6H), 2.26 (s, 6H), 1.92–1.83 (m, 2H), 1.79 (s, 3H), 1.77 (s, 3H), 1.75–1.69 (m, 2H), 1.63 (s, 3H), 1.55 (s, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 176.2, 171.3, 169.8, 165.4, 160.9, 159.8, 159.2, 156.0, 140.5, 140.4, 140.0, 131.5 (2× CH), 125.4, 121.0, 120.0, 115.8 (2× CH), 109.7, 99.5, 95.9, 69.7, 69.3, 68.1, 66.9, 56.7, 56.6, 43.6 (2× CH<sub>3</sub>), 43.5 (2× CH<sub>3</sub>), 37.0 (2× CH<sub>2</sub>), 26.1, 26.0, 25.9 (2× CH<sub>3</sub>), 18.3, 18.2. HRMS (ESI+): calcd for C<sub>39</sub>H<sub>55</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup>, 707.4020; found, 707.3997.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2,2′-((7-((3-Methylbut-2-en-1-yl)oxy)-2-(4-((3-methylbut-2-en-1-yl)oxy)phenyl)-4-oxo-4<i>H</i>-chromene-3,5-diyl)bis(oxy))bis(<i>N</i>-(3-(diethylamino)propyl)acetamide) (<b>54</b>)</h3><div class="NLM_p last">Compound <b>54</b> was synthesized from <b>42</b> (70 mg, 0.130 mmol), HATU (197.7 mg, 0.52 mmol), <i>N</i>,<i>N</i>-diethylpropane-1,3-diamine (82.0 μL, 0.52 mmol), and DIPEA (171.8 μL, 1.04 mmol) according to the procedure used to prepare <b>45</b>. The product was obtained as a yellow gel (74.7 mg, 75%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.12 (d, <i>J</i> = 8.3 Hz, 2H), 7.14 (d, <i>J</i> = 8.3 Hz, 2H), 6.72 (s, 1H), 6.44 (s, 1H), 5.51–5.43 (m, 1H), 5.35 (t, <i>J</i> = 7.6 Hz, 1H), 4.68–4.59 (m, 6H), 4.51 (d, <i>J</i> = 7.3 Hz, 2H), 3.51 (t, <i>J</i> = 5.8 Hz, 2H), 3.42 (t, <i>J</i> = 6.4 Hz, 2H), 3.28–3.10 (m, 12H), 2.14–2.04 (m, 2H), 2.03–1.94 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H), 1.66 (s, 3H), 1.57 (s, 3H), 1.34–1.28 (m, 12H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 176.2, 171.2, 169.7, 165.4, 160.9, 159.9, 159.3, 156.1, 140.5, 140.4, 140.1, 131.5 (2× CH), 125.4, 121.0, 119.9, 115.8 (2× CH), 109.7, 99.6, 96.0, 69.7, 69.4, 68.1, 66.9, 50.8, 50.6, 48.4 (2× CH<sub>2</sub>), 48.2 (2× CH<sub>2</sub>), 37.2 (2× CH<sub>2</sub>), 25.9 (2× CH<sub>3</sub>), 25.3 (2× CH<sub>2</sub>), 18.3, 18.1, 9.2 (2× CH<sub>3</sub>), 9.1 (2× CH<sub>3</sub>). HRMS (ESI+): calcd for C<sub>43</sub>H<sub>63</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup>, 763.4646; found, 763.4614.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Antibacterial Assay</h3><div class="NLM_p last">The MICs were measured in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines by broth microdilution methods. Bacterial cells were inoculated on Mueller–Hinton agar (MHA) plates at 37 °C for 24 h and adjusted to approximately 1 × 10<sup>6</sup> CFU/mL. Samples were first dissolved in dimethyl sulfoxide (DMSO)/H<sub>2</sub>O to prepare stock solutions (the final concentration of DMSO ≤2%). These samples were diluted in Mueller–Hinton Broth (MHB) medium to 100 μg/mL as the initial concentration. An aliquot (100 μL) of the bacterial suspension (1 × 10<sup>6</sup> CFU/mL) was added to the two-fold serial dilutions of samples (100 μL) in each well of 96-well plates. The 96-well plates were then incubated for 24 h at 37 °C. The lowest sample concentration to prevent the visible growth of bacteria was recorded as an MIC value. The MIC values were determined by measuring the OD<sub>600</sub> and visible observations. All experiments were carried out at least twice and with biological replicates.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Hemolytic Activity</h3><div class="NLM_p last">The hemolysis experiment was performed as described in previous reports.<a onclick="showRef(event, 'ref21 ref34'); return false;" href="javascript:void(0);" class="ref ref21 ref34">(21,34)</a> First, rabbit RBCs were centrifuged at 2500 rpm for 3 min and washed twice with PBS. Subsequently, the RBCs were suspended in PBS to prepare an 8% v/v suspension. The samples were first dissolved in DMSO or PBS and then diluted in PBS to prepare two-fold serial dilutions. The RBC suspension (100 μL) was incubated with two-fold serial dilutions of samples (100 μL) at 37 °C for 1 h. The final concentration of DMSO and RBCs in the mixture was controlled at 0.5 and 4%, respectively. Then, the mixture was centrifuged at 2500 rpm for 5 min, and the supernatant (100 μL) was transferred into a 96-well plate. The absorbance at 576 nm was determined using a BioTek multidetector microplate reader. 2% Triton X-100 solution was used as a positive control; PBS or 0.5% DMSO was used as a negative control. The hemolytic activity was calculated by the following equation: % hemolysis = [(Abs<sub>sample</sub> – Abs<sub>negative control</sub>)/(Abs<sub>positive control</sub> – Abs<sub>negative control</sub>)] × 100. All experiments were performed at least twice and with biological replicates.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Time-Kill Study</h3><div class="NLM_p last">Bacterial cells (<i>S. aureus</i> ATCC29213) were inoculated on MHA plates at 37 °C for 24 h and adjusted to approximately 1 × 10<sup>6</sup> CFU/mL. The bacterial suspension (1 mL) was treated with various concentrations (the final concentration = 4× and 8× MIC) of compound <b>45</b> or <b>52</b> (1 mL) and were incubated at 37 °C. At 0.5, 1, 2, 4, 8, and 24 h, the culture samples (100 μL) were separately removed and 10-fold serially diluted in PBS. Then, each dilution was plated onto the MHA plate and incubated at 37 °C for 24 h. Finally, the number of bacterial colony growth on plates was counted. All experiments were performed at least twice and with biological replicates.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Resistance Development Study</h3><div class="NLM_p last">The initial MICs of the compounds <b>45</b> and <b>52</b> against <i>S. aureus</i> ATCC29213 were obtained from the above method. Bacterial cells in a 96-well plate at a concentration of 0.5× MIC were used to prepare the bacterial suspension (∼10<sup>6</sup> CFU/mL) for the next MIC measurement. After incubation with samples at 37 °C for 24 h, the new MICs were determined. The experiment lasted for 19 days.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> SYTOX Green Assay</h3><div class="NLM_p last">Bacteria were first incubated overnight on MHA plates. These bacterial cells were then washed twice with PBS buffer (10 mM, pH = 7.2) and resuspended in PBS to adjust the bacterial cell concentration with an optical density at 600 nm of 0.2. The bacterial suspension was incubated in the dark with 0.3 μM SYTOX Green. The change in fluorescence intensity of the SYTOX Green dye was monitored using a microplate reader (excitation wavelength: 504 nm, emission wavelength: 523 nm). After the fluorescence signal was stable, test samples (1×, 2×, 4× and 8× MIC) dissolved in PBS/DMSO (final concentration of DMSO = 0.5%) were immediately added to the SYTOX Green-treated bacterial suspension. The change in fluorescence intensity that lasted for about 60 min was recorded. The blank control group consisted of 0.5% DMSO. All experiments were performed at least twice and with biological replicates.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Scanning Electron Microscopy</h3><div class="NLM_p last"><i>S. aureus</i> ATCC29213 cells were grown to the exponential phase, centrifuged at 5000 rpm for 5 min, washed twice with PBS (pH = 7.2), and resuspended in PBS to yield 5 × 10<sup>7</sup> CFU/mL. Compound <b>45</b> or <b>52</b> (8× MIC) was incubated with <i>S. aureus</i> ATCC29213 cells for 2 h at 37 °C, centrifuged at 5000 rpm for 5 min, and then washed twice with PBS. The bacterial cells treated with PBS were used as a negative control. The cell pellets were treated with 2.5% glutaraldehyde overnight at 4 °C. The cells were washed with fresh PBS and dehydrated with different gradients of ethanol (30, 50, 70, 90, and 95%). The cells were then treated three times with acetone and twice with tert-butanol and dried in vacuum. The samples were coated with gold and analyzed using a Thermo Scientific Apreo.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> LIVE/DEAD Fluorescence Staining Assay</h3><div class="NLM_p last">Bacterial membrane integrity was determined by using LIVE/DEAD BacLight bacterial viability kits L7007 (ThermoFisher, USA). <i>S. aureus</i> ATCC29213 in the logarithmic growth phase was centrifuged at 5000 rpm for 5 min, washed twice with PBS (10 mM, pH = 7.2), and resuspended in PBS to adjust the cell concentration to about 1 × 10<sup>8</sup> CFU/mL (OD<sub>600</sub> of 0.3–0.4). Then, compounds <b>45</b> and <b>52</b> (final concentration of 8× MIC) were mixed with the bacterial suspension and incubated at 37 °C for 2 h (150 rpm). After incubation, each sample was incubated with Syto 9 (5 μM) and PI stain (30 μM) in the dark for 15 min. Smears were prepared, and the cells were observed under a laser confocal microscope (ZEISS LSM 880). The treatment with sterile PBS was used as a negative control. The experiments were repeated twice.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Cytotoxicity Assay</h3><div class="NLM_p last">MDA-MB-231 human breast cancer cells or mouse corneal epithelial cells were cultured in 96-well plates, the cells were treated with two-fold serial dilutions of samples at 37 °C for 24 h with 5% CO<sub>2</sub>, and then 10 μL of CCK-8 reagent was added to each well at 37 °C for 1 h with 5% CO<sub>2</sub>. Absorbance was measured using a BioTek multidetector microplate reader at 450 nm. The percent viability of cells was calculated using the ratio of OD<sub>450</sub> for compound-treated cells to OD<sub>450</sub> for untreated cells. All experiments were performed at least three times with biological replicates.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> In Vivo Efficacy</h3><div class="NLM_p">Animal experiments were approved by the Laboratory Animal Center of South China Agricultural University and carried out in accordance with the policy of the Ministry of Health. Female C57BL6 mice (6–8 weeks, ∼20 g) were used. Bacterial cells (<i>S. aureus</i> ATCC 29213) were inoculated on MHA plates at 37 °C for 24 h and adjusted to approximately 5 × 10<sup>7</sup> CFU/mL for mice corneal infection.</div><div class="NLM_p last">The mice were immunosuppressed by intraperitoneal injection of cyclophosphamide (100 mg/kg) three times in 5 days before infection. Tribromoethanol (500 mg) was dissolved in <i>tert</i>-amyl alcohol (310 μL) to prepare 100% avertin and then diluted with sterile saline to prepare the anesthetics (2.5% avertin). The mice were anesthetized by intraperitoneal injection of 2.5% avertin (500 mg/kg). Mice corneal scratches of the left eye were created by sterile needles. Then, 15 μL of bacterial inoculum was dropped onto the injured cornea. One day after infection, these mice were randomly divided into three groups (five mice/group). Then, the respective compounds (5% vancomycin, 0.5% compound <b>52</b>, or 5% dextrose solution) were applied topically four times each day for 3 days. The mice were finally sacrificed. The infected corneas were collected and plated onto MHA plates for counting the numbers of viable bacteria. Statistical significance was calculated using the SPSS 22.0 software. <i>P</i> values were calculated using the independent <i>t</i>-test, and <i>P</i> ≤ 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00053" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36833" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36833" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00053?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00053</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">MIC values of amphiphilic kaempferol derivatives against various Gram-negative bacterial strains; fluorescence changes of compounds <b>45</b> and <b>52</b> without adding SYTOX Green; water solubility test; and HPLC traces of the final kaempferol compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_001.csv">jm0c00053_si_001.csv (5.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_002.pdf">jm0c00053_si_002.pdf (1.17 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00053" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shouping Liu</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Target & Clinical Pharmacology and the
State Key Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2415-076X" title="Orcid link">http://orcid.org/0000-0003-2415-076X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ff93968a8c97908a8f969198cdcfcec7bfcec9ccd19c9092"><span class="__cf_email__" data-cfemail="b1ddd8c4c2d9dec4c1d8dfd683818089f18087829fd2dedc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuimu Lin</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Target & Clinical Pharmacology and the
State Key Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongxia Li</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Target & Clinical Pharmacology and the
State Key Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yiwen Tao</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Target & Clinical Pharmacology and the
State Key Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiayong Liu</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Target & Clinical Pharmacology and the
State Key Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenchang Yuan</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Target & Clinical Pharmacology and the
State Key Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongzhi Chen</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Molecular Target & Clinical Pharmacology and the
State Key Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Liu</span> - <span class="hlFld-Affiliation affiliation">Guangdong
Key Laboratory of Optical Fiber Sensing and Communications, Institute
of Photonics Technology, Jinan University, Guangzhou, Guangdong 510632, P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions from all authors. All authors have approved the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This study was supported by the Talent Fund for High-Level University Construction of Guangzhou (B195002009029 to Shouping Liu, B195002009030 to Shuimu Lin) and the National Natural Science Foundation of China (21907019 to Shuimu Lin).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">HDPs</td><td class="NLM_def"><p class="first last">host defense peptides</p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>S. aureus</i></p></td></tr><tr><td class="NLM_term">MICs</td><td class="NLM_def"><p class="first last">minimum inhibitory concentrations</p></td></tr><tr><td class="NLM_term">CFUs</td><td class="NLM_def"><p class="first last">colony-forming units</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(3<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">MHA</td><td class="NLM_def"><p class="first last">Mueller–Hinton agar</p></td></tr><tr><td class="NLM_term">MHB</td><td class="NLM_def"><p class="first last">Mueller–Hinton Broth</p></td></tr><tr><td class="NLM_term">RBC</td><td class="NLM_def"><p class="first last">red blood cell</p></td></tr><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American-type culture collection</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 68 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theuretzbacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottwalt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaplewski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigelman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thwaites, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paccaud, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbarth, S.</span></span> <span> </span><span class="NLM_article-title">Analysis of the clinical antibacterial and antituberculosis pipeline</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">e40</span>– <span class="NLM_lpage">e50</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(18)30513-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2818%2930513-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30337260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFejtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=e40-e50&author=U.+Theuretzbacherauthor=S.+Gottwaltauthor=P.+Beyerauthor=M.+Butlerauthor=L.+Czaplewskiauthor=C.+Lienhardtauthor=L.+Mojaauthor=M.+Paulauthor=S.+Paulinauthor=J.+H.+Rexauthor=L.+L.+Silverauthor=M.+Spigelmanauthor=G.+E.+Thwaitesauthor=J.-P.+Paccaudauthor=S.+Harbarth&title=Analysis+of+the+clinical+antibacterial+and+antituberculosis+pipeline&doi=10.1016%2Fs1473-3099%2818%2930513-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the clinical antibacterial and antituberculosis pipeline</span></div><div class="casAuthors">Theuretzbacher, Ursula; Gottwalt, Simon; Beyer, Peter; Butler, Mark; Czaplewski, Lloyd; Lienhardt, Christian; Moja, Lorenzo; Paul, Mical; Paulin, Sarah; Rex, John H.; Silver, Lynn L.; Spigelman, Melvin; Thwaites, Guy E.; Paccaud, Jean-Pierre; Harbarth, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e40-e50</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This anal. of the global clin. antibacterial pipeline was done in support of the Global Action Plan on Antimicrobial Resistance.  The study analyzed to what extent antibacterial and antimycobacterial drugs for systemic human use as well as oral non-systemic antibacterial drugs for Clostridium difficile infections were active against pathogens included in the WHO priority pathogen list and their innovativeness measured by their absence of cross-resistance (new class, target, mode of action).  As of July 1, 2018, 30 new chem. entity (NCE) antibacterial drugs, ten biologics, ten NCEs against Mycobacterium tuberculosis, and four NCEs against C difficile were identified.  Of the 30 NCEs, 11 are expected to have some activity against at least one crit. priority pathogen expressing carbapenem resistance.  The clin. pipeline is dominated by derivs. of established classes and most development candidates display limited innovation.  New antibacterial drugs without pre-existing cross-resistance are under-represented and are urgently needed, esp. for geog. regions with high resistance rates among Gram-neg. bacteria and M tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWapn7G_qKT7Vg90H21EOLACvtfcHk0lgeoIgJTgLdsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFejtbvP&md5=38cf1c2a98bc2e353a6fa0fc01acce8d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930513-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930513-9%26sid%3Dliteratum%253Aachs%26aulast%3DTheuretzbacher%26aufirst%3DU.%26aulast%3DGottwalt%26aufirst%3DS.%26aulast%3DBeyer%26aufirst%3DP.%26aulast%3DButler%26aufirst%3DM.%26aulast%3DCzaplewski%26aufirst%3DL.%26aulast%3DLienhardt%26aufirst%3DC.%26aulast%3DMoja%26aufirst%3DL.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DPaulin%26aufirst%3DS.%26aulast%3DRex%26aufirst%3DJ.%2BH.%26aulast%3DSilver%26aufirst%3DL.%2BL.%26aulast%3DSpigelman%26aufirst%3DM.%26aulast%3DThwaites%26aufirst%3DG.%2BE.%26aulast%3DPaccaud%26aufirst%3DJ.-P.%26aulast%3DHarbarth%26aufirst%3DS.%26atitle%3DAnalysis%2520of%2520the%2520clinical%2520antibacterial%2520and%2520antituberculosis%2520pipeline%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2019%26volume%3D19%26spage%3De40%26epage%3De50%26doi%3D10.1016%2Fs1473-3099%2818%2930513-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roope, L. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouwels, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eibich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robotham, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wordsworth, S.</span></span> <span> </span><span class="NLM_article-title">The challenge of antimicrobial resistance: What economics can contribute</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>364</i></span>, <span class="NLM_elocation-id">eaau4679</span> <span class="refDoi"> DOI: 10.1126/science.aau4679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1126%2Fscience.aau4679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30948524" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2019&author=L.+S.+J.+Roopeauthor=R.+D.+Smithauthor=K.+B.+Pouwelsauthor=J.+Buchananauthor=L.+Abelauthor=P.+Eibichauthor=C.+C.+Butlerauthor=P.+S.+Tanauthor=A.+S.+Walkerauthor=J.+V.+Robothamauthor=S.+Wordsworth&title=The+challenge+of+antimicrobial+resistance%3A+What+economics+can+contribute&doi=10.1126%2Fscience.aau4679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.aau4679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aau4679%26sid%3Dliteratum%253Aachs%26aulast%3DRoope%26aufirst%3DL.%2BS.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26aulast%3DPouwels%26aufirst%3DK.%2BB.%26aulast%3DBuchanan%26aufirst%3DJ.%26aulast%3DAbel%26aufirst%3DL.%26aulast%3DEibich%26aufirst%3DP.%26aulast%3DButler%26aufirst%3DC.%2BC.%26aulast%3DTan%26aufirst%3DP.%2BS.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26aulast%3DRobotham%26aufirst%3DJ.%2BV.%26aulast%3DWordsworth%26aufirst%3DS.%26atitle%3DThe%2520challenge%2520of%2520antimicrobial%2520resistance%253A%2520What%2520economics%2520can%2520contribute%26jtitle%3DScience%26date%3D2019%26volume%3D364%26doi%3D10.1126%2Fscience.aau4679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossolini, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecile, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollini, S.</span></span> <span> </span><span class="NLM_article-title">Update on the antibiotic resistance crisis</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.coph.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=25254623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyitLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=56-60&author=G.+M.+Rossoliniauthor=F.+Arenaauthor=P.+Pecileauthor=S.+Pollini&title=Update+on+the+antibiotic+resistance+crisis&doi=10.1016%2Fj.coph.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the antibiotic resistance crisis</span></div><div class="casAuthors">Rossolini, Gian Maria; Arena, Fabio; Pecile, Patrizia; Pollini, Simona</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-60</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Antibiotics tend to lose their efficacy over time due to the emergence and dissemination of resistance among bacterial pathogens.  Strains with resistance to multiple antibiotic classes have emerged among major Gram-pos. and Gram-neg. species including Staphylococcus aureus, Enterococcus spp., Pseudomonas aeruginosa, Acinetobacter spp.  Enterobacteriaceae, and Neisseria gonorrhoeae.  With some Gram-negatives, resistance may involve most or even all the available antimicrobial options, resulting in extremely drug-resistant or totally drug-resistant phenotypes.  This so-called 'antibiotic resistance crisis' has been compounded by the lagging in antibiotic discovery and development programs occurred in recent years, and is jeopardizing the essential role played by antibiotics in current medical practices.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWUfhdUPFHvLVg90H21EOLACvtfcHk0lhDfxajSsfOfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyitLfE&md5=06565fe5cf882954e7f2704b77b5a61d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DRossolini%26aufirst%3DG.%2BM.%26aulast%3DArena%26aufirst%3DF.%26aulast%3DPecile%26aufirst%3DP.%26aulast%3DPollini%26aufirst%3DS.%26atitle%3DUpdate%2520on%2520the%2520antibiotic%2520resistance%2520crisis%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2014%26volume%3D18%26spage%3D56%26epage%3D60%26doi%3D10.1016%2Fj.coph.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, R. E.</span></span> <span> </span><span class="NLM_article-title">Antibiotics--an investment worth making?</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1512</span>– <span class="NLM_lpage">1514</span>, <span class="refDoi"> DOI: 10.1038/nbt1206-1512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnbt1206-1512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17160052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12gtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1512-1514&author=R.+E.+Christoffersen&title=Antibiotics%2D%2Dan+investment+worth+making%3F&doi=10.1038%2Fnbt1206-1512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics-an investment worth making?</span></div><div class="casAuthors">Christoffersen, Ralph E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1512-1514</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxRc5u6Ptz4bVg90H21EOLACvtfcHk0lhDfxajSsfOfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12gtb3I&md5=85f28c375852fb4fb5df8b9beb6e19ef</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt1206-1512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1206-1512%26sid%3Dliteratum%253Aachs%26aulast%3DChristoffersen%26aufirst%3DR.%2BE.%26atitle%3DAntibiotics--an%2520investment%2520worth%2520making%253F%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D1512%26epage%3D1514%26doi%3D10.1038%2Fnbt1206-1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lencastre, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluytmans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra-Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbarth, S.</span></span> <span> </span><span class="NLM_article-title">Methicillin-resistant Staphylococcus aureus</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">18033</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2018.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnrdp.2018.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29849094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC1MbhvF2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=18033&author=A.+S.+Leeauthor=H.+de+Lencastreauthor=J.+Garauauthor=J.+Kluytmansauthor=S.+Malhotra-Kumarauthor=A.+Peschelauthor=S.+Harbarth&title=Methicillin-resistant+Staphylococcus+aureus&doi=10.1038%2Fnrdp.2018.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Lee Andie S; Lee Andie S; de Lencastre Herminia; de Lencastre Herminia; Garau Javier; Kluytmans Jan; Kluytmans Jan; Malhotra-Kumar Surbhi; Peschel Andreas; Peschel Andreas; Harbarth Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18033</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged, disseminated globally and become a leading cause of bacterial infections in both health-care and community settings.  However, there is marked geographical variation in MRSA burden owing to several factors, including differences in local infection control practices and pathogen-specific characteristics of the circulating clones.  Different MRSA clones have resulted from the independent acquisition of staphylococcal cassette chromosome mec (SCCmec), which contains genes encoding proteins that render the bacterium resistant to most β-lactam antibiotics (such as methicillin), by several S. aureus clones.  The success of MRSA is a consequence of the extensive arsenal of virulence factors produced by S. aureus combined with β-lactam resistance and, for most clones, resistance to other antibiotic classes.  Clinical manifestations of MRSA range from asymptomatic colonization of the nasal mucosa to mild skin and soft tissue infections to fulminant invasive disease with high mortality.  Although treatment options for MRSA are limited, several new antimicrobials are under development.  An understanding of colonization dynamics, routes of transmission, risk factors for progression to infection and conditions that promote the emergence of resistance will enable optimization of strategies to effectively control MRSA.  Vaccine candidates are also under development and could become an effective prevention measure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKXTZtG2H7xFZoq0fPSOTvfW6udTcc2eZnORCRqVrCm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbhvF2rtQ%253D%253D&md5=876a11b74542a5f7ae71aee2c7fcfe65</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2018.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2018.33%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BS.%26aulast%3Dde%2BLencastre%26aufirst%3DH.%26aulast%3DGarau%26aufirst%3DJ.%26aulast%3DKluytmans%26aufirst%3DJ.%26aulast%3DMalhotra-Kumar%26aufirst%3DS.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DHarbarth%26aufirst%3DS.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2018%26volume%3D4%26spage%3D18033%26doi%3D10.1038%2Fnrdp.2018.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanberger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barie, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rello, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzueto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakr, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickkers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felleiter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engoren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Investigators, E. I. G. o.</span></span> <span> </span><span class="NLM_article-title">Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2011.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.ijantimicag.2011.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=21798720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSjtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=331-335&author=H.+Hanbergerauthor=S.+Waltherauthor=M.+Leoneauthor=P.+S.+Barieauthor=J.+Relloauthor=J.+Lipmanauthor=J.+C.+Marshallauthor=A.+Anzuetoauthor=Y.+Sakrauthor=P.+Pickkersauthor=P.+Felleiterauthor=M.+Engorenauthor=J.-L.+Vincentauthor=E.+I.+G.+o.+Investigators&title=Increased+mortality+associated+with+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29+infection+in+the+intensive+care+unit%3A+results+from+the+EPIC+II+study&doi=10.1016%2Fj.ijantimicag.2011.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study</span></div><div class="casAuthors">Hanberger, Hakan; Walther, Sten; Leone, Marc; Barie, Philip S.; Rello, Jordi; Lipman, Jeffrey; Marshall, John C.; Anzueto, Antonio; Sakr, Yasser; Pickkers, Peter; Felleiter, Peter; Engoren, Milo; Vincent, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">331-335</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Controversy continues regarding whether the presence of meticillin resistance increases mortality risk in Staphylococcus aureus infections.  In this study, we assessed the role of meticillin resistance in survival of patients with S. aureus infection included in the EPIC II point-prevalence study of infection in critically ill patients performed on 8 May 2007.  Demog., physiol., bacteriol. and therapeutic data were collected for 13 796 adult patients in 1265 participating Intensive Care Units (ICUs) from 75 countries on the study day.  ICU and hospital outcomes were recorded.  Characteristics of patients with meticillin-sensitive S. aureus (MSSA) and meticillin-resistant S. aureus (MRSA) infections were compared.  Co-morbidities, age, Simplified Acute Physiol. Score (SAPS) II, site of infection, geog. region and MRSA/MSSA were entered into a multivariate model, and adjusted odds ratios (ORs) [95% confidence interval (CI)] for ICU and hospital mortality rates were calcd.  On the study day, 7087 (51%) of the 13 796 patients were classified as infected.  There were 494 patients with MRSA infections and 505 patients with MSSA infections.  There were no significant differences between the two groups in use of mech. ventilation or haemofiltration/haemodialysis.  Cancer and chronic renal failure were more prevalent in MRSA than in MSSA patients.  ICU mortality rates were 29.1% and 20.5%, resp. (P < 0.01) and corresponding hospital mortality rates were 36.4% and 27.0% (P < 0.01).  Multivariate anal. of hospital mortality for MRSA infection showed an adjusted OR of 1.46 (95% CI 1.03-2.06) (P = 0.03).  In ICU patients, MRSA infection is therefore independently assocd. with an almost 50% higher likelihood of hospital death compared with MSSA infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4HSPK1VIakbVg90H21EOLACvtfcHk0lhMwADn-eG5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSjtLfI&md5=ebcf9c192d594519a4f131b50a4c3c22</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2011.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2011.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanberger%26aufirst%3DH.%26aulast%3DWalther%26aufirst%3DS.%26aulast%3DLeone%26aufirst%3DM.%26aulast%3DBarie%26aufirst%3DP.%2BS.%26aulast%3DRello%26aufirst%3DJ.%26aulast%3DLipman%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DJ.%2BC.%26aulast%3DAnzueto%26aufirst%3DA.%26aulast%3DSakr%26aufirst%3DY.%26aulast%3DPickkers%26aufirst%3DP.%26aulast%3DFelleiter%26aufirst%3DP.%26aulast%3DEngoren%26aufirst%3DM.%26aulast%3DVincent%26aufirst%3DJ.-L.%26aulast%3DInvestigators%26aufirst%3DE.%2BI.%2BG.%2Bo.%26atitle%3DIncreased%2520mortality%2520associated%2520with%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520infection%2520in%2520the%2520intensive%2520care%2520unit%253A%2520results%2520from%2520the%2520EPIC%2520II%2520study%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2011%26volume%3D38%26spage%3D331%26epage%3D335%26doi%3D10.1016%2Fj.ijantimicag.2011.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willyard, C.</span></span> <span> </span><span class="NLM_article-title">The drug-resistant bacteria that pose the greatest health threats</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>543</i></span>,  <span class="NLM_fpage">15</span>, <span class="refDoi"> DOI: 10.1038/nature.2017.21550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnature.2017.21550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28252092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1GmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=543&publication_year=2017&pages=15&author=C.+Willyard&title=The+drug-resistant+bacteria+that+pose+the+greatest+health+threats&doi=10.1038%2Fnature.2017.21550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The drug-resistant bacteria that pose the greatest health threats</span></div><div class="casAuthors">Willyard, Cassandra</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">543</span>
        (<span class="NLM_cas:issue">7643</span>),
    <span class="NLM_cas:pages">15</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">World Health Organization publishes list that it hopes will focus development of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoetDtnJjM3qbVg90H21EOLACvtfcHk0lhMwADn-eG5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1GmtLs%253D&md5=de1d82298a31ebd916bb4ef820173180</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature.2017.21550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2017.21550%26sid%3Dliteratum%253Aachs%26aulast%3DWillyard%26aufirst%3DC.%26atitle%3DThe%2520drug-resistant%2520bacteria%2520that%2520pose%2520the%2520greatest%2520health%2520threats%26jtitle%3DNature%26date%3D2017%26volume%3D543%26spage%3D15%26doi%3D10.1038%2Fnature.2017.21550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högberg, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plachouras, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quattrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoxha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colomb-Cotinat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretzschmar, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devleesschauwer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouakrim, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struelens, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suetens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catry, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latour, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobreva, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambic
Andraševic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soprek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budimir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paphitou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Žemlicková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schytte Olsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff Sönksen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Märtin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyytikäinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalava, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coignard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckmanns, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Sin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daikos, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gikas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiodras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontopidou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tóth, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guólaugsson, Ó.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristinsson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murchan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumpis, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuimiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Greeff, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koek, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elstrøm, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabicka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deptula, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryniewicz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caniça, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manageiro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popescu, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serban, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schréterová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litvová, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štefkovicová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klavs, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korošec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aracil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asensio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Vázquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billström, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span> <span> </span><span class="NLM_article-title">Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(18)30605-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2818%2930605-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30409683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BB3cvotFGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=56-66&author=A.+Cassiniauthor=L.+D.+H%C3%B6gbergauthor=D.+Plachourasauthor=A.+Quattrocchiauthor=A.+Hoxhaauthor=G.+S.+Simonsenauthor=M.+Colomb-Cotinatauthor=M.+E.+Kretzschmarauthor=B.+Devleesschauwerauthor=M.+Cecchiniauthor=D.+A.+Ouakrimauthor=T.+C.+Oliveiraauthor=M.+J.+Struelensauthor=C.+Suetensauthor=D.+L.+Monnetauthor=R.+Straussauthor=K.+Mertensauthor=T.+Struyfauthor=B.+Catryauthor=K.+Latourauthor=I.+N.+Ivanovauthor=E.+G.+Dobrevaauthor=A.+Tambic%0AAndra%C5%A1evicauthor=S.+Soprekauthor=A.+Budimirauthor=N.+Paphitouauthor=H.+%C5%BDemlickov%C3%A1author=S.+Schytte+Olsenauthor=U.+Wolff+S%C3%B6nksenauthor=P.+M%C3%A4rtinauthor=M.+Ivanovaauthor=O.+Lyytik%C3%A4inenauthor=J.+Jalavaauthor=B.+Coignardauthor=T.+Eckmannsauthor=M.+Abu+Sinauthor=S.+Hallerauthor=G.+L.+Daikosauthor=A.+Gikasauthor=S.+Tsiodrasauthor=F.+Kontopidouauthor=%C3%81.+T%C3%B3thauthor=%C3%81.+Hajduauthor=%C3%93.+Gu%C3%B3laugssonauthor=K.+G.+Kristinssonauthor=S.+Murchanauthor=K.+Burnsauthor=P.+Pezzottiauthor=C.+Gagliottiauthor=U.+Dumpisauthor=A.+Liuimieneauthor=M.+Perrinauthor=M.+A.+Borgauthor=S.+C.+de+Greeffauthor=J.+C.+Monenauthor=M.+B.+Koekauthor=P.+Elstr%C3%B8mauthor=D.+Zabickaauthor=A.+Deptulaauthor=W.+Hryniewiczauthor=M.+Cani%C3%A7aauthor=P.+J.+Nogueiraauthor=P.+A.+Fernandesauthor=V.+Manageiroauthor=G.+A.+Popescuauthor=R.+I.+Serbanauthor=E.+Schr%C3%A9terov%C3%A1author=S.+Litvov%C3%A1author=M.+%C5%A0tefkovicov%C3%A1author=J.+Kolmanauthor=I.+Klavsauthor=A.+Koro%C5%A1ecauthor=B.+Aracilauthor=A.+Asensioauthor=M.+P%C3%A9rez-V%C3%A1zquezauthor=H.+Billstr%C3%B6mauthor=S.+Larssonauthor=J.+S.+Reillyauthor=A.+Johnsonauthor=S.+Hopkins&title=Attributable+deaths+and+disability-adjusted+life-years+caused+by+infections+with+antibiotic-resistant+bacteria+in+the+EU+and+the+European+Economic+Area+in+2015%3A+a+population-level+modelling+analysis&doi=10.1016%2Fs1473-3099%2818%2930605-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis</span></div><div class="casAuthors">Cassini Alessandro; Hogberg Liselotte Diaz; Plachouras Diamantis; Quattrocchi Annalisa; Hoxha Ana; Struelens Marc J; Suetens Carl; Monnet Dominique L; Simonsen Gunnar Skov; Colomb-Cotinat Melanie; Kretzschmar Mirjam E; Devleesschauwer Brecht; Cecchini Michele; Ouakrim Driss Ait; Oliveira Tiago Cravo</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Infections due to antibiotic-resistant bacteria are threatening modern health care.  However, estimating their incidence, complications, and attributable mortality is challenging.  We aimed to estimate the burden of infections caused by antibiotic-resistant bacteria of public health concern in countries of the EU and European Economic Area (EEA) in 2015, measured in number of cases, attributable deaths, and disability-adjusted life-years (DALYs).  METHODS:  We estimated the incidence of infections with 16 antibiotic resistance-bacterium combinations from European Antimicrobial Resistance Surveillance Network (EARS-Net) 2015 data that was country-corrected for population coverage.  We multiplied the number of bloodstream infections (BSIs) by a conversion factor derived from the European Centre for Disease Prevention and Control point prevalence survey of health-care-associated infections in European acute care hospitals in 2011-12 to estimate the number of non-BSIs.  We developed disease outcome models for five types of infection on the basis of systematic reviews of the literature.  FINDINGS:  From EARS-Net data collected between Jan 1, 2015, and Dec 31, 2015, we estimated 671 689 (95% uncertainty interval [UI] 583 148-763 966) infections with antibiotic-resistant bacteria, of which 63·5% (426 277 of 671 689) were associated with health care.  These infections accounted for an estimated 33 110 (28 480-38 430) attributable deaths and 874 541 (768 837-989 068) DALYs.  The burden for the EU and EEA was highest in infants (aged <1 year) and people aged 65 years or older, had increased since 2007, and was highest in Italy and Greece.  INTERPRETATION:  Our results present the health burden of five types of infection with antibiotic-resistant bacteria expressed, for the first time, in DALYs.  The estimated burden of infections with antibiotic-resistant bacteria in the EU and EEA is substantial compared with that of other infectious diseases, and has increased since 2007.  Our burden estimates provide useful information for public health decision-makers prioritising interventions for infectious diseases.  FUNDING:  European Centre for Disease Prevention and Control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR76qXWYwPPXq69lAbTj9rGfW6udTcc2eb38FcO-Zux2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvotFGluw%253D%253D&md5=151619810730b07e3d84692f1d966b9a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930605-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930605-4%26sid%3Dliteratum%253Aachs%26aulast%3DCassini%26aufirst%3DA.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DL.%2BD.%26aulast%3DPlachouras%26aufirst%3DD.%26aulast%3DQuattrocchi%26aufirst%3DA.%26aulast%3DHoxha%26aufirst%3DA.%26aulast%3DSimonsen%26aufirst%3DG.%2BS.%26aulast%3DColomb-Cotinat%26aufirst%3DM.%26aulast%3DKretzschmar%26aufirst%3DM.%2BE.%26aulast%3DDevleesschauwer%26aufirst%3DB.%26aulast%3DCecchini%26aufirst%3DM.%26aulast%3DOuakrim%26aufirst%3DD.%2BA.%26aulast%3DOliveira%26aufirst%3DT.%2BC.%26aulast%3DStruelens%26aufirst%3DM.%2BJ.%26aulast%3DSuetens%26aufirst%3DC.%26aulast%3DMonnet%26aufirst%3DD.%2BL.%26aulast%3DStrauss%26aufirst%3DR.%26aulast%3DMertens%26aufirst%3DK.%26aulast%3DStruyf%26aufirst%3DT.%26aulast%3DCatry%26aufirst%3DB.%26aulast%3DLatour%26aufirst%3DK.%26aulast%3DIvanov%26aufirst%3DI.%2BN.%26aulast%3DDobreva%26aufirst%3DE.%2BG.%26aulast%3DTambic%2BAndra%25C5%25A1evic%26aufirst%3DA.%26aulast%3DSoprek%26aufirst%3DS.%26aulast%3DBudimir%26aufirst%3DA.%26aulast%3DPaphitou%26aufirst%3DN.%26aulast%3D%25C5%25BDemlickov%25C3%25A1%26aufirst%3DH.%26aulast%3DSchytte%2BOlsen%26aufirst%3DS.%26aulast%3DWolff%2BS%25C3%25B6nksen%26aufirst%3DU.%26aulast%3DM%25C3%25A4rtin%26aufirst%3DP.%26aulast%3DIvanova%26aufirst%3DM.%26aulast%3DLyytik%25C3%25A4inen%26aufirst%3DO.%26aulast%3DJalava%26aufirst%3DJ.%26aulast%3DCoignard%26aufirst%3DB.%26aulast%3DEckmanns%26aufirst%3DT.%26aulast%3DAbu%2BSin%26aufirst%3DM.%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DDaikos%26aufirst%3DG.%2BL.%26aulast%3DGikas%26aufirst%3DA.%26aulast%3DTsiodras%26aufirst%3DS.%26aulast%3DKontopidou%26aufirst%3DF.%26aulast%3DT%25C3%25B3th%26aufirst%3D%25C3%2581.%26aulast%3DHajdu%26aufirst%3D%25C3%2581.%26aulast%3DGu%25C3%25B3laugsson%26aufirst%3D%25C3%2593.%26aulast%3DKristinsson%26aufirst%3DK.%2BG.%26aulast%3DMurchan%26aufirst%3DS.%26aulast%3DBurns%26aufirst%3DK.%26aulast%3DPezzotti%26aufirst%3DP.%26aulast%3DGagliotti%26aufirst%3DC.%26aulast%3DDumpis%26aufirst%3DU.%26aulast%3DLiuimiene%26aufirst%3DA.%26aulast%3DPerrin%26aufirst%3DM.%26aulast%3DBorg%26aufirst%3DM.%2BA.%26aulast%3Dde%2BGreeff%26aufirst%3DS.%2BC.%26aulast%3DMonen%26aufirst%3DJ.%2BC.%26aulast%3DKoek%26aufirst%3DM.%2BB.%26aulast%3DElstr%25C3%25B8m%26aufirst%3DP.%26aulast%3DZabicka%26aufirst%3DD.%26aulast%3DDeptula%26aufirst%3DA.%26aulast%3DHryniewicz%26aufirst%3DW.%26aulast%3DCani%25C3%25A7a%26aufirst%3DM.%26aulast%3DNogueira%26aufirst%3DP.%2BJ.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26aulast%3DManageiro%26aufirst%3DV.%26aulast%3DPopescu%26aufirst%3DG.%2BA.%26aulast%3DSerban%26aufirst%3DR.%2BI.%26aulast%3DSchr%25C3%25A9terov%25C3%25A1%26aufirst%3DE.%26aulast%3DLitvov%25C3%25A1%26aufirst%3DS.%26aulast%3D%25C5%25A0tefkovicov%25C3%25A1%26aufirst%3DM.%26aulast%3DKolman%26aufirst%3DJ.%26aulast%3DKlavs%26aufirst%3DI.%26aulast%3DKoro%25C5%25A1ec%26aufirst%3DA.%26aulast%3DAracil%26aufirst%3DB.%26aulast%3DAsensio%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-V%25C3%25A1zquez%26aufirst%3DM.%26aulast%3DBillstr%25C3%25B6m%26aufirst%3DH.%26aulast%3DLarsson%26aufirst%3DS.%26aulast%3DReilly%26aufirst%3DJ.%2BS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DHopkins%26aufirst%3DS.%26atitle%3DAttributable%2520deaths%2520and%2520disability-adjusted%2520life-years%2520caused%2520by%2520infections%2520with%2520antibiotic-resistant%2520bacteria%2520in%2520the%2520EU%2520and%2520the%2520European%2520Economic%2520Area%2520in%25202015%253A%2520a%2520population-level%2520modelling%2520analysis%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2019%26volume%3D19%26spage%3D56%26epage%3D66%26doi%3D10.1016%2Fs1473-3099%2818%2930605-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tacconelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbarth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulcini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlmeter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluytmans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeli, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Outterson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaleri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houchens, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theuretzbacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboderin, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Abri, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awang Jalil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzonana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkert, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cars, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornaglia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyar, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giske, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman Blanco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryniewicz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kattula, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanj, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieny, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlov, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labarca, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laxminarayan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibovici, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy-Hara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra-Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndoye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramon-Pardo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Baño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanguinetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si-Mehand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbakk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thwaites, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Meer, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kinh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villegas, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wechsler-Fördös, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertheim, H. F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesangula, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorzet, A.</span></span> <span> </span><span class="NLM_article-title">Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(17)30753-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2817%2930753-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29276051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC1MzkvFOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=318-327&author=E.+Tacconelliauthor=E.+Carraraauthor=A.+Savoldiauthor=S.+Harbarthauthor=M.+Mendelsonauthor=D.+L.+Monnetauthor=C.+Pulciniauthor=G.+Kahlmeterauthor=J.+Kluytmansauthor=Y.+Carmeliauthor=M.+Ouelletteauthor=K.+Outtersonauthor=J.+Patelauthor=M.+Cavaleriauthor=E.+M.+Coxauthor=C.+R.+Houchensauthor=M.+L.+Graysonauthor=P.+Hansenauthor=N.+Singhauthor=U.+Theuretzbacherauthor=N.+Magriniauthor=A.+O.+Aboderinauthor=S.+S.+Al-Abriauthor=N.+Awang+Jalilauthor=N.+Benzonanaauthor=S.+Bhattacharyaauthor=A.+J.+Brinkauthor=F.+R.+Burkertauthor=O.+Carsauthor=G.+Cornagliaauthor=O.+J.+Dyarauthor=A.+W.+Friedrichauthor=A.+C.+Galesauthor=S.+Gandraauthor=C.+G.+Giskeauthor=D.+A.+Goffauthor=H.+Goossensauthor=T.+Gottliebauthor=M.+Guzman+Blancoauthor=W.+Hryniewiczauthor=D.+Kattulaauthor=T.+Jinksauthor=S.+S.+Kanjauthor=L.+Kerrauthor=M.-P.+Kienyauthor=Y.+S.+Kimauthor=R.+S.+Kozlovauthor=J.+Labarcaauthor=R.+Laxminarayanauthor=K.+Lederauthor=L.+Leiboviciauthor=G.+Levy-Haraauthor=J.+Littmanauthor=S.+Malhotra-Kumarauthor=V.+Manchandaauthor=L.+Mojaauthor=B.+Ndoyeauthor=A.+Panauthor=D.+L.+Patersonauthor=M.+Paulauthor=H.+Qiuauthor=P.+Ramon-Pardoauthor=J.+Rodr%C3%ADguez-Ba%C3%B1oauthor=M.+Sanguinettiauthor=S.+Senguptaauthor=M.+Sharlandauthor=M.+Si-Mehandauthor=L.+L.+Silverauthor=W.+Songauthor=M.+Steinbakkauthor=J.+Thomsenauthor=G.+E.+Thwaitesauthor=J.+W.+van+der+Meerauthor=N.+Van+Kinhauthor=S.+Vegaauthor=M.+V.+Villegasauthor=A.+Wechsler-F%C3%B6rd%C3%B6sauthor=H.+F.+L.+Wertheimauthor=E.+Wesangulaauthor=N.+Woodfordauthor=F.+O.+Yilmazauthor=A.+Zorzet&title=Discovery%2C+research%2C+and+development+of+new+antibiotics%3A+the+WHO+priority+list+of+antibiotic-resistant+bacteria+and+tuberculosis&doi=10.1016%2Fs1473-3099%2817%2930753-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</span></div><div class="casAuthors">Tacconelli Evelina; Carrara Elena; Savoldi Alessia; Harbarth Stephan; Mendelson Marc; Monnet Dominique L; Pulcini Celine; Kahlmeter Gunnar; Kluytmans Jan; Carmeli Yehuda; Ouellette Marc; Outterson Kevin; Patel Jean; Cavaleri Marco; Cox Edward M; Houchens Chris R; Grayson M Lindsay; Hansen Paul; Singh Nalini; Theuretzbacher Ursula; Magrini Nicola</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">318-327</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide.  Due to its large public health and societal implications, multidrug-resistant tuberculosis has been long regarded by WHO as a global priority for investment in new drugs.  In 2016, WHO was requested by member states to create a priority list of other antibiotic-resistant bacteria to support research and development of effective drugs.  METHODS:  We used a multicriteria decision analysis method to prioritise antibiotic-resistant bacteria; this method involved the identification of relevant criteria to assess priority against which each antibiotic-resistant bacterium was rated.  The final priority ranking of the antibiotic-resistant bacteria was established after a preference-based survey was used to obtain expert weighting of criteria.  FINDINGS:  We selected 20 bacterial species with 25 patterns of acquired resistance and ten criteria to assess priority: mortality, health-care burden, community burden, prevalence of resistance, 10-year trend of resistance, transmissibility, preventability in the community setting, preventability in the health-care setting, treatability, and pipeline.  We stratified the priority list into three tiers (critical, high, and medium priority), using the 33rd percentile of the bacterium's total scores as the cutoff.  Critical-priority bacteria included carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa, and carbapenem-resistant and third-generation cephalosporin-resistant Enterobacteriaceae.  The highest ranked Gram-positive bacteria (high priority) were vancomycin-resistant Enterococcus faecium and meticillin-resistant Staphylococcus aureus.  Of the bacteria typically responsible for community-acquired infections, clarithromycin-resistant Helicobacter pylori, and fluoroquinolone-resistant Campylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were included in the high-priority tier.  INTERPRETATION:  Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria.  The global strategy should include antibiotic-resistant bacteria responsible for community-acquired infections such as Salmonella spp, Campylobacter spp, N gonorrhoeae, and H pylori.  FUNDING:  World Health Organization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkARC7DR8uZLGbPKh4T9eAfW6udTcc2ebdrGZDxyRNuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzkvFOgsA%253D%253D&md5=14021ec57670b29fec6a88226a6a1fdd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2817%2930753-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252817%252930753-3%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DE.%26aulast%3DCarrara%26aufirst%3DE.%26aulast%3DSavoldi%26aufirst%3DA.%26aulast%3DHarbarth%26aufirst%3DS.%26aulast%3DMendelson%26aufirst%3DM.%26aulast%3DMonnet%26aufirst%3DD.%2BL.%26aulast%3DPulcini%26aufirst%3DC.%26aulast%3DKahlmeter%26aufirst%3DG.%26aulast%3DKluytmans%26aufirst%3DJ.%26aulast%3DCarmeli%26aufirst%3DY.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DOutterson%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DCavaleri%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DE.%2BM.%26aulast%3DHouchens%26aufirst%3DC.%2BR.%26aulast%3DGrayson%26aufirst%3DM.%2BL.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DTheuretzbacher%26aufirst%3DU.%26aulast%3DMagrini%26aufirst%3DN.%26aulast%3DAboderin%26aufirst%3DA.%2BO.%26aulast%3DAl-Abri%26aufirst%3DS.%2BS.%26aulast%3DAwang%2BJalil%26aufirst%3DN.%26aulast%3DBenzonana%26aufirst%3DN.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBrink%26aufirst%3DA.%2BJ.%26aulast%3DBurkert%26aufirst%3DF.%2BR.%26aulast%3DCars%26aufirst%3DO.%26aulast%3DCornaglia%26aufirst%3DG.%26aulast%3DDyar%26aufirst%3DO.%2BJ.%26aulast%3DFriedrich%26aufirst%3DA.%2BW.%26aulast%3DGales%26aufirst%3DA.%2BC.%26aulast%3DGandra%26aufirst%3DS.%26aulast%3DGiske%26aufirst%3DC.%2BG.%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DGoossens%26aufirst%3DH.%26aulast%3DGottlieb%26aufirst%3DT.%26aulast%3DGuzman%2BBlanco%26aufirst%3DM.%26aulast%3DHryniewicz%26aufirst%3DW.%26aulast%3DKattula%26aufirst%3DD.%26aulast%3DJinks%26aufirst%3DT.%26aulast%3DKanj%26aufirst%3DS.%2BS.%26aulast%3DKerr%26aufirst%3DL.%26aulast%3DKieny%26aufirst%3DM.-P.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKozlov%26aufirst%3DR.%2BS.%26aulast%3DLabarca%26aufirst%3DJ.%26aulast%3DLaxminarayan%26aufirst%3DR.%26aulast%3DLeder%26aufirst%3DK.%26aulast%3DLeibovici%26aufirst%3DL.%26aulast%3DLevy-Hara%26aufirst%3DG.%26aulast%3DLittman%26aufirst%3DJ.%26aulast%3DMalhotra-Kumar%26aufirst%3DS.%26aulast%3DManchanda%26aufirst%3DV.%26aulast%3DMoja%26aufirst%3DL.%26aulast%3DNdoye%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DPaterson%26aufirst%3DD.%2BL.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DRamon-Pardo%26aufirst%3DP.%26aulast%3DRodr%25C3%25ADguez-Ba%25C3%25B1o%26aufirst%3DJ.%26aulast%3DSanguinetti%26aufirst%3DM.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DSharland%26aufirst%3DM.%26aulast%3DSi-Mehand%26aufirst%3DM.%26aulast%3DSilver%26aufirst%3DL.%2BL.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DSteinbakk%26aufirst%3DM.%26aulast%3DThomsen%26aufirst%3DJ.%26aulast%3DThwaites%26aufirst%3DG.%2BE.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%26aulast%3DVan%2BKinh%26aufirst%3DN.%26aulast%3DVega%26aufirst%3DS.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DWechsler-F%25C3%25B6rd%25C3%25B6s%26aufirst%3DA.%26aulast%3DWertheim%26aufirst%3DH.%2BF.%2BL.%26aulast%3DWesangula%26aufirst%3DE.%26aulast%3DWoodford%26aufirst%3DN.%26aulast%3DYilmaz%26aufirst%3DF.%2BO.%26aulast%3DZorzet%26aufirst%3DA.%26atitle%3DDiscovery%252C%2520research%252C%2520and%2520development%2520of%2520new%2520antibiotics%253A%2520the%2520WHO%2520priority%2520list%2520of%2520antibiotic-resistant%2520bacteria%2520and%2520tuberculosis%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2018%26volume%3D18%26spage%3D318%26epage%3D327%26doi%3D10.1016%2Fs1473-3099%2817%2930753-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kullar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, E. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathwani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escandón-Vargas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villegas, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Bergh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, M.</span></span> <span> </span><span class="NLM_article-title">A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">e56</span>– <span class="NLM_lpage">e63</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(16)30386-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2816%2930386-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=27866945" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=e56-e63&author=D.+A.+Goffauthor=R.+Kullarauthor=E.+J.+C.+Goldsteinauthor=M.+Gilchristauthor=D.+Nathwaniauthor=A.+C.+Chengauthor=K.+A.+Cairnsauthor=K.+Escand%C3%B3n-Vargasauthor=M.+V.+Villegasauthor=A.+Brinkauthor=D.+van+den+Berghauthor=M.+Mendelson&title=A+global+call+from+five+countries+to+collaborate+in+antibiotic+stewardship%3A+united+we+succeed%2C+divided+we+might+fail&doi=10.1016%2Fs1473-3099%2816%2930386-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2930386-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252930386-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DKullar%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DE.%2BJ.%2BC.%26aulast%3DGilchrist%26aufirst%3DM.%26aulast%3DNathwani%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCairns%26aufirst%3DK.%2BA.%26aulast%3DEscand%25C3%25B3n-Vargas%26aufirst%3DK.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DBrink%26aufirst%3DA.%26aulast%3Dvan%2Bden%2BBergh%26aufirst%3DD.%26aulast%3DMendelson%26aufirst%3DM.%26atitle%3DA%2520global%2520call%2520from%2520five%2520countries%2520to%2520collaborate%2520in%2520antibiotic%2520stewardship%253A%2520united%2520we%2520succeed%252C%2520divided%2520we%2520might%2520fail%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26spage%3De56%26epage%3De63%26doi%3D10.1016%2Fs1473-3099%2816%2930386-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel DNA gyrase-inhibiting spiropyrimidinetriones as potent antibiotics for treatment of infections caused by multidrug-resistant Gram-positive bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2950</span>– <span class="NLM_lpage">2973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01750</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01750" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVCns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2950-2973&author=C.+Shiauthor=Y.+Zhangauthor=T.+Wangauthor=W.+Luauthor=S.+Zhangauthor=B.+Guoauthor=Q.+Chenauthor=C.+Luoauthor=X.+Zhouauthor=Y.+Yang&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+DNA+gyrase-inhibiting+spiropyrimidinetriones+as+potent+antibiotics+for+treatment+of+infections+caused+by+multidrug-resistant+Gram-positive+bacteria&doi=10.1021%2Facs.jmedchem.8b01750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria</span></div><div class="casAuthors">Shi, Chenghui; Zhang, Yinyong; Wang, Ting; Lu, Wenchao; Zhang, Shuhua; Guo, Bin; Chen, Qian; Luo, Cheng; Zhou, Xianli; Yang, Yushe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2950-2973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">OSpiropyrimidinetriones are a novel class of antibacterial agents that target the bacterial type II topoisomerase via a new mode of action.  Compd. ETX0914 is thus far the only drug from this class that is being evaluated in clin. trials.  To improve the antibacterial activity and pharmacokinetic properties of ETX0914, we carried out systematic structural modification of this compd., and a no. of compds. with increased potency were obtained.  The most promising compd. I, with incorporation of a spirocyclopropane at the oxazolidinone 5 position reduced metab., exhibited excellent antibacterial activity against Gram-pos. pathogens and a good pharmacokinetic profile combined with high aq. soly.  In addn., compd. I exhibited good selectivity for Staphylococcus aureus gyrase over human Topo IIα.  In a murine model of systemic methicillin-resistant S. aureus infection, I exhibited superior in vivo efficacy (ED50 = 3.87 mg/kg) compared to ETX0914 (ED50 = 11.51 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ6gparWwzX7Vg90H21EOLACvtfcHk0lith2-Z6Tp6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVCns7w%253D&md5=cda4a55200d7e942dced7859975df17c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01750%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520DNA%2520gyrase-inhibiting%2520spiropyrimidinetriones%2520as%2520potent%2520antibiotics%2520for%2520treatment%2520of%2520infections%2520caused%2520by%2520multidrug-resistant%2520Gram-positive%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2950%26epage%3D2973%26doi%3D10.1021%2Facs.jmedchem.8b01750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahl, H.-G.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1551</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1038/nbt1267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnbt1267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17160061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12gtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1551-1557&author=R.+E.+W.+Hancockauthor=H.-G.+Sahl&title=Antimicrobial+and+host-defense+peptides+as+new+anti-infective+therapeutic+strategies&doi=10.1038%2Fnbt1267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies</span></div><div class="casAuthors">Hancock, Robert E. W.; Sahl, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1551-1557</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Short cationic amphiphilic peptides with antimicrobial and/or immunomodulatory activities are present in virtually every life form, as an important component of (innate) immune defenses.  These host-defense peptides provide a template for two sep. classes of antimicrobial drugs.  Direct-acting antimicrobial host-defense peptides can be rapid-acting and potent, and possess an unusually broad spectrum of activity; consequently, they have prospects as new antibiotics, although clin. trials to date have shown efficacy only as topical agents.  But for these compds. to fulfill their therapeutic promise and overcome clin. setbacks, further work is needed to understand their mechanisms of action and reduce the potential for unwanted toxicity, to make them more resistant to protease degrdn. and improve serum half-life, as well as to devise means of manufg. them on a large scale in a consistent and cost-effective manner.  In contrast, the role of cationic host-defense peptides in modulating the innate immune response and boosting infection-resolving immunity while dampening potentially harmful pro-inflammatory (septic) responses gives these peptides the potential to become an entirely new therapeutic approach against bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDCXCNhkv3_bVg90H21EOLACvtfcHk0lh-BeZouLDr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12gtbvM&md5=57cbc9e0a85bcdf82663d840622886e1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnbt1267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1267%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26aulast%3DSahl%26aufirst%3DH.-G.%26atitle%3DAntimicrobial%2520and%2520host-defense%2520peptides%2520as%2520new%2520anti-infective%2520therapeutic%2520strategies%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D1551%26epage%3D1557%26doi%3D10.1038%2Fnbt1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghimire, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimley, W. C.</span></span> <span> </span><span class="NLM_article-title">Mechanistic landscape of membrane-permeabilizing peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">6040</span>– <span class="NLM_lpage">6085</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00520</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00520" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltV2jug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=6040-6085&author=S.+Guhaauthor=J.+Ghimireauthor=E.+Wuauthor=W.+C.+Wimley&title=Mechanistic+landscape+of+membrane-permeabilizing+peptides&doi=10.1021%2Facs.chemrev.8b00520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic landscape of membrane-permeabilizing peptides</span></div><div class="casAuthors">Guha, Shantanu; Ghimire, Jenisha; Wu, Eric; Wimley, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6040-6085</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Membrane-permeabilizing peptides (MPPs) are as ubiquitous as the lipid bilayer membranes they act upon.  Produced by all forms of life, most MPPs are used offensively or defensively against the membranes of other organisms.  Just as Nature has found many uses for them, translational scientists have worked for decades to design or optimize MPPs for applications in the lab. and in the clinic ranging from antibacterial and antiviral therapy and prophylaxis to anticancer therapeutics and drug delivery.  Here, we review the field of MPPs.  We discuss the diversity of their sources and structures, the systems and methods used to measure their activities, and the behaviors that are obsd.  We discuss the fact that "mechanism" is not a discrete or a static entity for a MPP, but rather the result of a heterogeneous and dynamic ensemble of structural states that vary in response to many different exptl. conditions.  This has led to an almost complete lack of discrete 3-dimensional active structures among the thousands of known MPPs and a lack of useful or predictive sequence-structure-function relation rules.  Ultimately, we discuss how it may be more useful to think of MPP mechanisms as broad regions of a mechanistic landscape rather than discrete mol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmLwhESI81t7Vg90H21EOLACvtfcHk0lh-BeZouLDr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltV2jug%253D%253D&md5=a591e43ebc009cbe483ba932a2b93fee</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00520%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DS.%26aulast%3DGhimire%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DWimley%26aufirst%3DW.%2BC.%26atitle%3DMechanistic%2520landscape%2520of%2520membrane-permeabilizing%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D6040%26epage%3D6085%26doi%3D10.1021%2Facs.chemrev.8b00520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, A.</span></span> <span> </span><span class="NLM_article-title">antimicrobial peptides with high proteolytic resistance for combating Gram-negative bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2286</span>– <span class="NLM_lpage">2304</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01348</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01348" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisl2lsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2286-2304&author=J.+Wangauthor=J.+Songauthor=Z.+Yangauthor=S.+Heauthor=Y.+Yangauthor=X.+Fengauthor=X.+Douauthor=A.+Shan&title=antimicrobial+peptides+with+high+proteolytic+resistance+for+combating+Gram-negative+bacteria&doi=10.1021%2Facs.jmedchem.8b01348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria</span></div><div class="casAuthors">Wang, Jiajun; Song, Jing; Yang, Zhanyi; He, Shiqi; Yang, Yi; Feng, Xingjun; Dou, Xiujing; Shan, Anshan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2286-2304</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Poor proteolytic resistance is an urgent problem to be solved in the clin. application of antimicrobial peptides (AMPs), yet common solns., such as complicated chem. modifications and utilization of D-amino acids, greatly increase the difficulty and cost of producing AMPs.  In this work, a set of novel peptides was synthesized based on an antitrypsin/antichymotrypsin hydrolytic peptide structure unit (XYPX)n (X represents I, L, and V; Y represents R and K), which was designed using a systematic natural amino acid arrangement.  Of these peptides, 1 of them with 7 repeat units had the highest av. selectivity index (GMSI = 99.07) for all of the Gram-neg. bacteria tested and remained highly effective in combating Escherichia coli infection in vivo.  Importantly, the same peptide also had dramatic resistance to a high concn. of trypsin/chymotrypsin hydrolysis and exerted bactericidal activity through a membrane-disruptive mechanism.  Overall, these findings provide new approaches for the development of antiprotease hydrolytic peptides that target Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5SNyY4JzKxLVg90H21EOLACvtfcHk0ljjq3ZLCYJxAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisl2lsrs%253D&md5=0a5b9a7741b7b397b9f15e1d9ac30970</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01348%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DDou%26aufirst%3DX.%26aulast%3DShan%26aufirst%3DA.%26atitle%3Dantimicrobial%2520peptides%2520with%2520high%2520proteolytic%2520resistance%2520for%2520combating%2520Gram-negative%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2286%26epage%3D2304%26doi%3D10.1021%2Facs.jmedchem.8b01348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brogden, K. A.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnrmicro1098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=15703760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslGjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=238-250&author=K.+A.+Brogden&title=Antimicrobial+peptides%3A+pore+formers+or+metabolic+inhibitors+in+bacteria%3F&doi=10.1038%2Fnrmicro1098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?</span></div><div class="casAuthors">Brogden, Kim A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-250</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antimicrobial peptides are an abundant and diverse group of mols. that are produced by many tissues and cell types in a variety of invertebrate, plant and animal species.  Their amino acid compn., amphipathicity, cationic charge and size allow them to attach to and insert into membrane bilayers to form pores by 'barrel-stave', 'carpet' or 'toroidal-pore' mechanisms.  Although these models are helpful for defining mechanisms of antimicrobial peptide activity, their relevance to how peptides damage and kill microorganisms still need to be clarified.  Recently, there has been speculation that transmembrane pore formation is not the only mechanism of microbial killing.  In fact several observations suggest that translocated peptides can alter cytoplasmic membrane septum formation, inhibit cell-wall synthesis, inhibit nucleic-acid synthesis, inhibit protein synthesis or inhibit enzymic activity.  In this review the different models of antimicrobial-peptide-induced pore formation and cell killing are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHqUgWDiIDGbVg90H21EOLACvtfcHk0ljjq3ZLCYJxAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslGjtbo%253D&md5=3f795db1fe7d3288a97317b65ceaf0c7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1098%26sid%3Dliteratum%253Aachs%26aulast%3DBrogden%26aufirst%3DK.%2BA.%26atitle%3DAntimicrobial%2520peptides%253A%2520pore%2520formers%2520or%2520metabolic%2520inhibitors%2520in%2520bacteria%253F%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2005%26volume%3D3%26spage%3D238%26epage%3D250%26doi%3D10.1038%2Fnrmicro1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousef, A. E.</span></span> <span> </span><span class="NLM_article-title">Brevibacillin, a cationic lipopeptide that binds to lipoteichoic acid and subsequently disrupts cytoplasmic membrane of Staphylococcus aureus</span>. <i>Microbiol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.micres.2016.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.micres.2016.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28024522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOju7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2017&pages=18-23&author=X.+Yangauthor=E.+Huangauthor=A.+E.+Yousef&title=Brevibacillin%2C+a+cationic+lipopeptide+that+binds+to+lipoteichoic+acid+and+subsequently+disrupts+cytoplasmic+membrane+of+Staphylococcus+aureus&doi=10.1016%2Fj.micres.2016.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Brevibacillin, a cationic lipopeptide that binds to lipoteichoic acid and subsequently disrupts cytoplasmic membrane of Staphylococcus aureus</span></div><div class="casAuthors">Yang, Xu; Huang, En; Yousef, Ahmed E.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiological Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18-23</span>CODEN:
                <span class="NLM_cas:coden">MCRSEJ</span>;
        ISSN:<span class="NLM_cas:issn">0944-5013</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Brevibacillin is a newly-discovered antimicrobial lipopeptide produced by Brevibacillus laterosporus OSY-I1.  It is active against Gram-pos. bacteria, including antibiotic resistant strains.  This research was initiated to investigate the mechanism of action of brevibacillin against an indicator strain, Staphylococcus aureus ATCC 6538.  Results of the study proved that brevibacillin binds to lipoteichoic acid (LTA) on cell wall before interacting with cell membrane.  Addnl., brevibacillin disrupts S. aureus cytoplasmic membrane by increasing its permeability, depolarization and potassium leakage.  Therefore, cytoplasmic membrane serves as a major target for brevibacillin.  Despite the presence of multiple sites on S. aureus cell envelope, scanning electron microscope observation didn't reveal evidence of cell lysis or any morphol. defects in cells treated with brevibacillin.  Based on the results of this study, we propose that the electrostatic interaction between the cationic brevibacillin and the anionic LTA helped the accumulation of the antimicrobial agent at cell surface; this was followed by translocation of the lipopeptide to the cytoplasmic membrane and disrupting its vital functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXfm_MH3lvWbVg90H21EOLACvtfcHk0ljaetliTYQ3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOju7nK&md5=a10a9ba739e19ddf9e8c53cc15eba72e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.micres.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micres.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DYousef%26aufirst%3DA.%2BE.%26atitle%3DBrevibacillin%252C%2520a%2520cationic%2520lipopeptide%2520that%2520binds%2520to%2520lipoteichoic%2520acid%2520and%2520subsequently%2520disrupts%2520cytoplasmic%2520membrane%2520of%2520Staphylococcus%2520aureus%26jtitle%3DMicrobiol.%2520Res.%26date%3D2017%26volume%3D195%26spage%3D18%26epage%3D23%26doi%3D10.1016%2Fj.micres.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Findlay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span> <span> </span><span class="NLM_article-title">Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4049</span>– <span class="NLM_lpage">4058</span>, <span class="refDoi"> DOI: 10.1128/aac.00530-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAAC.00530-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=20696877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlegsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4049-4058&author=B.+Findlayauthor=G.+G.+Zhanelauthor=F.+Schweizer&title=Cationic+amphiphiles%2C+a+new+generation+of+antimicrobials+inspired+by+the+natural+antimicrobial+peptide+scaffold&doi=10.1128%2Faac.00530-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold</span></div><div class="casAuthors">Findlay, Brandon; Zhanel, George G.; Schweizer, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4049-4058</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Naturally occurring cationic antimicrobial peptides (AMPs) and their mimics form a diverse class of antibacterial agents currently validated in preclin. and clin. settings for the treatment of infections caused by antimicrobial-resistant bacteria.  Numerous studies with linear, cyclic, and diastereomeric AMPs have strongly supported the hypothesis that their physicochem. properties, rather than any specific amino acid sequence, are responsible for their microbiol. activities.  It is generally believed that the amphiphilic topol. is essential for insertion into and disruption of the cytoplasmic membrane.  In particular, the ability to rapidly kill bacteria and the relative difficulty with which bacteria develop resistance make AMPs and their mimics attractive targets for drug development.  However, the therapeutic use of naturally occurring AMPs is hampered by the high manufg. costs, poor pharmacokinetic properties, and low bacteriol. efficacy in animal models.  In order to overcome these problems, a variety of novel and structurally diverse cationic amphiphiles that mimic the amphiphilic topol. of AMPs have recently appeared.  Many of these compds. exhibit superior pharmacokinetic properties and reduced in vitro toxicity while retaining potent antibacterial activity against resistant and nonresistant bacteria.  In summary, cationic amphiphiles promise to provide a new and rich source of diverse antibacterial lead structures in the years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2qkJWVEGPeLVg90H21EOLACvtfcHk0ljaetliTYQ3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlegsbbF&md5=ee4e47e560a45a12d8a9625e9f8ce62c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.00530-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00530-10%26sid%3Dliteratum%253Aachs%26aulast%3DFindlay%26aufirst%3DB.%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DSchweizer%26aufirst%3DF.%26atitle%3DCationic%2520amphiphiles%252C%2520a%2520new%2520generation%2520of%2520antimicrobials%2520inspired%2520by%2520the%2520natural%2520antimicrobial%2520peptide%2520scaffold%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4049%26epage%3D4058%26doi%3D10.1128%2Faac.00530-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Membrane-active hydantoin derivatives as antibiotic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8456</span>– <span class="NLM_lpage">8465</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00847</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00847" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8456-8465&author=M.+Suauthor=D.+Xiaauthor=P.+Tengauthor=A.+Nimmagaddaauthor=C.+Zhangauthor=T.+Odomauthor=A.+Caoauthor=Y.+Huauthor=J.+Cai&title=Membrane-active+hydantoin+derivatives+as+antibiotic+agents&doi=10.1021%2Facs.jmedchem.7b00847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-Active Hydantoin Derivatives as Antibiotic Agents</span></div><div class="casAuthors">Su, Ma; Xia, Donglin; Teng, Peng; Nimmagadda, Alekhya; Zhang, Chao; Odom, Timothy; Cao, Annie; Hu, Yong; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8456-8465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydantoin (imidazolidinedione) derivs. such as nitrofurantoin are small mols. that have aroused considerable interest recently due to their low rate of bacterial resistance.  However, their moderate antimicrobial activity may hamper their application combating antibiotic resistance in the long run.  Herein we report the design of bacterial membrane-active hydantoin derivs., from which we identified compds. that show much more potent antimicrobial activity against a panel of clin. relevant Gram-pos. and Gram-neg. bacterial strains than nitrofurantoin.  These compds. are able to act on bacterial membranes, analogous to natural host-defense peptides (HDPs).  Addnl., these hydantoin compds. could not only kill bacterial pathogens rapidly, but also prevent the development of methicillin-resistant Staphylococcus aureus (MRSA) bacterial resistance under the tested conditions.  More intriguingly, the lead compd. exhibited in vivo efficacy which is much superior to vancomycin by eradicating bacteria and suppressing inflammation caused by MRSA-induced pneumonia on a rat model, demonstrating their promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp48yfWduVgk7Vg90H21EOLACvtfcHk0ljaetliTYQ3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK&md5=04a2e9ba317c8f7f444db7cdd6bffce7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00847%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DM.%26aulast%3DXia%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DOdom%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DMembrane-active%2520hydantoin%2520derivatives%2520as%2520antibiotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8456%26epage%3D8465%26doi%3D10.1021%2Facs.jmedchem.7b00847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, W. H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasco, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrand, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okhuysen, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontoyiannis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasqualini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arap, W.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1073/pnas.1221924110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1073%2Fpnas.1221924110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=23345420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvVKmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=3477-3482&author=D.+M.+McGrathauthor=E.+M.+Barbuauthor=W.+H.+P.+Driessenauthor=T.+M.+Lascoauthor=J.+J.+Tarrandauthor=P.+C.+Okhuysenauthor=D.+P.+Kontoyiannisauthor=R.+L.+Sidmanauthor=R.+Pasqualiniauthor=W.+Arap&title=Mechanism+of+action+and+initial+evaluation+of+a+membrane+active+all-D-enantiomer+antimicrobial+peptidomimetic&doi=10.1073%2Fpnas.1221924110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic</span></div><div class="casAuthors">McGrath, Danielle M.; Barbu, E. Magda; Driessen, Wouter H. P.; Lasco, Todd M.; Tarrand, Jeffrey J.; Okhuysen, Pablo C.; Kontoyiannis, Dimitrios P.; Sidman, Richard L.; Pasqualini, Renata; Arap, Wadih</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3477-3482, S3477/1-S3477/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Development of therapy against infections caused by antibiotic-resistant pathogens is a major unmet need in contemporary medicine.  In previous work, our group chem. modified an antimicrobial peptidomimetic motif for targeted applications against cancer and obesity.  Here, we show that the modified motif per se is resistant to proteolytic degrdn. and is a candidate antiinfective agent.  We also show that the susceptibility of microorganisms to the drug is independent of bacterial growth phase.  Moreover, this peptidomimetic selectively interferes with the integrity and function of the microbial surface lipid bilayer, data indicative that bacterial death results from membrane disruption followed by dissipation of membrane potential.  Finally, we demonstrate two potential translational applications: use against biofilms and synergy with antibiotics in use.  In summary, we introduce the mechanism of action and the initial evaluation of a prototype drug and a platform for the development of D-enantiomer antimicrobial peptidomimetics that target bacterial membranes of certain Gram-neg. problem pathogens with promising translational applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJwWb5lxPHzbVg90H21EOLACvtfcHk0liy8XKCJgcZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvVKmsrc%253D&md5=dce1c5db4bd8eb36f2c26e4e10fd0fc8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1221924110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1221924110%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DD.%2BM.%26aulast%3DBarbu%26aufirst%3DE.%2BM.%26aulast%3DDriessen%26aufirst%3DW.%2BH.%2BP.%26aulast%3DLasco%26aufirst%3DT.%2BM.%26aulast%3DTarrand%26aufirst%3DJ.%2BJ.%26aulast%3DOkhuysen%26aufirst%3DP.%2BC.%26aulast%3DKontoyiannis%26aufirst%3DD.%2BP.%26aulast%3DSidman%26aufirst%3DR.%2BL.%26aulast%3DPasqualini%26aufirst%3DR.%26aulast%3DArap%26aufirst%3DW.%26atitle%3DMechanism%2520of%2520action%2520and%2520initial%2520evaluation%2520of%2520a%2520membrane%2520active%2520all-D-enantiomer%2520antimicrobial%2520peptidomimetic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D3477%26epage%3D3482%26doi%3D10.1073%2Fpnas.1221924110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.-S.</span></span> <span> </span><span class="NLM_article-title">Rational design of dimeric lysine N-alkylamides as potent and broad-spectrum antibacterial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2865</span>– <span class="NLM_lpage">2874</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls12rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2865-2874&author=Y.+Niuauthor=M.+Wangauthor=Y.+Caoauthor=A.+Nimmagaddaauthor=J.+Huauthor=Y.+Wuauthor=J.+Caiauthor=X.-S.+Ye&title=Rational+design+of+dimeric+lysine+N-alkylamides+as+potent+and+broad-spectrum+antibacterial+agents&doi=10.1021%2Facs.jmedchem.7b01704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of dimeric lysine N-alkylamides as potent and broad-spectrum antibacterial agents</span></div><div class="casAuthors">Niu, Youhong; Wang, Minghui; Cao, Yafei; Nimmagadda, Alekhya; Hu, Jianxing; Wu, Yanfen; Cai, Jianfeng; Ye, Xin-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2865-2874</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibiotic resistance is one of the biggest threats to public health, and new antibacterial agents hence are in an urgent need to combat infectious diseases caused by multidrug-resistant (MDR) pathogens.  Utilizing dimerization strategy, we rationally designed and efficiently synthesized a new series of small mol. dimeric lysine alkylamides as mimics of AMPs.  Evaluation of these mimics against a panel of Gram-pos. and Gram-neg. bacteria including MDR strains was performed, and a broad-spectrum and potent compd. 3d was identified.  This compd. displayed high specificity toward bacteria over mammalian cell.  Time-kill kinetics and mechanistic studies suggest that compd. 3d quickly eliminated bacteria in a bactericidal mode by disrupting bacterial cell membrane.  In addn., lead compd. 3d could inhibit biofilm formation and did not develop drug resistance in S. aureus and E. coli over 14 passages.  These results suggested that dimeric lysine nonylamide has immense potential as a new type of novel small mol. agent to combat antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnI-sRpeWWrVg90H21EOLACvtfcHk0liy8XKCJgcZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls12rs7g%253D&md5=f304b5d88750ec42c05b798d12ffca56</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01704%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DX.-S.%26atitle%3DRational%2520design%2520of%2520dimeric%2520lysine%2520N-alkylamides%2520as%2520potent%2520and%2520broad-spectrum%2520antibacterial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2865%26epage%3D2874%26doi%3D10.1021%2Facs.jmedchem.7b01704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span> <span> </span><span class="NLM_article-title">Symmetrically substituted xanthone amphiphiles combat Gram-positive bacterial resistance with enhanced membrane selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1362</span>– <span class="NLM_lpage">1378</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01403</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01403" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1362-1378&author=S.+Linauthor=J.-J.+Kohauthor=T.+T.+Aungauthor=F.+Limauthor=J.+Liauthor=H.+Zouauthor=L.+Wangauthor=R.+Lakshminarayananauthor=C.+Vermaauthor=Y.+Wangauthor=D.+T.+H.+Tanauthor=D.+Caoauthor=R.+W.+Beuermanauthor=L.+Renauthor=S.+Liu&title=Symmetrically+substituted+xanthone+amphiphiles+combat+Gram-positive+bacterial+resistance+with+enhanced+membrane+selectivity&doi=10.1021%2Facs.jmedchem.6b01403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity</span></div><div class="casAuthors">Lin, Shuimu; Koh, Jun-Jie; Aung, Thet Tun; Lim, Fanghui; Li, Jianguo; Zou, Hanxun; Wang, Lin; Lakshminarayanan, Rajamani; Verma, Chandra; Wang, Yingjun; Tan, Donald T. H.; Cao, Derong; Beuerman, Roger W.; Ren, Li; Liu, Shouping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1362-1378</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This is the first report of the design of a new series of sym. xanthone derivs. that mimic antimicrobial peptides using a total synthesis approach.  This novel design is advantageous because of its low cost, synthetic simplicity and versatility, and easy tuning of amphiphilicity by controlling the incorporated cationic and hydrophobic moieties.  Two water-sol. optimized compds., 6 and 18, showed potent activities against Gram-pos. bacteria, including MRSA and VRE (MICs = 0.78-6.25 μg/mL) with a rapid bactericidal effect, low toxicity, and no emergence of drug resistance.  Both compds. demonstrated enhanced membrane selectivity that was higher than those of most membrane-active antimicrobials in clin. trials or previous reports.  The compds. appear to kill bacteria by disrupting their membranes.  Significantly, 6 was effective in vivo using a mouse model of corneal infection.  These results provide compelling evidence that these compds. have therapeutic potential as novel antimicrobials for multidrug-resistant Gram-pos. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJxwyFlLljvLVg90H21EOLACvtfcHk0liy8XKCJgcZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2nt7w%253D&md5=7d795198c3ad66d9944d122e3b76b0a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01403%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKoh%26aufirst%3DJ.-J.%26aulast%3DAung%26aufirst%3DT.%2BT.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLakshminarayanan%26aufirst%3DR.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BH.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DSymmetrically%2520substituted%2520xanthone%2520amphiphiles%2520combat%2520Gram-positive%2520bacterial%2520resistance%2520with%2520enhanced%2520membrane%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1362%26epage%3D1378%26doi%3D10.1021%2Facs.jmedchem.6b01403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonuguntala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Selective and broad spectrum amphiphilic small molecules to combat bacterial resistance and eradicate biofilms</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">13670</span>– <span class="NLM_lpage">13673</span>, <span class="refDoi"> DOI: 10.1039/c5cc05159b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1039%2FC5CC05159B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26226319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=13670-13673&author=J.+Hoqueauthor=M.+M.+Konaiauthor=S.+Samaddarauthor=S.+Gonuguntalaauthor=G.+B.+Manjunathauthor=C.+Ghoshauthor=J.+Haldar&title=Selective+and+broad+spectrum+amphiphilic+small+molecules+to+combat+bacterial+resistance+and+eradicate+biofilms&doi=10.1039%2Fc5cc05159b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and broad spectrum amphiphilic small molecules to combat bacterial resistance and eradicate biofilms</span></div><div class="casAuthors">Hoque, Jiaul; Konai, Mohini M.; Samaddar, Sandip; Gonuguntala, Spandhana; Manjunath, Goutham B.; Ghosh, Chandradhish; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">71</span>),
    <span class="NLM_cas:pages">13670-13673</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Rationally designed amphiphilic small mols. selectively kill drug-sensitive and drug-resistant bacteria over mammalian cells.  The small mols. disperse preformed biofilms and reduce viable bacterial count in the biofilms.  Moreover, this class of membrane-active mols. disarms the development of bacterial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmZEe5Q7DlrVg90H21EOLACvtfcHk0liyIXUjNdzVbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7zN&md5=b2504aee26021ce12a94747d4dba615f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5CC05159B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC05159B%26sid%3Dliteratum%253Aachs%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DGonuguntala%26aufirst%3DS.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DSelective%2520and%2520broad%2520spectrum%2520amphiphilic%2520small%2520molecules%2520to%2520combat%2520bacterial%2520resistance%2520and%2520eradicate%2520biofilms%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D13670%26epage%3D13673%26doi%3D10.1039%2Fc5cc05159b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mensa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGrado, W. F.</span></span> <span> </span><span class="NLM_article-title">Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5136</span>– <span class="NLM_lpage">5145</span>, <span class="refDoi"> DOI: 10.1128/aac.02955-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2Faac.02955-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=24936592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5136-5145&author=B.+Mensaauthor=G.+L.+Howellauthor=R.+Scottauthor=W.+F.+DeGrado&title=Comparative+mechanistic+studies+of+brilacidin%2C+daptomycin%2C+and+the+antimicrobial+peptide+LL16&doi=10.1128%2Faac.02955-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16</span></div><div class="casAuthors">Mensa, Bruk; Howell, Gabriella L.; Scott, Richard; DeGrado, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5136-5145, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brilacidin (PMX30063) has shown potent bactericidal activity against drug-resistant and -susceptible strains of multiple Gram-neg. and Gram-pos. pathogens.  In this study, we demonstrate that brilacidin causes membrane depolarization in the Gram-pos. bacterium Staphylococcus aureus, to an extent comparable to that caused by the lipopeptidic drug daptomycin.  Transcriptional profiling of Staphylococcus aureus by deep sequencing shows that the global response to brilacidin treatment is well correlated to those of treatment with daptomycin and the cationic antimicrobial peptide LL37 and mostly indicates abrogation of cell wall and membrane functions.  Furthermore, the upregulation of various chaperones and proteases by brilacidin and daptomycin indicates that cytoplasmic protein misfolding stress may be a contributor to the mechanism of action of these drugs.  These stress responses were orchestrated mainly by three two-component systems, GraSR, VraSR, and NsaSR, which have been implicated in virulence and drug resistance against other clin. available antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqtP1aYaCLLVg90H21EOLACvtfcHk0liyIXUjNdzVbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqtbnE&md5=23e73a23fd1f1dd05de0d5c773fcf755</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2Faac.02955-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02955-14%26sid%3Dliteratum%253Aachs%26aulast%3DMensa%26aufirst%3DB.%26aulast%3DHowell%26aufirst%3DG.%2BL.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DDeGrado%26aufirst%3DW.%2BF.%26atitle%3DComparative%2520mechanistic%2520studies%2520of%2520brilacidin%252C%2520daptomycin%252C%2520and%2520the%2520antimicrobial%2520peptide%2520LL16%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5136%26epage%3D5145%26doi%3D10.1128%2Faac.02955-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanowski, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mah, F. S.</span></span> <span> </span><span class="NLM_article-title">An independent evaluation of a novel peptide mimetic, Brilacidin (PMX30063), for ocular anti-infective</span>. <i>J. Ocul. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1089/jop.2015.0098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1089%2Fjop.2015.0098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26501484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28Xosl2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=23-27&author=R.+P.+Kowalskiauthor=E.+G.+Romanowskiauthor=K.+A.+Yatesauthor=F.+S.+Mah&title=An+independent+evaluation+of+a+novel+peptide+mimetic%2C+Brilacidin+%28PMX30063%29%2C+for+ocular+anti-infective&doi=10.1089%2Fjop.2015.0098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-infective</span></div><div class="casAuthors">Kowalski, Regis P.; Romanowski, Eric G.; Yates, Kathleen A.; Mah, Francis S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ocular Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">JOPTFU</span>;
        ISSN:<span class="NLM_cas:issn">1080-7683</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Objective: Brilacidin (BRI), a novel defensin mimetic, was evaluated as an ocular anti-infective.  Methods: In vitro: Potency based on MIC90s was compared for 50 Staphylococcus aureus (SA), 50 Staphylococcus epidermidis (SE), and 25 each of Streptococcus pneumonia (SP), Streptococcus viridans (SV), Moraxella (MS), Haemophilus influenzae (HI), Pseudomonas aeruginosa (PA), and Serratia marcescens (SM).  In vivo: Using established methods, ocular toxicity was graded with Draize testing.  For efficacy testing, both corneas of 24 rabbits were infected with methicillin-resistant S. aureus (MRSA), whereas the corneal epithelium was removed in the left eye.  After 4 h, 21 topical drops over 5 h were administered to 4 groups: BRI 0.5%, vancomycin (VAN) 5%, saline, and no treatment.  The eyes were clin. graded and the corneas were harvested for colony counts.  Results: In vitro: Both SA and SE had the lowest min. inhibitory concns. among the bacterial groups.  The MIC90s to BRI for SP, SV, MS, HI, PA, and SM were 4, 32, 256, 32, 16, and 128-fold higher, resp., than SA and SE.  In vivo: Draize testing detd. BRI 0.5% to be minimally irritating.  For abraded corneas, BRI was not statistically different from VAN for reducing MRSA.  BRI was bactericidal.  For intact corneas, VAN reduced more CFU than BRI.  BRI reduced CFU in abraded corneas more than intact corneas suggesting poor corneal penetration.  Conclusions: BRI has Gram-pos. in vitro activity; topical BRI 0.5% was minimally irritating; and BRI 0.5% was equally efficacious as VAN in a MRSA keratitis model when the corneal epithelium was removed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7mz9C2Tiw77Vg90H21EOLACvtfcHk0liyIXUjNdzVbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xosl2ltw%253D%253D&md5=6590d3fd9747f075907e6dfab1a51164</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1089%2Fjop.2015.0098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fjop.2015.0098%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DR.%2BP.%26aulast%3DRomanowski%26aufirst%3DE.%2BG.%26aulast%3DYates%26aufirst%3DK.%2BA.%26aulast%3DMah%26aufirst%3DF.%2BS.%26atitle%3DAn%2520independent%2520evaluation%2520of%2520a%2520novel%2520peptide%2520mimetic%252C%2520Brilacidin%2520%2528PMX30063%2529%252C%2520for%2520ocular%2520anti-infective%26jtitle%3DJ.%2520Ocul.%2520Pharmacol.%2520Ther.%26date%3D2016%26volume%3D32%26spage%3D23%26epage%3D27%26doi%3D10.1089%2Fjop.2015.0098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsdal, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaten, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span> <span> </span><span class="NLM_article-title">A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5786</span>– <span class="NLM_lpage">5795</span>, <span class="refDoi"> DOI: 10.1021/jm200450h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200450h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5786-5795&author=J.+Isakssonauthor=B.+O.+Brandsdalauthor=M.+Engqvistauthor=G.+E.+Flatenauthor=J.+S.+M.+Svendsenauthor=W.+Stensen&title=A+synthetic+antimicrobial+peptidomimetic+%28LTX+109%29%3A+stereochemical+impact+on+membrane+disruption&doi=10.1021%2Fjm200450h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption</span></div><div class="casAuthors">Isaksson, Johan; Brandsdal, Bjoern O.; Engqvist, Magnus; Flaten, Goeril Eide; Svendsen, John S. Mjoeen; Stensen, Wenche</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5786-5795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">LTX 109 is a synthetic antimicrobial peptidomimetic (SAMP) currently in clin. phase II trials for topical treatment of infections of multiresistant bacterial strains.  All possible eight stereoisomers of the peptidomimetic have been synthesized and tested for antimicrobial effect, hemolysis, and hydrophobicity, revealing a strong and unusual dependence on the stereochem. for a mol. proposed to act on a general membrane mechanism.  The three-dimensional structures were assessed using NMR spectroscopy and mol. dynamics (MD) simulations in aq. soln. and in phospholipid bilayers.  The soln. structures of the most active stereoisomers are perfectly preorganized for insertion into the membrane, whereas the less active isomers need to pay an energy penalty in order to enter the lipid bilayer.  This effect is also found to be reinforced by a significantly improved water soly. of the less active isomers due to a guanidinyl-π stacking that helps to solvate the hydrophobic surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5IxYJkubahrVg90H21EOLACvtfcHk0lhk5r-HdoYJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSlu74%253D&md5=081d8fb5a6bcc47c299f0d8497436298</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm200450h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200450h%26sid%3Dliteratum%253Aachs%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DBrandsdal%26aufirst%3DB.%2BO.%26aulast%3DEngqvist%26aufirst%3DM.%26aulast%3DFlaten%26aufirst%3DG.%2BE.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%2BM.%26aulast%3DStensen%26aufirst%3DW.%26atitle%3DA%2520synthetic%2520antimicrobial%2520peptidomimetic%2520%2528LTX%2520109%2529%253A%2520stereochemical%2520impact%2520on%2520membrane%2520disruption%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5786%26epage%3D5795%26doi%3D10.1021%2Fjm200450h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J. P. E.</span></span> <span> </span><span class="NLM_article-title">Flavonoids: modulators of brain function?</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">ES60</span>– <span class="NLM_lpage">ES77</span>, <span class="refDoi"> DOI: 10.1017/s0007114508965776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1017%2FS0007114508965776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=18503736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BD1cvgtl2msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=ES60-ES77&author=J.+P.+E.+Spencer&title=Flavonoids%3A+modulators+of+brain+function%3F&doi=10.1017%2Fs0007114508965776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoids: modulators of brain function?</span></div><div class="casAuthors">Spencer Jeremy P E</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99 E Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">ES60-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Emerging evidence suggests that dietary phytochemicals, in particular flavonoids, may exert beneficial effects on the central nervous system by protecting neurons against stress-induced injury, by suppressing neuroinflammation and by improving cognitive function.  It is likely that flavonoids exert such effects, through selective actions on different components of a number of protein kinase and lipid kinase signalling cascades, such as the phosphatidylinositol-3 kinase (PI3K)/Akt, protein kinase C and mitogen-activated protein kinase (MAPK) pathways.  This review explores the potential inhibitory or stimulatory actions of flavonoids within these pathways, and describes how such interactions are likely to underlie neurological effects through their ability to affect the activation state of target molecules and/or by modulating gene expression.  Future research directions are outlined in relation to the precise site(s) of action of flavonoids within signalling pathways and the sequence of events that allow them to regulate neuronal function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMIza6rH6dnc-crCu0nI_sfW6udTcc2eYdM9fxKDwABbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvgtl2msQ%253D%253D&md5=2362938fddc05be3dd0209708e316de2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1017%2FS0007114508965776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114508965776%26sid%3Dliteratum%253Aachs%26aulast%3DSpencer%26aufirst%3DJ.%2BP.%2BE.%26atitle%3DFlavonoids%253A%2520modulators%2520of%2520brain%2520function%253F%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2008%26volume%3D99%26spage%3DES60%26epage%3DES77%26doi%3D10.1017%2Fs0007114508965776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span> <span> </span><span class="NLM_article-title">A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.bmc.2019.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30733087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisFWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=677-685&author=L.+Zhaoauthor=X.+Yuanauthor=J.+Wangauthor=Y.+Fengauthor=F.+Jiauthor=Z.+Liauthor=J.+Bian&title=A+review+on+flavones+targeting+serine%2Fthreonine+protein+kinases+for+potential+anticancer+drugs&doi=10.1016%2Fj.bmc.2019.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs</span></div><div class="casAuthors">Zhao, Lulu; Yuan, Xinyu; Wang, Jubo; Feng, Yifan; Ji, Fei; Li, Zhiyu; Bian, Jinlei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">677-685</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinases have been important targets for antitumor targets due to their key roles in regulating multiple cell signaling pathways.  Numerous compds. contg. flavonoid scaffold as an indispensable anchor have been found to be potent inhibitors of protein kinases.  Some of these flavonoids have been in clin. research as protein kinases inhibitors.  Thus, the present review mainly focuses on the structural requirement for anticancer potential of flavone derivs. targeting several key serine/threonine protein kinases.  This information may provide an opportunity to scientists of medicinal chem. to design multi-functional flavone derivs. for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmyQGt6sovELVg90H21EOLACvtfcHk0lhk5r-HdoYJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisFWns7k%253D&md5=a8b98bcec680fac93880ea6be56bc1b6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBian%26aufirst%3DJ.%26atitle%3DA%2520review%2520on%2520flavones%2520targeting%2520serine%252Fthreonine%2520protein%2520kinases%2520for%2520potential%2520anticancer%2520drugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D677%26epage%3D685%26doi%3D10.1016%2Fj.bmc.2019.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span> <span> </span><span class="NLM_article-title">Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor</span>. <i>Anticancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1097/cad.0000000000000708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1097%2FCAD.0000000000000708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BB3cvjsV2rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=153-158&author=W.+Maauthor=X.+Liuauthor=W.+Du&title=Baicalin+induces+apoptosis+in+SW480+cells+through+downregulation+of+the+SP1+transcription+factor&doi=10.1097%2Fcad.0000000000000708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor</span></div><div class="casAuthors">Ma Wenkang; Liu Xueyuan; Du Wei</div><div class="citationInfo"><span class="NLM_cas:title">Anti-cancer drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-158</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer occurs throughout the world but is most common in developed countries.  Cancer progression is believed to be driven by genetic mutations in this complex condition.  Risk factors for developing colorectal cancer include a genetic family history, long-term ulcerative colitis, and colonic polyps.  The use of baicalin has been reported to be clinically efficacious against colon tumors in Asian countries despite an unclear mechanism of action.  Several cancers have been found to be biologically dependent on the specificity protein 1 (sp1) transcription factor family.  We hypothesized that baicalin may exert its chemotherapeutic effects by sp1 downregulation.  Using the SW480 human colorectal cancer cell line, we investigated the physiological properties of baicalin.  Our experiments were designed toward clarifying three goals: (a) to determine the mRNA expression profile of transcription factors in colorectal cancer patients using a microarray-based analysis; (b) to determine the effects of baicalin on the sp1 transcription factor with western blotting and reporter cell assays; and (c) to contrast the effects of mithramycin-A (an sp1 transcription factor inhibitor) and baicalin using western blotting and reporter cell assays.  Both baicalin and mithramycin-A downregulated sp1 expression, attenuated SW480 cell proliferation, and increased cell apoptosis.  Baicalin inhibited sp1 expression and led to SW480 apoptosis, thus clarifying the effect of this traditional Chinese medicine compound in the treatment of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxLHvjTTM3m2BAiYWy6n3SfW6udTcc2eZFeUAfysRYobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvjsV2rug%253D%253D&md5=088066d71290e8e3194829470f752025</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000708%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DW.%26atitle%3DBaicalin%2520induces%2520apoptosis%2520in%2520SW480%2520cells%2520through%2520downregulation%2520of%2520the%2520SP1%2520transcription%2520factor%26jtitle%3DAnticancer%2520Drugs%26date%3D2019%26volume%3D30%26spage%3D153%26epage%3D158%26doi%3D10.1097%2Fcad.0000000000000708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.-Z.</span></span> <span> </span><span class="NLM_article-title">Antibacterial effect and mode of action of flavonoids from licorice against Methicillin-resistant Staphylococcus aureus</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2489</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2019.02489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.3389%2Ffmicb.2019.02489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=31749783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BB3MfhsVamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2489&author=S.-C.+Wuauthor=Z.-Q.+Yangauthor=F.+Liuauthor=W.-J.+Pengauthor=S.-Q.+Quauthor=Q.+Liauthor=X.-B.+Songauthor=K.+Zhuauthor=J.-Z.+Shen&title=Antibacterial+effect+and+mode+of+action+of+flavonoids+from+licorice+against+Methicillin-resistant+Staphylococcus+aureus&doi=10.3389%2Ffmicb.2019.02489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial Effect and Mode of Action of Flavonoids From Licorice Against Methicillin-Resistant Staphylococcus aureus</span></div><div class="casAuthors">Wu Shuai-Cheng; Yang Zhi-Qiang; Liu Fei; Peng Wen-Jing; Qu Shao-Qi; Li Qian; Song Xiang-Bin; Zhu Kui; Shen Jian-Zhong; Wu Shuai-Cheng; Wu Shuai-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2489</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Staphylococcus aureus is a bacterial pathogen that causes food poisoning, various infections, and sepsis.  Effective strategies and new drugs are needed to control S. aureus associated infections due to the emergence and rapid dissemination of antibiotic resistance.  In the present study, the antibacterial activity, potential mode of action, and applications of flavonoids from licorice were investigated.  Here, we showed that glabrol, licochalcone A, licochalcone C, and licochalcone E displayed high efficiency against methicillin-resistant Staphylococcus aureus (MRSA).  Glabrol, licochalcone A, licochalcone C, and licochalcone E exhibited low cytotoxicity without hemolytic activity based on safety evaluation.  Glabrol displayed rapid bactericidal activity with low levels of resistance development in vitro.  Meanwhile, glabrol rapidly increased bacterial membrane permeability and dissipated the proton move force.  Furthermore, we found that peptidoglycan, phosphatidylglycerol, and cardiolipin inhibited the antibacterial activity of glabrol.  Molecular docking showed that glabrol binds to phosphatidylglycerol and cardiolipin through the formation of hydrogen bonds.  Lastly, glabrol showed antibacterial activity against MRSA in both in vivo and in vitro models.  Altogether, these results suggest that glabrol is a promising lead compound for the design of membrane-active antibacterial agents against MRSA and can be used as a disinfectant candidate as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTE3s5V2R8p8--MdeMhXAHkfW6udTcc2eZFeUAfysRYobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MfhsVamug%253D%253D&md5=27765d8ae20cef4d50e472572336cfde</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2019.02489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2019.02489%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.-C.%26aulast%3DYang%26aufirst%3DZ.-Q.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DPeng%26aufirst%3DW.-J.%26aulast%3DQu%26aufirst%3DS.-Q.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DSong%26aufirst%3DX.-B.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DShen%26aufirst%3DJ.-Z.%26atitle%3DAntibacterial%2520effect%2520and%2520mode%2520of%2520action%2520of%2520flavonoids%2520from%2520licorice%2520against%2520Methicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DFront.%2520Microbiol.%26date%3D2019%26volume%3D10%26spage%3D2489%26doi%3D10.3389%2Ffmicb.2019.02489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kładna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berczynski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dundar, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unlusoy, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakinowska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboul-Enein, H. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antioxidant activity of new pyrimidin/benzothiazol-substituted piperazinyl flavones</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2308</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.4155%2Ffmc-2018-0206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30273015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=2293-2308&author=A.+K%C5%82adnaauthor=P.+Berczynskiauthor=O.+B.+Dundarauthor=M.+C.+Unlusoyauthor=E.+Sariauthor=B.+Bakinowskaauthor=I.+Krukauthor=H.+Y.+Aboul-Enein&title=Synthesis+and+in+vitro+antioxidant+activity+of+new+pyrimidin%2Fbenzothiazol-substituted+piperazinyl+flavones&doi=10.4155%2Ffmc-2018-0206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antioxidant activity of new pyrimidin/benzothiazol-substituted piperazinyl flavones</span></div><div class="casAuthors">Kladna, Aleksandra; Berczynski, Pawel; Duendar, Oya Bozdag; Uenluesoy, Meltem Ceylan; Sari, Elmas; Bakinowska, Bernadetta; Kruk, Irena; Aboul-Enein, Hassan Y.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2293-2308</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: Synthesis of novel 2(2-hydroxyphenyl) pyrimidine/benzothiazole piperazinyl-substituted flavones end evaluate their antioxidant activity.  Results: Six novel 2-(2-hydroxyphenyl) pyrimidine/benzothiazole-substituted flavones were synthesized, their structures were confirmed by elementary and spectral analyses.  The compds. were evaluated for their in vitro antioxidant potency by employing various antioxidant assays.  Conclusion: All tested compds. acted as scavengers of free radicals like hydroxyl (15-45%), 2,2-diphenyl-1-picrylhydrazyl• (17-48%) at 1.25 and 0.5 mM concns. resp.  The total antioxidant status activity values of the compds. ranged from 234.1 to 464.1 μm trolox equiv./g, the total antioxidant capacity - from 24.9 to 52.7 μm trolox equiv. per g.  Compds. incorporating the benzothiazole group on the piperazine ring were more effective antioxidants than those with the 2-(2-hydroxyphenyl) pyrimidine group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_k3oe5Ro_GbVg90H21EOLACvtfcHk0lgTdVAbappa8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtb3E&md5=b16dfa08857ec85ac4b4ca5b66dcc1e4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0206%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C5%2582adna%26aufirst%3DA.%26aulast%3DBerczynski%26aufirst%3DP.%26aulast%3DDundar%26aufirst%3DO.%2BB.%26aulast%3DUnlusoy%26aufirst%3DM.%2BC.%26aulast%3DSari%26aufirst%3DE.%26aulast%3DBakinowska%26aufirst%3DB.%26aulast%3DKruk%26aufirst%3DI.%26aulast%3DAboul-Enein%26aufirst%3DH.%2BY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antioxidant%2520activity%2520of%2520new%2520pyrimidin%252Fbenzothiazol-substituted%2520piperazinyl%2520flavones%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D2293%26epage%3D2308%26doi%3D10.4155%2Ffmc-2018-0206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">Antioxidant protection of nobiletin, 5-demethylnobiletin, tangeretin, and 5-demethyltangeretin from Citrus peel in Saccharomyces cerevisiae</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">3155</span>– <span class="NLM_lpage">3160</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.8b00509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.8b00509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=3155-3160&author=M.+Wangauthor=D.+Mengauthor=P.+Zhangauthor=X.+Wangauthor=G.+Duauthor=C.+Brennanauthor=S.+Liauthor=C.-T.+Hoauthor=H.+Zhao&title=Antioxidant+protection+of+nobiletin%2C+5-demethylnobiletin%2C+tangeretin%2C+and+5-demethyltangeretin+from+Citrus+peel+in+Saccharomyces+cerevisiae&doi=10.1021%2Facs.jafc.8b00509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant Protection of Nobiletin, 5-Demethylnobiletin, Tangeretin, and 5-Demethyltangeretin from Citrus Peel in Saccharomyces cerevisiae</span></div><div class="casAuthors">Wang, Meiyan; Meng, Dan; Zhang, Peng; Wang, Xiangxing; Du, Gang; Brennan, Charles; Li, Shiming; Ho, Chi-Tang; Zhao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3155-3160</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aging and oxidative-related events are closely assocd. with the oxidative damages induced by excess reactive oxygen species (ROS).  The phytochems. nobiletin (NBT) and tangeretin (TAN) and their 5-demethylated derivs. 5-demethylnobiletin (5-DN) and 5-demethyltangeretin (5-DT) are the representative polymethoxyflavone (PMF) compds. found in aged citrus peels.  Although the health benefits from PMFs due to their antioxidant activities have been well documented, a systematic assessment regarding the antioxidn. process of PMFs is still lacking attention.  Herein, the authors investigated the effects of the four PMFs subjected to oxidative stress including hydrogen peroxide, carbon tetrachloride, and cadmium sulfate using an emerging model organism Saccharomyces cerevisiae.  As expected, all four of the PMFs exhibited improved cellular tolerance with decreasing lipid peroxidn. and ROS.  Furthermore, by using the mutant strains deficient in catalase, superoxide dismutase, or glutathione synthase, NBT, 5-DN, and TAN appear to contribute to the increased tolerance by activating cytosolic catalase under CCl4, while the antioxidant protection conferred by 5-DT against H2O2 and CdSO4 seems to require cytosolic catalase and glutathione, resp.  However, the involvement of Ctt1 and Sod1 is achieved neither by decreasing lipid peroxidn. nor by scavenging intracellular ROS according to the authors' results.  In addn., a comparison of antioxidant capability of the four PMFs was conducted in this study.  In general, this research tries to explore the antioxidant mechanism of PMFs in Saccharomyces cerevisiae, hoping to provide an example for developing more efficacious dietary antioxidants to battle against oxidative- or age-related illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8e5wZTsTgfbVg90H21EOLACvtfcHk0lgTdVAbappa8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWhsbk%253D&md5=e9a9fcb60abf9c1c3020af50440e0497</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.8b00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.8b00509%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DC.-T.%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DAntioxidant%2520protection%2520of%2520nobiletin%252C%25205-demethylnobiletin%252C%2520tangeretin%252C%2520and%25205-demethyltangeretin%2520from%2520Citrus%2520peel%2520in%2520Saccharomyces%2520cerevisiae%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2018%26volume%3D66%26spage%3D3155%26epage%3D3160%26doi%3D10.1021%2Facs.jafc.8b00509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span> <span> </span><span class="NLM_article-title">Antiviral flavones from the leaves of Nicotiana tabacum</span>. <i>Phytochem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.phytol.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.phytol.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFahsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=75-78&author=L.+Yuanauthor=W.+Huangauthor=C.+Zhangauthor=N.+Xiangauthor=C.+Liuauthor=G.+Yangauthor=Y.+Chenauthor=M.+Miaoauthor=Y.+Ma&title=Antiviral+flavones+from+the+leaves+of+Nicotiana+tabacum&doi=10.1016%2Fj.phytol.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral flavones from the leaves of Nicotiana tabacum</span></div><div class="casAuthors">Yuan, Lin; Huang, Wenzhong; Zhang, Chengming; Xiang, Nengjun; Liu, Chunbo; Yang, Guangyu; Chen, Yongkuang; Miao, Mingming; Ma, Yinhai</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-78</span>CODEN:
                <span class="NLM_cas:coden">PLHEBK</span>;
        ISSN:<span class="NLM_cas:issn">1874-3900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three new flavones, tabaflavones A-C (1-3), together with three known flavones (4-6), were isolated from the leaves of Nicotiana tabacum.  Their structures were elucidated by spectroscopic methods, including extensive 1D and 2D NMR techniques.  Compds. 1-6 were evaluated for their anti-tobacco mosaic virus (anti-TMV) activities.  The results showed compd. 1 exhibited moderate anti-TMV activity with inhibition rate of 29.2%, which is close to that of the pos. control.  The other compds. also showed the anti-TMV activities with inhibition rates in the range of 14.2-20.8%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW5ZZGKFwFE7Vg90H21EOLACvtfcHk0lgTdVAbappa8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFahsrc%253D&md5=930421451631a585932511515897c887</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.phytol.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytol.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DAntiviral%2520flavones%2520from%2520the%2520leaves%2520of%2520Nicotiana%2520tabacum%26jtitle%3DPhytochem.%2520Lett.%26date%3D2015%26volume%3D12%26spage%3D75%26epage%3D78%26doi%3D10.1016%2Fj.phytol.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Izneid, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shariati, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orhan, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondal, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mubarak, M. S.</span></span> <span> </span><span class="NLM_article-title">Luteolin, a flavonoid, as an anticancer agent: a review</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">108612</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.108612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.biopha.2019.108612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30798142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1Sht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2019&pages=108612&author=M.+Imranauthor=A.+Raufauthor=T.+Abu-Izneidauthor=M.+Nadeemauthor=M.+A.+Shariatiauthor=I.+A.+Khanauthor=A.+Imranauthor=I.+E.+Orhanauthor=M.+Rizwanauthor=M.+Atifauthor=T.+A.+Gondalauthor=M.+S.+Mubarak&title=Luteolin%2C+a+flavonoid%2C+as+an+anticancer+agent%3A+a+review&doi=10.1016%2Fj.biopha.2019.108612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin, a flavonoid, as an anticancer agent: A review</span></div><div class="casAuthors">Imran, Muhammad; Rauf, Abdur; Abu-Izneid, Tareq; Nadeem, Muhammad; Shariati, Mohammad Ali; Khan, Imtiaz Ali; Imran, Ali; Orhan, Ilkay Erdogan; Rizwan, Muhammad; Atif, Muhammad; Gondal, Tanweer Aslam; Mubarak, Mohammad S.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108612</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Many food-derived phytochems. and their derivs. represent a cornucopia of new anti-cancer compds.  Luteolin (3,4,5,7-tetrahydroxy flavone) is a flavonoid found in different plants such as vegetables, medicinal herbs, and fruits.  It acts as an anticancer agent against various types of human malignancies such as lung, breast, glioblastoma, prostate, colon, and pancreatic cancers.  It also blocks cancer development in vitro and in vivo by inhibition of proliferation of tumor cells, protection from carcinogenic stimuli, and activation of cell cycle arrest, and by inducing apoptosis through different signaling pathways.  Luteolin can addnl. reverse epithelial-mesenchymal transition (EMT) through a mechanism that involves cytoskeleton shrinkage, induction of the epithelial biomarker E-cadherin expression, and by down-regulation of the mesenchymal biomarkers N-cadherin, snail, and vimentin.  Furthermore, luteolin increases levels of intracellular reactive oxygen species (ROS) by activation of lethal endoplasmic reticulum stress response and mitochondrial dysfunction in glioblastoma cells, and by activation of ER stress-assocd. proteins expressions, including phosphorylation of eIF2α, PERK, CHOP, ATF4, and cleaved-caspase 12.  Accordingly, the present review article summarizes the progress of recent research on luteolin against several human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg6HTDMmg6A7Vg90H21EOLACvtfcHk0lggsvhAxdQcWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1Sht7c%253D&md5=c2711c1d50f07a82871151c28def79c3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.108612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.108612%26sid%3Dliteratum%253Aachs%26aulast%3DImran%26aufirst%3DM.%26aulast%3DRauf%26aufirst%3DA.%26aulast%3DAbu-Izneid%26aufirst%3DT.%26aulast%3DNadeem%26aufirst%3DM.%26aulast%3DShariati%26aufirst%3DM.%2BA.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DImran%26aufirst%3DA.%26aulast%3DOrhan%26aufirst%3DI.%2BE.%26aulast%3DRizwan%26aufirst%3DM.%26aulast%3DAtif%26aufirst%3DM.%26aulast%3DGondal%26aufirst%3DT.%2BA.%26aulast%3DMubarak%26aufirst%3DM.%2BS.%26atitle%3DLuteolin%252C%2520a%2520flavonoid%252C%2520as%2520an%2520anticancer%2520agent%253A%2520a%2520review%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D112%26spage%3D108612%26doi%3D10.1016%2Fj.biopha.2019.108612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, W. L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span> <span> </span><span class="NLM_article-title">Semisynthetic flavone-derived antimicrobials with therapeutic potential against Methicillin-resistant Staphylococcus aureus (MRSA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6152</span>– <span class="NLM_lpage">6165</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00380</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00380" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVersr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6152-6165&author=S.+Linauthor=J.-J.+Kohauthor=T.+T.+Aungauthor=W.+L.+W.+Sinauthor=F.+Limauthor=L.+Wangauthor=R.+Lakshminarayananauthor=L.+Zhouauthor=D.+T.+H.+Tanauthor=D.+Caoauthor=R.+W.+Beuermanauthor=L.+Renauthor=S.+Liu&title=Semisynthetic+flavone-derived+antimicrobials+with+therapeutic+potential+against+Methicillin-resistant+Staphylococcus+aureus+%28MRSA%29&doi=10.1021%2Facs.jmedchem.7b00380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA)</span></div><div class="casAuthors">Lin, Shuimu; Koh, Jun-Jie; Aung, Thet Tun; Sin, Wan Ling Wendy; Lim, Fanghui; Wang, Lin; Lakshminarayanan, Rajamani; Zhou, Lei; Tan, Donald T. H.; Cao, Derong; Beuerman, Roger W.; Ren, Li; Liu, Shouping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6152-6165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of semisynthetic flavone-based small mols. mimicking antimicrobial peptides has been designed from natural icaritin to combat drug-resistant Gram-pos. bacterial infections.  Compd. I contg. two arginine residues exhibited excellent antibacterial activity against Gram-pos. bacteria, including MRSA, and very low toxicity to mammalian cells, resulting in a high selectivity of more than 511, comparable to that of several membrane-active antibiotics in clin. trials.  The data show for the first time that icaritin derivs. effectively kill bacteria.  Meanwhile, this is the first study deploying a biomimicking strategy to design potent flavone-based membrane targeting antimicrobials. I showed rapid bactericidal activity by disrupting the bacterial membrane and can circumvent the development of bacterial resistance.  Importantly, I was highly efficacious in a mouse model of corneal infection caused by MRSA and S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMUva-wo6G47Vg90H21EOLACvtfcHk0lggsvhAxdQcWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVersr%252FE&md5=3cf0f204fb781e4f13391af4b749d9fe</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00380%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKoh%26aufirst%3DJ.-J.%26aulast%3DAung%26aufirst%3DT.%2BT.%26aulast%3DSin%26aufirst%3DW.%2BL.%2BW.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLakshminarayanan%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BH.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DSemisynthetic%2520flavone-derived%2520antimicrobials%2520with%2520therapeutic%2520potential%2520against%2520Methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6152%26epage%3D6165%26doi%3D10.1021%2Facs.jmedchem.7b00380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. C.</span></span> <span> </span><span class="NLM_article-title">A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention</span>. <i>Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">2099</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1016/j.foodchem.2012.11.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.foodchem.2012.11.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=23497863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVKisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2013&pages=2099-2107&author=A.+Y.+Chenauthor=Y.+C.+Chen&title=A+review+of+the+dietary+flavonoid%2C+kaempferol+on+human+health+and+cancer+chemoprevention&doi=10.1016%2Fj.foodchem.2012.11.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention</span></div><div class="casAuthors">Chen, Allen Y.; Chen, Yi Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Food Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2099-2107</span>CODEN:
                <span class="NLM_cas:coden">FOCHDJ</span>;
        ISSN:<span class="NLM_cas:issn">0308-8146</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kaempferol is a polyphenol antioxidant found in fruits and vegetables.  Many studies have described the beneficial effects of dietary kaempferol in reducing the risk of chronic diseases, esp. cancer.  Epidemiol. studies have shown an inverse relationship between kaempferol intake and cancer.  Kaempferol may help by augmenting the body's antioxidant defense against free radicals, which promote the development of cancer.  At the mol. level, kaempferol has been reported to modulate a no. of key elements in cellular signal transduction pathways linked to apoptosis, angiogenesis, inflammation, and metastasis.  Significantly, kaempferol inhibits cancer cell growth and angiogenesis and induces cancer cell apoptosis, but on the other hand, kaempferol appears to preserve normal cell viability, in some cases exerting a protective effect.  The aim of this review is to synthesize information concerning the extn. of kaempferol, as well as to provide insights into the mol. basis of its potential chemo-preventative activities, with an emphasis on its ability to control intracellular signaling cascades that regulate the aforementioned processes.  Chemoprevention using nanotechnol. to improve the bioavailability of kaempferol is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg4bf2Crr3prVg90H21EOLACvtfcHk0liPPdd7pxPZmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVKisr4%253D&md5=1e6d7041619b2dd06a8fa06ed872af2a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.foodchem.2012.11.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.foodchem.2012.11.139%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DA.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BC.%26atitle%3DA%2520review%2520of%2520the%2520dietary%2520flavonoid%252C%2520kaempferol%2520on%2520human%2520health%2520and%2520cancer%2520chemoprevention%26jtitle%3DFood%2520Chem.%26date%3D2013%26volume%3D138%26spage%3D2099%26epage%3D2107%26doi%3D10.1016%2Fj.foodchem.2012.11.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somerset, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannot, L.</span></span> <span> </span><span class="NLM_article-title">Dietary flavonoid sources in Australian adults</span>. <i>Nutr. Canc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1080/01635580802143836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1080%2F01635580802143836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=18584477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=442-449&author=S.+M.+Somersetauthor=L.+Johannot&title=Dietary+flavonoid+sources+in+Australian+adults&doi=10.1080%2F01635580802143836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary flavonoid sources in Australian adults</span></div><div class="casAuthors">Somerset, Shawn M.; Johannot, Lidwine</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition and Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-449</span>CODEN:
                <span class="NLM_cas:coden">NUCADQ</span>;
        ISSN:<span class="NLM_cas:issn">0163-5581</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Evidence from lab.-based in vitro studies provides compelling evidence supporting the involvement of dietary flavonoid intake in human cancer risk.  Assocns. between intakes of individual flavonoids and disease outcomes at the population level are emerging from recent epidemiol. studies.  As an important step in the development of methods to assess flavonoid intakes across populations, the major sources of dietary flavonoids in the adult Australian population were identified.  Data from a 24-h diet recall questionnaire used in a national nutrition survey (NNS95-comprising a sample of 10,851 subjects aged 19 yr and over) were combined with U.S. Department of Agriculture data on flavonoid content of foods to identify key sources.  Black and green teas clearly were the dominant sources of the flavonols kaempferol, myricetin, and quercetin.  Other significant flavonol sources included onion (isorhamnetin and quercetin), broccoli (kaempferol and quercetin), apple (quercetin), grape (quercetin), coffee (myrcetin), and beans (quercetin).  Black and green teas also were dominant sources of flavon-3-ols, with wine, apples, and pears contributing somewhat.  In terms of flavanone consumption, oranges (hesperetin and naringenin), lemon (eriodictyol), mandarin (hesperetin), and grapefruit (naringenin) were the major sources.  Parsley (apigenin), celery (apigenin and luteolin), and English spinach (luteolin) were the major flavone sources.  Wine was the major anthocyanidin source (delphinidin, malvidin, peonidin and petunidin), with smaller amts. from cherry (peonidin) and blue-berry (delphinidin, malvidin, peonidin and petunidin).  It is suggested that the relatively small no. of aforementioned key foods form the basis of food frequency questionnaires to assess flavonoid intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNE4PdXY63r7Vg90H21EOLACvtfcHk0liPPdd7pxPZmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmsLfI&md5=161c5c10382026dfdf6b608e182db810</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1080%2F01635580802143836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01635580802143836%26sid%3Dliteratum%253Aachs%26aulast%3DSomerset%26aufirst%3DS.%2BM.%26aulast%3DJohannot%26aufirst%3DL.%26atitle%3DDietary%2520flavonoid%2520sources%2520in%2520Australian%2520adults%26jtitle%3DNutr.%2520Canc.%26date%3D2008%26volume%3D60%26spage%3D442%26epage%3D449%26doi%3D10.1080%2F01635580802143836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devi, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malar, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daglia, M.</span></span> <span> </span><span class="NLM_article-title">Kaempferol and inflammation: from chemistry to medicine</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.phrs.2015.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=25982933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1eqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2015&pages=1-10&author=K.+P.+Deviauthor=D.+S.+Malarauthor=S.+F.+Nabaviauthor=A.+Suredaauthor=J.+Xiaoauthor=S.+M.+Nabaviauthor=M.+Daglia&title=Kaempferol+and+inflammation%3A+from+chemistry+to+medicine&doi=10.1016%2Fj.phrs.2015.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Kaempferol and inflammation: From chemistry to medicine</span></div><div class="casAuthors">Devi, Kasi Pandima; Malar, Dicson Sheeja; Nabavi, Seyed Fazel; Sureda, Antoni; Xiao, Jianbo; Nabavi, Seyed Mohammad; Daglia, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inflammation is an important process of human healing response, wherein the tissues respond to injuries induced by many agents including pathogens.  It is characterized by pain, redness and heat in the injured tissues.  Chronic inflammation seems to be assocd. with different types of diseases such as arthritis, allergies, atherosclerosis, and even cancer.  In recent years natural product based drugs are considered as the novel therapeutic strategy for prevention and treatment of inflammatory diseases.  Among the different types of phyto-constituents present in natural products, flavonoids which occur in many vegetable foods and herbal medicines are considered as the most active constituent, which has the potency to ameliorate inflammation under both in vitro and in vivo conditions.  Kaempferol is a natural flavonol present in different plant species, which has been described to possess potent anti-inflammatory properties.  Despite the voluminous literature on the anti-inflammatory effects of kaempferol, only very limited review articles has been published on this topic.  Hence the present review is aimed to provide a crit. overview on the anti-inflammatory effects and the mechanisms of action of kaempferol, based on the current scientific literature.  In addn., emphasis is also given on the chem., natural sources, bioavailability and toxicity of kaempferol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoVUg55PZOvLVg90H21EOLACvtfcHk0liPPdd7pxPZmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1eqsb0%253D&md5=db81321e284a813e4faa76c7f284e4c8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DDevi%26aufirst%3DK.%2BP.%26aulast%3DMalar%26aufirst%3DD.%2BS.%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26aulast%3DDaglia%26aufirst%3DM.%26atitle%3DKaempferol%2520and%2520inflammation%253A%2520from%2520chemistry%2520to%2520medicine%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D99%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.phrs.2015.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span> <span> </span><span class="NLM_article-title">Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0197563</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0197563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1371%2Fjournal.pone.0197563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29771951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWktrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=J.+Wangauthor=X.+Fangauthor=L.+Geauthor=F.+Caoauthor=L.+Zhaoauthor=Z.+Wangauthor=W.+Xiao&title=Antitumor%2C+antioxidant+and+anti-inflammatory+activities+of+kaempferol+and+its+corresponding+glycosides+and+the+enzymatic+preparation+of+kaempferol&doi=10.1371%2Fjournal.pone.0197563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol</span></div><div class="casAuthors">Wang, Jingqiu; Fang, Xianying; Ge, Lin; Cao, Fuliang; Zhao, Linguo; Wang, Zhenzhong; Xiao, Wei</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0197563/1-e0197563/12</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Kaempferol (kae) and its glycosides are widely distributed in nature and show multiple bioactivities, yet few reports have compared them.  In this paper, we report the antitumor, antioxidant and anti-inflammatory activity differences of kae, kae-7-O-glucoside (kae-7-O-glu), kae-3-O-rhamnoside (kae-3-O-rha) and kae-3-O-rutinoside (kae-3-O-rut).  Kae showed the highest antiproliferation effect on the human hepatoma cell line HepG2, mouse colon cancer cell line CT26 and mouse melanoma cell line B16F1.  Kae also significantly inhibited AKT phosphorylation and cleaved caspase-9, caspase-7, caspase-3 and PARP in HepG2 cells.  A kae-induced increase in DPPH and ABTS radical scavenging activity, inhibition of Con A (Con A)-induced activation of T cell proliferation and NO or ROS prodn. in LPS-induced RAW 264.7 macrophage cells were also seen.  Kae glycosides were used to produce kae via environment-friendly enzymic hydrolysis.  Kae-7-O-glu and kae-3-O-rut were hydrolyzed to kae by β-glucosidase and/or α-L-rhamnosidase.  This paper demonstrates the application of enzymic catalysis to obtain highly biol. active kae.  This work provides a novel and efficient prepn. of high-value flavone-related products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIaWUSZiEuEbVg90H21EOLACvtfcHk0lhmZOh2Aq9gmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWktrnI&md5=88c701d9f16fe2ad4294412a3616a5d3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0197563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0197563%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DW.%26atitle%3DAntitumor%252C%2520antioxidant%2520and%2520anti-inflammatory%2520activities%2520of%2520kaempferol%2520and%2520its%2520corresponding%2520glycosides%2520and%2520the%2520enzymatic%2520preparation%2520of%2520kaempferol%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0197563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuli, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Punia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, T. K.</span></span> <span> </span><span class="NLM_article-title">Kaempferol – a dietary anticancer molecule with multiple mechanisms of action: recent trends and advancements</span>. <i>J. Funct. Foods</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.jff.2017.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.jff.2017.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=32288791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=203-219&author=D.+Kashyapauthor=A.+Sharmaauthor=H.+S.+Tuliauthor=K.+Sakauthor=S.+Puniaauthor=T.+K.+Mukherjee&title=Kaempferol+%E2%80%93+a+dietary+anticancer+molecule+with+multiple+mechanisms+of+action%3A+recent+trends+and+advancements&doi=10.1016%2Fj.jff.2017.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Kaempferol - A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements</span></div><div class="casAuthors">Kashyap, Dharambir; Sharma, Ajay; Tuli, Hardeep Singh; Sak, Katrin; Punia, Sandeep; Mukherjee, Tapan K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Functional Foods</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">203-219</span>CODEN:
                <span class="NLM_cas:coden">JFFOAX</span>;
        ISSN:<span class="NLM_cas:issn">1756-4646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The consumption of diet-based naturally bioactive metabolites is preferred to synthetic material in order to avert health-assocd. disorders.  Among the plant-derived polyphenols, kaempferol (KMF) is considered as a valuable functional food ingredient with a broad range of therapeutic applications such as anti-cancer, antioxidant and anti-inflammatory uses.  KMF acts on a range of intracellular as well as extracellular targets involved in the cell signaling pathways that in turn are known to regulate the hallmarks of cancer growth progressions like apoptosis, cell cycle, invasion or metastasis, angiogenesis and inflammation.  Importantly, the understanding of mechanisms of action of KMF-mediated therapeutic effects may help the scientific community to design novel strategies for the treatment of dreadful diseases.  The current review summarizes the various types of mol. targets of KMF in cancer cells as well as other health-assocd. disorders.  In addn., this review also highlights the absorption, metab. and epidemiol. findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNPeLnkMeULVg90H21EOLACvtfcHk0lhmZOh2Aq9gmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGrt7k%253D&md5=f73501f4bcb9d884a79a026cbc9bdc94</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jff.2017.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jff.2017.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DKashyap%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DTuli%26aufirst%3DH.%2BS.%26aulast%3DSak%26aufirst%3DK.%26aulast%3DPunia%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DT.%2BK.%26atitle%3DKaempferol%2520%25E2%2580%2593%2520a%2520dietary%2520anticancer%2520molecule%2520with%2520multiple%2520mechanisms%2520of%2520action%253A%2520recent%2520trends%2520and%2520advancements%26jtitle%3DJ.%2520Funct.%2520Foods%26date%3D2017%26volume%3D30%26spage%3D203%26epage%3D219%26doi%3D10.1016%2Fj.jff.2017.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">Kaempferol inhibits thrombosis and platelet activation</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.biochi.2015.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26073152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWqsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=177-186&author=J.-H.+Choiauthor=S.-E.+Parkauthor=S.-J.+Kimauthor=S.+Kim&title=Kaempferol+inhibits+thrombosis+and+platelet+activation&doi=10.1016%2Fj.biochi.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Kaempferol inhibits thrombosis and platelet activation</span></div><div class="casAuthors">Choi, Jun-Hui; Park, Se-Eun; Kim, Sung-Jun; Kim, Seung</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The objectives of the present study were to investigate whether kaempferol affects pro-coagulant proteinase activity, fibrin clot formation, blood clot and thrombin (or collagen/epinephrine)-stimulated platelet activation, thrombosis, and coagulation in ICR (Imprinting Control Region) mice and SD (Sprague-Dawley) rats.  Kaempferol significantly inhibited the enzymic activities of thrombin and FXa by 68 ± 1.6% and 52 ± 2.4%, resp.  Kaempferol also inhibited fibrin polymer formation in turbidity.  Microscopic anal. was performed using a fluorescent conjugate.  Kaempferol completely attenuated phosphorylation of extracellular signal-regulated kinase (ERK) 1/2, p38, c-Jun N-terminal kinase (JNK) 1/2, and phosphoinositide 3-kinase (PI3K)/PKB (AKT) in thrombin-stimulated platelets and delayed aggregation time (clotting) by 34.6% in an assay of collagen/epinephrine-stimulated platelet activation.  Moreover, kaempferol protected against thrombosis development in 3 animal models, including collagen/epinephrine- and thrombin-induced acute thromboembolism models and an FeCl3-induced carotid arterial thrombus model.  The ex vivo anticoagulant effect of kaempferol was further confirmed in ICR mice.  This study demonstrated that kaempferol may be clin. useful due to its ability to reduce or prevent thrombotic challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZTwqTXixT-LVg90H21EOLACvtfcHk0lhmZOh2Aq9gmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWqsrjL&md5=c66bfda155ffc6e677fd7b0e00b5f4d3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.-H.%26aulast%3DPark%26aufirst%3DS.-E.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DKaempferol%2520inhibits%2520thrombosis%2520and%2520platelet%2520activation%26jtitle%3DBiochimie%26date%3D2015%26volume%3D115%26spage%3D177%26epage%3D186%26doi%3D10.1016%2Fj.biochi.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desiderio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saw, C. L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.-N.</span></span> <span> </span><span class="NLM_article-title">Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1002/bdd.677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1002%2Fbdd.677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=19722166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=356-365&author=A.+Barveauthor=C.+Chenauthor=V.+Hebbarauthor=J.+Desiderioauthor=C.+L.-L.+Sawauthor=A.-N.+Kong&title=Metabolism%2C+oral+bioavailability+and+pharmacokinetics+of+chemopreventive+kaempferol+in+rats&doi=10.1002%2Fbdd.677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats</span></div><div class="casAuthors">Barve, Avantika; Chen, Chi; Hebbar, Vidya; Desiderio, Joseph; Saw, Constance Lay-Lay; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">356-365</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The purpose of this study was to compare the hepatic and small intestinal metab., and to examine bioavailability and gastro-intestinal first-pass effects, of kaempferol in rats.  Liver and small intestinal microsomes fortified with either NADPH or UDPGA were incubated with varying concns. of kaempferol for up to 120 min.  Based on the values of the kinetic consts. (Km and Vmax), the propensity for UDPGA-dependent conjugation compared with NADPH-dependent oxidative metab. was higher for both hepatic and small intestinal microsomes.  Male Sprague-Dawley rats were administered kaempferol i.v. (10, 25 mg/kg) or orally (100, 250 mg/kg).  Gastro-intestinal first-pass effects were obsd. by collecting portal blood after oral administration of 100 mg/kg kaempferol.  Pharmacokinetic parameters were obtained by non-compartmental anal. using WinNonlin.  After i.v. administration, the plasma concn.-time profiles for 10 and 25 mg/kg were consistent with high clearance (∼3 L/h/kg) and large vols. of distribution (8-12 L/h/kg).  The disposition was characterized by a terminal half-life value of 3-4 h.  After oral administration the plasma concn.-time profiles demonstrated fairly rapid absorption (tmax∼1-2 h).  The area under the curve (AUC) values after i.v. and oral doses increased approx. proportional to the dose.  The bioavailability (F) was poor at ∼2%.  Anal. of portal plasma after oral administration revealed low to moderate absorption.  Taken together, the low F of kaempferol is attributed in part to extensive first-pass metab. by glucuronidation and other metabolic pathways in the gut and in the liver.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-E0E1IXPFHbVg90H21EOLACvtfcHk0lgCQYrSsaB7FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vO&md5=263d0e5efa3d7b7d4a2a75edfec7913a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fbdd.677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.677%26sid%3Dliteratum%253Aachs%26aulast%3DBarve%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHebbar%26aufirst%3DV.%26aulast%3DDesiderio%26aufirst%3DJ.%26aulast%3DSaw%26aufirst%3DC.%2BL.-L.%26aulast%3DKong%26aufirst%3DA.-N.%26atitle%3DMetabolism%252C%2520oral%2520bioavailability%2520and%2520pharmacokinetics%2520of%2520chemopreventive%2520kaempferol%2520in%2520rats%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2009%26volume%3D30%26spage%3D356%26epage%3D365%26doi%3D10.1002%2Fbdd.677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.-S.</span></span> <span> </span><span class="NLM_article-title">Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats</span>. <i>Arch Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1007/s12272-009-1127-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1007%2Fs12272-009-1127-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=19183886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFShurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=133-138&author=C.+Liauthor=X.+Liauthor=J.-S.+Choi&title=Enhanced+bioavailability+of+etoposide+after+oral+or+intravenous+administration+of+etoposide+with+kaempferol+in+rats&doi=10.1007%2Fs12272-009-1127-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats</span></div><div class="casAuthors">Li, Cheng; Li, Xiuguo; Choi, Jun-Shik</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-138</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">This study was to investigate the effect of kaempferol on the pharmacokinetics of etoposide after oral or i.v. administration of etoposide in rats.  The oral (6 mg/kg) or i.v. (2 mg/kg) etoposide was administered to rats alone or 30 min after the oral kaempferol (1, 4, or 12 mg/kg) administration.  Compared to the oral control group, the presence of kaempferol significantly (4 mg/kg; 12 mg/kg) increased the area under the plasma concn.-time curve (AUC) and the peak concn. (Cmax) of the oral etoposide.  Kaempferol decreased significantly (4 or 12 mg/kg) the total body clearance (CL/F) of oral etoposide, while there was no significant change in the terminal half life (t1/2), the elimination rate const. (Kel) and the time to reach the peak concn. (Tmax) of etoposide in the presense of kaempferol.  Compared to the i.v. control group, the presence of kaempferol enhanced the AUC of i.v. administered etoposide, however, only presence of 12 mg/kg of kaempferol significant increased AUC of etoposide.  The enhanced bioavailability of oral etoposide by kaempferol could have been due to an inhibition of cytochrom P 450 (CYP) 3A and P-glycoprotein (P-gp) in the intestinal or decreased total body clearance in the liver by kaempferol.  The dosage regimen of etoposide should be taken into consideration for potential drug interaction when combined with kaempferol or dietary supplements contg. kaempferol in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEUI64W-sOS7Vg90H21EOLACvtfcHk0lgCQYrSsaB7FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFShurc%253D&md5=2075bb879dff852b0143835a2a6aa873</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs12272-009-1127-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-009-1127-z%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DJ.-S.%26atitle%3DEnhanced%2520bioavailability%2520of%2520etoposide%2520after%2520oral%2520or%2520intravenous%2520administration%2520of%2520etoposide%2520with%2520kaempferol%2520in%2520rats%26jtitle%3DArch%2520Pharm.%2520Res.%26date%3D2009%26volume%3D32%26spage%3D133%26epage%3D138%26doi%3D10.1007%2Fs12272-009-1127-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">George, C. F.</span></span> <span> </span><span class="NLM_article-title">Drug metabolism by the gastrointestinal mucosa</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">274</span>, <span class="refDoi"> DOI: 10.2165/00003088-198106040-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.2165%2F00003088-198106040-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=6113909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADyaL3MXltVyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1981&pages=259-274&author=C.+F.+George&title=Drug+metabolism+by+the+gastrointestinal+mucosa&doi=10.2165%2F00003088-198106040-00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Drug metabolism by the gastrointestinal mucosa</span></div><div class="casAuthors">George, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-74</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUFZlCZxC8X7Vg90H21EOLACvtfcHk0lgCQYrSsaB7FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltVyhsLw%253D&md5=001e30dd2772386febdd747d5dcb19d0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2165%2F00003088-198106040-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-198106040-00002%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DC.%2BF.%26atitle%3DDrug%2520metabolism%2520by%2520the%2520gastrointestinal%2520mucosa%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1981%26volume%3D6%26spage%3D259%26epage%3D274%26doi%3D10.2165%2F00003088-198106040-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beriashvili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kralt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Mazen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span> <span> </span><span class="NLM_article-title">Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2018.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.chemphyslip.2018.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30278162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOgsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2018&pages=73-79&author=D.+Beriashviliauthor=R.+Taylorauthor=B.+Kraltauthor=N.+Abu+Mazenauthor=S.+D.+Taylorauthor=M.+Palmer&title=Mechanistic+studies+on+the+effect+of+membrane+lipid+acyl+chain+composition+on+daptomycin+pore+formation&doi=10.1016%2Fj.chemphyslip.2018.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation</span></div><div class="casAuthors">Beriashvili, David; Taylor, Robert; Kralt, Braden; Abu Mazen, Nooran; Taylor, Scott D.; Palmer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-79</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Daptomycin is a lipopeptide antibiotic that binds and permeabilizes the cell membranes of Gram-pos. bacteria.  Membrane permeabilization requires both calcium and phosphatidylglycerol (PG) in the target membrane, and it correlates with the formation of an oligomer that likely comprises eight subunits, which are evenly distributed between the two membrane leaflets.  In both bacterial cells and model membranes, changes in the fatty acyl compn. of the membrane phospholipids can prevent permeabilization.  We here used liposomes to study the effect of phospholipids contg. oleoyl and other fatty acyl residues on daptomycin activity, and made the following observations: (1) Oleic acid residues inhibited permeabilization when part not only of PG, but also of other phospholipids (PC or cardiolipin). (2) When included in an otherwise daptomycin-susceptible lipid mixt., even 10% of dioleoyl lipid (DOPC) can strongly inhibit permeabilization. (3) The inhibitory effect of fatty acyl residues appears to correlate more with their chain length than with unsatn. (4) Under all conditions tested, permeabilization coincided with octamer formation, whereas tetramers were obsd. on membranes that were not permeabilized.  Overall, our findings further support the notion that the octamer is indeed the functional transmembrane pore, and that fatty acyl residues may prevent pore formation by preventing the alignment of tetramers across the two membrane leaflets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwNRk4m22p1bVg90H21EOLACvtfcHk0ljNTSymlo7EjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOgsL7F&md5=587d4c87318e5a0898f76744488e0af4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2018.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2018.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DBeriashvili%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DKralt%26aufirst%3DB.%26aulast%3DAbu%2BMazen%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BD.%26aulast%3DPalmer%26aufirst%3DM.%26atitle%3DMechanistic%2520studies%2520on%2520the%2520effect%2520of%2520membrane%2520lipid%2520acyl%2520chain%2520composition%2520on%2520daptomycin%2520pore%2520formation%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2018%26volume%3D216%26spage%3D73%26epage%3D79%26doi%3D10.1016%2Fj.chemphyslip.2018.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. W.</span></span> <span> </span><span class="NLM_article-title">Molecular state of the membrane-active antibiotic Daptomycin</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2017.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.bpj.2017.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28700928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=82-90&author=M.-T.+Leeauthor=W.-C.+Hungauthor=M.-H.+Hsiehauthor=H.+Chenauthor=Y.-Y.+Changauthor=H.+W.+Huang&title=Molecular+state+of+the+membrane-active+antibiotic+Daptomycin&doi=10.1016%2Fj.bpj.2017.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular State of the Membrane-Active Antibiotic Daptomycin</span></div><div class="casAuthors">Lee, Ming-Tao; Hung, Wei-Chin; Hsieh, Meng-Hsuan; Chen, Hsiung; Chang, Yu-Yung; Huang, Huey W.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-90</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Membrane-active antibiotics are potential alternatives to the resistance-prone conventional antibiotics.  Daptomycin, a cyclic lipopeptide, is the only membrane-active antibiotic approved by the U.S.  Food and Drug Administration so far.  The drug interacts with the cytoplasmic membranes of Gram-pos. pathogens, causing membrane permeabilization to ions and cell death.  The antibiotic activity is calcium-ion dependent and correlates with the target membrane's content of phosphatidylglycerol (PG).  For such a complex reaction with membranes, it has been difficult to uncover the mol. process that underlies its antibacterial activity.  The role of the cofactor, calcium ions, has been confusing.  Many have proposed that calcium ions binding to daptomycin is a precondition for membrane interaction.  Here, the authors report the findings on the mol. state of daptomycin before and after its membrane-binding reaction, particularly at therapeutic concns. in the low micromolar range.  The authors were able to perform small-angle x-ray scattering at sufficiently low daptomycin concns. to det. that the mols. are monomeric before membrane binding.  By careful CD analyses of daptomycin with Ca2+ and PG-contg. membranes, the authors found that there are only two states identifiable by CD, one before and another after membrane binding; all other CD spectra are linear combinations of the two.  Before membrane binding, the mol. state of daptomycin as defined by CD is the same with or without calcium ions.  The authors are able to det. the stoichiometric ratios of the membrane-binding reaction.  The stoichiometric ratio of daptomycin to calcium is 2:3.  The stoichiometric ratio of daptomycin to PG is ∼1:1 if only the PG lipids in the outer leaflets of membranes are accessible to daptomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR46iV-oX0W7Vg90H21EOLACvtfcHk0ljNTSymlo7EjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSitro%253D&md5=c48a4046ffd79b9973b2cefd994e6cd8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2017.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2017.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-T.%26aulast%3DHung%26aufirst%3DW.-C.%26aulast%3DHsieh%26aufirst%3DM.-H.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.-Y.%26aulast%3DHuang%26aufirst%3DH.%2BW.%26atitle%3DMolecular%2520state%2520of%2520the%2520membrane-active%2520antibiotic%2520Daptomycin%26jtitle%3DBiophys.%2520J.%26date%3D2017%26volume%3D113%26spage%3D82%26epage%3D90%26doi%3D10.1016%2Fj.bpj.2017.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berditsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jäger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strempel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overhage, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, A. S.</span></span> <span> </span><span class="NLM_article-title">Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5288</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1128/aac.00682-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAAC.00682-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26077259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyit7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=5288-5296&author=M.+Berditschauthor=T.+J%C3%A4gerauthor=N.+Strempelauthor=T.+Schwartzauthor=J.+Overhageauthor=A.+S.+Ulrich&title=Synergistic+effect+of+membrane-active+peptides+polymyxin+B+and+gramicidin+S+on+multidrug-resistant+strains+and+biofilms+of+Pseudomonas+aeruginosa&doi=10.1128%2Faac.00682-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa</span></div><div class="casAuthors">Berditsch, Marina; Jaeger, Thomas; Strempel, Nikola; Schwartz, Thomas; Overhage, Joerg; Ulricha, Anne S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5288-5296</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Multidrug-resistant Pseudomonas aeruginosa is a major cause of severe hospital-acquired infections.  Currently, polymyxin B (PMB) is a last-resort antibiotic for the treatment of infections caused by Gram-neg. bacteria, despite its undesirable side effects.  The delivery of drug combinations has been shown to reduce the required therapeutic doses of antibacterial agents and thereby their toxicity if a synergistic effect is present.  In this study, the authors investigated the synergy between two cyclic antimicrobial peptides, PMB and gramicidin S (GS), against different P. aeruginosa isolates, using a quant. checkerboard assay with resazurin as a growth indicator.  Among the 28 strains that we studied, 20 strains showed a distinct synergistic effect, represented by a fractional inhibitory concn. index (FICI) of ≤0.5.  Remarkably, several clin. P. aeruginosa isolates that grew as small colony variants revealed a nonsynergistic effect, as indicated by FICIs between >0.5 and ≤0.70.  In addn. to inhibiting the growth of planktonic bacteria, the peptide combinations significantly decreased static biofilm growth compared with treatment with the individual peptides.  There was also a faster and more prolonged effect when the combination of PMB and GS was used compared with single-peptide treatments on the metabolic activity of pregrown biofilms.  The results of the present study define a synergistic interaction between two cyclic membrane-active peptides toward 17 multidrug-resistant P. aeruginosa and biofilms of P. aeruginosa strain PAO1.  Thus, the application of PMB and GS in combination is a promising option for a topical medication and in the prevention of acute and chronic infections caused by multidrug-resistant or biofilm-forming P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqijw44ZAF7LrVg90H21EOLACvtfcHk0ljNTSymlo7EjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyit7vN&md5=ae302e7ffc0edab83bf376efdfe23103</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FAAC.00682-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00682-15%26sid%3Dliteratum%253Aachs%26aulast%3DBerditsch%26aufirst%3DM.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DT.%26aulast%3DStrempel%26aufirst%3DN.%26aulast%3DSchwartz%26aufirst%3DT.%26aulast%3DOverhage%26aufirst%3DJ.%26aulast%3DUlrich%26aufirst%3DA.%2BS.%26atitle%3DSynergistic%2520effect%2520of%2520membrane-active%2520peptides%2520polymyxin%2520B%2520and%2520gramicidin%2520S%2520on%2520multidrug-resistant%2520strains%2520and%2520biofilms%2520of%2520Pseudomonas%2520aeruginosa%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D5288%26epage%3D5296%26doi%3D10.1128%2Faac.00682-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yahav, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farbman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibovici, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, M.</span></span> <span> </span><span class="NLM_article-title">Colistin: new lessons on an old antibiotic</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1111/j.1469-0691.2011.03734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1111%2Fj.1469-0691.2011.03734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=22168320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslyqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=18-29&author=D.+Yahavauthor=L.+Farbmanauthor=L.+Leiboviciauthor=M.+Paul&title=Colistin%3A+new+lessons+on+an+old+antibiotic&doi=10.1111%2Fj.1469-0691.2011.03734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Colistin: new lessons on an old antibiotic</span></div><div class="casAuthors">Yahav, D.; Farbman, L.; Leibovici, L.; Paul, M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-29</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Colistin has been re-introduced into clin. practice for the treatment of carbapenem-resistant Gram-neg. bacteria.  Studies in the last decade attempted to reconstruct the path that present-day medications undergo prior to clin. use.  In this review, we summarize the results of recent clin. studies.  Colistin was assocd. with lower mortality than no effective treatment and higher unadjusted mortality than β-lactams in non-randomized clin. studies.  However, it was administered to sicker patients with carabapenem-resistant bacteria.  Overall, nephrotoxicity rates were not higher with colistin in these studies, and colistin-induced nephrotoxicity is reversible in most patients.  The emergence of colistin resistance has been described in high-use settings.  Synergy with carbapenem, rifampin and other antibiotics has been reported in vitro.  Randomized controlled trials are ongoing or in planning to assess this and other aspects of colistin use in clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-f1voXWR2OrVg90H21EOLACvtfcHk0lgLMs3UNXGNaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslyqsLw%253D&md5=d68fa79542339eefbc897ca95a95bb9b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2011.03734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2011.03734.x%26sid%3Dliteratum%253Aachs%26aulast%3DYahav%26aufirst%3DD.%26aulast%3DFarbman%26aufirst%3DL.%26aulast%3DLeibovici%26aufirst%3DL.%26aulast%3DPaul%26aufirst%3DM.%26atitle%3DColistin%253A%2520new%2520lessons%2520on%2520an%2520old%2520antibiotic%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2012%26volume%3D18%26spage%3D18%26epage%3D29%26doi%3D10.1111%2Fj.1469-0691.2011.03734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooderham, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span> <span> </span><span class="NLM_article-title">Antibacterial peptides for therapeutic use: obstacles and realistic outlook</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.coph.2006.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=16890021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=468-472&author=A.+Marrauthor=W.+Gooderhamauthor=R.+Hancock&title=Antibacterial+peptides+for+therapeutic+use%3A+obstacles+and+realistic+outlook&doi=10.1016%2Fj.coph.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial peptides for therapeutic use: Obstacles and realistic outlook</span></div><div class="casAuthors">Marr, Alexandra K.; Gooderham, William J.; Hancock, Robert E. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">468-472</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cationic antimicrobial peptides are produced by almost all species of life as a component of their immediate non-specific defense against infections.  The assets of these peptides in clin. application include their potential for broad-spectrum activity, rapid bactericidal activity and low propensity for resistance development, whereas possible disadvantages include their high cost, limited stability (esp. when composed of L-amino acids), and unknown toxicol. and pharmacokinetics.  Initial barriers to their success are being increasingly overcome with the development of stable, more cost-effective and potent broad-spectrum synthetic peptides.  Thus, there is hope that they will spawn a new generation of antimicrobials with a broad range of topical and systemic applications against infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZe7bT4WbvLLVg90H21EOLACvtfcHk0lgLMs3UNXGNaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWrs7s%253D&md5=3dfb70f1b93480ea8fb6c3b509168498</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMarr%26aufirst%3DA.%26aulast%3DGooderham%26aufirst%3DW.%26aulast%3DHancock%26aufirst%3DR.%26atitle%3DAntibacterial%2520peptides%2520for%2520therapeutic%2520use%253A%2520obstacles%2520and%2520realistic%2520outlook%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D468%26epage%3D472%26doi%3D10.1016%2Fj.coph.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uppu, D. S. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baul, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siersma, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemparala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamoen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Isosteric substitution in cationic-amphiphilic polymers reveals an important role for hydrogen bonding in bacterial membrane interactions</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4623</span>, <span class="refDoi"> DOI: 10.1039/c6sc00615a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1039%2FC6SC00615A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30155109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1Kku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=4613-4623&author=D.+S.+S.+M.+Uppuauthor=M.+M.+Konaiauthor=U.+Baulauthor=P.+Singhauthor=T.+K.+Siersmaauthor=S.+Samaddarauthor=S.+Vemparalaauthor=L.+W.+Hamoenauthor=C.+Narayanaauthor=J.+Haldar&title=Isosteric+substitution+in+cationic-amphiphilic+polymers+reveals+an+important+role+for+hydrogen+bonding+in+bacterial+membrane+interactions&doi=10.1039%2Fc6sc00615a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Isosteric substitution in cationic-amphiphilic polymers reveals an important role for hydrogen bonding in bacterial membrane interactions</span></div><div class="casAuthors">Uppu, D. S. S. M.; Konai, M. M.; Baul, U.; Singh, P.; Siersma, T. K.; Samaddar, S.; Vemparala, S.; Hamoen, L. W.; Narayana, C.; Haldar, J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4613-4623</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Biomimetic antibacterial polymers, the functional mimics of antimicrobial peptides (AMPs), targeting the bacterial cell membrane have been developed to combat the problem of antibiotic resistance.  Amphiphilicity, a balance of cationic charge and hydrophobicity, in these polymers has been shown to be pivotal for their selective interactions with anionic lipid membranes of bacteria instead of zwitterionic mammalian (human erythrocyte) membranes.  However, it is unclear if and to what extent hydrogen bonding in amphiphilic antibacterial polymers contributes to this membrane binding specificity.  To address this, we employ isosteric substitution of ester with amide moieties that differ in their potency for hydrogen bonding in the side chains of N-alkyl maleimide based amphiphilic polymers.  Our studies reveal that amide polymer (AC3P) is a potent antibacterial agent with high membrane-disrupting properties compared to its ester counterpart (EC3P).  To understand these differences we performed bio-phys. expts. and mol. dynamics (MD) simulations which showed strong interactions of AC3P including hydrogen bonding with lipid head groups of bacterial model lipid bilayers, that are absent in EC3P, make them selective for bacterial membranes.  Mechanistic investigations of these polymers in bacteria revealed specific membrane disruptive activity leading to the delocalization of cell division related proteins.  This unprecedented and unique concept provides an understanding of bacterial membrane interactions highlighting the role of hydrogen bonding.  Thus, these findings will have significant implications in efficient design of potent membrane-active agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZpQ3SyiOjgLVg90H21EOLACvtfcHk0lhIW46kIPHK8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1Kku7c%253D&md5=eb844bdde33cb303db17cd788eb5006d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC6SC00615A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC00615A%26sid%3Dliteratum%253Aachs%26aulast%3DUppu%26aufirst%3DD.%2BS.%2BS.%2BM.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DBaul%26aufirst%3DU.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DSiersma%26aufirst%3DT.%2BK.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DVemparala%26aufirst%3DS.%26aulast%3DHamoen%26aufirst%3DL.%2BW.%26aulast%3DNarayana%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DIsosteric%2520substitution%2520in%2520cationic-amphiphilic%2520polymers%2520reveals%2520an%2520important%2520role%2520for%2520hydrogen%2520bonding%2520in%2520bacterial%2520membrane%2520interactions%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D4613%26epage%3D4623%26doi%3D10.1039%2Fc6sc00615a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.-Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and cancer cell growth inhibitory activity of icaritin derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.ejmech.2015.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26079090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=139-150&author=C.+Wangauthor=P.+Wuauthor=J.-F.+Shiauthor=Z.-H.+Jiangauthor=X.-Y.+Wei&title=Synthesis+and+cancer+cell+growth+inhibitory+activity+of+icaritin+derivatives&doi=10.1016%2Fj.ejmech.2015.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and cancer cell growth inhibitory activity of icaritin derivatives</span></div><div class="casAuthors">Wang, Chen; Wu, Ping; Shi, Jing-Fang; Jiang, Zi-Hua; Wei, Xiao-Yi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">139-150</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of icaritin derivs. bearing carboxylic acid or carboxylic ester groups are synthesized and their in vitro cytotoxic activity against three cancer cell lines, MCF-7, MDA-MB-435s and A549, are evaluated by MTT assay.  Several compds. show higher cytotoxic activity than the parent compd. icaritin against these cancer cell lines.  The compds. are even more cytotoxic to MCF-7 cells than the clinic drug tamoxifen.  Moreover, one compd. is found to be nontoxic to normal cells (Vero) and two compds. exhibit good selectivity towards estrogen receptor pos. MCF-7 breast cancer cells over estrogen receptor neg. MDA-MB-435s breast cancer cells.  The structure activity relationship anal. has revealed that mono-substitution at either a C-3 or a C-7 hydroxy group of icaritin could improve the cytotoxicity of icaritin, and the C-3 hydroxyl group may be a preferable site for chem. modification.  In addn., the length, the flexibility and the addnl. branching substituent group of the substitution chain(s) at both C-3 and C-7 hydroxyl groups can all affect the anti-cancer activity of these derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-9Kl4p9bPF7Vg90H21EOLACvtfcHk0lhIW46kIPHK8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltLnI&md5=04682c8199edad180b1e656848f1b428</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DJ.-F.%26aulast%3DJiang%26aufirst%3DZ.-H.%26aulast%3DWei%26aufirst%3DX.-Y.%26atitle%3DSynthesis%2520and%2520cancer%2520cell%2520growth%2520inhibitory%2520activity%2520of%2520icaritin%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D100%26spage%3D139%26epage%3D150%26doi%3D10.1016%2Fj.ejmech.2015.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salleh, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervushin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span> <span> </span><span class="NLM_article-title">Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1021/jm501285x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501285x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=739-752&author=J.-J.+Kohauthor=S.+Linauthor=T.+T.+Aungauthor=F.+Limauthor=H.+Zouauthor=Y.+Baiauthor=J.+Liauthor=H.+Linauthor=L.+M.+Pangauthor=W.+L.+Kohauthor=S.+M.+Sallehauthor=R.+Lakshminarayananauthor=L.+Zhouauthor=S.+Qiuauthor=K.+Pervushinauthor=C.+Vermaauthor=D.+T.+H.+Tanauthor=D.+Caoauthor=S.+Liuauthor=R.+W.+Beuerman&title=Amino+acid+modified+xanthone+derivatives%3A+novel%2C+highly+promising+membrane-active+antimicrobials+for+multidrug-resistant+Gram-positive+bacterial+infections&doi=10.1021%2Fjm501285x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Modified Xanthone Derivatives: Novel, Highly Promising Membrane-Active Antimicrobials for Multidrug-Resistant Gram-Positive Bacterial Infections</span></div><div class="casAuthors">Koh, Jun-Jie; Lin, Shuimu; Aung, Thet Tun; Lim, Fanghui; Zou, Hanxun; Bai, Yang; Li, Jianguo; Lin, Huifen; Pang, Li Mei; Koh, Wee Luan; Salleh, Shuhaida Mohamed; Lakshminarayanan, Rajamani; Zhou, Lei; Qiu, Shengxiang; Pervushin, Konstantin; Verma, Chandra; Tan, Donald T. H.; Cao, Derong; Liu, Shouping; Beuerman, Roger W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">739-752</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibiotic resistance is a crit. global health care crisis requiring urgent action to develop more effective antibiotics.  Utilizing the hydrophobic scaffold of xanthone, we identified three components that mimicked the action of an antimicrobial cationic peptide to produce membrane-targeting antimicrobials.  Compds. 5c and 6, which contain a hydrophobic xanthone core, lipophilic chains, and cationic amino acids, displayed very promising antimicrobial activity against multidrug-resistant Gram-pos. bacteria, including MRSA and VRE, rapid time-kill, avoidance of antibiotic resistance, and low toxicity.  The bacterial membrane selectivity of these mols. was comparable to that of several membrane-targeting antibiotics in clin. trials. 5c and 6 were effective in a mouse model of corneal infection by S. aureus and MRSA.  Evidence is presented indicating that 5c and 6 target the neg. charged bacterial membrane via a combination of electrostatic and hydrophobic interactions.  These results suggest that 5c and 6 have significant promise for combating life-threatening infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWNgK4aLyoWrVg90H21EOLACvtfcHk0liwyVQdbMzMQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegurnJ&md5=005cd4868c611bd6ae9a983821a99468</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm501285x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501285x%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DJ.-J.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DAung%26aufirst%3DT.%2BT.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DL.%2BM.%26aulast%3DKoh%26aufirst%3DW.%2BL.%26aulast%3DSalleh%26aufirst%3DS.%2BM.%26aulast%3DLakshminarayanan%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DPervushin%26aufirst%3DK.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BH.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26atitle%3DAmino%2520acid%2520modified%2520xanthone%2520derivatives%253A%2520novel%252C%2520highly%2520promising%2520membrane-active%2520antimicrobials%2520for%2520multidrug-resistant%2520Gram-positive%2520bacterial%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D739%26epage%3D752%26doi%3D10.1021%2Fjm501285x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyrager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faissner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillancourt, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshavn, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamoorthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee Yong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stys, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storr, T.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer’s disease</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5636</span>– <span class="NLM_lpage">5643</span>, <span class="refDoi"> DOI: 10.1039/c7sc01269a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1039%2Fc7sc01269a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28989601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1yitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=5636-5643&author=M.+R.+Jonesauthor=E.+Mathieuauthor=C.+Dyragerauthor=S.+Faissnerauthor=Z.+Vaillancourtauthor=K.+J.+Korshavnauthor=M.+H.+Limauthor=A.+Ramamoorthyauthor=V.+Wee+Yongauthor=S.+Tsutsuiauthor=P.+K.+Stysauthor=T.+Storr&title=Multi-target-directed+phenol-triazole+ligands+as+therapeutic+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc7sc01269a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease</span></div><div class="casAuthors">Jones, Michael R.; Mathieu, Emilie; Dyrager, Christine; Faissner, Simon; Vaillancourt, Zavier; Korshavn, Kyle J.; Lim, Mi Hee; Ramamoorthy, Ayyalusamy; Wee Yong, V.; Tsutsui, Shigeki; Stys, Peter K.; Storr, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5636-5643</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial disease that is characterized by the formation of intracellular neurofibrillary tangles and extracellular amyloid-β (Aβ) plaque deposits.  Increased oxidative stress, metal ion dysregulation, and the formation of toxic Aβ peptide oligomers are all considered to contribute to the etiol. of AD.  In this work we have developed a series of ligands that are multi-target-directed in order to address several disease properties. 2-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)phenol (POH), 2-(1-(2-morpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PMorph), and 2-(1-(2-thiomorpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PTMorph) have been synthesized and screened for their antioxidant capacity, Cu-binding affinity, interaction with the Aβ peptide and modulation of Aβ peptide aggregation, and the ability to limit Aβ1-42-induced neurotoxicity in human neuronal culture.  The synthetic protocol and structural variance incorporated via click chem., highlights the influence of R-group modification on ligand-Aβ interactions and neuroprotective effects.  Overall, this study demonstrates that the phenol-triazole ligand scaffold can target multiple factors assocd. with AD, thus warranting further therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv3gpDPj7eaLVg90H21EOLACvtfcHk0liwyVQdbMzMQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1yitL0%253D&md5=c70d2f489b8d762cfc246c0dc1428f1a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2Fc7sc01269a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc7sc01269a%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%2BR.%26aulast%3DMathieu%26aufirst%3DE.%26aulast%3DDyrager%26aufirst%3DC.%26aulast%3DFaissner%26aufirst%3DS.%26aulast%3DVaillancourt%26aufirst%3DZ.%26aulast%3DKorshavn%26aufirst%3DK.%2BJ.%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DWee%2BYong%26aufirst%3DV.%26aulast%3DTsutsui%26aufirst%3DS.%26aulast%3DStys%26aufirst%3DP.%2BK.%26aulast%3DStorr%26aufirst%3DT.%26atitle%3DMulti-target-directed%2520phenol-triazole%2520ligands%2520as%2520therapeutic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26spage%3D5636%26epage%3D5643%26doi%3D10.1039%2Fc7sc01269a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oae, S.</span></span> <span> </span><span class="NLM_article-title">Reaction of aromatic nitro compounds with elemental sulfur in liquid ammonia and amines</span>. <i>Phosphorus Sulfur</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1080/03086647908077473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1080%2F03086647908077473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADyaL3cXlsV2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1979&pages=229-234&author=R.+Satoauthor=S.+Takizawaauthor=S.+Oae&title=Reaction+of+aromatic+nitro+compounds+with+elemental+sulfur+in+liquid+ammonia+and+amines&doi=10.1080%2F03086647908077473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of aromatic nitro compounds with elemental sulfur in liquid ammonia and amines</span></div><div class="casAuthors">Sato, Ryu; Takizawa, Saburo; Oae, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus and Sulfur and the Related Elements</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-34</span>CODEN:
                <span class="NLM_cas:coden">PREEDF</span>;
        ISSN:<span class="NLM_cas:issn">0308-664X</span>.
    </div><div class="casAbstract">Arom. nitro compds. [PhNO2, 4-O2NC6H4OH, 4-O2NC6H4OMe, 4-O2NC6H4Me, 3-O2NC6H4Cl, 4-O2NC6H4CN] were reduced with elemental S in NH3(l) and in liq. amines [PrNH2, BuNH2, Et2NH, morpholine, piperidine], to give the corresponding anilines.  Introduction of a substituent on the benzene ring or variation of the amine changed the pattern of this reaction.  Thus, 4-nitrotoluene and 4-cyanonitrobenzene gave not only the corresponding reduced products but also 4,4'-dicyanodiphenyl disulfide and 4-cyanoaniline.  Probable mechanisms of these reactions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojfYGulk2Qx7Vg90H21EOLACvtfcHk0liwyVQdbMzMQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlsV2qs7g%253D&md5=134f93966aca755ab9db9ea0f223e7a4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1080%2F03086647908077473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03086647908077473%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DR.%26aulast%3DTakizawa%26aufirst%3DS.%26aulast%3DOae%26aufirst%3DS.%26atitle%3DReaction%2520of%2520aromatic%2520nitro%2520compounds%2520with%2520elemental%2520sulfur%2520in%2520liquid%2520ammonia%2520and%2520amines%26jtitle%3DPhosphorus%2520Sulfur%26date%3D1979%26volume%3D7%26spage%3D229%26epage%3D234%26doi%3D10.1080%2F03086647908077473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rathinakumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkenhorst, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimley, W. C.</span></span> <span> </span><span class="NLM_article-title">Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">7609</span>– <span class="NLM_lpage">7617</span>, <span class="refDoi"> DOI: 10.1021/ja8093247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja8093247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFOmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=7609-7617&author=R.+Rathinakumarauthor=W.+F.+Walkenhorstauthor=W.+C.+Wimley&title=Broad-spectrum+antimicrobial+peptides+by+rational+combinatorial+design+and+high-throughput+screening%3A+the+importance+of+interfacial+activity&doi=10.1021%2Fja8093247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Broad-Spectrum Antimicrobial Peptides by Rational Combinatorial Design and High-Throughput Screening: The Importance of Interfacial Activity</span></div><div class="casAuthors">Rathinakumar, Ramesh; Walkenhorst, William F.; Wimley, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7609-7617</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently described 10 peptides selected from a 16 384-member combinatorial library based on their ability to permeabilize synthetic lipid vesicles in vitro.  These peptides did not share a common sequence motif, length, or net charge; nonetheless, they shared a mechanism of action that is similar to the natural membrane permeabilizing antimicrobial peptides (AMP).  To characterize the selected peptides and to compare the activity of AMPs in vivo and in vitro, we report on the biol. activity of the same selected peptides in bacteria, fungi, and mammalian cells.  Each of the peptides has sterilizing activity against all classes of microbes tested, at 2-8 μM peptide, with only slight hemolytic or cytotoxicity against mammalian cells.  Similar to many natural AMPs, bacteria are killed within a few minutes of peptide addn., and the lethal step in vivo is membrane permeabilization.  Single D-amino acid substitutions eliminated or diminished the secondary structure of the peptides, and yet, they retained activity against some microbes.  Thus, secondary structure and biol. activity are not coupled, consistent with the hypothesis that AMPs do not form pores of well-defined structure in membranes but rather destabilize membranes by partitioning into membrane interfaces and disturbing the organization of the lipids, a property that we have called "interfacial activity".  The observation that broad-spectrum activity, but not all antimicrobial activity, is lost by small changes to the peptides suggests that the in vitro screen is specifically selecting for the rare peptides that have broad-spectrum activity.  We put forth the hypothesis that methods focusing on screening peptide libraries in vitro for members with the appropriate interfacial activity can enable the design, selection, and discovery of novel, potent, and broad-spectrum membrane-active antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_PuRl_scnlbVg90H21EOLACvtfcHk0lgRoX6InvI6EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFOmsro%253D&md5=9e58c4974aed1aac26cbe35b9441f887</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja8093247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja8093247%26sid%3Dliteratum%253Aachs%26aulast%3DRathinakumar%26aufirst%3DR.%26aulast%3DWalkenhorst%26aufirst%3DW.%2BF.%26aulast%3DWimley%26aufirst%3DW.%2BC.%26atitle%3DBroad-spectrum%2520antimicrobial%2520peptides%2520by%2520rational%2520combinatorial%2520design%2520and%2520high-throughput%2520screening%253A%2520the%2520importance%2520of%2520interfacial%2520activity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D7609%26epage%3D7617%26doi%3D10.1021%2Fja8093247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derebe, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callenberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Propheter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, L. V.</span></span> <span> </span><span class="NLM_article-title">Antibacterial membrane attack by a pore-forming intestinal C-type lectin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nature12729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnature12729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=24256734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ovVagsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=103-107&author=S.+Mukherjeeauthor=H.+Zhengauthor=M.+G.+Derebeauthor=K.+M.+Callenbergauthor=C.+L.+Partchauthor=D.+Rollinsauthor=D.+C.+Propheterauthor=J.+Rizoauthor=M.+Grabeauthor=Q.-X.+Jiangauthor=L.+V.+Hooper&title=Antibacterial+membrane+attack+by+a+pore-forming+intestinal+C-type+lectin&doi=10.1038%2Fnature12729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial membrane attack by a pore-forming intestinal C-type lectin</span></div><div class="casAuthors">Mukherjee Sohini; Derebe Mehabaw G; Rollins Darcy; Propheter Daniel C; Zheng Hui; Callenberg Keith M; Partch Carrie L; Rizo Josep; Grabe Michael; Jiang Qiu-Xing; Hooper Lora V</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">103-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human body-surface epithelia coexist in close association with complex bacterial communities and are protected by a variety of antibacterial proteins.  C-type lectins of the RegIII family are bactericidal proteins that limit direct contact between bacteria and the intestinal epithelium and thus promote tolerance to the intestinal microbiota.  RegIII lectins recognize their bacterial targets by binding peptidoglycan carbohydrate, but the mechanism by which they kill bacteria is unknown.  Here we elucidate the mechanistic basis for RegIII bactericidal activity.  We show that human RegIIIα (also known as HIP/PAP) binds membrane phospholipids and kills bacteria by forming a hexameric membrane-permeabilizing oligomeric pore.  We derive a three-dimensional model of the RegIIIα pore by docking the RegIIIα crystal structure into a cryo-electron microscopic map of the pore complex, and show that the model accords with experimentally determined properties of the pore.  Lipopolysaccharide inhibits RegIIIα pore-forming activity, explaining why RegIIIα is bactericidal for Gram-positive but not Gram-negative bacteria.  Our findings identify C-type lectins as mediators of membrane attack in the mucosal immune system, and provide detailed insight into an antibacterial mechanism that promotes mutualism with the resident microbiota.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKlyEjWbjBdyjiVMCqkKxVfW6udTcc2eaXY7zsudbLpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ovVagsg%253D%253D&md5=a6bcf611db65fec251706982bd3b0c21</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnature12729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12729%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DDerebe%26aufirst%3DM.%2BG.%26aulast%3DCallenberg%26aufirst%3DK.%2BM.%26aulast%3DPartch%26aufirst%3DC.%2BL.%26aulast%3DRollins%26aufirst%3DD.%26aulast%3DPropheter%26aufirst%3DD.%2BC.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DGrabe%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DQ.-X.%26aulast%3DHooper%26aufirst%3DL.%2BV.%26atitle%3DAntibacterial%2520membrane%2520attack%2520by%2520a%2520pore-forming%2520intestinal%2520C-type%2520lectin%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D103%26epage%3D107%26doi%3D10.1038%2Fnature12729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millard, P. J.</span></span> <span> </span><span class="NLM_article-title">Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2421</span>– <span class="NLM_lpage">2431</span>, <span class="refDoi"> DOI: 10.1128/aem.63.6.2421-2431.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAEM.63.6.2421-2431.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=9172364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFGisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=2421-2431&author=B.+L.+Rothauthor=M.+Pootauthor=S.+T.+Yueauthor=P.+J.+Millard&title=Bacterial+viability+and+antibiotic+susceptibility+testing+with+SYTOX+green+nucleic+acid+stain&doi=10.1128%2Faem.63.6.2421-2431.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain</span></div><div class="casAuthors">Roth, Bruce L.; Poot, Martin; Yue, Stephen T.; Millard, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2421-2431</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A fluorescent nucleic acid stain that does not penetrate living cells was used to assess the integrity of the plasma membranes of bacteria.  SYTOX Green nucleic acid stain is an unsym. cyanine dye with three pos. charges that is completely excluded from live eukaryotic and prokaryotic cells.  Binding of SYTOX Green stain to nucleic acids resulted in a >500-fold enhancement in fluorescence emission (absorption and emission maxima at 502 and 523 nm, resp.), rendering bacteria with compromised plasma membranes brightly green fluorescent.  SYTOX Green stain is readily excited by the 488-nm line of the argon ion laser.  The fluorescence signal from membrane-compromised bacteria labeled with SYTOX Green stain with typically >10-fold brighter than that from intact organisms.  Bacterial suspensions labeled with SYTOX Green stain emitted green fluorescence in proportion to the fraction of permeabilized cells in the population, which was quantified by microscopy, fluorometry, or flow cytometry.  Flow cytometric and fluorometric approaches were used to quantify the effect of β-lactam antibiotics on the cell membrane integrity of Escherichia coli.  Detection and discrimination of live and permeabilized cells labeled with SYTOX Green stain by flow cytometry was markedly improved over those by propidium iodide-based tests.  These studies showed that bacterial baleing with SYTOX Green stain is an effective alternative to conventional methods for measuring bacterial viability and antibiotic susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxkVUBxik7T7Vg90H21EOLACvtfcHk0lgRoX6InvI6EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFGisbk%253D&md5=174863923aaafd556aee6be6956077da</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FAEM.63.6.2421-2431.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.63.6.2421-2431.1997%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DPoot%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DS.%2BT.%26aulast%3DMillard%26aufirst%3DP.%2BJ.%26atitle%3DBacterial%2520viability%2520and%2520antibiotic%2520susceptibility%2520testing%2520with%2520SYTOX%2520green%2520nucleic%2520acid%2520stain%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D1997%26volume%3D63%26spage%3D2421%26epage%3D2431%26doi%3D10.1128%2Faem.63.6.2421-2431.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamrani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, E.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan Leong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Park, M. B.</span></span> <span> </span><span class="NLM_article-title">A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability</span>. <i>Nat. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/nmat2915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnmat2915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=21151166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=149-156&author=P.+Liauthor=Y.+F.+Poonauthor=W.+Liauthor=H.-Y.+Zhuauthor=S.+H.+Yeapauthor=Y.+Caoauthor=X.+Qiauthor=C.+Zhouauthor=M.+Lamraniauthor=R.+W.+Beuermanauthor=E.-T.+Kangauthor=Y.+Muauthor=C.+M.+Liauthor=M.+W.+Changauthor=S.+S.+Jan+Leongauthor=M.+B.+Chan-Park&title=A+polycationic+antimicrobial+and+biocompatible+hydrogel+with+microbe+membrane+suctioning+ability&doi=10.1038%2Fnmat2915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability</span></div><div class="casAuthors">Li, Peng; Poon, Yin Fun; Li, Weifeng; Zhu, Hong-Yuan; Yeap, Siew Hooi; Cao, Ye; Qi, Xiaobao; Zhou, Chuncai; Lamrani, Mouad; Beuerman, Roger W.; Kang, En-Tang; Mu, Yuguang; Li, Chang Ming; Chang, Matthew W.; Leong, Susanna Su Jan; Chan-Park, Mary B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Materials</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-156</span>CODEN:
                <span class="NLM_cas:coden">NMAACR</span>;
        ISSN:<span class="NLM_cas:issn">1476-1122</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite advanced sterilization and aseptic techniques, infections assocd. with medical implants have not been eradicated.  Most present coatings cannot simultaneously fulfil the requirements of antibacterial and antifungal activity as well as biocompatibility and reusability.  Here, we report an antimicrobial hydrogel based on dimethyldecylammonium chitosan (with high quaternization)-graft-poly(ethylene glycol) methacrylate (DMDC-Q-g-EM) and poly(ethylene glycol) diacrylate, which has excellent antimicrobial efficacy against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus and Fusarium solani.  The proposed mechanism of the antimicrobial activity of the polycationic hydrogel is by attraction of sections of anionic microbial membrane into the internal nanopores of the hydrogel, like an 'anion sponge', leading to microbial membrane disruption and then microbe death.  We have also demonstrated a thin uniform adherent coating of the hydrogel by simple UV immobilization.  An animal study shows that DMDC-Q-g-EM hydrogel coating is biocompatible with rabbit conjunctiva and has no toxicity to the epithelial cells or the underlying stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRETRDXi5GKLVg90H21EOLACvtfcHk0lhaeiso3UrsEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovV2isQ%253D%253D&md5=18b8c0d55f18af86bd3e5de9d4a9dadd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnmat2915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmat2915%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DPoon%26aufirst%3DY.%2BF.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.-Y.%26aulast%3DYeap%26aufirst%3DS.%2BH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DLamrani%26aufirst%3DM.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26aulast%3DKang%26aufirst%3DE.-T.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DChang%26aufirst%3DM.%2BW.%26aulast%3DJan%2BLeong%26aufirst%3DS.%2BS.%26aulast%3DChan-Park%26aufirst%3DM.%2BB.%26atitle%3DA%2520polycationic%2520antimicrobial%2520and%2520biocompatible%2520hydrogel%2520with%2520microbe%2520membrane%2520suctioning%2520ability%26jtitle%3DNat.%2520Mater.%26date%3D2011%26volume%3D10%26spage%3D149%26epage%3D156%26doi%3D10.1038%2Fnmat2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosshard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weilenmann, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, T.</span></span> <span> </span><span class="NLM_article-title">Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight kit in combination with flow cytometry</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3283</span>– <span class="NLM_lpage">3290</span>, <span class="refDoi"> DOI: 10.1128/aem.02750-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAEM.02750-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17384309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslSnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=3283-3290&author=M.+Berneyauthor=F.+Hammesauthor=F.+Bosshardauthor=H.-U.+Weilenmannauthor=T.+Egli&title=Assessment+and+interpretation+of+bacterial+viability+by+using+the+LIVE%2FDEAD+BacLight+kit+in+combination+with+flow+cytometry&doi=10.1128%2Faem.02750-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight kit in combination with flow cytometry</span></div><div class="casAuthors">Berney, Michael; Hammes, Frederik; Bosshard, Franziska; Weilenmann, Hans-Ulrich; Egli, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3283-3290</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The com. available LIVE/DEAD BacLight kit is enjoying increased popularity among researchers in various fields of microbiol.  Its use in combination with flow cytometry brought up new questions about how to interpret LIVE/DEAD staining results.  Intermediate states, normally difficult to detect with epifluorescence microscopy, are a common phenomenon when the assay is used in flow cytometry and still lack rationale.  It is shown here that the application of propidium iodide in combination with a green fluorescent total nucleic acid stain on UVA-irradiated cells of Escherichia coli, Salmonella enterica serovar Typhimurium, Shigella flexneri, and a community of freshwater bacteria resulted in a clear and distinctive flow cytometric staining pattern.  In the gram-neg. bacterium E. coli as well as in the two enteric pathogens, the pattern can be related to the presence of intermediate cellular states characterized by the degree of damage afflicted specifically on the bacterial outer membrane.  This hypothesis is supported by the fact that EDTA-treated nonirradiated cells exhibit the same staining properties.  On the contrary, this pattern was not obsd. in gram-pos. Enterococcus faecalis, which lacks an outer membrane.  Our observations add a new aspect to the LIVE/DEAD stain, which so far was believed to be dependent only on cytoplasmic membrane permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo37Tn6MrFabVg90H21EOLACvtfcHk0lhaeiso3UrsEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslSnu7o%253D&md5=a44bb8a22a9d26de6683699b075e5eb3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FAEM.02750-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.02750-06%26sid%3Dliteratum%253Aachs%26aulast%3DBerney%26aufirst%3DM.%26aulast%3DHammes%26aufirst%3DF.%26aulast%3DBosshard%26aufirst%3DF.%26aulast%3DWeilenmann%26aufirst%3DH.-U.%26aulast%3DEgli%26aufirst%3DT.%26atitle%3DAssessment%2520and%2520interpretation%2520of%2520bacterial%2520viability%2520by%2520using%2520the%2520LIVE%252FDEAD%2520BacLight%2520kit%2520in%2520combination%2520with%2520flow%2520cytometry%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2007%26volume%3D73%26spage%3D3283%26epage%3D3290%26doi%3D10.1128%2Faem.02750-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Sessions, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Periaswamy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. Y.</span></span> <span> </span><span class="NLM_article-title">A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">917</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03325-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fs41467-018-03325-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29500445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrnt1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=917&author=W.+Chinauthor=G.+Zhongauthor=Q.+Puauthor=C.+Yangauthor=W.+Louauthor=P.+F.+De+Sessionsauthor=B.+Periaswamyauthor=A.+Leeauthor=Z.+C.+Liangauthor=X.+Dingauthor=S.+Gaoauthor=C.+W.+Chuauthor=S.+Biancoauthor=C.+Baoauthor=Y.+W.+Tongauthor=W.+Fanauthor=M.+Wuauthor=J.+L.+Hedrickauthor=Y.+Y.+Yang&title=A+macromolecular+approach+to+eradicate+multidrug+resistant+bacterial+infections+while+mitigating+drug+resistance+onset&doi=10.1038%2Fs41467-018-03325-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset</span></div><div class="casAuthors">Chin Willy; Yang Chuan; Lee Ashlynn; Liang Zhen Chang; Ding Xin; Gao Shujun; Yang Yi Yan; Chin Willy; Zhong Guansheng; Lou Weiyang; Bao Chang; Fan Weimin; Pu Qinqin; Wu Min; De Sessions Paola Florez; Periaswamy Balamurugan; Chu Collins Wenhan; Bianco Simone; Hedrick James L; Tong Yen Wah</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">917</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Polymyxins remain the last line treatment for multidrug-resistant (MDR) infections.  As polymyxins resistance emerges, there is an urgent need to develop effective antimicrobial agents capable of mitigating MDR.  Here, we report biodegradable guanidinium-functionalized polycarbonates with a distinctive mechanism that does not induce drug resistance.  Unlike conventional antibiotics, repeated use of the polymers does not lead to drug resistance.  Transcriptomic analysis of bacteria further supports development of resistance to antibiotics but not to the macromolecules after 30 treatments.  Importantly, high in vivo treatment efficacy of the macromolecules is achieved in MDR A. baumannii-, E. coli-, K. pneumoniae-, methicillin-resistant S. aureus-, cecal ligation and puncture-induced polymicrobial peritonitis, and P. aeruginosa lung infection mouse models while remaining non-toxic (e.g., therapeutic index-ED50/LD50: 1473 for A. baumannii infection).  These biodegradable synthetic macromolecules have been demonstrated to have broad spectrum in vivo antimicrobial activity, and have excellent potential as systemic antimicrobials against MDR infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPzHSE9LOK2QyMywPm6HgQfW6udTcc2eYS70VYo9VdSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrnt1Kqtw%253D%253D&md5=69d579a0a7cd0a5e2e2c0aeba186f522</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03325-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03325-6%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DG.%26aulast%3DPu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLou%26aufirst%3DW.%26aulast%3DDe%2BSessions%26aufirst%3DP.%2BF.%26aulast%3DPeriaswamy%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DZ.%2BC.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DC.%2BW.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DY.%2BW.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DHedrick%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BY.%26atitle%3DA%2520macromolecular%2520approach%2520to%2520eradicate%2520multidrug%2520resistant%2520bacterial%2520infections%2520while%2520mitigating%2520drug%2520resistance%2520onset%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D917%26doi%3D10.1038%2Fs41467-018-03325-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vikesland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maile-Moskowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, N.</span></span> <span> </span><span class="NLM_article-title">Differential drivers of antimicrobial resistance across the world</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.8b00643</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.8b00643" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktlOqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=916-924&author=P.+Vikeslandauthor=E.+Garnerauthor=S.+Guptaauthor=S.+Kangauthor=A.+Maile-Moskowitzauthor=N.+Zhu&title=Differential+drivers+of+antimicrobial+resistance+across+the+world&doi=10.1021%2Facs.accounts.8b00643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Drivers of Antimicrobial Resistance across the World</span></div><div class="casAuthors">Vikesland, Peter; Garner, Emily; Gupta, Suraj; Kang, Seju; Maile-Moskowitz, Ayella; Zhu, Ni</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">916-924</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antimicrobial resistance (AMR) is one of the greatest threats faced by humankind.  The development of resistance in clin. and hospital settings has been well documented ever since the initial discovery of penicillin and the subsequent introduction of sulfonamides as clin. antibiotics.  In contrast, the environmental (i.e., community-acquired) dimensions of resistance dissemination have been only more recently delineated.  The global spread of antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARGs) between air, water, soil, and food is now well documented, while the factors that affect ARB and ARG dissemination (e.g., water and air quality, antibiotic fluxes, urbanization, sanitation practices) in these and other environmental matrixes are just now beginning to be more fully appreciated.In this Account, we discuss how the global perpetuation of resistance is dictated by highly interconnected socioeconomic risk factors and illustrate that development status should be more fully considered when developing global strategies to address AMR.  We first differentiate low to middle income countries (LMICs) and high-income countries (HICs), then we summarize the modes of action of com. available antibiotics, and then discuss the four primary mechanisms by which bacteria develop resistance to those antibiotics.  Resistance is disseminated via both vertical gene transfer (VGT; parent to offspring) as well as by horizontal gene transfer (HGT; cell to cell transference of genetic material).  A key challenge hindering attempts to control resistance dissemination is the presence of native, environmental bacteria that can harbor ARGs.  Such environmental "resistomes" have potential to transfer resistance to pathogens via HGT.  Of particular concern is the development of resistance to antibiotics of last-resort such as the cephalosporins, carbapenems, and polymyxins.We then illustrate how antibiotic use differs in LMICs relative to HICs in terms of the vols. of antibiotics used and their fate within local environments.  Antibiotic use in HICs has remained flat over the past 15 years, while in LMICs use over the same period has increased substantially as a result of economic improvements and changes in diet.  These use and fate differences impact local citizens and thus the local dissemination of AMR.  Various phys., social, and economic circumstances within LMICs potentially favor AMR dissemination.  We focus on three phys. factors: changing population d., sanitation infrastructure, and solid-waste disposal.  We show that high population densities in cities within LMICs that suffer from poor sanitation and solid-waste disposal can potentially impact the dissemination of resistance.  In the final section, we discuss potential monitoring approaches to quantify the spread of resistance both within LMICs as well as in HICs.  We posit that culture-based approaches, mol. approaches, and cutting-edge nanotechnol.-based methods for monitoring ARB and ARGs should be considered both within HICs and, as appropriate, within LMICs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRfuY4_Wvzk7Vg90H21EOLACvtfcHk0liu54S_K6JE4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktlOqsrs%253D&md5=bec2a3f62b68867760d6eee400681646</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.8b00643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.8b00643%26sid%3Dliteratum%253Aachs%26aulast%3DVikesland%26aufirst%3DP.%26aulast%3DGarner%26aufirst%3DE.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DMaile-Moskowitz%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DN.%26atitle%3DDifferential%2520drivers%2520of%2520antimicrobial%2520resistance%2520across%2520the%2520world%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2019%26volume%3D52%26spage%3D916%26epage%3D924%26doi%3D10.1021%2Facs.accounts.8b00643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel terminal bipheny-based diapophytoene desaturases (CrtN) inhibitors as anti-MRSA/VISR/LRSA agents with reduced hERG activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01300</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01300" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=224-250&author=B.+Liauthor=S.+Niauthor=F.+Maoauthor=F.+Chenauthor=Y.+Liuauthor=H.+Weiauthor=W.+Chenauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+terminal+bipheny-based+diapophytoene+desaturases+%28CrtN%29+inhibitors+as+anti-MRSA%2FVISR%2FLRSA+agents+with+reduced+hERG+activity&doi=10.1021%2Facs.jmedchem.7b01300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity</span></div><div class="casAuthors">Li, Baoli; Ni, Shuaishuai; Mao, Fei; Chen, Feifei; Liu, Yifu; Wei, Hanwen; Chen, Wenhua; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections.  More than 100 new compds. were synthesized, which target the overwhelming the defects of the CrtN inhibitor 1 (I).  Analogs 23a ((E)-3-([1,1'-biphenyl]-4-yl)-N-(benzofuran-3-ylmethyl)-N-methylprop-2-en-1-amine hydrochloride) and 23b ((E)-N-((1H-indol-7-yl)methyl)-3-([1,1'-biphenyl]-4-yl)-N-methylprop-2-en-1-amine hydrochloride) demonstrated a significant activity against pigmented S. aureus Newman and 13 MRSA strains (IC50 = 0.02-10.5 nM), along with lower hERG inhibition (IC50 > 30 μM, ∼10-fold decrease in comparison with 1).  Furthermore, 23a and 23b were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid.  Remarkably, 23a could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that 23a has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rqm9J1xyJbVg90H21EOLACvtfcHk0liu54S_K6JE4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF&md5=d92739f38cc85e69ca280dc62b198934</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01300%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DNi%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520terminal%2520bipheny-based%2520diapophytoene%2520desaturases%2520%2528CrtN%2529%2520inhibitors%2520as%2520anti-MRSA%252FVISR%252FLRSA%2520agents%2520with%2520reduced%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D224%26epage%3D250%26doi%3D10.1021%2Facs.jmedchem.7b01300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’onnell, K. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmond, G. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">10706</span>– <span class="NLM_lpage">10733</span>, <span class="refDoi"> DOI: 10.1002/anie.201209979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1002%2Fanie.201209979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=24038605" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10706-10733&author=K.+M.+G.+O%E2%80%99onnellauthor=J.+T.+Hodgkinsonauthor=H.+F.+Soreauthor=M.+Welchauthor=G.+P.+C.+Salmondauthor=D.+R.+Spring&title=Combating+multidrug-resistant+bacteria%3A+current+strategies+for+the+discovery+of+novel+antibacterials&doi=10.1002%2Fanie.201209979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.201209979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201209979%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599onnell%26aufirst%3DK.%2BM.%2BG.%26aulast%3DHodgkinson%26aufirst%3DJ.%2BT.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DSalmond%26aufirst%3DG.%2BP.%2BC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DCombating%2520multidrug-resistant%2520bacteria%253A%2520current%2520strategies%2520for%2520the%2520discovery%2520of%2520novel%2520antibacterials%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2013%26volume%3D52%26spage%3D10706%26epage%3D10733%26doi%3D10.1002%2Fanie.201209979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sani, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Separovic, F.</span></span> <span> </span><span class="NLM_article-title">How Membrane-active peptides cet into lipid membranes</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.6b00074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.6b00074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFeqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=1130-1138&author=M.-A.+Saniauthor=F.+Separovic&title=How+Membrane-active+peptides+cet+into+lipid+membranes&doi=10.1021%2Facs.accounts.6b00074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">How Membrane-Active Peptides Get into Lipid Membranes</span></div><div class="casAuthors">Sani, Marc-Antoine; Separovic, Frances</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1130-1138</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The structure-function relationship for a family of antimicrobial peptides (AMPs) from the skin of Australian tree frogs is discussed and compared with that of peptide toxins from bee and Australian scorpion venoms.  Although these membrane-active peptides induce a similar cellular fate by disrupting the lipid bilayer integrity, their lytic activity is achieved via different modes of action, which are investigated in relation to amino acid sequence, secondary structure, and membrane lipid compn.  In order to better understand what structural features govern the interaction between peptides and lipid membranes, cell-penetrating peptides (CPPs), which translocate through the membrane without compromising its integrity, are also discussed.AMPs possess membrane lytic activities that are naturally designed to target the cellular membrane of pathogens or competitors.  They are extremely diverse in amino acid compn. and often show specificity against a particular strain of microbe.  Since our antibiotic arsenal is declining precariously in the face of the rise in multiantibiotic resistance, AMPs increasingly are seen as a promising alternative.  In an effort to understand their mol. mechanism, biophys. studies of a myriad of AMPs have been reported, yet no unifying mechanism has emerged, rendering difficult the rational design of drug leads.  Similarly, a wide variety of cytotoxic peptides are found in venoms, the best known being melittin, yet again, predicting their activity based on a particular amino acid compn. or secondary structure remains elusive.  A common feature of these membrane-active peptides is their preference for the lipid environment.  Indeed, they are mainly unstructured in soln. and, in the presence of lipid membranes, quickly adsorb onto the surface, change their secondary structure, eventually insert into the hydrophobic core of the membrane bilayer, and finally disrupt the bilayer integrity.  These steps define the mol. mechanism by which these membrane-active peptides lyse membranes.  The last class of membrane-active peptides discussed are the CPPs, which translocate across the lipid bilayer without inducing severe disruption and have potential as drug vehicles.  CPPs are typically highly charged and can show antimicrobial activity by targeting an intracellular target rather than via a direct membrane lytic mechanism.A crit. aspect in the structure-function relationship of membrane-active peptides is their specific activity relative to the lipid membrane compn. of the cell target.  Cell membranes have a wide diversity of lipids, and those of eukaryotic and prokaryotic species differ greatly in compn. and structure.  The activity of AMPs from Australian tree frogs, toxins, and CPPs has been investigated within various lipid systems to assess whether a relationship between peptide and membrane compn. could be identified.  NMR spectroscopy techniques are being used to gain atomistic details of how these membrane-active peptides interact with model membranes and cells, and in particular, competitive assays demonstrate the difference between affinity and activity for a specific lipid environment.  Overall, the interactions between these relatively small sized peptides and various lipid bilayers give insight into how these peptides function at the membrane interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLQ9FWucXXbVg90H21EOLACvtfcHk0ljClUvjUL7kqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFeqs78%253D&md5=b7c94da7a365d90d40b5ba58dea51322</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.6b00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.6b00074%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.-A.%26aulast%3DSeparovic%26aufirst%3DF.%26atitle%3DHow%2520Membrane-active%2520peptides%2520cet%2520into%2520lipid%2520membranes%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2016%26volume%3D49%26spage%3D1130%26epage%3D1138%26doi%3D10.1021%2Facs.accounts.6b00074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thaker, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cankaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, G. N.</span></span> <span> </span><span class="NLM_article-title">Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with Gram-negative activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">485</span>, <span class="refDoi"> DOI: 10.1021/ml300307b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300307b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslahu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=481-485&author=H.+D.+Thakerauthor=A.+Cankayaauthor=R.+W.+Scottauthor=G.+N.+Tew&title=Role+of+amphiphilicity+in+the+design+of+synthetic+mimics+of+antimicrobial+peptides+with+Gram-negative+activity&doi=10.1021%2Fml300307b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with gram-negative activity</span></div><div class="casAuthors">Thaker, Hitesh D.; Cankaya, Alper; Scott, Richard W.; Tew, Gregory N.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-485</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two new series of aryl SMAMPs (synthetic mimics of antimicrobial peptides) with facially amphiphilic (FA) and disrupted amphiphilic (DA) topologies were designed and synthesized to directly assess the role of amphiphilicity on their antimicrobial activity against Gram-pos. and Gram-neg. bacteria in closely related structures.  The FA SMAMPs displayed broad spectrum antimicrobial activity against both Gram-pos. S. aureus and Gram-neg. E. coli, whereas the DA SMAMPs, which contained a polar amide bond in between the hydrophobic moieties, only exhibited activity toward S. aureus with increasing hydrophobicity.  The integy moment (IW) was used to quantify the amphiphilicity of the SMAMPs and confirmed that it is crit. for the design of SMAMPs with Gram-neg. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjC0kntuFqrVg90H21EOLACvtfcHk0ljClUvjUL7kqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslahu7o%253D&md5=8361bfc67f53d455f2323ca87d2a31e2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fml300307b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300307b%26sid%3Dliteratum%253Aachs%26aulast%3DThaker%26aufirst%3DH.%2BD.%26aulast%3DCankaya%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DTew%26aufirst%3DG.%2BN.%26atitle%3DRole%2520of%2520amphiphilicity%2520in%2520the%2520design%2520of%2520synthetic%2520mimics%2520of%2520antimicrobial%2520peptides%2520with%2520Gram-negative%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D481%26epage%3D485%26doi%3D10.1021%2Fml300307b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rotem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, A.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial peptide mimics for improved therapeutic properties</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1788</i></span>,  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2008.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.bbamem.2008.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=19028449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1GhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1788&publication_year=2009&pages=1582-1592&author=S.+Rotemauthor=A.+Mor&title=Antimicrobial+peptide+mimics+for+improved+therapeutic+properties&doi=10.1016%2Fj.bbamem.2008.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial peptide mimics for improved therapeutic properties</span></div><div class="casAuthors">Rotem, Shahar; Mor, Amram</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1788</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1582-1592</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The relatively recent recognition of the major role played by antimicrobial peptides (AMPs) in sustaining an effective host response to immune challenges was greatly influenced by studies of amphibian peptides.  AMPs are also widely regarded as a potential source of future antibiotics owing to a remarkable set of advantageous properties ranging from mol. simplicity to low-resistance swift-kill of a broad range of microbial cells.  However, the peptide formula per se, represents less than ideal drug candidates, namely because of poor bioavailability issues, potential immunogenicity, optional toxicity and high prodn. costs.  To address these issues, synthetic peptides have been designed, reproducing the crit. peptide biophys. characteristic in unnatural sequence-specific oligomers.  Thus, the use of peptidomimetics to overcome the limitations inherent to peptides phys. characteristics is becoming an important and promising approach for improving the therapeutic potential of AMPs.  Here, we review most recent advances in the design strategies and the biophys. properties of the main classes of mimics to natural AMPs, emphasizing the importance of structure-activity relationship studies in fine-tuning of their physicochem. attributes for improved antimicrobial properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Fo1isOgcjbVg90H21EOLACvtfcHk0ljClUvjUL7kqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1GhtL4%253D&md5=dd1481ddd791081c51865b7f24569108</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2008.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2008.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DRotem%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DA.%26atitle%3DAntimicrobial%2520peptide%2520mimics%2520for%2520improved%2520therapeutic%2520properties%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1788%26spage%3D1582%26epage%3D1592%26doi%3D10.1016%2Fj.bbamem.2008.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lio, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, E. T.</span></span> <span> </span><span class="NLM_article-title">Topical antibacterial agents</span>. <i>Med. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1016/j.mcna.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.mcna.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslSisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=703-721&author=P.+A.+Lioauthor=E.+T.+Kaye&title=Topical+antibacterial+agents&doi=10.1016%2Fj.mcna.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Topical Antibacterial Agents</span></div><div class="casAuthors">Lio, Peter A.; Kaye, Elaine T.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Clinics of North America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">703-721</span>CODEN:
                <span class="NLM_cas:coden">MCNAA9</span>;
        ISSN:<span class="NLM_cas:issn">0025-7125</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Decreased systemic toxicity, ease of application, and increased concns. at the target site are some of the important advantages topical antibacterial agents offer.  This article reviews the literature on selected indications for these agents and provides in-depth examn. of specific agents for the prophylaxis and treatment of skin and wound infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdQzkvM5_dcLVg90H21EOLACvtfcHk0ljMbDb4OowiVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslSisLc%253D&md5=84488de6c8acc6abd917ae620514ffa2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DLio%26aufirst%3DP.%2BA.%26aulast%3DKaye%26aufirst%3DE.%2BT.%26atitle%3DTopical%2520antibacterial%2520agents%26jtitle%3DMed.%2520Clin.%26date%3D2011%26volume%3D95%26spage%3D703%26epage%3D721%26doi%3D10.1016%2Fj.mcna.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Budak, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baykara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivanc, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicek, S.</span></span> <span> </span><span class="NLM_article-title">Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis</span>. <i>Cutan. Ocul. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.3109/15569527.2015.1058273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.3109%2F15569527.2015.1058273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26100380" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=126-130&author=B.+A.+Budakauthor=M.+Baykaraauthor=S.+A.+Kivancauthor=H.+Yilmazauthor=S.+Cicek&title=Comparing+the+ocular+surface+effects+of+topical+vancomycin+and+linezolid+for+treating+bacterial+keratitis&doi=10.3109%2F15569527.2015.1058273"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.3109%2F15569527.2015.1058273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15569527.2015.1058273%26sid%3Dliteratum%253Aachs%26aulast%3DBudak%26aufirst%3DB.%2BA.%26aulast%3DBaykara%26aufirst%3DM.%26aulast%3DKivanc%26aufirst%3DS.%2BA.%26aulast%3DYilmaz%26aufirst%3DH.%26aulast%3DCicek%26aufirst%3DS.%26atitle%3DComparing%2520the%2520ocular%2520surface%2520effects%2520of%2520topical%2520vancomycin%2520and%2520linezolid%2520for%2520treating%2520bacterial%2520keratitis%26jtitle%3DCutan.%2520Ocul.%2520Toxicol.%26date%3D2016%26volume%3D35%26spage%3D126%26epage%3D130%26doi%3D10.3109%2F15569527.2015.1058273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kollef, M. H.</span></span> <span> </span><span class="NLM_article-title">Limitations of vancomycin in the management of resistant staphylococcal infections</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">S191</span>– <span class="NLM_lpage">S195</span>, <span class="refDoi"> DOI: 10.1086/519470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1086%2F519470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17712746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=S191-S195&author=M.+H.+Kollef&title=Limitations+of+vancomycin+in+the+management+of+resistant+staphylococcal+infections&doi=10.1086%2F519470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Limitations of vancomycin in the management of resistant staphylococcal infections</span></div><div class="casAuthors">Kollef, Marin H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S191-S195</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Vancomycin is effective against methicillin-resistant Staphylococcus aureus and has been widely used in the past few years.  However, several recent reports have highlighted the limitations of vancomycin, and its role in the management of serious infections is now being reconsidered.  Vancomycin treatment failure rates are assocd. with an increase in the min. inhibitory concn. as well as a decrease in the rate of bacterial killing.  The intrinsic limitations of vancomycin also include poor tissue penetration, particularly in the lung; relatively slow bacterial killing; and the potential for toxicity.  In addn., intermediate-level vancomycin resistance has emerged among staphylococci, as have rare cases of fully resistant strains.  Because of these problems, when using vancomycin, it is probably prudent to carefully establish the diagnosis, test for antimicrobial susceptibility, and monitor serum trough concns. to ensure adequate dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBH-llmKSIY7Vg90H21EOLACvtfcHk0ljMbDb4OowiVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrrN&md5=a0dfef666bbe14e28f1d60a33e5a2b25</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1086%2F519470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F519470%26sid%3Dliteratum%253Aachs%26aulast%3DKollef%26aufirst%3DM.%2BH.%26atitle%3DLimitations%2520of%2520vancomycin%2520in%2520the%2520management%2520of%2520resistant%2520staphylococcal%2520infections%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2007%26volume%3D45%26spage%3DS191%26epage%3DS195%26doi%3D10.1086%2F519470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jed F. Fisher, <span class="NLM_string-name hlFld-ContribAuthor">Shahriar Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3412-3463. <a href="https://doi.org/10.1021/acs.chemrev.0c01010" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c01010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c01010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c01010%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3D%2525CE%2525B2-Lactams%252Bagainst%252Bthe%252BFortress%252Bof%252Bthe%252BGram-Positive%252BStaphylococcus%252Baureus%252BBacterium%26aulast%3DFisher%26aufirst%3DJed%2BF.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D17092020%26date%3D29122020%26volume%3D121%26issue%3D6%26spage%3D3412%26epage%3D3463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuimu Lin, John D. Wade, <span class="NLM_string-name hlFld-ContribAuthor">Shouping Liu</span>. </span><span class="cited-content_cbyCitation_article-title">De Novo Design of Flavonoid-Based Mimetics of Cationic Antimicrobial Peptides: Discovery, Development, and Applications. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (1)
                                     , 104-119. <a href="https://doi.org/10.1021/acs.accounts.0c00550" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00550%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDe%252BNovo%252BDesign%252Bof%252BFlavonoid-Based%252BMimetics%252Bof%252BCationic%252BAntimicrobial%252BPeptides%25253A%252BDiscovery%25252C%252BDevelopment%25252C%252Band%252BApplications%26aulast%3DLin%26aufirst%3DShuimu%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D30082020%26date%3D21122020%26volume%3D54%26issue%3D1%26spage%3D104%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Narsaiah  Battini</span>, <span class="hlFld-ContribAuthor ">Mohammad Fawad  Ansari</span>, <span class="hlFld-ContribAuthor ">Cheng‐He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Quinazolonethiazoles as New Potential Conquerors towards
              Pseudomonas Aeruginosa. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>39 </em>
                                    (5)
                                     , 1093-1103. <a href="https://doi.org/10.1002/cjoc.202000627" title="DOI URL">https://doi.org/10.1002/cjoc.202000627</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202000627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202000627%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BQuinazolonethiazoles%252Bas%252BNew%252BPotential%252BConquerors%252Btowards%252BPseudomonas%252BAeruginosa%26aulast%3DWang%26aufirst%3DJie%26date%3D2021%26date%3D2021%26volume%3D39%26issue%3D5%26spage%3D1093%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Guo</span>, <span class="hlFld-ContribAuthor ">Ruige  Yang</span>, <span class="hlFld-ContribAuthor ">Fangfang  Chen</span>, <span class="hlFld-ContribAuthor ">Tingting  Yan</span>, <span class="hlFld-ContribAuthor ">Tingyu  Wen</span>, <span class="hlFld-ContribAuthor ">Fang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Su</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Juan  Du</span>, <span class="hlFld-ContribAuthor ">Jifeng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Triphenyl-sesquineolignan analogues derived from Illicium simonsii Maxim exhibit potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) by disrupting bacterial membranes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104824. <a href="https://doi.org/10.1016/j.bioorg.2021.104824" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104824</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104824%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DTriphenyl-sesquineolignan%252Banalogues%252Bderived%252Bfrom%252BIllicium%252Bsimonsii%252BMaxim%252Bexhibit%252Bpotent%252Bantibacterial%252Bactivity%252Bagainst%252Bmethicillin-resistant%252BStaphylococcus%252Baureus%252B%252528MRSA%252529%252Bby%252Bdisrupting%252Bbacterial%252Bmembranes%26aulast%3DGuo%26aufirst%3DYong%26date%3D2021%26volume%3D110%26spage%3D104824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Davide  Barreca</span>, <span class="hlFld-ContribAuthor ">Domenico  Trombetta</span>, <span class="hlFld-ContribAuthor ">Antonella  Smeriglio</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Mandalari</span>, <span class="hlFld-ContribAuthor ">Orazio  Romeo</span>, <span class="hlFld-ContribAuthor ">Maria Rosa  Felice</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Gattuso</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Nabavi</span>. </span><span class="cited-content_cbyCitation_article-title">Food flavonols: Nutraceuticals with complex health benefits and functionalities. </span><span class="cited-content_cbyCitation_journal-name">Trends in Food Science & Technology</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1016/j.tifs.2021.03.030" title="DOI URL">https://doi.org/10.1016/j.tifs.2021.03.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tifs.2021.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tifs.2021.03.030%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Food%2520Science%2520%2526%2520Technology%26atitle%3DFood%252Bflavonols%25253A%252BNutraceuticals%252Bwith%252Bcomplex%252Bhealth%252Bbenefits%252Band%252Bfunctionalities%26aulast%3DBarreca%26aufirst%3DDavide%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design concept for amphiphilic kaempferol-based antimicrobial agents by biomimicking the chemical structure and biological functions of HDPs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>1–15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-iodoalkanes or 3,3-dimethylallyl bromide (2 equiv), K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 1.5–10 h. (b) 1,3-dibromopropanes, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4–6 h. (c) Diethylamine, DMF, 50 °C, 24 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>16–24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) α,ω-dibromoalkanes, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4–6 h. (b) Diethylamine, DMF, 50 °C, 24 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>28–40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) corresponding amines, DMF, 50 °C, 24 h. (b) Iodomethane, CH<sub>3</sub>OH, room temperature (RT), overnight.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>41–48</b> and <b>52–54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ethyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4–12 h. (b) LiOH, THF, H<sub>2</sub>O, RT, 1.5 h. (c) Corresponding aliphatic amines or basic amino acids, HATU, DIPEA, DMF, RT, overnight.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Cationic Amphiphilic Flavone Derivatives <b>49–51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiOH, THF, CH<sub>3</sub>OH, H<sub>2</sub>O, RT, 1.5 h. (b) H-Arg-OMe·2HCl or <i>N</i>,<i>N</i>-dimethyl-1,3-propanediamine, HATU, DIPEA, DMF, RT, overnight.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time-kill kinetics of <b>45</b>, <b>52</b>, and vancomycin against <i>S. aureus</i> ATCC29213.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cytoplasmic membrane permeabilization of compounds <b>45</b> and <b>52</b> at different concentrations (1×, 2×, 4×, and 8× MIC) against <i>S. aureus</i> ATCC29213 and MRSA NCTC10442.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Differential effects of compounds <b>45</b> and <b>52</b> on the morphologies of <i>S. aureus</i> ATCC29213 (as seen by SEM). The <i>S. aureus</i> ATCC29213 cells were treated with PBS (a), 8× MIC <b>45</b> (b), and 8× MIC <b>52</b> (c), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Fluorescence microscopy of flavone compounds-induced permeabilization of <i>S. aureus</i> ATCC29213 cells visualized by Syto 9 and PI staining. The <i>S. aureus</i> ATCC29213 cells were treated with PBS (A), 8× MIC <b>45</b> (B), and 8× MIC <b>52</b> (C), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bacterial resistance studies. (A) Compounds <b>45</b>, <b>52</b>, and norfloxacin against <i>S. aureus</i> ATCC29213. (B) Separated plot for compounds <b>45</b> and <b>52</b> against <i>S. aureus</i> ATCC29213.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cytotoxicity evaluation of compounds <b>45</b> and <b>52</b> against MDA-MB-231 human breast cancer cells (a) or mouse corneal epithelial cells (b) using CCK-8 assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/medium/jm0c00053_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo antimicrobial efficacy of <b>52</b> (0.5%) and vancomycin (5%) in a murine <i>S. aureus</i> ATCC29213-induced corneal infection model. (*) <i>P</i> < 0.05 and (**) <i>P</i> < 0.05 compared with the negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00053/20200604/images/large/jm0c00053_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00053&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 68 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theuretzbacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottwalt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaplewski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigelman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thwaites, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paccaud, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbarth, S.</span></span> <span> </span><span class="NLM_article-title">Analysis of the clinical antibacterial and antituberculosis pipeline</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">e40</span>– <span class="NLM_lpage">e50</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(18)30513-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2818%2930513-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30337260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFejtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=e40-e50&author=U.+Theuretzbacherauthor=S.+Gottwaltauthor=P.+Beyerauthor=M.+Butlerauthor=L.+Czaplewskiauthor=C.+Lienhardtauthor=L.+Mojaauthor=M.+Paulauthor=S.+Paulinauthor=J.+H.+Rexauthor=L.+L.+Silverauthor=M.+Spigelmanauthor=G.+E.+Thwaitesauthor=J.-P.+Paccaudauthor=S.+Harbarth&title=Analysis+of+the+clinical+antibacterial+and+antituberculosis+pipeline&doi=10.1016%2Fs1473-3099%2818%2930513-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the clinical antibacterial and antituberculosis pipeline</span></div><div class="casAuthors">Theuretzbacher, Ursula; Gottwalt, Simon; Beyer, Peter; Butler, Mark; Czaplewski, Lloyd; Lienhardt, Christian; Moja, Lorenzo; Paul, Mical; Paulin, Sarah; Rex, John H.; Silver, Lynn L.; Spigelman, Melvin; Thwaites, Guy E.; Paccaud, Jean-Pierre; Harbarth, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e40-e50</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This anal. of the global clin. antibacterial pipeline was done in support of the Global Action Plan on Antimicrobial Resistance.  The study analyzed to what extent antibacterial and antimycobacterial drugs for systemic human use as well as oral non-systemic antibacterial drugs for Clostridium difficile infections were active against pathogens included in the WHO priority pathogen list and their innovativeness measured by their absence of cross-resistance (new class, target, mode of action).  As of July 1, 2018, 30 new chem. entity (NCE) antibacterial drugs, ten biologics, ten NCEs against Mycobacterium tuberculosis, and four NCEs against C difficile were identified.  Of the 30 NCEs, 11 are expected to have some activity against at least one crit. priority pathogen expressing carbapenem resistance.  The clin. pipeline is dominated by derivs. of established classes and most development candidates display limited innovation.  New antibacterial drugs without pre-existing cross-resistance are under-represented and are urgently needed, esp. for geog. regions with high resistance rates among Gram-neg. bacteria and M tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWapn7G_qKT7Vg90H21EOLACvtfcHk0lgnezSmdr1O1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFejtbvP&md5=38cf1c2a98bc2e353a6fa0fc01acce8d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930513-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930513-9%26sid%3Dliteratum%253Aachs%26aulast%3DTheuretzbacher%26aufirst%3DU.%26aulast%3DGottwalt%26aufirst%3DS.%26aulast%3DBeyer%26aufirst%3DP.%26aulast%3DButler%26aufirst%3DM.%26aulast%3DCzaplewski%26aufirst%3DL.%26aulast%3DLienhardt%26aufirst%3DC.%26aulast%3DMoja%26aufirst%3DL.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DPaulin%26aufirst%3DS.%26aulast%3DRex%26aufirst%3DJ.%2BH.%26aulast%3DSilver%26aufirst%3DL.%2BL.%26aulast%3DSpigelman%26aufirst%3DM.%26aulast%3DThwaites%26aufirst%3DG.%2BE.%26aulast%3DPaccaud%26aufirst%3DJ.-P.%26aulast%3DHarbarth%26aufirst%3DS.%26atitle%3DAnalysis%2520of%2520the%2520clinical%2520antibacterial%2520and%2520antituberculosis%2520pipeline%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2019%26volume%3D19%26spage%3De40%26epage%3De50%26doi%3D10.1016%2Fs1473-3099%2818%2930513-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roope, L. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouwels, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eibich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robotham, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wordsworth, S.</span></span> <span> </span><span class="NLM_article-title">The challenge of antimicrobial resistance: What economics can contribute</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>364</i></span>, <span class="NLM_elocation-id">eaau4679</span> <span class="refDoi"> DOI: 10.1126/science.aau4679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1126%2Fscience.aau4679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30948524" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2019&author=L.+S.+J.+Roopeauthor=R.+D.+Smithauthor=K.+B.+Pouwelsauthor=J.+Buchananauthor=L.+Abelauthor=P.+Eibichauthor=C.+C.+Butlerauthor=P.+S.+Tanauthor=A.+S.+Walkerauthor=J.+V.+Robothamauthor=S.+Wordsworth&title=The+challenge+of+antimicrobial+resistance%3A+What+economics+can+contribute&doi=10.1126%2Fscience.aau4679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.aau4679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aau4679%26sid%3Dliteratum%253Aachs%26aulast%3DRoope%26aufirst%3DL.%2BS.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26aulast%3DPouwels%26aufirst%3DK.%2BB.%26aulast%3DBuchanan%26aufirst%3DJ.%26aulast%3DAbel%26aufirst%3DL.%26aulast%3DEibich%26aufirst%3DP.%26aulast%3DButler%26aufirst%3DC.%2BC.%26aulast%3DTan%26aufirst%3DP.%2BS.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26aulast%3DRobotham%26aufirst%3DJ.%2BV.%26aulast%3DWordsworth%26aufirst%3DS.%26atitle%3DThe%2520challenge%2520of%2520antimicrobial%2520resistance%253A%2520What%2520economics%2520can%2520contribute%26jtitle%3DScience%26date%3D2019%26volume%3D364%26doi%3D10.1126%2Fscience.aau4679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossolini, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecile, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollini, S.</span></span> <span> </span><span class="NLM_article-title">Update on the antibiotic resistance crisis</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.coph.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=25254623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyitLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=56-60&author=G.+M.+Rossoliniauthor=F.+Arenaauthor=P.+Pecileauthor=S.+Pollini&title=Update+on+the+antibiotic+resistance+crisis&doi=10.1016%2Fj.coph.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the antibiotic resistance crisis</span></div><div class="casAuthors">Rossolini, Gian Maria; Arena, Fabio; Pecile, Patrizia; Pollini, Simona</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-60</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Antibiotics tend to lose their efficacy over time due to the emergence and dissemination of resistance among bacterial pathogens.  Strains with resistance to multiple antibiotic classes have emerged among major Gram-pos. and Gram-neg. species including Staphylococcus aureus, Enterococcus spp., Pseudomonas aeruginosa, Acinetobacter spp.  Enterobacteriaceae, and Neisseria gonorrhoeae.  With some Gram-negatives, resistance may involve most or even all the available antimicrobial options, resulting in extremely drug-resistant or totally drug-resistant phenotypes.  This so-called 'antibiotic resistance crisis' has been compounded by the lagging in antibiotic discovery and development programs occurred in recent years, and is jeopardizing the essential role played by antibiotics in current medical practices.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWUfhdUPFHvLVg90H21EOLACvtfcHk0lieAfDA4Q2vQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyitLfE&md5=06565fe5cf882954e7f2704b77b5a61d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DRossolini%26aufirst%3DG.%2BM.%26aulast%3DArena%26aufirst%3DF.%26aulast%3DPecile%26aufirst%3DP.%26aulast%3DPollini%26aufirst%3DS.%26atitle%3DUpdate%2520on%2520the%2520antibiotic%2520resistance%2520crisis%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2014%26volume%3D18%26spage%3D56%26epage%3D60%26doi%3D10.1016%2Fj.coph.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, R. E.</span></span> <span> </span><span class="NLM_article-title">Antibiotics--an investment worth making?</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1512</span>– <span class="NLM_lpage">1514</span>, <span class="refDoi"> DOI: 10.1038/nbt1206-1512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnbt1206-1512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17160052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12gtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1512-1514&author=R.+E.+Christoffersen&title=Antibiotics%2D%2Dan+investment+worth+making%3F&doi=10.1038%2Fnbt1206-1512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics-an investment worth making?</span></div><div class="casAuthors">Christoffersen, Ralph E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1512-1514</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxRc5u6Ptz4bVg90H21EOLACvtfcHk0lieAfDA4Q2vQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12gtb3I&md5=85f28c375852fb4fb5df8b9beb6e19ef</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt1206-1512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1206-1512%26sid%3Dliteratum%253Aachs%26aulast%3DChristoffersen%26aufirst%3DR.%2BE.%26atitle%3DAntibiotics--an%2520investment%2520worth%2520making%253F%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D1512%26epage%3D1514%26doi%3D10.1038%2Fnbt1206-1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lencastre, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluytmans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra-Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbarth, S.</span></span> <span> </span><span class="NLM_article-title">Methicillin-resistant Staphylococcus aureus</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">18033</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2018.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnrdp.2018.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29849094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC1MbhvF2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=18033&author=A.+S.+Leeauthor=H.+de+Lencastreauthor=J.+Garauauthor=J.+Kluytmansauthor=S.+Malhotra-Kumarauthor=A.+Peschelauthor=S.+Harbarth&title=Methicillin-resistant+Staphylococcus+aureus&doi=10.1038%2Fnrdp.2018.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Lee Andie S; Lee Andie S; de Lencastre Herminia; de Lencastre Herminia; Garau Javier; Kluytmans Jan; Kluytmans Jan; Malhotra-Kumar Surbhi; Peschel Andreas; Peschel Andreas; Harbarth Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18033</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged, disseminated globally and become a leading cause of bacterial infections in both health-care and community settings.  However, there is marked geographical variation in MRSA burden owing to several factors, including differences in local infection control practices and pathogen-specific characteristics of the circulating clones.  Different MRSA clones have resulted from the independent acquisition of staphylococcal cassette chromosome mec (SCCmec), which contains genes encoding proteins that render the bacterium resistant to most β-lactam antibiotics (such as methicillin), by several S. aureus clones.  The success of MRSA is a consequence of the extensive arsenal of virulence factors produced by S. aureus combined with β-lactam resistance and, for most clones, resistance to other antibiotic classes.  Clinical manifestations of MRSA range from asymptomatic colonization of the nasal mucosa to mild skin and soft tissue infections to fulminant invasive disease with high mortality.  Although treatment options for MRSA are limited, several new antimicrobials are under development.  An understanding of colonization dynamics, routes of transmission, risk factors for progression to infection and conditions that promote the emergence of resistance will enable optimization of strategies to effectively control MRSA.  Vaccine candidates are also under development and could become an effective prevention measure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKXTZtG2H7xFZoq0fPSOTvfW6udTcc2eYZw-2tAV1wIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbhvF2rtQ%253D%253D&md5=876a11b74542a5f7ae71aee2c7fcfe65</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2018.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2018.33%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BS.%26aulast%3Dde%2BLencastre%26aufirst%3DH.%26aulast%3DGarau%26aufirst%3DJ.%26aulast%3DKluytmans%26aufirst%3DJ.%26aulast%3DMalhotra-Kumar%26aufirst%3DS.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DHarbarth%26aufirst%3DS.%26atitle%3DMethicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2018%26volume%3D4%26spage%3D18033%26doi%3D10.1038%2Fnrdp.2018.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanberger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barie, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rello, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzueto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakr, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickkers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felleiter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engoren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Investigators, E. I. G. o.</span></span> <span> </span><span class="NLM_article-title">Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2011.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.ijantimicag.2011.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=21798720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSjtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=331-335&author=H.+Hanbergerauthor=S.+Waltherauthor=M.+Leoneauthor=P.+S.+Barieauthor=J.+Relloauthor=J.+Lipmanauthor=J.+C.+Marshallauthor=A.+Anzuetoauthor=Y.+Sakrauthor=P.+Pickkersauthor=P.+Felleiterauthor=M.+Engorenauthor=J.-L.+Vincentauthor=E.+I.+G.+o.+Investigators&title=Increased+mortality+associated+with+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29+infection+in+the+intensive+care+unit%3A+results+from+the+EPIC+II+study&doi=10.1016%2Fj.ijantimicag.2011.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study</span></div><div class="casAuthors">Hanberger, Hakan; Walther, Sten; Leone, Marc; Barie, Philip S.; Rello, Jordi; Lipman, Jeffrey; Marshall, John C.; Anzueto, Antonio; Sakr, Yasser; Pickkers, Peter; Felleiter, Peter; Engoren, Milo; Vincent, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">331-335</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Controversy continues regarding whether the presence of meticillin resistance increases mortality risk in Staphylococcus aureus infections.  In this study, we assessed the role of meticillin resistance in survival of patients with S. aureus infection included in the EPIC II point-prevalence study of infection in critically ill patients performed on 8 May 2007.  Demog., physiol., bacteriol. and therapeutic data were collected for 13 796 adult patients in 1265 participating Intensive Care Units (ICUs) from 75 countries on the study day.  ICU and hospital outcomes were recorded.  Characteristics of patients with meticillin-sensitive S. aureus (MSSA) and meticillin-resistant S. aureus (MRSA) infections were compared.  Co-morbidities, age, Simplified Acute Physiol. Score (SAPS) II, site of infection, geog. region and MRSA/MSSA were entered into a multivariate model, and adjusted odds ratios (ORs) [95% confidence interval (CI)] for ICU and hospital mortality rates were calcd.  On the study day, 7087 (51%) of the 13 796 patients were classified as infected.  There were 494 patients with MRSA infections and 505 patients with MSSA infections.  There were no significant differences between the two groups in use of mech. ventilation or haemofiltration/haemodialysis.  Cancer and chronic renal failure were more prevalent in MRSA than in MSSA patients.  ICU mortality rates were 29.1% and 20.5%, resp. (P < 0.01) and corresponding hospital mortality rates were 36.4% and 27.0% (P < 0.01).  Multivariate anal. of hospital mortality for MRSA infection showed an adjusted OR of 1.46 (95% CI 1.03-2.06) (P = 0.03).  In ICU patients, MRSA infection is therefore independently assocd. with an almost 50% higher likelihood of hospital death compared with MSSA infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4HSPK1VIakbVg90H21EOLACvtfcHk0lhgYJsyKzdb2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSjtLfI&md5=ebcf9c192d594519a4f131b50a4c3c22</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2011.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2011.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanberger%26aufirst%3DH.%26aulast%3DWalther%26aufirst%3DS.%26aulast%3DLeone%26aufirst%3DM.%26aulast%3DBarie%26aufirst%3DP.%2BS.%26aulast%3DRello%26aufirst%3DJ.%26aulast%3DLipman%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DJ.%2BC.%26aulast%3DAnzueto%26aufirst%3DA.%26aulast%3DSakr%26aufirst%3DY.%26aulast%3DPickkers%26aufirst%3DP.%26aulast%3DFelleiter%26aufirst%3DP.%26aulast%3DEngoren%26aufirst%3DM.%26aulast%3DVincent%26aufirst%3DJ.-L.%26aulast%3DInvestigators%26aufirst%3DE.%2BI.%2BG.%2Bo.%26atitle%3DIncreased%2520mortality%2520associated%2520with%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520infection%2520in%2520the%2520intensive%2520care%2520unit%253A%2520results%2520from%2520the%2520EPIC%2520II%2520study%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2011%26volume%3D38%26spage%3D331%26epage%3D335%26doi%3D10.1016%2Fj.ijantimicag.2011.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willyard, C.</span></span> <span> </span><span class="NLM_article-title">The drug-resistant bacteria that pose the greatest health threats</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>543</i></span>,  <span class="NLM_fpage">15</span>, <span class="refDoi"> DOI: 10.1038/nature.2017.21550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnature.2017.21550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28252092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1GmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=543&publication_year=2017&pages=15&author=C.+Willyard&title=The+drug-resistant+bacteria+that+pose+the+greatest+health+threats&doi=10.1038%2Fnature.2017.21550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The drug-resistant bacteria that pose the greatest health threats</span></div><div class="casAuthors">Willyard, Cassandra</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">543</span>
        (<span class="NLM_cas:issue">7643</span>),
    <span class="NLM_cas:pages">15</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">World Health Organization publishes list that it hopes will focus development of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoetDtnJjM3qbVg90H21EOLACvtfcHk0lhgYJsyKzdb2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1GmtLs%253D&md5=de1d82298a31ebd916bb4ef820173180</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature.2017.21550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2017.21550%26sid%3Dliteratum%253Aachs%26aulast%3DWillyard%26aufirst%3DC.%26atitle%3DThe%2520drug-resistant%2520bacteria%2520that%2520pose%2520the%2520greatest%2520health%2520threats%26jtitle%3DNature%26date%3D2017%26volume%3D543%26spage%3D15%26doi%3D10.1038%2Fnature.2017.21550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högberg, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plachouras, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quattrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoxha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colomb-Cotinat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretzschmar, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devleesschauwer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouakrim, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struelens, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suetens, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catry, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latour, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobreva, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambic
Andraševic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soprek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budimir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paphitou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Žemlicková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schytte Olsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff Sönksen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Märtin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyytikäinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalava, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coignard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckmanns, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Sin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daikos, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gikas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiodras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontopidou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tóth, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guólaugsson, Ó.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristinsson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murchan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumpis, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuimiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Greeff, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koek, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elstrøm, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabicka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deptula, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryniewicz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caniça, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manageiro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popescu, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serban, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schréterová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litvová, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štefkovicová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klavs, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korošec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aracil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asensio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Vázquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billström, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span> <span> </span><span class="NLM_article-title">Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(18)30605-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2818%2930605-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30409683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BB3cvotFGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=56-66&author=A.+Cassiniauthor=L.+D.+H%C3%B6gbergauthor=D.+Plachourasauthor=A.+Quattrocchiauthor=A.+Hoxhaauthor=G.+S.+Simonsenauthor=M.+Colomb-Cotinatauthor=M.+E.+Kretzschmarauthor=B.+Devleesschauwerauthor=M.+Cecchiniauthor=D.+A.+Ouakrimauthor=T.+C.+Oliveiraauthor=M.+J.+Struelensauthor=C.+Suetensauthor=D.+L.+Monnetauthor=R.+Straussauthor=K.+Mertensauthor=T.+Struyfauthor=B.+Catryauthor=K.+Latourauthor=I.+N.+Ivanovauthor=E.+G.+Dobrevaauthor=A.+Tambic%0AAndra%C5%A1evicauthor=S.+Soprekauthor=A.+Budimirauthor=N.+Paphitouauthor=H.+%C5%BDemlickov%C3%A1author=S.+Schytte+Olsenauthor=U.+Wolff+S%C3%B6nksenauthor=P.+M%C3%A4rtinauthor=M.+Ivanovaauthor=O.+Lyytik%C3%A4inenauthor=J.+Jalavaauthor=B.+Coignardauthor=T.+Eckmannsauthor=M.+Abu+Sinauthor=S.+Hallerauthor=G.+L.+Daikosauthor=A.+Gikasauthor=S.+Tsiodrasauthor=F.+Kontopidouauthor=%C3%81.+T%C3%B3thauthor=%C3%81.+Hajduauthor=%C3%93.+Gu%C3%B3laugssonauthor=K.+G.+Kristinssonauthor=S.+Murchanauthor=K.+Burnsauthor=P.+Pezzottiauthor=C.+Gagliottiauthor=U.+Dumpisauthor=A.+Liuimieneauthor=M.+Perrinauthor=M.+A.+Borgauthor=S.+C.+de+Greeffauthor=J.+C.+Monenauthor=M.+B.+Koekauthor=P.+Elstr%C3%B8mauthor=D.+Zabickaauthor=A.+Deptulaauthor=W.+Hryniewiczauthor=M.+Cani%C3%A7aauthor=P.+J.+Nogueiraauthor=P.+A.+Fernandesauthor=V.+Manageiroauthor=G.+A.+Popescuauthor=R.+I.+Serbanauthor=E.+Schr%C3%A9terov%C3%A1author=S.+Litvov%C3%A1author=M.+%C5%A0tefkovicov%C3%A1author=J.+Kolmanauthor=I.+Klavsauthor=A.+Koro%C5%A1ecauthor=B.+Aracilauthor=A.+Asensioauthor=M.+P%C3%A9rez-V%C3%A1zquezauthor=H.+Billstr%C3%B6mauthor=S.+Larssonauthor=J.+S.+Reillyauthor=A.+Johnsonauthor=S.+Hopkins&title=Attributable+deaths+and+disability-adjusted+life-years+caused+by+infections+with+antibiotic-resistant+bacteria+in+the+EU+and+the+European+Economic+Area+in+2015%3A+a+population-level+modelling+analysis&doi=10.1016%2Fs1473-3099%2818%2930605-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis</span></div><div class="casAuthors">Cassini Alessandro; Hogberg Liselotte Diaz; Plachouras Diamantis; Quattrocchi Annalisa; Hoxha Ana; Struelens Marc J; Suetens Carl; Monnet Dominique L; Simonsen Gunnar Skov; Colomb-Cotinat Melanie; Kretzschmar Mirjam E; Devleesschauwer Brecht; Cecchini Michele; Ouakrim Driss Ait; Oliveira Tiago Cravo</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Infections due to antibiotic-resistant bacteria are threatening modern health care.  However, estimating their incidence, complications, and attributable mortality is challenging.  We aimed to estimate the burden of infections caused by antibiotic-resistant bacteria of public health concern in countries of the EU and European Economic Area (EEA) in 2015, measured in number of cases, attributable deaths, and disability-adjusted life-years (DALYs).  METHODS:  We estimated the incidence of infections with 16 antibiotic resistance-bacterium combinations from European Antimicrobial Resistance Surveillance Network (EARS-Net) 2015 data that was country-corrected for population coverage.  We multiplied the number of bloodstream infections (BSIs) by a conversion factor derived from the European Centre for Disease Prevention and Control point prevalence survey of health-care-associated infections in European acute care hospitals in 2011-12 to estimate the number of non-BSIs.  We developed disease outcome models for five types of infection on the basis of systematic reviews of the literature.  FINDINGS:  From EARS-Net data collected between Jan 1, 2015, and Dec 31, 2015, we estimated 671 689 (95% uncertainty interval [UI] 583 148-763 966) infections with antibiotic-resistant bacteria, of which 63·5% (426 277 of 671 689) were associated with health care.  These infections accounted for an estimated 33 110 (28 480-38 430) attributable deaths and 874 541 (768 837-989 068) DALYs.  The burden for the EU and EEA was highest in infants (aged <1 year) and people aged 65 years or older, had increased since 2007, and was highest in Italy and Greece.  INTERPRETATION:  Our results present the health burden of five types of infection with antibiotic-resistant bacteria expressed, for the first time, in DALYs.  The estimated burden of infections with antibiotic-resistant bacteria in the EU and EEA is substantial compared with that of other infectious diseases, and has increased since 2007.  Our burden estimates provide useful information for public health decision-makers prioritising interventions for infectious diseases.  FUNDING:  European Centre for Disease Prevention and Control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR76qXWYwPPXq69lAbTj9rGfW6udTcc2eZhKZZ4AEaOKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvotFGluw%253D%253D&md5=151619810730b07e3d84692f1d966b9a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930605-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930605-4%26sid%3Dliteratum%253Aachs%26aulast%3DCassini%26aufirst%3DA.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DL.%2BD.%26aulast%3DPlachouras%26aufirst%3DD.%26aulast%3DQuattrocchi%26aufirst%3DA.%26aulast%3DHoxha%26aufirst%3DA.%26aulast%3DSimonsen%26aufirst%3DG.%2BS.%26aulast%3DColomb-Cotinat%26aufirst%3DM.%26aulast%3DKretzschmar%26aufirst%3DM.%2BE.%26aulast%3DDevleesschauwer%26aufirst%3DB.%26aulast%3DCecchini%26aufirst%3DM.%26aulast%3DOuakrim%26aufirst%3DD.%2BA.%26aulast%3DOliveira%26aufirst%3DT.%2BC.%26aulast%3DStruelens%26aufirst%3DM.%2BJ.%26aulast%3DSuetens%26aufirst%3DC.%26aulast%3DMonnet%26aufirst%3DD.%2BL.%26aulast%3DStrauss%26aufirst%3DR.%26aulast%3DMertens%26aufirst%3DK.%26aulast%3DStruyf%26aufirst%3DT.%26aulast%3DCatry%26aufirst%3DB.%26aulast%3DLatour%26aufirst%3DK.%26aulast%3DIvanov%26aufirst%3DI.%2BN.%26aulast%3DDobreva%26aufirst%3DE.%2BG.%26aulast%3DTambic%2BAndra%25C5%25A1evic%26aufirst%3DA.%26aulast%3DSoprek%26aufirst%3DS.%26aulast%3DBudimir%26aufirst%3DA.%26aulast%3DPaphitou%26aufirst%3DN.%26aulast%3D%25C5%25BDemlickov%25C3%25A1%26aufirst%3DH.%26aulast%3DSchytte%2BOlsen%26aufirst%3DS.%26aulast%3DWolff%2BS%25C3%25B6nksen%26aufirst%3DU.%26aulast%3DM%25C3%25A4rtin%26aufirst%3DP.%26aulast%3DIvanova%26aufirst%3DM.%26aulast%3DLyytik%25C3%25A4inen%26aufirst%3DO.%26aulast%3DJalava%26aufirst%3DJ.%26aulast%3DCoignard%26aufirst%3DB.%26aulast%3DEckmanns%26aufirst%3DT.%26aulast%3DAbu%2BSin%26aufirst%3DM.%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DDaikos%26aufirst%3DG.%2BL.%26aulast%3DGikas%26aufirst%3DA.%26aulast%3DTsiodras%26aufirst%3DS.%26aulast%3DKontopidou%26aufirst%3DF.%26aulast%3DT%25C3%25B3th%26aufirst%3D%25C3%2581.%26aulast%3DHajdu%26aufirst%3D%25C3%2581.%26aulast%3DGu%25C3%25B3laugsson%26aufirst%3D%25C3%2593.%26aulast%3DKristinsson%26aufirst%3DK.%2BG.%26aulast%3DMurchan%26aufirst%3DS.%26aulast%3DBurns%26aufirst%3DK.%26aulast%3DPezzotti%26aufirst%3DP.%26aulast%3DGagliotti%26aufirst%3DC.%26aulast%3DDumpis%26aufirst%3DU.%26aulast%3DLiuimiene%26aufirst%3DA.%26aulast%3DPerrin%26aufirst%3DM.%26aulast%3DBorg%26aufirst%3DM.%2BA.%26aulast%3Dde%2BGreeff%26aufirst%3DS.%2BC.%26aulast%3DMonen%26aufirst%3DJ.%2BC.%26aulast%3DKoek%26aufirst%3DM.%2BB.%26aulast%3DElstr%25C3%25B8m%26aufirst%3DP.%26aulast%3DZabicka%26aufirst%3DD.%26aulast%3DDeptula%26aufirst%3DA.%26aulast%3DHryniewicz%26aufirst%3DW.%26aulast%3DCani%25C3%25A7a%26aufirst%3DM.%26aulast%3DNogueira%26aufirst%3DP.%2BJ.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26aulast%3DManageiro%26aufirst%3DV.%26aulast%3DPopescu%26aufirst%3DG.%2BA.%26aulast%3DSerban%26aufirst%3DR.%2BI.%26aulast%3DSchr%25C3%25A9terov%25C3%25A1%26aufirst%3DE.%26aulast%3DLitvov%25C3%25A1%26aufirst%3DS.%26aulast%3D%25C5%25A0tefkovicov%25C3%25A1%26aufirst%3DM.%26aulast%3DKolman%26aufirst%3DJ.%26aulast%3DKlavs%26aufirst%3DI.%26aulast%3DKoro%25C5%25A1ec%26aufirst%3DA.%26aulast%3DAracil%26aufirst%3DB.%26aulast%3DAsensio%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-V%25C3%25A1zquez%26aufirst%3DM.%26aulast%3DBillstr%25C3%25B6m%26aufirst%3DH.%26aulast%3DLarsson%26aufirst%3DS.%26aulast%3DReilly%26aufirst%3DJ.%2BS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DHopkins%26aufirst%3DS.%26atitle%3DAttributable%2520deaths%2520and%2520disability-adjusted%2520life-years%2520caused%2520by%2520infections%2520with%2520antibiotic-resistant%2520bacteria%2520in%2520the%2520EU%2520and%2520the%2520European%2520Economic%2520Area%2520in%25202015%253A%2520a%2520population-level%2520modelling%2520analysis%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2019%26volume%3D19%26spage%3D56%26epage%3D66%26doi%3D10.1016%2Fs1473-3099%2818%2930605-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tacconelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbarth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulcini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlmeter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluytmans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeli, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Outterson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaleri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houchens, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theuretzbacher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboderin, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Abri, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awang Jalil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzonana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkert, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cars, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornaglia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyar, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gales, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giske, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman Blanco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryniewicz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kattula, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanj, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieny, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlov, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labarca, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laxminarayan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibovici, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy-Hara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra-Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndoye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramon-Pardo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Baño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanguinetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si-Mehand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbakk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thwaites, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Meer, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kinh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villegas, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wechsler-Fördös, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertheim, H. F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesangula, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodford, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorzet, A.</span></span> <span> </span><span class="NLM_article-title">Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(17)30753-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2817%2930753-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29276051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC1MzkvFOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=318-327&author=E.+Tacconelliauthor=E.+Carraraauthor=A.+Savoldiauthor=S.+Harbarthauthor=M.+Mendelsonauthor=D.+L.+Monnetauthor=C.+Pulciniauthor=G.+Kahlmeterauthor=J.+Kluytmansauthor=Y.+Carmeliauthor=M.+Ouelletteauthor=K.+Outtersonauthor=J.+Patelauthor=M.+Cavaleriauthor=E.+M.+Coxauthor=C.+R.+Houchensauthor=M.+L.+Graysonauthor=P.+Hansenauthor=N.+Singhauthor=U.+Theuretzbacherauthor=N.+Magriniauthor=A.+O.+Aboderinauthor=S.+S.+Al-Abriauthor=N.+Awang+Jalilauthor=N.+Benzonanaauthor=S.+Bhattacharyaauthor=A.+J.+Brinkauthor=F.+R.+Burkertauthor=O.+Carsauthor=G.+Cornagliaauthor=O.+J.+Dyarauthor=A.+W.+Friedrichauthor=A.+C.+Galesauthor=S.+Gandraauthor=C.+G.+Giskeauthor=D.+A.+Goffauthor=H.+Goossensauthor=T.+Gottliebauthor=M.+Guzman+Blancoauthor=W.+Hryniewiczauthor=D.+Kattulaauthor=T.+Jinksauthor=S.+S.+Kanjauthor=L.+Kerrauthor=M.-P.+Kienyauthor=Y.+S.+Kimauthor=R.+S.+Kozlovauthor=J.+Labarcaauthor=R.+Laxminarayanauthor=K.+Lederauthor=L.+Leiboviciauthor=G.+Levy-Haraauthor=J.+Littmanauthor=S.+Malhotra-Kumarauthor=V.+Manchandaauthor=L.+Mojaauthor=B.+Ndoyeauthor=A.+Panauthor=D.+L.+Patersonauthor=M.+Paulauthor=H.+Qiuauthor=P.+Ramon-Pardoauthor=J.+Rodr%C3%ADguez-Ba%C3%B1oauthor=M.+Sanguinettiauthor=S.+Senguptaauthor=M.+Sharlandauthor=M.+Si-Mehandauthor=L.+L.+Silverauthor=W.+Songauthor=M.+Steinbakkauthor=J.+Thomsenauthor=G.+E.+Thwaitesauthor=J.+W.+van+der+Meerauthor=N.+Van+Kinhauthor=S.+Vegaauthor=M.+V.+Villegasauthor=A.+Wechsler-F%C3%B6rd%C3%B6sauthor=H.+F.+L.+Wertheimauthor=E.+Wesangulaauthor=N.+Woodfordauthor=F.+O.+Yilmazauthor=A.+Zorzet&title=Discovery%2C+research%2C+and+development+of+new+antibiotics%3A+the+WHO+priority+list+of+antibiotic-resistant+bacteria+and+tuberculosis&doi=10.1016%2Fs1473-3099%2817%2930753-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</span></div><div class="casAuthors">Tacconelli Evelina; Carrara Elena; Savoldi Alessia; Harbarth Stephan; Mendelson Marc; Monnet Dominique L; Pulcini Celine; Kahlmeter Gunnar; Kluytmans Jan; Carmeli Yehuda; Ouellette Marc; Outterson Kevin; Patel Jean; Cavaleri Marco; Cox Edward M; Houchens Chris R; Grayson M Lindsay; Hansen Paul; Singh Nalini; Theuretzbacher Ursula; Magrini Nicola</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">318-327</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide.  Due to its large public health and societal implications, multidrug-resistant tuberculosis has been long regarded by WHO as a global priority for investment in new drugs.  In 2016, WHO was requested by member states to create a priority list of other antibiotic-resistant bacteria to support research and development of effective drugs.  METHODS:  We used a multicriteria decision analysis method to prioritise antibiotic-resistant bacteria; this method involved the identification of relevant criteria to assess priority against which each antibiotic-resistant bacterium was rated.  The final priority ranking of the antibiotic-resistant bacteria was established after a preference-based survey was used to obtain expert weighting of criteria.  FINDINGS:  We selected 20 bacterial species with 25 patterns of acquired resistance and ten criteria to assess priority: mortality, health-care burden, community burden, prevalence of resistance, 10-year trend of resistance, transmissibility, preventability in the community setting, preventability in the health-care setting, treatability, and pipeline.  We stratified the priority list into three tiers (critical, high, and medium priority), using the 33rd percentile of the bacterium's total scores as the cutoff.  Critical-priority bacteria included carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa, and carbapenem-resistant and third-generation cephalosporin-resistant Enterobacteriaceae.  The highest ranked Gram-positive bacteria (high priority) were vancomycin-resistant Enterococcus faecium and meticillin-resistant Staphylococcus aureus.  Of the bacteria typically responsible for community-acquired infections, clarithromycin-resistant Helicobacter pylori, and fluoroquinolone-resistant Campylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were included in the high-priority tier.  INTERPRETATION:  Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria.  The global strategy should include antibiotic-resistant bacteria responsible for community-acquired infections such as Salmonella spp, Campylobacter spp, N gonorrhoeae, and H pylori.  FUNDING:  World Health Organization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkARC7DR8uZLGbPKh4T9eAfW6udTcc2ebqAQPXmJJXNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzkvFOgsA%253D%253D&md5=14021ec57670b29fec6a88226a6a1fdd</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2817%2930753-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252817%252930753-3%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DE.%26aulast%3DCarrara%26aufirst%3DE.%26aulast%3DSavoldi%26aufirst%3DA.%26aulast%3DHarbarth%26aufirst%3DS.%26aulast%3DMendelson%26aufirst%3DM.%26aulast%3DMonnet%26aufirst%3DD.%2BL.%26aulast%3DPulcini%26aufirst%3DC.%26aulast%3DKahlmeter%26aufirst%3DG.%26aulast%3DKluytmans%26aufirst%3DJ.%26aulast%3DCarmeli%26aufirst%3DY.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DOutterson%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DCavaleri%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DE.%2BM.%26aulast%3DHouchens%26aufirst%3DC.%2BR.%26aulast%3DGrayson%26aufirst%3DM.%2BL.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DTheuretzbacher%26aufirst%3DU.%26aulast%3DMagrini%26aufirst%3DN.%26aulast%3DAboderin%26aufirst%3DA.%2BO.%26aulast%3DAl-Abri%26aufirst%3DS.%2BS.%26aulast%3DAwang%2BJalil%26aufirst%3DN.%26aulast%3DBenzonana%26aufirst%3DN.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBrink%26aufirst%3DA.%2BJ.%26aulast%3DBurkert%26aufirst%3DF.%2BR.%26aulast%3DCars%26aufirst%3DO.%26aulast%3DCornaglia%26aufirst%3DG.%26aulast%3DDyar%26aufirst%3DO.%2BJ.%26aulast%3DFriedrich%26aufirst%3DA.%2BW.%26aulast%3DGales%26aufirst%3DA.%2BC.%26aulast%3DGandra%26aufirst%3DS.%26aulast%3DGiske%26aufirst%3DC.%2BG.%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DGoossens%26aufirst%3DH.%26aulast%3DGottlieb%26aufirst%3DT.%26aulast%3DGuzman%2BBlanco%26aufirst%3DM.%26aulast%3DHryniewicz%26aufirst%3DW.%26aulast%3DKattula%26aufirst%3DD.%26aulast%3DJinks%26aufirst%3DT.%26aulast%3DKanj%26aufirst%3DS.%2BS.%26aulast%3DKerr%26aufirst%3DL.%26aulast%3DKieny%26aufirst%3DM.-P.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKozlov%26aufirst%3DR.%2BS.%26aulast%3DLabarca%26aufirst%3DJ.%26aulast%3DLaxminarayan%26aufirst%3DR.%26aulast%3DLeder%26aufirst%3DK.%26aulast%3DLeibovici%26aufirst%3DL.%26aulast%3DLevy-Hara%26aufirst%3DG.%26aulast%3DLittman%26aufirst%3DJ.%26aulast%3DMalhotra-Kumar%26aufirst%3DS.%26aulast%3DManchanda%26aufirst%3DV.%26aulast%3DMoja%26aufirst%3DL.%26aulast%3DNdoye%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DPaterson%26aufirst%3DD.%2BL.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DRamon-Pardo%26aufirst%3DP.%26aulast%3DRodr%25C3%25ADguez-Ba%25C3%25B1o%26aufirst%3DJ.%26aulast%3DSanguinetti%26aufirst%3DM.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DSharland%26aufirst%3DM.%26aulast%3DSi-Mehand%26aufirst%3DM.%26aulast%3DSilver%26aufirst%3DL.%2BL.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DSteinbakk%26aufirst%3DM.%26aulast%3DThomsen%26aufirst%3DJ.%26aulast%3DThwaites%26aufirst%3DG.%2BE.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%26aulast%3DVan%2BKinh%26aufirst%3DN.%26aulast%3DVega%26aufirst%3DS.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DWechsler-F%25C3%25B6rd%25C3%25B6s%26aufirst%3DA.%26aulast%3DWertheim%26aufirst%3DH.%2BF.%2BL.%26aulast%3DWesangula%26aufirst%3DE.%26aulast%3DWoodford%26aufirst%3DN.%26aulast%3DYilmaz%26aufirst%3DF.%2BO.%26aulast%3DZorzet%26aufirst%3DA.%26atitle%3DDiscovery%252C%2520research%252C%2520and%2520development%2520of%2520new%2520antibiotics%253A%2520the%2520WHO%2520priority%2520list%2520of%2520antibiotic-resistant%2520bacteria%2520and%2520tuberculosis%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2018%26volume%3D18%26spage%3D318%26epage%3D327%26doi%3D10.1016%2Fs1473-3099%2817%2930753-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kullar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, E. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathwani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escandón-Vargas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villegas, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Bergh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, M.</span></span> <span> </span><span class="NLM_article-title">A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">e56</span>– <span class="NLM_lpage">e63</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(16)30386-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2FS1473-3099%2816%2930386-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=27866945" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=e56-e63&author=D.+A.+Goffauthor=R.+Kullarauthor=E.+J.+C.+Goldsteinauthor=M.+Gilchristauthor=D.+Nathwaniauthor=A.+C.+Chengauthor=K.+A.+Cairnsauthor=K.+Escand%C3%B3n-Vargasauthor=M.+V.+Villegasauthor=A.+Brinkauthor=D.+van+den+Berghauthor=M.+Mendelson&title=A+global+call+from+five+countries+to+collaborate+in+antibiotic+stewardship%3A+united+we+succeed%2C+divided+we+might+fail&doi=10.1016%2Fs1473-3099%2816%2930386-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2816%2930386-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252816%252930386-3%26sid%3Dliteratum%253Aachs%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DKullar%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DE.%2BJ.%2BC.%26aulast%3DGilchrist%26aufirst%3DM.%26aulast%3DNathwani%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCairns%26aufirst%3DK.%2BA.%26aulast%3DEscand%25C3%25B3n-Vargas%26aufirst%3DK.%26aulast%3DVillegas%26aufirst%3DM.%2BV.%26aulast%3DBrink%26aufirst%3DA.%26aulast%3Dvan%2Bden%2BBergh%26aufirst%3DD.%26aulast%3DMendelson%26aufirst%3DM.%26atitle%3DA%2520global%2520call%2520from%2520five%2520countries%2520to%2520collaborate%2520in%2520antibiotic%2520stewardship%253A%2520united%2520we%2520succeed%252C%2520divided%2520we%2520might%2520fail%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26spage%3De56%26epage%3De63%26doi%3D10.1016%2Fs1473-3099%2816%2930386-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel DNA gyrase-inhibiting spiropyrimidinetriones as potent antibiotics for treatment of infections caused by multidrug-resistant Gram-positive bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2950</span>– <span class="NLM_lpage">2973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01750</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01750" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVCns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2950-2973&author=C.+Shiauthor=Y.+Zhangauthor=T.+Wangauthor=W.+Luauthor=S.+Zhangauthor=B.+Guoauthor=Q.+Chenauthor=C.+Luoauthor=X.+Zhouauthor=Y.+Yang&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+DNA+gyrase-inhibiting+spiropyrimidinetriones+as+potent+antibiotics+for+treatment+of+infections+caused+by+multidrug-resistant+Gram-positive+bacteria&doi=10.1021%2Facs.jmedchem.8b01750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria</span></div><div class="casAuthors">Shi, Chenghui; Zhang, Yinyong; Wang, Ting; Lu, Wenchao; Zhang, Shuhua; Guo, Bin; Chen, Qian; Luo, Cheng; Zhou, Xianli; Yang, Yushe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2950-2973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">OSpiropyrimidinetriones are a novel class of antibacterial agents that target the bacterial type II topoisomerase via a new mode of action.  Compd. ETX0914 is thus far the only drug from this class that is being evaluated in clin. trials.  To improve the antibacterial activity and pharmacokinetic properties of ETX0914, we carried out systematic structural modification of this compd., and a no. of compds. with increased potency were obtained.  The most promising compd. I, with incorporation of a spirocyclopropane at the oxazolidinone 5 position reduced metab., exhibited excellent antibacterial activity against Gram-pos. pathogens and a good pharmacokinetic profile combined with high aq. soly.  In addn., compd. I exhibited good selectivity for Staphylococcus aureus gyrase over human Topo IIα.  In a murine model of systemic methicillin-resistant S. aureus infection, I exhibited superior in vivo efficacy (ED50 = 3.87 mg/kg) compared to ETX0914 (ED50 = 11.51 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ6gparWwzX7Vg90H21EOLACvtfcHk0ljxoxtC6l0gFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVCns7w%253D&md5=cda4a55200d7e942dced7859975df17c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01750%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520DNA%2520gyrase-inhibiting%2520spiropyrimidinetriones%2520as%2520potent%2520antibiotics%2520for%2520treatment%2520of%2520infections%2520caused%2520by%2520multidrug-resistant%2520Gram-positive%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2950%26epage%3D2973%26doi%3D10.1021%2Facs.jmedchem.8b01750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahl, H.-G.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1551</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1038/nbt1267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnbt1267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17160061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12gtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1551-1557&author=R.+E.+W.+Hancockauthor=H.-G.+Sahl&title=Antimicrobial+and+host-defense+peptides+as+new+anti-infective+therapeutic+strategies&doi=10.1038%2Fnbt1267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies</span></div><div class="casAuthors">Hancock, Robert E. W.; Sahl, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1551-1557</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Short cationic amphiphilic peptides with antimicrobial and/or immunomodulatory activities are present in virtually every life form, as an important component of (innate) immune defenses.  These host-defense peptides provide a template for two sep. classes of antimicrobial drugs.  Direct-acting antimicrobial host-defense peptides can be rapid-acting and potent, and possess an unusually broad spectrum of activity; consequently, they have prospects as new antibiotics, although clin. trials to date have shown efficacy only as topical agents.  But for these compds. to fulfill their therapeutic promise and overcome clin. setbacks, further work is needed to understand their mechanisms of action and reduce the potential for unwanted toxicity, to make them more resistant to protease degrdn. and improve serum half-life, as well as to devise means of manufg. them on a large scale in a consistent and cost-effective manner.  In contrast, the role of cationic host-defense peptides in modulating the innate immune response and boosting infection-resolving immunity while dampening potentially harmful pro-inflammatory (septic) responses gives these peptides the potential to become an entirely new therapeutic approach against bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDCXCNhkv3_bVg90H21EOLACvtfcHk0ljxoxtC6l0gFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12gtbvM&md5=57cbc9e0a85bcdf82663d840622886e1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnbt1267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1267%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26aulast%3DSahl%26aufirst%3DH.-G.%26atitle%3DAntimicrobial%2520and%2520host-defense%2520peptides%2520as%2520new%2520anti-infective%2520therapeutic%2520strategies%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D1551%26epage%3D1557%26doi%3D10.1038%2Fnbt1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghimire, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimley, W. C.</span></span> <span> </span><span class="NLM_article-title">Mechanistic landscape of membrane-permeabilizing peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">6040</span>– <span class="NLM_lpage">6085</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00520</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00520" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltV2jug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=6040-6085&author=S.+Guhaauthor=J.+Ghimireauthor=E.+Wuauthor=W.+C.+Wimley&title=Mechanistic+landscape+of+membrane-permeabilizing+peptides&doi=10.1021%2Facs.chemrev.8b00520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic landscape of membrane-permeabilizing peptides</span></div><div class="casAuthors">Guha, Shantanu; Ghimire, Jenisha; Wu, Eric; Wimley, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6040-6085</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Membrane-permeabilizing peptides (MPPs) are as ubiquitous as the lipid bilayer membranes they act upon.  Produced by all forms of life, most MPPs are used offensively or defensively against the membranes of other organisms.  Just as Nature has found many uses for them, translational scientists have worked for decades to design or optimize MPPs for applications in the lab. and in the clinic ranging from antibacterial and antiviral therapy and prophylaxis to anticancer therapeutics and drug delivery.  Here, we review the field of MPPs.  We discuss the diversity of their sources and structures, the systems and methods used to measure their activities, and the behaviors that are obsd.  We discuss the fact that "mechanism" is not a discrete or a static entity for a MPP, but rather the result of a heterogeneous and dynamic ensemble of structural states that vary in response to many different exptl. conditions.  This has led to an almost complete lack of discrete 3-dimensional active structures among the thousands of known MPPs and a lack of useful or predictive sequence-structure-function relation rules.  Ultimately, we discuss how it may be more useful to think of MPP mechanisms as broad regions of a mechanistic landscape rather than discrete mol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmLwhESI81t7Vg90H21EOLACvtfcHk0lhy9WlsiH9AFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltV2jug%253D%253D&md5=a591e43ebc009cbe483ba932a2b93fee</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00520%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DS.%26aulast%3DGhimire%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DWimley%26aufirst%3DW.%2BC.%26atitle%3DMechanistic%2520landscape%2520of%2520membrane-permeabilizing%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D6040%26epage%3D6085%26doi%3D10.1021%2Facs.chemrev.8b00520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, A.</span></span> <span> </span><span class="NLM_article-title">antimicrobial peptides with high proteolytic resistance for combating Gram-negative bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2286</span>– <span class="NLM_lpage">2304</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01348</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01348" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisl2lsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2286-2304&author=J.+Wangauthor=J.+Songauthor=Z.+Yangauthor=S.+Heauthor=Y.+Yangauthor=X.+Fengauthor=X.+Douauthor=A.+Shan&title=antimicrobial+peptides+with+high+proteolytic+resistance+for+combating+Gram-negative+bacteria&doi=10.1021%2Facs.jmedchem.8b01348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria</span></div><div class="casAuthors">Wang, Jiajun; Song, Jing; Yang, Zhanyi; He, Shiqi; Yang, Yi; Feng, Xingjun; Dou, Xiujing; Shan, Anshan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2286-2304</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Poor proteolytic resistance is an urgent problem to be solved in the clin. application of antimicrobial peptides (AMPs), yet common solns., such as complicated chem. modifications and utilization of D-amino acids, greatly increase the difficulty and cost of producing AMPs.  In this work, a set of novel peptides was synthesized based on an antitrypsin/antichymotrypsin hydrolytic peptide structure unit (XYPX)n (X represents I, L, and V; Y represents R and K), which was designed using a systematic natural amino acid arrangement.  Of these peptides, 1 of them with 7 repeat units had the highest av. selectivity index (GMSI = 99.07) for all of the Gram-neg. bacteria tested and remained highly effective in combating Escherichia coli infection in vivo.  Importantly, the same peptide also had dramatic resistance to a high concn. of trypsin/chymotrypsin hydrolysis and exerted bactericidal activity through a membrane-disruptive mechanism.  Overall, these findings provide new approaches for the development of antiprotease hydrolytic peptides that target Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5SNyY4JzKxLVg90H21EOLACvtfcHk0lhy9WlsiH9AFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisl2lsrs%253D&md5=0a5b9a7741b7b397b9f15e1d9ac30970</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01348%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DDou%26aufirst%3DX.%26aulast%3DShan%26aufirst%3DA.%26atitle%3Dantimicrobial%2520peptides%2520with%2520high%2520proteolytic%2520resistance%2520for%2520combating%2520Gram-negative%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2286%26epage%3D2304%26doi%3D10.1021%2Facs.jmedchem.8b01348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brogden, K. A.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnrmicro1098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=15703760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslGjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=238-250&author=K.+A.+Brogden&title=Antimicrobial+peptides%3A+pore+formers+or+metabolic+inhibitors+in+bacteria%3F&doi=10.1038%2Fnrmicro1098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?</span></div><div class="casAuthors">Brogden, Kim A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-250</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antimicrobial peptides are an abundant and diverse group of mols. that are produced by many tissues and cell types in a variety of invertebrate, plant and animal species.  Their amino acid compn., amphipathicity, cationic charge and size allow them to attach to and insert into membrane bilayers to form pores by 'barrel-stave', 'carpet' or 'toroidal-pore' mechanisms.  Although these models are helpful for defining mechanisms of antimicrobial peptide activity, their relevance to how peptides damage and kill microorganisms still need to be clarified.  Recently, there has been speculation that transmembrane pore formation is not the only mechanism of microbial killing.  In fact several observations suggest that translocated peptides can alter cytoplasmic membrane septum formation, inhibit cell-wall synthesis, inhibit nucleic-acid synthesis, inhibit protein synthesis or inhibit enzymic activity.  In this review the different models of antimicrobial-peptide-induced pore formation and cell killing are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHqUgWDiIDGbVg90H21EOLACvtfcHk0lhy9WlsiH9AFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslGjtbo%253D&md5=3f795db1fe7d3288a97317b65ceaf0c7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1098%26sid%3Dliteratum%253Aachs%26aulast%3DBrogden%26aufirst%3DK.%2BA.%26atitle%3DAntimicrobial%2520peptides%253A%2520pore%2520formers%2520or%2520metabolic%2520inhibitors%2520in%2520bacteria%253F%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2005%26volume%3D3%26spage%3D238%26epage%3D250%26doi%3D10.1038%2Fnrmicro1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousef, A. E.</span></span> <span> </span><span class="NLM_article-title">Brevibacillin, a cationic lipopeptide that binds to lipoteichoic acid and subsequently disrupts cytoplasmic membrane of Staphylococcus aureus</span>. <i>Microbiol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.micres.2016.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.micres.2016.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28024522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOju7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2017&pages=18-23&author=X.+Yangauthor=E.+Huangauthor=A.+E.+Yousef&title=Brevibacillin%2C+a+cationic+lipopeptide+that+binds+to+lipoteichoic+acid+and+subsequently+disrupts+cytoplasmic+membrane+of+Staphylococcus+aureus&doi=10.1016%2Fj.micres.2016.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Brevibacillin, a cationic lipopeptide that binds to lipoteichoic acid and subsequently disrupts cytoplasmic membrane of Staphylococcus aureus</span></div><div class="casAuthors">Yang, Xu; Huang, En; Yousef, Ahmed E.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiological Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18-23</span>CODEN:
                <span class="NLM_cas:coden">MCRSEJ</span>;
        ISSN:<span class="NLM_cas:issn">0944-5013</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Brevibacillin is a newly-discovered antimicrobial lipopeptide produced by Brevibacillus laterosporus OSY-I1.  It is active against Gram-pos. bacteria, including antibiotic resistant strains.  This research was initiated to investigate the mechanism of action of brevibacillin against an indicator strain, Staphylococcus aureus ATCC 6538.  Results of the study proved that brevibacillin binds to lipoteichoic acid (LTA) on cell wall before interacting with cell membrane.  Addnl., brevibacillin disrupts S. aureus cytoplasmic membrane by increasing its permeability, depolarization and potassium leakage.  Therefore, cytoplasmic membrane serves as a major target for brevibacillin.  Despite the presence of multiple sites on S. aureus cell envelope, scanning electron microscope observation didn't reveal evidence of cell lysis or any morphol. defects in cells treated with brevibacillin.  Based on the results of this study, we propose that the electrostatic interaction between the cationic brevibacillin and the anionic LTA helped the accumulation of the antimicrobial agent at cell surface; this was followed by translocation of the lipopeptide to the cytoplasmic membrane and disrupting its vital functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXfm_MH3lvWbVg90H21EOLACvtfcHk0lgi2Y1d4lvGCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOju7nK&md5=a10a9ba739e19ddf9e8c53cc15eba72e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.micres.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micres.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DYousef%26aufirst%3DA.%2BE.%26atitle%3DBrevibacillin%252C%2520a%2520cationic%2520lipopeptide%2520that%2520binds%2520to%2520lipoteichoic%2520acid%2520and%2520subsequently%2520disrupts%2520cytoplasmic%2520membrane%2520of%2520Staphylococcus%2520aureus%26jtitle%3DMicrobiol.%2520Res.%26date%3D2017%26volume%3D195%26spage%3D18%26epage%3D23%26doi%3D10.1016%2Fj.micres.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Findlay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span> <span> </span><span class="NLM_article-title">Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4049</span>– <span class="NLM_lpage">4058</span>, <span class="refDoi"> DOI: 10.1128/aac.00530-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAAC.00530-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=20696877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlegsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4049-4058&author=B.+Findlayauthor=G.+G.+Zhanelauthor=F.+Schweizer&title=Cationic+amphiphiles%2C+a+new+generation+of+antimicrobials+inspired+by+the+natural+antimicrobial+peptide+scaffold&doi=10.1128%2Faac.00530-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold</span></div><div class="casAuthors">Findlay, Brandon; Zhanel, George G.; Schweizer, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4049-4058</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Naturally occurring cationic antimicrobial peptides (AMPs) and their mimics form a diverse class of antibacterial agents currently validated in preclin. and clin. settings for the treatment of infections caused by antimicrobial-resistant bacteria.  Numerous studies with linear, cyclic, and diastereomeric AMPs have strongly supported the hypothesis that their physicochem. properties, rather than any specific amino acid sequence, are responsible for their microbiol. activities.  It is generally believed that the amphiphilic topol. is essential for insertion into and disruption of the cytoplasmic membrane.  In particular, the ability to rapidly kill bacteria and the relative difficulty with which bacteria develop resistance make AMPs and their mimics attractive targets for drug development.  However, the therapeutic use of naturally occurring AMPs is hampered by the high manufg. costs, poor pharmacokinetic properties, and low bacteriol. efficacy in animal models.  In order to overcome these problems, a variety of novel and structurally diverse cationic amphiphiles that mimic the amphiphilic topol. of AMPs have recently appeared.  Many of these compds. exhibit superior pharmacokinetic properties and reduced in vitro toxicity while retaining potent antibacterial activity against resistant and nonresistant bacteria.  In summary, cationic amphiphiles promise to provide a new and rich source of diverse antibacterial lead structures in the years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2qkJWVEGPeLVg90H21EOLACvtfcHk0lgi2Y1d4lvGCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlegsbbF&md5=ee4e47e560a45a12d8a9625e9f8ce62c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.00530-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00530-10%26sid%3Dliteratum%253Aachs%26aulast%3DFindlay%26aufirst%3DB.%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DSchweizer%26aufirst%3DF.%26atitle%3DCationic%2520amphiphiles%252C%2520a%2520new%2520generation%2520of%2520antimicrobials%2520inspired%2520by%2520the%2520natural%2520antimicrobial%2520peptide%2520scaffold%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4049%26epage%3D4058%26doi%3D10.1128%2Faac.00530-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Membrane-active hydantoin derivatives as antibiotic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8456</span>– <span class="NLM_lpage">8465</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00847</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00847" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8456-8465&author=M.+Suauthor=D.+Xiaauthor=P.+Tengauthor=A.+Nimmagaddaauthor=C.+Zhangauthor=T.+Odomauthor=A.+Caoauthor=Y.+Huauthor=J.+Cai&title=Membrane-active+hydantoin+derivatives+as+antibiotic+agents&doi=10.1021%2Facs.jmedchem.7b00847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-Active Hydantoin Derivatives as Antibiotic Agents</span></div><div class="casAuthors">Su, Ma; Xia, Donglin; Teng, Peng; Nimmagadda, Alekhya; Zhang, Chao; Odom, Timothy; Cao, Annie; Hu, Yong; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8456-8465</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydantoin (imidazolidinedione) derivs. such as nitrofurantoin are small mols. that have aroused considerable interest recently due to their low rate of bacterial resistance.  However, their moderate antimicrobial activity may hamper their application combating antibiotic resistance in the long run.  Herein we report the design of bacterial membrane-active hydantoin derivs., from which we identified compds. that show much more potent antimicrobial activity against a panel of clin. relevant Gram-pos. and Gram-neg. bacterial strains than nitrofurantoin.  These compds. are able to act on bacterial membranes, analogous to natural host-defense peptides (HDPs).  Addnl., these hydantoin compds. could not only kill bacterial pathogens rapidly, but also prevent the development of methicillin-resistant Staphylococcus aureus (MRSA) bacterial resistance under the tested conditions.  More intriguingly, the lead compd. exhibited in vivo efficacy which is much superior to vancomycin by eradicating bacteria and suppressing inflammation caused by MRSA-induced pneumonia on a rat model, demonstrating their promising therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp48yfWduVgk7Vg90H21EOLACvtfcHk0lgi2Y1d4lvGCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sku7jK&md5=04a2e9ba317c8f7f444db7cdd6bffce7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00847%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DM.%26aulast%3DXia%26aufirst%3DD.%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DOdom%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DMembrane-active%2520hydantoin%2520derivatives%2520as%2520antibiotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8456%26epage%3D8465%26doi%3D10.1021%2Facs.jmedchem.7b00847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, W. H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasco, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrand, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okhuysen, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontoyiannis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasqualini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arap, W.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3482</span>, <span class="refDoi"> DOI: 10.1073/pnas.1221924110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1073%2Fpnas.1221924110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=23345420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvVKmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=3477-3482&author=D.+M.+McGrathauthor=E.+M.+Barbuauthor=W.+H.+P.+Driessenauthor=T.+M.+Lascoauthor=J.+J.+Tarrandauthor=P.+C.+Okhuysenauthor=D.+P.+Kontoyiannisauthor=R.+L.+Sidmanauthor=R.+Pasqualiniauthor=W.+Arap&title=Mechanism+of+action+and+initial+evaluation+of+a+membrane+active+all-D-enantiomer+antimicrobial+peptidomimetic&doi=10.1073%2Fpnas.1221924110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic</span></div><div class="casAuthors">McGrath, Danielle M.; Barbu, E. Magda; Driessen, Wouter H. P.; Lasco, Todd M.; Tarrand, Jeffrey J.; Okhuysen, Pablo C.; Kontoyiannis, Dimitrios P.; Sidman, Richard L.; Pasqualini, Renata; Arap, Wadih</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3477-3482, S3477/1-S3477/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Development of therapy against infections caused by antibiotic-resistant pathogens is a major unmet need in contemporary medicine.  In previous work, our group chem. modified an antimicrobial peptidomimetic motif for targeted applications against cancer and obesity.  Here, we show that the modified motif per se is resistant to proteolytic degrdn. and is a candidate antiinfective agent.  We also show that the susceptibility of microorganisms to the drug is independent of bacterial growth phase.  Moreover, this peptidomimetic selectively interferes with the integrity and function of the microbial surface lipid bilayer, data indicative that bacterial death results from membrane disruption followed by dissipation of membrane potential.  Finally, we demonstrate two potential translational applications: use against biofilms and synergy with antibiotics in use.  In summary, we introduce the mechanism of action and the initial evaluation of a prototype drug and a platform for the development of D-enantiomer antimicrobial peptidomimetics that target bacterial membranes of certain Gram-neg. problem pathogens with promising translational applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJwWb5lxPHzbVg90H21EOLACvtfcHk0lj0THhkw9CjiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvVKmsrc%253D&md5=dce1c5db4bd8eb36f2c26e4e10fd0fc8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1221924110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1221924110%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DD.%2BM.%26aulast%3DBarbu%26aufirst%3DE.%2BM.%26aulast%3DDriessen%26aufirst%3DW.%2BH.%2BP.%26aulast%3DLasco%26aufirst%3DT.%2BM.%26aulast%3DTarrand%26aufirst%3DJ.%2BJ.%26aulast%3DOkhuysen%26aufirst%3DP.%2BC.%26aulast%3DKontoyiannis%26aufirst%3DD.%2BP.%26aulast%3DSidman%26aufirst%3DR.%2BL.%26aulast%3DPasqualini%26aufirst%3DR.%26aulast%3DArap%26aufirst%3DW.%26atitle%3DMechanism%2520of%2520action%2520and%2520initial%2520evaluation%2520of%2520a%2520membrane%2520active%2520all-D-enantiomer%2520antimicrobial%2520peptidomimetic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D3477%26epage%3D3482%26doi%3D10.1073%2Fpnas.1221924110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmagadda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.-S.</span></span> <span> </span><span class="NLM_article-title">Rational design of dimeric lysine N-alkylamides as potent and broad-spectrum antibacterial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2865</span>– <span class="NLM_lpage">2874</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls12rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2865-2874&author=Y.+Niuauthor=M.+Wangauthor=Y.+Caoauthor=A.+Nimmagaddaauthor=J.+Huauthor=Y.+Wuauthor=J.+Caiauthor=X.-S.+Ye&title=Rational+design+of+dimeric+lysine+N-alkylamides+as+potent+and+broad-spectrum+antibacterial+agents&doi=10.1021%2Facs.jmedchem.7b01704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of dimeric lysine N-alkylamides as potent and broad-spectrum antibacterial agents</span></div><div class="casAuthors">Niu, Youhong; Wang, Minghui; Cao, Yafei; Nimmagadda, Alekhya; Hu, Jianxing; Wu, Yanfen; Cai, Jianfeng; Ye, Xin-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2865-2874</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibiotic resistance is one of the biggest threats to public health, and new antibacterial agents hence are in an urgent need to combat infectious diseases caused by multidrug-resistant (MDR) pathogens.  Utilizing dimerization strategy, we rationally designed and efficiently synthesized a new series of small mol. dimeric lysine alkylamides as mimics of AMPs.  Evaluation of these mimics against a panel of Gram-pos. and Gram-neg. bacteria including MDR strains was performed, and a broad-spectrum and potent compd. 3d was identified.  This compd. displayed high specificity toward bacteria over mammalian cell.  Time-kill kinetics and mechanistic studies suggest that compd. 3d quickly eliminated bacteria in a bactericidal mode by disrupting bacterial cell membrane.  In addn., lead compd. 3d could inhibit biofilm formation and did not develop drug resistance in S. aureus and E. coli over 14 passages.  These results suggested that dimeric lysine nonylamide has immense potential as a new type of novel small mol. agent to combat antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnI-sRpeWWrVg90H21EOLACvtfcHk0lj0THhkw9CjiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls12rs7g%253D&md5=f304b5d88750ec42c05b798d12ffca56</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01704%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNimmagadda%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DX.-S.%26atitle%3DRational%2520design%2520of%2520dimeric%2520lysine%2520N-alkylamides%2520as%2520potent%2520and%2520broad-spectrum%2520antibacterial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2865%26epage%3D2874%26doi%3D10.1021%2Facs.jmedchem.7b01704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span> <span> </span><span class="NLM_article-title">Symmetrically substituted xanthone amphiphiles combat Gram-positive bacterial resistance with enhanced membrane selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1362</span>– <span class="NLM_lpage">1378</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01403</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01403" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1362-1378&author=S.+Linauthor=J.-J.+Kohauthor=T.+T.+Aungauthor=F.+Limauthor=J.+Liauthor=H.+Zouauthor=L.+Wangauthor=R.+Lakshminarayananauthor=C.+Vermaauthor=Y.+Wangauthor=D.+T.+H.+Tanauthor=D.+Caoauthor=R.+W.+Beuermanauthor=L.+Renauthor=S.+Liu&title=Symmetrically+substituted+xanthone+amphiphiles+combat+Gram-positive+bacterial+resistance+with+enhanced+membrane+selectivity&doi=10.1021%2Facs.jmedchem.6b01403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity</span></div><div class="casAuthors">Lin, Shuimu; Koh, Jun-Jie; Aung, Thet Tun; Lim, Fanghui; Li, Jianguo; Zou, Hanxun; Wang, Lin; Lakshminarayanan, Rajamani; Verma, Chandra; Wang, Yingjun; Tan, Donald T. H.; Cao, Derong; Beuerman, Roger W.; Ren, Li; Liu, Shouping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1362-1378</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This is the first report of the design of a new series of sym. xanthone derivs. that mimic antimicrobial peptides using a total synthesis approach.  This novel design is advantageous because of its low cost, synthetic simplicity and versatility, and easy tuning of amphiphilicity by controlling the incorporated cationic and hydrophobic moieties.  Two water-sol. optimized compds., 6 and 18, showed potent activities against Gram-pos. bacteria, including MRSA and VRE (MICs = 0.78-6.25 μg/mL) with a rapid bactericidal effect, low toxicity, and no emergence of drug resistance.  Both compds. demonstrated enhanced membrane selectivity that was higher than those of most membrane-active antimicrobials in clin. trials or previous reports.  The compds. appear to kill bacteria by disrupting their membranes.  Significantly, 6 was effective in vivo using a mouse model of corneal infection.  These results provide compelling evidence that these compds. have therapeutic potential as novel antimicrobials for multidrug-resistant Gram-pos. infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJxwyFlLljvLVg90H21EOLACvtfcHk0lhVQgNSOhqEfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2nt7w%253D&md5=7d795198c3ad66d9944d122e3b76b0a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01403%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKoh%26aufirst%3DJ.-J.%26aulast%3DAung%26aufirst%3DT.%2BT.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLakshminarayanan%26aufirst%3DR.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BH.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DSymmetrically%2520substituted%2520xanthone%2520amphiphiles%2520combat%2520Gram-positive%2520bacterial%2520resistance%2520with%2520enhanced%2520membrane%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1362%26epage%3D1378%26doi%3D10.1021%2Facs.jmedchem.6b01403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonuguntala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunath, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Selective and broad spectrum amphiphilic small molecules to combat bacterial resistance and eradicate biofilms</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">13670</span>– <span class="NLM_lpage">13673</span>, <span class="refDoi"> DOI: 10.1039/c5cc05159b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1039%2FC5CC05159B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26226319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=13670-13673&author=J.+Hoqueauthor=M.+M.+Konaiauthor=S.+Samaddarauthor=S.+Gonuguntalaauthor=G.+B.+Manjunathauthor=C.+Ghoshauthor=J.+Haldar&title=Selective+and+broad+spectrum+amphiphilic+small+molecules+to+combat+bacterial+resistance+and+eradicate+biofilms&doi=10.1039%2Fc5cc05159b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and broad spectrum amphiphilic small molecules to combat bacterial resistance and eradicate biofilms</span></div><div class="casAuthors">Hoque, Jiaul; Konai, Mohini M.; Samaddar, Sandip; Gonuguntala, Spandhana; Manjunath, Goutham B.; Ghosh, Chandradhish; Haldar, Jayanta</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">71</span>),
    <span class="NLM_cas:pages">13670-13673</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Rationally designed amphiphilic small mols. selectively kill drug-sensitive and drug-resistant bacteria over mammalian cells.  The small mols. disperse preformed biofilms and reduce viable bacterial count in the biofilms.  Moreover, this class of membrane-active mols. disarms the development of bacterial resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmZEe5Q7DlrVg90H21EOLACvtfcHk0lhVQgNSOhqEfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Sqs7zN&md5=b2504aee26021ce12a94747d4dba615f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5CC05159B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC05159B%26sid%3Dliteratum%253Aachs%26aulast%3DHoque%26aufirst%3DJ.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DGonuguntala%26aufirst%3DS.%26aulast%3DManjunath%26aufirst%3DG.%2BB.%26aulast%3DGhosh%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DSelective%2520and%2520broad%2520spectrum%2520amphiphilic%2520small%2520molecules%2520to%2520combat%2520bacterial%2520resistance%2520and%2520eradicate%2520biofilms%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D13670%26epage%3D13673%26doi%3D10.1039%2Fc5cc05159b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mensa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGrado, W. F.</span></span> <span> </span><span class="NLM_article-title">Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5136</span>– <span class="NLM_lpage">5145</span>, <span class="refDoi"> DOI: 10.1128/aac.02955-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2Faac.02955-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=24936592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5136-5145&author=B.+Mensaauthor=G.+L.+Howellauthor=R.+Scottauthor=W.+F.+DeGrado&title=Comparative+mechanistic+studies+of+brilacidin%2C+daptomycin%2C+and+the+antimicrobial+peptide+LL16&doi=10.1128%2Faac.02955-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16</span></div><div class="casAuthors">Mensa, Bruk; Howell, Gabriella L.; Scott, Richard; DeGrado, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5136-5145, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brilacidin (PMX30063) has shown potent bactericidal activity against drug-resistant and -susceptible strains of multiple Gram-neg. and Gram-pos. pathogens.  In this study, we demonstrate that brilacidin causes membrane depolarization in the Gram-pos. bacterium Staphylococcus aureus, to an extent comparable to that caused by the lipopeptidic drug daptomycin.  Transcriptional profiling of Staphylococcus aureus by deep sequencing shows that the global response to brilacidin treatment is well correlated to those of treatment with daptomycin and the cationic antimicrobial peptide LL37 and mostly indicates abrogation of cell wall and membrane functions.  Furthermore, the upregulation of various chaperones and proteases by brilacidin and daptomycin indicates that cytoplasmic protein misfolding stress may be a contributor to the mechanism of action of these drugs.  These stress responses were orchestrated mainly by three two-component systems, GraSR, VraSR, and NsaSR, which have been implicated in virulence and drug resistance against other clin. available antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqtP1aYaCLLVg90H21EOLACvtfcHk0lhVQgNSOhqEfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqtbnE&md5=23e73a23fd1f1dd05de0d5c773fcf755</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2Faac.02955-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02955-14%26sid%3Dliteratum%253Aachs%26aulast%3DMensa%26aufirst%3DB.%26aulast%3DHowell%26aufirst%3DG.%2BL.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DDeGrado%26aufirst%3DW.%2BF.%26atitle%3DComparative%2520mechanistic%2520studies%2520of%2520brilacidin%252C%2520daptomycin%252C%2520and%2520the%2520antimicrobial%2520peptide%2520LL16%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5136%26epage%3D5145%26doi%3D10.1128%2Faac.02955-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanowski, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mah, F. S.</span></span> <span> </span><span class="NLM_article-title">An independent evaluation of a novel peptide mimetic, Brilacidin (PMX30063), for ocular anti-infective</span>. <i>J. Ocul. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1089/jop.2015.0098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1089%2Fjop.2015.0098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26501484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28Xosl2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=23-27&author=R.+P.+Kowalskiauthor=E.+G.+Romanowskiauthor=K.+A.+Yatesauthor=F.+S.+Mah&title=An+independent+evaluation+of+a+novel+peptide+mimetic%2C+Brilacidin+%28PMX30063%29%2C+for+ocular+anti-infective&doi=10.1089%2Fjop.2015.0098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-infective</span></div><div class="casAuthors">Kowalski, Regis P.; Romanowski, Eric G.; Yates, Kathleen A.; Mah, Francis S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ocular Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">JOPTFU</span>;
        ISSN:<span class="NLM_cas:issn">1080-7683</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Objective: Brilacidin (BRI), a novel defensin mimetic, was evaluated as an ocular anti-infective.  Methods: In vitro: Potency based on MIC90s was compared for 50 Staphylococcus aureus (SA), 50 Staphylococcus epidermidis (SE), and 25 each of Streptococcus pneumonia (SP), Streptococcus viridans (SV), Moraxella (MS), Haemophilus influenzae (HI), Pseudomonas aeruginosa (PA), and Serratia marcescens (SM).  In vivo: Using established methods, ocular toxicity was graded with Draize testing.  For efficacy testing, both corneas of 24 rabbits were infected with methicillin-resistant S. aureus (MRSA), whereas the corneal epithelium was removed in the left eye.  After 4 h, 21 topical drops over 5 h were administered to 4 groups: BRI 0.5%, vancomycin (VAN) 5%, saline, and no treatment.  The eyes were clin. graded and the corneas were harvested for colony counts.  Results: In vitro: Both SA and SE had the lowest min. inhibitory concns. among the bacterial groups.  The MIC90s to BRI for SP, SV, MS, HI, PA, and SM were 4, 32, 256, 32, 16, and 128-fold higher, resp., than SA and SE.  In vivo: Draize testing detd. BRI 0.5% to be minimally irritating.  For abraded corneas, BRI was not statistically different from VAN for reducing MRSA.  BRI was bactericidal.  For intact corneas, VAN reduced more CFU than BRI.  BRI reduced CFU in abraded corneas more than intact corneas suggesting poor corneal penetration.  Conclusions: BRI has Gram-pos. in vitro activity; topical BRI 0.5% was minimally irritating; and BRI 0.5% was equally efficacious as VAN in a MRSA keratitis model when the corneal epithelium was removed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7mz9C2Tiw77Vg90H21EOLACvtfcHk0lgAapgMFyYV5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xosl2ltw%253D%253D&md5=6590d3fd9747f075907e6dfab1a51164</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1089%2Fjop.2015.0098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fjop.2015.0098%26sid%3Dliteratum%253Aachs%26aulast%3DKowalski%26aufirst%3DR.%2BP.%26aulast%3DRomanowski%26aufirst%3DE.%2BG.%26aulast%3DYates%26aufirst%3DK.%2BA.%26aulast%3DMah%26aufirst%3DF.%2BS.%26atitle%3DAn%2520independent%2520evaluation%2520of%2520a%2520novel%2520peptide%2520mimetic%252C%2520Brilacidin%2520%2528PMX30063%2529%252C%2520for%2520ocular%2520anti-infective%26jtitle%3DJ.%2520Ocul.%2520Pharmacol.%2520Ther.%26date%3D2016%26volume%3D32%26spage%3D23%26epage%3D27%26doi%3D10.1089%2Fjop.2015.0098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsdal, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaten, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span> <span> </span><span class="NLM_article-title">A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5786</span>– <span class="NLM_lpage">5795</span>, <span class="refDoi"> DOI: 10.1021/jm200450h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200450h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5786-5795&author=J.+Isakssonauthor=B.+O.+Brandsdalauthor=M.+Engqvistauthor=G.+E.+Flatenauthor=J.+S.+M.+Svendsenauthor=W.+Stensen&title=A+synthetic+antimicrobial+peptidomimetic+%28LTX+109%29%3A+stereochemical+impact+on+membrane+disruption&doi=10.1021%2Fjm200450h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption</span></div><div class="casAuthors">Isaksson, Johan; Brandsdal, Bjoern O.; Engqvist, Magnus; Flaten, Goeril Eide; Svendsen, John S. Mjoeen; Stensen, Wenche</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5786-5795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">LTX 109 is a synthetic antimicrobial peptidomimetic (SAMP) currently in clin. phase II trials for topical treatment of infections of multiresistant bacterial strains.  All possible eight stereoisomers of the peptidomimetic have been synthesized and tested for antimicrobial effect, hemolysis, and hydrophobicity, revealing a strong and unusual dependence on the stereochem. for a mol. proposed to act on a general membrane mechanism.  The three-dimensional structures were assessed using NMR spectroscopy and mol. dynamics (MD) simulations in aq. soln. and in phospholipid bilayers.  The soln. structures of the most active stereoisomers are perfectly preorganized for insertion into the membrane, whereas the less active isomers need to pay an energy penalty in order to enter the lipid bilayer.  This effect is also found to be reinforced by a significantly improved water soly. of the less active isomers due to a guanidinyl-π stacking that helps to solvate the hydrophobic surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5IxYJkubahrVg90H21EOLACvtfcHk0lgAapgMFyYV5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSlu74%253D&md5=081d8fb5a6bcc47c299f0d8497436298</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm200450h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200450h%26sid%3Dliteratum%253Aachs%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DBrandsdal%26aufirst%3DB.%2BO.%26aulast%3DEngqvist%26aufirst%3DM.%26aulast%3DFlaten%26aufirst%3DG.%2BE.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%2BM.%26aulast%3DStensen%26aufirst%3DW.%26atitle%3DA%2520synthetic%2520antimicrobial%2520peptidomimetic%2520%2528LTX%2520109%2529%253A%2520stereochemical%2520impact%2520on%2520membrane%2520disruption%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5786%26epage%3D5795%26doi%3D10.1021%2Fjm200450h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J. P. E.</span></span> <span> </span><span class="NLM_article-title">Flavonoids: modulators of brain function?</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">ES60</span>– <span class="NLM_lpage">ES77</span>, <span class="refDoi"> DOI: 10.1017/s0007114508965776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1017%2FS0007114508965776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=18503736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BD1cvgtl2msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=ES60-ES77&author=J.+P.+E.+Spencer&title=Flavonoids%3A+modulators+of+brain+function%3F&doi=10.1017%2Fs0007114508965776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoids: modulators of brain function?</span></div><div class="casAuthors">Spencer Jeremy P E</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of nutrition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99 E Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">ES60-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Emerging evidence suggests that dietary phytochemicals, in particular flavonoids, may exert beneficial effects on the central nervous system by protecting neurons against stress-induced injury, by suppressing neuroinflammation and by improving cognitive function.  It is likely that flavonoids exert such effects, through selective actions on different components of a number of protein kinase and lipid kinase signalling cascades, such as the phosphatidylinositol-3 kinase (PI3K)/Akt, protein kinase C and mitogen-activated protein kinase (MAPK) pathways.  This review explores the potential inhibitory or stimulatory actions of flavonoids within these pathways, and describes how such interactions are likely to underlie neurological effects through their ability to affect the activation state of target molecules and/or by modulating gene expression.  Future research directions are outlined in relation to the precise site(s) of action of flavonoids within signalling pathways and the sequence of events that allow them to regulate neuronal function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMIza6rH6dnc-crCu0nI_sfW6udTcc2eYF7fLHaHWU_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvgtl2msQ%253D%253D&md5=2362938fddc05be3dd0209708e316de2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1017%2FS0007114508965776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114508965776%26sid%3Dliteratum%253Aachs%26aulast%3DSpencer%26aufirst%3DJ.%2BP.%2BE.%26atitle%3DFlavonoids%253A%2520modulators%2520of%2520brain%2520function%253F%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2008%26volume%3D99%26spage%3DES60%26epage%3DES77%26doi%3D10.1017%2Fs0007114508965776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span> <span> </span><span class="NLM_article-title">A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.bmc.2019.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30733087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisFWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=677-685&author=L.+Zhaoauthor=X.+Yuanauthor=J.+Wangauthor=Y.+Fengauthor=F.+Jiauthor=Z.+Liauthor=J.+Bian&title=A+review+on+flavones+targeting+serine%2Fthreonine+protein+kinases+for+potential+anticancer+drugs&doi=10.1016%2Fj.bmc.2019.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs</span></div><div class="casAuthors">Zhao, Lulu; Yuan, Xinyu; Wang, Jubo; Feng, Yifan; Ji, Fei; Li, Zhiyu; Bian, Jinlei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">677-685</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinases have been important targets for antitumor targets due to their key roles in regulating multiple cell signaling pathways.  Numerous compds. contg. flavonoid scaffold as an indispensable anchor have been found to be potent inhibitors of protein kinases.  Some of these flavonoids have been in clin. research as protein kinases inhibitors.  Thus, the present review mainly focuses on the structural requirement for anticancer potential of flavone derivs. targeting several key serine/threonine protein kinases.  This information may provide an opportunity to scientists of medicinal chem. to design multi-functional flavone derivs. for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmyQGt6sovELVg90H21EOLACvtfcHk0li-GsiVjqEHAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisFWns7k%253D&md5=a8b98bcec680fac93880ea6be56bc1b6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBian%26aufirst%3DJ.%26atitle%3DA%2520review%2520on%2520flavones%2520targeting%2520serine%252Fthreonine%2520protein%2520kinases%2520for%2520potential%2520anticancer%2520drugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D677%26epage%3D685%26doi%3D10.1016%2Fj.bmc.2019.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span> <span> </span><span class="NLM_article-title">Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor</span>. <i>Anticancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1097/cad.0000000000000708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1097%2FCAD.0000000000000708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BB3cvjsV2rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=153-158&author=W.+Maauthor=X.+Liuauthor=W.+Du&title=Baicalin+induces+apoptosis+in+SW480+cells+through+downregulation+of+the+SP1+transcription+factor&doi=10.1097%2Fcad.0000000000000708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor</span></div><div class="casAuthors">Ma Wenkang; Liu Xueyuan; Du Wei</div><div class="citationInfo"><span class="NLM_cas:title">Anti-cancer drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-158</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer occurs throughout the world but is most common in developed countries.  Cancer progression is believed to be driven by genetic mutations in this complex condition.  Risk factors for developing colorectal cancer include a genetic family history, long-term ulcerative colitis, and colonic polyps.  The use of baicalin has been reported to be clinically efficacious against colon tumors in Asian countries despite an unclear mechanism of action.  Several cancers have been found to be biologically dependent on the specificity protein 1 (sp1) transcription factor family.  We hypothesized that baicalin may exert its chemotherapeutic effects by sp1 downregulation.  Using the SW480 human colorectal cancer cell line, we investigated the physiological properties of baicalin.  Our experiments were designed toward clarifying three goals: (a) to determine the mRNA expression profile of transcription factors in colorectal cancer patients using a microarray-based analysis; (b) to determine the effects of baicalin on the sp1 transcription factor with western blotting and reporter cell assays; and (c) to contrast the effects of mithramycin-A (an sp1 transcription factor inhibitor) and baicalin using western blotting and reporter cell assays.  Both baicalin and mithramycin-A downregulated sp1 expression, attenuated SW480 cell proliferation, and increased cell apoptosis.  Baicalin inhibited sp1 expression and led to SW480 apoptosis, thus clarifying the effect of this traditional Chinese medicine compound in the treatment of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxLHvjTTM3m2BAiYWy6n3SfW6udTcc2eYvUfnfN7UzE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvjsV2rug%253D%253D&md5=088066d71290e8e3194829470f752025</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000708%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DW.%26atitle%3DBaicalin%2520induces%2520apoptosis%2520in%2520SW480%2520cells%2520through%2520downregulation%2520of%2520the%2520SP1%2520transcription%2520factor%26jtitle%3DAnticancer%2520Drugs%26date%3D2019%26volume%3D30%26spage%3D153%26epage%3D158%26doi%3D10.1097%2Fcad.0000000000000708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.-Z.</span></span> <span> </span><span class="NLM_article-title">Antibacterial effect and mode of action of flavonoids from licorice against Methicillin-resistant Staphylococcus aureus</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2489</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2019.02489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.3389%2Ffmicb.2019.02489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=31749783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BB3MfhsVamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2489&author=S.-C.+Wuauthor=Z.-Q.+Yangauthor=F.+Liuauthor=W.-J.+Pengauthor=S.-Q.+Quauthor=Q.+Liauthor=X.-B.+Songauthor=K.+Zhuauthor=J.-Z.+Shen&title=Antibacterial+effect+and+mode+of+action+of+flavonoids+from+licorice+against+Methicillin-resistant+Staphylococcus+aureus&doi=10.3389%2Ffmicb.2019.02489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial Effect and Mode of Action of Flavonoids From Licorice Against Methicillin-Resistant Staphylococcus aureus</span></div><div class="casAuthors">Wu Shuai-Cheng; Yang Zhi-Qiang; Liu Fei; Peng Wen-Jing; Qu Shao-Qi; Li Qian; Song Xiang-Bin; Zhu Kui; Shen Jian-Zhong; Wu Shuai-Cheng; Wu Shuai-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2489</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Staphylococcus aureus is a bacterial pathogen that causes food poisoning, various infections, and sepsis.  Effective strategies and new drugs are needed to control S. aureus associated infections due to the emergence and rapid dissemination of antibiotic resistance.  In the present study, the antibacterial activity, potential mode of action, and applications of flavonoids from licorice were investigated.  Here, we showed that glabrol, licochalcone A, licochalcone C, and licochalcone E displayed high efficiency against methicillin-resistant Staphylococcus aureus (MRSA).  Glabrol, licochalcone A, licochalcone C, and licochalcone E exhibited low cytotoxicity without hemolytic activity based on safety evaluation.  Glabrol displayed rapid bactericidal activity with low levels of resistance development in vitro.  Meanwhile, glabrol rapidly increased bacterial membrane permeability and dissipated the proton move force.  Furthermore, we found that peptidoglycan, phosphatidylglycerol, and cardiolipin inhibited the antibacterial activity of glabrol.  Molecular docking showed that glabrol binds to phosphatidylglycerol and cardiolipin through the formation of hydrogen bonds.  Lastly, glabrol showed antibacterial activity against MRSA in both in vivo and in vitro models.  Altogether, these results suggest that glabrol is a promising lead compound for the design of membrane-active antibacterial agents against MRSA and can be used as a disinfectant candidate as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTE3s5V2R8p8--MdeMhXAHkfW6udTcc2eYvUfnfN7UzE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MfhsVamug%253D%253D&md5=27765d8ae20cef4d50e472572336cfde</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2019.02489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2019.02489%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.-C.%26aulast%3DYang%26aufirst%3DZ.-Q.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DPeng%26aufirst%3DW.-J.%26aulast%3DQu%26aufirst%3DS.-Q.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DSong%26aufirst%3DX.-B.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DShen%26aufirst%3DJ.-Z.%26atitle%3DAntibacterial%2520effect%2520and%2520mode%2520of%2520action%2520of%2520flavonoids%2520from%2520licorice%2520against%2520Methicillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DFront.%2520Microbiol.%26date%3D2019%26volume%3D10%26spage%3D2489%26doi%3D10.3389%2Ffmicb.2019.02489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kładna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berczynski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dundar, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unlusoy, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakinowska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboul-Enein, H. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antioxidant activity of new pyrimidin/benzothiazol-substituted piperazinyl flavones</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2308</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.4155%2Ffmc-2018-0206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30273015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=2293-2308&author=A.+K%C5%82adnaauthor=P.+Berczynskiauthor=O.+B.+Dundarauthor=M.+C.+Unlusoyauthor=E.+Sariauthor=B.+Bakinowskaauthor=I.+Krukauthor=H.+Y.+Aboul-Enein&title=Synthesis+and+in+vitro+antioxidant+activity+of+new+pyrimidin%2Fbenzothiazol-substituted+piperazinyl+flavones&doi=10.4155%2Ffmc-2018-0206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antioxidant activity of new pyrimidin/benzothiazol-substituted piperazinyl flavones</span></div><div class="casAuthors">Kladna, Aleksandra; Berczynski, Pawel; Duendar, Oya Bozdag; Uenluesoy, Meltem Ceylan; Sari, Elmas; Bakinowska, Bernadetta; Kruk, Irena; Aboul-Enein, Hassan Y.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2293-2308</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: Synthesis of novel 2(2-hydroxyphenyl) pyrimidine/benzothiazole piperazinyl-substituted flavones end evaluate their antioxidant activity.  Results: Six novel 2-(2-hydroxyphenyl) pyrimidine/benzothiazole-substituted flavones were synthesized, their structures were confirmed by elementary and spectral analyses.  The compds. were evaluated for their in vitro antioxidant potency by employing various antioxidant assays.  Conclusion: All tested compds. acted as scavengers of free radicals like hydroxyl (15-45%), 2,2-diphenyl-1-picrylhydrazyl• (17-48%) at 1.25 and 0.5 mM concns. resp.  The total antioxidant status activity values of the compds. ranged from 234.1 to 464.1 μm trolox equiv./g, the total antioxidant capacity - from 24.9 to 52.7 μm trolox equiv. per g.  Compds. incorporating the benzothiazole group on the piperazine ring were more effective antioxidants than those with the 2-(2-hydroxyphenyl) pyrimidine group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_k3oe5Ro_GbVg90H21EOLACvtfcHk0ljku2Y5X1xdFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtb3E&md5=b16dfa08857ec85ac4b4ca5b66dcc1e4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0206%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C5%2582adna%26aufirst%3DA.%26aulast%3DBerczynski%26aufirst%3DP.%26aulast%3DDundar%26aufirst%3DO.%2BB.%26aulast%3DUnlusoy%26aufirst%3DM.%2BC.%26aulast%3DSari%26aufirst%3DE.%26aulast%3DBakinowska%26aufirst%3DB.%26aulast%3DKruk%26aufirst%3DI.%26aulast%3DAboul-Enein%26aufirst%3DH.%2BY.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antioxidant%2520activity%2520of%2520new%2520pyrimidin%252Fbenzothiazol-substituted%2520piperazinyl%2520flavones%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D2293%26epage%3D2308%26doi%3D10.4155%2Ffmc-2018-0206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span> <span> </span><span class="NLM_article-title">Antioxidant protection of nobiletin, 5-demethylnobiletin, tangeretin, and 5-demethyltangeretin from Citrus peel in Saccharomyces cerevisiae</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">3155</span>– <span class="NLM_lpage">3160</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.8b00509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.8b00509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=3155-3160&author=M.+Wangauthor=D.+Mengauthor=P.+Zhangauthor=X.+Wangauthor=G.+Duauthor=C.+Brennanauthor=S.+Liauthor=C.-T.+Hoauthor=H.+Zhao&title=Antioxidant+protection+of+nobiletin%2C+5-demethylnobiletin%2C+tangeretin%2C+and+5-demethyltangeretin+from+Citrus+peel+in+Saccharomyces+cerevisiae&doi=10.1021%2Facs.jafc.8b00509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant Protection of Nobiletin, 5-Demethylnobiletin, Tangeretin, and 5-Demethyltangeretin from Citrus Peel in Saccharomyces cerevisiae</span></div><div class="casAuthors">Wang, Meiyan; Meng, Dan; Zhang, Peng; Wang, Xiangxing; Du, Gang; Brennan, Charles; Li, Shiming; Ho, Chi-Tang; Zhao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3155-3160</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aging and oxidative-related events are closely assocd. with the oxidative damages induced by excess reactive oxygen species (ROS).  The phytochems. nobiletin (NBT) and tangeretin (TAN) and their 5-demethylated derivs. 5-demethylnobiletin (5-DN) and 5-demethyltangeretin (5-DT) are the representative polymethoxyflavone (PMF) compds. found in aged citrus peels.  Although the health benefits from PMFs due to their antioxidant activities have been well documented, a systematic assessment regarding the antioxidn. process of PMFs is still lacking attention.  Herein, the authors investigated the effects of the four PMFs subjected to oxidative stress including hydrogen peroxide, carbon tetrachloride, and cadmium sulfate using an emerging model organism Saccharomyces cerevisiae.  As expected, all four of the PMFs exhibited improved cellular tolerance with decreasing lipid peroxidn. and ROS.  Furthermore, by using the mutant strains deficient in catalase, superoxide dismutase, or glutathione synthase, NBT, 5-DN, and TAN appear to contribute to the increased tolerance by activating cytosolic catalase under CCl4, while the antioxidant protection conferred by 5-DT against H2O2 and CdSO4 seems to require cytosolic catalase and glutathione, resp.  However, the involvement of Ctt1 and Sod1 is achieved neither by decreasing lipid peroxidn. nor by scavenging intracellular ROS according to the authors' results.  In addn., a comparison of antioxidant capability of the four PMFs was conducted in this study.  In general, this research tries to explore the antioxidant mechanism of PMFs in Saccharomyces cerevisiae, hoping to provide an example for developing more efficacious dietary antioxidants to battle against oxidative- or age-related illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8e5wZTsTgfbVg90H21EOLACvtfcHk0ljku2Y5X1xdFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWhsbk%253D&md5=e9a9fcb60abf9c1c3020af50440e0497</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.8b00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.8b00509%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DC.-T.%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DAntioxidant%2520protection%2520of%2520nobiletin%252C%25205-demethylnobiletin%252C%2520tangeretin%252C%2520and%25205-demethyltangeretin%2520from%2520Citrus%2520peel%2520in%2520Saccharomyces%2520cerevisiae%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2018%26volume%3D66%26spage%3D3155%26epage%3D3160%26doi%3D10.1021%2Facs.jafc.8b00509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span> <span> </span><span class="NLM_article-title">Antiviral flavones from the leaves of Nicotiana tabacum</span>. <i>Phytochem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.phytol.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.phytol.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFahsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=75-78&author=L.+Yuanauthor=W.+Huangauthor=C.+Zhangauthor=N.+Xiangauthor=C.+Liuauthor=G.+Yangauthor=Y.+Chenauthor=M.+Miaoauthor=Y.+Ma&title=Antiviral+flavones+from+the+leaves+of+Nicotiana+tabacum&doi=10.1016%2Fj.phytol.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral flavones from the leaves of Nicotiana tabacum</span></div><div class="casAuthors">Yuan, Lin; Huang, Wenzhong; Zhang, Chengming; Xiang, Nengjun; Liu, Chunbo; Yang, Guangyu; Chen, Yongkuang; Miao, Mingming; Ma, Yinhai</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-78</span>CODEN:
                <span class="NLM_cas:coden">PLHEBK</span>;
        ISSN:<span class="NLM_cas:issn">1874-3900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three new flavones, tabaflavones A-C (1-3), together with three known flavones (4-6), were isolated from the leaves of Nicotiana tabacum.  Their structures were elucidated by spectroscopic methods, including extensive 1D and 2D NMR techniques.  Compds. 1-6 were evaluated for their anti-tobacco mosaic virus (anti-TMV) activities.  The results showed compd. 1 exhibited moderate anti-TMV activity with inhibition rate of 29.2%, which is close to that of the pos. control.  The other compds. also showed the anti-TMV activities with inhibition rates in the range of 14.2-20.8%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW5ZZGKFwFE7Vg90H21EOLACvtfcHk0ljku2Y5X1xdFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFahsrc%253D&md5=930421451631a585932511515897c887</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.phytol.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytol.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DAntiviral%2520flavones%2520from%2520the%2520leaves%2520of%2520Nicotiana%2520tabacum%26jtitle%3DPhytochem.%2520Lett.%26date%3D2015%26volume%3D12%26spage%3D75%26epage%3D78%26doi%3D10.1016%2Fj.phytol.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Izneid, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shariati, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orhan, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondal, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mubarak, M. S.</span></span> <span> </span><span class="NLM_article-title">Luteolin, a flavonoid, as an anticancer agent: a review</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">108612</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.108612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.biopha.2019.108612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30798142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1Sht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2019&pages=108612&author=M.+Imranauthor=A.+Raufauthor=T.+Abu-Izneidauthor=M.+Nadeemauthor=M.+A.+Shariatiauthor=I.+A.+Khanauthor=A.+Imranauthor=I.+E.+Orhanauthor=M.+Rizwanauthor=M.+Atifauthor=T.+A.+Gondalauthor=M.+S.+Mubarak&title=Luteolin%2C+a+flavonoid%2C+as+an+anticancer+agent%3A+a+review&doi=10.1016%2Fj.biopha.2019.108612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin, a flavonoid, as an anticancer agent: A review</span></div><div class="casAuthors">Imran, Muhammad; Rauf, Abdur; Abu-Izneid, Tareq; Nadeem, Muhammad; Shariati, Mohammad Ali; Khan, Imtiaz Ali; Imran, Ali; Orhan, Ilkay Erdogan; Rizwan, Muhammad; Atif, Muhammad; Gondal, Tanweer Aslam; Mubarak, Mohammad S.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108612</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Many food-derived phytochems. and their derivs. represent a cornucopia of new anti-cancer compds.  Luteolin (3,4,5,7-tetrahydroxy flavone) is a flavonoid found in different plants such as vegetables, medicinal herbs, and fruits.  It acts as an anticancer agent against various types of human malignancies such as lung, breast, glioblastoma, prostate, colon, and pancreatic cancers.  It also blocks cancer development in vitro and in vivo by inhibition of proliferation of tumor cells, protection from carcinogenic stimuli, and activation of cell cycle arrest, and by inducing apoptosis through different signaling pathways.  Luteolin can addnl. reverse epithelial-mesenchymal transition (EMT) through a mechanism that involves cytoskeleton shrinkage, induction of the epithelial biomarker E-cadherin expression, and by down-regulation of the mesenchymal biomarkers N-cadherin, snail, and vimentin.  Furthermore, luteolin increases levels of intracellular reactive oxygen species (ROS) by activation of lethal endoplasmic reticulum stress response and mitochondrial dysfunction in glioblastoma cells, and by activation of ER stress-assocd. proteins expressions, including phosphorylation of eIF2α, PERK, CHOP, ATF4, and cleaved-caspase 12.  Accordingly, the present review article summarizes the progress of recent research on luteolin against several human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg6HTDMmg6A7Vg90H21EOLACvtfcHk0liApGcAopamYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1Sht7c%253D&md5=c2711c1d50f07a82871151c28def79c3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.108612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.108612%26sid%3Dliteratum%253Aachs%26aulast%3DImran%26aufirst%3DM.%26aulast%3DRauf%26aufirst%3DA.%26aulast%3DAbu-Izneid%26aufirst%3DT.%26aulast%3DNadeem%26aufirst%3DM.%26aulast%3DShariati%26aufirst%3DM.%2BA.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DImran%26aufirst%3DA.%26aulast%3DOrhan%26aufirst%3DI.%2BE.%26aulast%3DRizwan%26aufirst%3DM.%26aulast%3DAtif%26aufirst%3DM.%26aulast%3DGondal%26aufirst%3DT.%2BA.%26aulast%3DMubarak%26aufirst%3DM.%2BS.%26atitle%3DLuteolin%252C%2520a%2520flavonoid%252C%2520as%2520an%2520anticancer%2520agent%253A%2520a%2520review%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D112%26spage%3D108612%26doi%3D10.1016%2Fj.biopha.2019.108612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, W. L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span> <span> </span><span class="NLM_article-title">Semisynthetic flavone-derived antimicrobials with therapeutic potential against Methicillin-resistant Staphylococcus aureus (MRSA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6152</span>– <span class="NLM_lpage">6165</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00380</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00380" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVersr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6152-6165&author=S.+Linauthor=J.-J.+Kohauthor=T.+T.+Aungauthor=W.+L.+W.+Sinauthor=F.+Limauthor=L.+Wangauthor=R.+Lakshminarayananauthor=L.+Zhouauthor=D.+T.+H.+Tanauthor=D.+Caoauthor=R.+W.+Beuermanauthor=L.+Renauthor=S.+Liu&title=Semisynthetic+flavone-derived+antimicrobials+with+therapeutic+potential+against+Methicillin-resistant+Staphylococcus+aureus+%28MRSA%29&doi=10.1021%2Facs.jmedchem.7b00380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA)</span></div><div class="casAuthors">Lin, Shuimu; Koh, Jun-Jie; Aung, Thet Tun; Sin, Wan Ling Wendy; Lim, Fanghui; Wang, Lin; Lakshminarayanan, Rajamani; Zhou, Lei; Tan, Donald T. H.; Cao, Derong; Beuerman, Roger W.; Ren, Li; Liu, Shouping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6152-6165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of semisynthetic flavone-based small mols. mimicking antimicrobial peptides has been designed from natural icaritin to combat drug-resistant Gram-pos. bacterial infections.  Compd. I contg. two arginine residues exhibited excellent antibacterial activity against Gram-pos. bacteria, including MRSA, and very low toxicity to mammalian cells, resulting in a high selectivity of more than 511, comparable to that of several membrane-active antibiotics in clin. trials.  The data show for the first time that icaritin derivs. effectively kill bacteria.  Meanwhile, this is the first study deploying a biomimicking strategy to design potent flavone-based membrane targeting antimicrobials. I showed rapid bactericidal activity by disrupting the bacterial membrane and can circumvent the development of bacterial resistance.  Importantly, I was highly efficacious in a mouse model of corneal infection caused by MRSA and S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMUva-wo6G47Vg90H21EOLACvtfcHk0liApGcAopamYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVersr%252FE&md5=3cf0f204fb781e4f13391af4b749d9fe</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00380%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKoh%26aufirst%3DJ.-J.%26aulast%3DAung%26aufirst%3DT.%2BT.%26aulast%3DSin%26aufirst%3DW.%2BL.%2BW.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLakshminarayanan%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BH.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DSemisynthetic%2520flavone-derived%2520antimicrobials%2520with%2520therapeutic%2520potential%2520against%2520Methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6152%26epage%3D6165%26doi%3D10.1021%2Facs.jmedchem.7b00380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. C.</span></span> <span> </span><span class="NLM_article-title">A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention</span>. <i>Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">2099</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1016/j.foodchem.2012.11.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.foodchem.2012.11.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=23497863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVKisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2013&pages=2099-2107&author=A.+Y.+Chenauthor=Y.+C.+Chen&title=A+review+of+the+dietary+flavonoid%2C+kaempferol+on+human+health+and+cancer+chemoprevention&doi=10.1016%2Fj.foodchem.2012.11.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention</span></div><div class="casAuthors">Chen, Allen Y.; Chen, Yi Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Food Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2099-2107</span>CODEN:
                <span class="NLM_cas:coden">FOCHDJ</span>;
        ISSN:<span class="NLM_cas:issn">0308-8146</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kaempferol is a polyphenol antioxidant found in fruits and vegetables.  Many studies have described the beneficial effects of dietary kaempferol in reducing the risk of chronic diseases, esp. cancer.  Epidemiol. studies have shown an inverse relationship between kaempferol intake and cancer.  Kaempferol may help by augmenting the body's antioxidant defense against free radicals, which promote the development of cancer.  At the mol. level, kaempferol has been reported to modulate a no. of key elements in cellular signal transduction pathways linked to apoptosis, angiogenesis, inflammation, and metastasis.  Significantly, kaempferol inhibits cancer cell growth and angiogenesis and induces cancer cell apoptosis, but on the other hand, kaempferol appears to preserve normal cell viability, in some cases exerting a protective effect.  The aim of this review is to synthesize information concerning the extn. of kaempferol, as well as to provide insights into the mol. basis of its potential chemo-preventative activities, with an emphasis on its ability to control intracellular signaling cascades that regulate the aforementioned processes.  Chemoprevention using nanotechnol. to improve the bioavailability of kaempferol is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg4bf2Crr3prVg90H21EOLACvtfcHk0liApGcAopamYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVKisr4%253D&md5=1e6d7041619b2dd06a8fa06ed872af2a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.foodchem.2012.11.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.foodchem.2012.11.139%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DA.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BC.%26atitle%3DA%2520review%2520of%2520the%2520dietary%2520flavonoid%252C%2520kaempferol%2520on%2520human%2520health%2520and%2520cancer%2520chemoprevention%26jtitle%3DFood%2520Chem.%26date%3D2013%26volume%3D138%26spage%3D2099%26epage%3D2107%26doi%3D10.1016%2Fj.foodchem.2012.11.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somerset, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannot, L.</span></span> <span> </span><span class="NLM_article-title">Dietary flavonoid sources in Australian adults</span>. <i>Nutr. Canc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1080/01635580802143836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1080%2F01635580802143836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=18584477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=442-449&author=S.+M.+Somersetauthor=L.+Johannot&title=Dietary+flavonoid+sources+in+Australian+adults&doi=10.1080%2F01635580802143836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary flavonoid sources in Australian adults</span></div><div class="casAuthors">Somerset, Shawn M.; Johannot, Lidwine</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition and Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-449</span>CODEN:
                <span class="NLM_cas:coden">NUCADQ</span>;
        ISSN:<span class="NLM_cas:issn">0163-5581</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Evidence from lab.-based in vitro studies provides compelling evidence supporting the involvement of dietary flavonoid intake in human cancer risk.  Assocns. between intakes of individual flavonoids and disease outcomes at the population level are emerging from recent epidemiol. studies.  As an important step in the development of methods to assess flavonoid intakes across populations, the major sources of dietary flavonoids in the adult Australian population were identified.  Data from a 24-h diet recall questionnaire used in a national nutrition survey (NNS95-comprising a sample of 10,851 subjects aged 19 yr and over) were combined with U.S. Department of Agriculture data on flavonoid content of foods to identify key sources.  Black and green teas clearly were the dominant sources of the flavonols kaempferol, myricetin, and quercetin.  Other significant flavonol sources included onion (isorhamnetin and quercetin), broccoli (kaempferol and quercetin), apple (quercetin), grape (quercetin), coffee (myrcetin), and beans (quercetin).  Black and green teas also were dominant sources of flavon-3-ols, with wine, apples, and pears contributing somewhat.  In terms of flavanone consumption, oranges (hesperetin and naringenin), lemon (eriodictyol), mandarin (hesperetin), and grapefruit (naringenin) were the major sources.  Parsley (apigenin), celery (apigenin and luteolin), and English spinach (luteolin) were the major flavone sources.  Wine was the major anthocyanidin source (delphinidin, malvidin, peonidin and petunidin), with smaller amts. from cherry (peonidin) and blue-berry (delphinidin, malvidin, peonidin and petunidin).  It is suggested that the relatively small no. of aforementioned key foods form the basis of food frequency questionnaires to assess flavonoid intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNE4PdXY63r7Vg90H21EOLACvtfcHk0lhvI2IcK7f7Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmsLfI&md5=161c5c10382026dfdf6b608e182db810</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1080%2F01635580802143836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01635580802143836%26sid%3Dliteratum%253Aachs%26aulast%3DSomerset%26aufirst%3DS.%2BM.%26aulast%3DJohannot%26aufirst%3DL.%26atitle%3DDietary%2520flavonoid%2520sources%2520in%2520Australian%2520adults%26jtitle%3DNutr.%2520Canc.%26date%3D2008%26volume%3D60%26spage%3D442%26epage%3D449%26doi%3D10.1080%2F01635580802143836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devi, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malar, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daglia, M.</span></span> <span> </span><span class="NLM_article-title">Kaempferol and inflammation: from chemistry to medicine</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.phrs.2015.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=25982933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1eqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2015&pages=1-10&author=K.+P.+Deviauthor=D.+S.+Malarauthor=S.+F.+Nabaviauthor=A.+Suredaauthor=J.+Xiaoauthor=S.+M.+Nabaviauthor=M.+Daglia&title=Kaempferol+and+inflammation%3A+from+chemistry+to+medicine&doi=10.1016%2Fj.phrs.2015.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Kaempferol and inflammation: From chemistry to medicine</span></div><div class="casAuthors">Devi, Kasi Pandima; Malar, Dicson Sheeja; Nabavi, Seyed Fazel; Sureda, Antoni; Xiao, Jianbo; Nabavi, Seyed Mohammad; Daglia, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inflammation is an important process of human healing response, wherein the tissues respond to injuries induced by many agents including pathogens.  It is characterized by pain, redness and heat in the injured tissues.  Chronic inflammation seems to be assocd. with different types of diseases such as arthritis, allergies, atherosclerosis, and even cancer.  In recent years natural product based drugs are considered as the novel therapeutic strategy for prevention and treatment of inflammatory diseases.  Among the different types of phyto-constituents present in natural products, flavonoids which occur in many vegetable foods and herbal medicines are considered as the most active constituent, which has the potency to ameliorate inflammation under both in vitro and in vivo conditions.  Kaempferol is a natural flavonol present in different plant species, which has been described to possess potent anti-inflammatory properties.  Despite the voluminous literature on the anti-inflammatory effects of kaempferol, only very limited review articles has been published on this topic.  Hence the present review is aimed to provide a crit. overview on the anti-inflammatory effects and the mechanisms of action of kaempferol, based on the current scientific literature.  In addn., emphasis is also given on the chem., natural sources, bioavailability and toxicity of kaempferol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoVUg55PZOvLVg90H21EOLACvtfcHk0lhvI2IcK7f7Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1eqsb0%253D&md5=db81321e284a813e4faa76c7f284e4c8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DDevi%26aufirst%3DK.%2BP.%26aulast%3DMalar%26aufirst%3DD.%2BS.%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26aulast%3DDaglia%26aufirst%3DM.%26atitle%3DKaempferol%2520and%2520inflammation%253A%2520from%2520chemistry%2520to%2520medicine%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D99%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.phrs.2015.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span> <span> </span><span class="NLM_article-title">Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0197563</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0197563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1371%2Fjournal.pone.0197563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29771951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWktrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=J.+Wangauthor=X.+Fangauthor=L.+Geauthor=F.+Caoauthor=L.+Zhaoauthor=Z.+Wangauthor=W.+Xiao&title=Antitumor%2C+antioxidant+and+anti-inflammatory+activities+of+kaempferol+and+its+corresponding+glycosides+and+the+enzymatic+preparation+of+kaempferol&doi=10.1371%2Fjournal.pone.0197563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol</span></div><div class="casAuthors">Wang, Jingqiu; Fang, Xianying; Ge, Lin; Cao, Fuliang; Zhao, Linguo; Wang, Zhenzhong; Xiao, Wei</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0197563/1-e0197563/12</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Kaempferol (kae) and its glycosides are widely distributed in nature and show multiple bioactivities, yet few reports have compared them.  In this paper, we report the antitumor, antioxidant and anti-inflammatory activity differences of kae, kae-7-O-glucoside (kae-7-O-glu), kae-3-O-rhamnoside (kae-3-O-rha) and kae-3-O-rutinoside (kae-3-O-rut).  Kae showed the highest antiproliferation effect on the human hepatoma cell line HepG2, mouse colon cancer cell line CT26 and mouse melanoma cell line B16F1.  Kae also significantly inhibited AKT phosphorylation and cleaved caspase-9, caspase-7, caspase-3 and PARP in HepG2 cells.  A kae-induced increase in DPPH and ABTS radical scavenging activity, inhibition of Con A (Con A)-induced activation of T cell proliferation and NO or ROS prodn. in LPS-induced RAW 264.7 macrophage cells were also seen.  Kae glycosides were used to produce kae via environment-friendly enzymic hydrolysis.  Kae-7-O-glu and kae-3-O-rut were hydrolyzed to kae by β-glucosidase and/or α-L-rhamnosidase.  This paper demonstrates the application of enzymic catalysis to obtain highly biol. active kae.  This work provides a novel and efficient prepn. of high-value flavone-related products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIaWUSZiEuEbVg90H21EOLACvtfcHk0lhvI2IcK7f7Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWktrnI&md5=88c701d9f16fe2ad4294412a3616a5d3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0197563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0197563%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DW.%26atitle%3DAntitumor%252C%2520antioxidant%2520and%2520anti-inflammatory%2520activities%2520of%2520kaempferol%2520and%2520its%2520corresponding%2520glycosides%2520and%2520the%2520enzymatic%2520preparation%2520of%2520kaempferol%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0197563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuli, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Punia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, T. K.</span></span> <span> </span><span class="NLM_article-title">Kaempferol – a dietary anticancer molecule with multiple mechanisms of action: recent trends and advancements</span>. <i>J. Funct. Foods</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.jff.2017.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.jff.2017.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=32288791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=203-219&author=D.+Kashyapauthor=A.+Sharmaauthor=H.+S.+Tuliauthor=K.+Sakauthor=S.+Puniaauthor=T.+K.+Mukherjee&title=Kaempferol+%E2%80%93+a+dietary+anticancer+molecule+with+multiple+mechanisms+of+action%3A+recent+trends+and+advancements&doi=10.1016%2Fj.jff.2017.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Kaempferol - A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements</span></div><div class="casAuthors">Kashyap, Dharambir; Sharma, Ajay; Tuli, Hardeep Singh; Sak, Katrin; Punia, Sandeep; Mukherjee, Tapan K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Functional Foods</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">203-219</span>CODEN:
                <span class="NLM_cas:coden">JFFOAX</span>;
        ISSN:<span class="NLM_cas:issn">1756-4646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The consumption of diet-based naturally bioactive metabolites is preferred to synthetic material in order to avert health-assocd. disorders.  Among the plant-derived polyphenols, kaempferol (KMF) is considered as a valuable functional food ingredient with a broad range of therapeutic applications such as anti-cancer, antioxidant and anti-inflammatory uses.  KMF acts on a range of intracellular as well as extracellular targets involved in the cell signaling pathways that in turn are known to regulate the hallmarks of cancer growth progressions like apoptosis, cell cycle, invasion or metastasis, angiogenesis and inflammation.  Importantly, the understanding of mechanisms of action of KMF-mediated therapeutic effects may help the scientific community to design novel strategies for the treatment of dreadful diseases.  The current review summarizes the various types of mol. targets of KMF in cancer cells as well as other health-assocd. disorders.  In addn., this review also highlights the absorption, metab. and epidemiol. findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNPeLnkMeULVg90H21EOLACvtfcHk0liPgHH1F8G2CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGrt7k%253D&md5=f73501f4bcb9d884a79a026cbc9bdc94</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jff.2017.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jff.2017.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DKashyap%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DTuli%26aufirst%3DH.%2BS.%26aulast%3DSak%26aufirst%3DK.%26aulast%3DPunia%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DT.%2BK.%26atitle%3DKaempferol%2520%25E2%2580%2593%2520a%2520dietary%2520anticancer%2520molecule%2520with%2520multiple%2520mechanisms%2520of%2520action%253A%2520recent%2520trends%2520and%2520advancements%26jtitle%3DJ.%2520Funct.%2520Foods%26date%3D2017%26volume%3D30%26spage%3D203%26epage%3D219%26doi%3D10.1016%2Fj.jff.2017.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">Kaempferol inhibits thrombosis and platelet activation</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.biochi.2015.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26073152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWqsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=177-186&author=J.-H.+Choiauthor=S.-E.+Parkauthor=S.-J.+Kimauthor=S.+Kim&title=Kaempferol+inhibits+thrombosis+and+platelet+activation&doi=10.1016%2Fj.biochi.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Kaempferol inhibits thrombosis and platelet activation</span></div><div class="casAuthors">Choi, Jun-Hui; Park, Se-Eun; Kim, Sung-Jun; Kim, Seung</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The objectives of the present study were to investigate whether kaempferol affects pro-coagulant proteinase activity, fibrin clot formation, blood clot and thrombin (or collagen/epinephrine)-stimulated platelet activation, thrombosis, and coagulation in ICR (Imprinting Control Region) mice and SD (Sprague-Dawley) rats.  Kaempferol significantly inhibited the enzymic activities of thrombin and FXa by 68 ± 1.6% and 52 ± 2.4%, resp.  Kaempferol also inhibited fibrin polymer formation in turbidity.  Microscopic anal. was performed using a fluorescent conjugate.  Kaempferol completely attenuated phosphorylation of extracellular signal-regulated kinase (ERK) 1/2, p38, c-Jun N-terminal kinase (JNK) 1/2, and phosphoinositide 3-kinase (PI3K)/PKB (AKT) in thrombin-stimulated platelets and delayed aggregation time (clotting) by 34.6% in an assay of collagen/epinephrine-stimulated platelet activation.  Moreover, kaempferol protected against thrombosis development in 3 animal models, including collagen/epinephrine- and thrombin-induced acute thromboembolism models and an FeCl3-induced carotid arterial thrombus model.  The ex vivo anticoagulant effect of kaempferol was further confirmed in ICR mice.  This study demonstrated that kaempferol may be clin. useful due to its ability to reduce or prevent thrombotic challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZTwqTXixT-LVg90H21EOLACvtfcHk0liPgHH1F8G2CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWqsrjL&md5=c66bfda155ffc6e677fd7b0e00b5f4d3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.-H.%26aulast%3DPark%26aufirst%3DS.-E.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DKaempferol%2520inhibits%2520thrombosis%2520and%2520platelet%2520activation%26jtitle%3DBiochimie%26date%3D2015%26volume%3D115%26spage%3D177%26epage%3D186%26doi%3D10.1016%2Fj.biochi.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desiderio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saw, C. L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.-N.</span></span> <span> </span><span class="NLM_article-title">Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1002/bdd.677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1002%2Fbdd.677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=19722166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=356-365&author=A.+Barveauthor=C.+Chenauthor=V.+Hebbarauthor=J.+Desiderioauthor=C.+L.-L.+Sawauthor=A.-N.+Kong&title=Metabolism%2C+oral+bioavailability+and+pharmacokinetics+of+chemopreventive+kaempferol+in+rats&doi=10.1002%2Fbdd.677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats</span></div><div class="casAuthors">Barve, Avantika; Chen, Chi; Hebbar, Vidya; Desiderio, Joseph; Saw, Constance Lay-Lay; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">356-365</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The purpose of this study was to compare the hepatic and small intestinal metab., and to examine bioavailability and gastro-intestinal first-pass effects, of kaempferol in rats.  Liver and small intestinal microsomes fortified with either NADPH or UDPGA were incubated with varying concns. of kaempferol for up to 120 min.  Based on the values of the kinetic consts. (Km and Vmax), the propensity for UDPGA-dependent conjugation compared with NADPH-dependent oxidative metab. was higher for both hepatic and small intestinal microsomes.  Male Sprague-Dawley rats were administered kaempferol i.v. (10, 25 mg/kg) or orally (100, 250 mg/kg).  Gastro-intestinal first-pass effects were obsd. by collecting portal blood after oral administration of 100 mg/kg kaempferol.  Pharmacokinetic parameters were obtained by non-compartmental anal. using WinNonlin.  After i.v. administration, the plasma concn.-time profiles for 10 and 25 mg/kg were consistent with high clearance (∼3 L/h/kg) and large vols. of distribution (8-12 L/h/kg).  The disposition was characterized by a terminal half-life value of 3-4 h.  After oral administration the plasma concn.-time profiles demonstrated fairly rapid absorption (tmax∼1-2 h).  The area under the curve (AUC) values after i.v. and oral doses increased approx. proportional to the dose.  The bioavailability (F) was poor at ∼2%.  Anal. of portal plasma after oral administration revealed low to moderate absorption.  Taken together, the low F of kaempferol is attributed in part to extensive first-pass metab. by glucuronidation and other metabolic pathways in the gut and in the liver.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-E0E1IXPFHbVg90H21EOLACvtfcHk0liPgHH1F8G2CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnt7vO&md5=263d0e5efa3d7b7d4a2a75edfec7913a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fbdd.677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.677%26sid%3Dliteratum%253Aachs%26aulast%3DBarve%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHebbar%26aufirst%3DV.%26aulast%3DDesiderio%26aufirst%3DJ.%26aulast%3DSaw%26aufirst%3DC.%2BL.-L.%26aulast%3DKong%26aufirst%3DA.-N.%26atitle%3DMetabolism%252C%2520oral%2520bioavailability%2520and%2520pharmacokinetics%2520of%2520chemopreventive%2520kaempferol%2520in%2520rats%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2009%26volume%3D30%26spage%3D356%26epage%3D365%26doi%3D10.1002%2Fbdd.677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.-S.</span></span> <span> </span><span class="NLM_article-title">Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats</span>. <i>Arch Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1007/s12272-009-1127-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1007%2Fs12272-009-1127-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=19183886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFShurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=133-138&author=C.+Liauthor=X.+Liauthor=J.-S.+Choi&title=Enhanced+bioavailability+of+etoposide+after+oral+or+intravenous+administration+of+etoposide+with+kaempferol+in+rats&doi=10.1007%2Fs12272-009-1127-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats</span></div><div class="casAuthors">Li, Cheng; Li, Xiuguo; Choi, Jun-Shik</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-138</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">This study was to investigate the effect of kaempferol on the pharmacokinetics of etoposide after oral or i.v. administration of etoposide in rats.  The oral (6 mg/kg) or i.v. (2 mg/kg) etoposide was administered to rats alone or 30 min after the oral kaempferol (1, 4, or 12 mg/kg) administration.  Compared to the oral control group, the presence of kaempferol significantly (4 mg/kg; 12 mg/kg) increased the area under the plasma concn.-time curve (AUC) and the peak concn. (Cmax) of the oral etoposide.  Kaempferol decreased significantly (4 or 12 mg/kg) the total body clearance (CL/F) of oral etoposide, while there was no significant change in the terminal half life (t1/2), the elimination rate const. (Kel) and the time to reach the peak concn. (Tmax) of etoposide in the presense of kaempferol.  Compared to the i.v. control group, the presence of kaempferol enhanced the AUC of i.v. administered etoposide, however, only presence of 12 mg/kg of kaempferol significant increased AUC of etoposide.  The enhanced bioavailability of oral etoposide by kaempferol could have been due to an inhibition of cytochrom P 450 (CYP) 3A and P-glycoprotein (P-gp) in the intestinal or decreased total body clearance in the liver by kaempferol.  The dosage regimen of etoposide should be taken into consideration for potential drug interaction when combined with kaempferol or dietary supplements contg. kaempferol in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEUI64W-sOS7Vg90H21EOLACvtfcHk0lhdvl-w0-GF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFShurc%253D&md5=2075bb879dff852b0143835a2a6aa873</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs12272-009-1127-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-009-1127-z%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DJ.-S.%26atitle%3DEnhanced%2520bioavailability%2520of%2520etoposide%2520after%2520oral%2520or%2520intravenous%2520administration%2520of%2520etoposide%2520with%2520kaempferol%2520in%2520rats%26jtitle%3DArch%2520Pharm.%2520Res.%26date%3D2009%26volume%3D32%26spage%3D133%26epage%3D138%26doi%3D10.1007%2Fs12272-009-1127-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">George, C. F.</span></span> <span> </span><span class="NLM_article-title">Drug metabolism by the gastrointestinal mucosa</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">274</span>, <span class="refDoi"> DOI: 10.2165/00003088-198106040-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.2165%2F00003088-198106040-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=6113909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADyaL3MXltVyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1981&pages=259-274&author=C.+F.+George&title=Drug+metabolism+by+the+gastrointestinal+mucosa&doi=10.2165%2F00003088-198106040-00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Drug metabolism by the gastrointestinal mucosa</span></div><div class="casAuthors">George, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-74</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">A review with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUFZlCZxC8X7Vg90H21EOLACvtfcHk0lhdvl-w0-GF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltVyhsLw%253D&md5=001e30dd2772386febdd747d5dcb19d0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2165%2F00003088-198106040-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-198106040-00002%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DC.%2BF.%26atitle%3DDrug%2520metabolism%2520by%2520the%2520gastrointestinal%2520mucosa%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1981%26volume%3D6%26spage%3D259%26epage%3D274%26doi%3D10.2165%2F00003088-198106040-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beriashvili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kralt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Mazen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span> <span> </span><span class="NLM_article-title">Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2018.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.chemphyslip.2018.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30278162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOgsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2018&pages=73-79&author=D.+Beriashviliauthor=R.+Taylorauthor=B.+Kraltauthor=N.+Abu+Mazenauthor=S.+D.+Taylorauthor=M.+Palmer&title=Mechanistic+studies+on+the+effect+of+membrane+lipid+acyl+chain+composition+on+daptomycin+pore+formation&doi=10.1016%2Fj.chemphyslip.2018.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation</span></div><div class="casAuthors">Beriashvili, David; Taylor, Robert; Kralt, Braden; Abu Mazen, Nooran; Taylor, Scott D.; Palmer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-79</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Daptomycin is a lipopeptide antibiotic that binds and permeabilizes the cell membranes of Gram-pos. bacteria.  Membrane permeabilization requires both calcium and phosphatidylglycerol (PG) in the target membrane, and it correlates with the formation of an oligomer that likely comprises eight subunits, which are evenly distributed between the two membrane leaflets.  In both bacterial cells and model membranes, changes in the fatty acyl compn. of the membrane phospholipids can prevent permeabilization.  We here used liposomes to study the effect of phospholipids contg. oleoyl and other fatty acyl residues on daptomycin activity, and made the following observations: (1) Oleic acid residues inhibited permeabilization when part not only of PG, but also of other phospholipids (PC or cardiolipin). (2) When included in an otherwise daptomycin-susceptible lipid mixt., even 10% of dioleoyl lipid (DOPC) can strongly inhibit permeabilization. (3) The inhibitory effect of fatty acyl residues appears to correlate more with their chain length than with unsatn. (4) Under all conditions tested, permeabilization coincided with octamer formation, whereas tetramers were obsd. on membranes that were not permeabilized.  Overall, our findings further support the notion that the octamer is indeed the functional transmembrane pore, and that fatty acyl residues may prevent pore formation by preventing the alignment of tetramers across the two membrane leaflets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwNRk4m22p1bVg90H21EOLACvtfcHk0lhdvl-w0-GF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOgsL7F&md5=587d4c87318e5a0898f76744488e0af4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2018.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2018.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DBeriashvili%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DKralt%26aufirst%3DB.%26aulast%3DAbu%2BMazen%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BD.%26aulast%3DPalmer%26aufirst%3DM.%26atitle%3DMechanistic%2520studies%2520on%2520the%2520effect%2520of%2520membrane%2520lipid%2520acyl%2520chain%2520composition%2520on%2520daptomycin%2520pore%2520formation%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2018%26volume%3D216%26spage%3D73%26epage%3D79%26doi%3D10.1016%2Fj.chemphyslip.2018.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. W.</span></span> <span> </span><span class="NLM_article-title">Molecular state of the membrane-active antibiotic Daptomycin</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2017.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.bpj.2017.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28700928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlSitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=82-90&author=M.-T.+Leeauthor=W.-C.+Hungauthor=M.-H.+Hsiehauthor=H.+Chenauthor=Y.-Y.+Changauthor=H.+W.+Huang&title=Molecular+state+of+the+membrane-active+antibiotic+Daptomycin&doi=10.1016%2Fj.bpj.2017.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular State of the Membrane-Active Antibiotic Daptomycin</span></div><div class="casAuthors">Lee, Ming-Tao; Hung, Wei-Chin; Hsieh, Meng-Hsuan; Chen, Hsiung; Chang, Yu-Yung; Huang, Huey W.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-90</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Membrane-active antibiotics are potential alternatives to the resistance-prone conventional antibiotics.  Daptomycin, a cyclic lipopeptide, is the only membrane-active antibiotic approved by the U.S.  Food and Drug Administration so far.  The drug interacts with the cytoplasmic membranes of Gram-pos. pathogens, causing membrane permeabilization to ions and cell death.  The antibiotic activity is calcium-ion dependent and correlates with the target membrane's content of phosphatidylglycerol (PG).  For such a complex reaction with membranes, it has been difficult to uncover the mol. process that underlies its antibacterial activity.  The role of the cofactor, calcium ions, has been confusing.  Many have proposed that calcium ions binding to daptomycin is a precondition for membrane interaction.  Here, the authors report the findings on the mol. state of daptomycin before and after its membrane-binding reaction, particularly at therapeutic concns. in the low micromolar range.  The authors were able to perform small-angle x-ray scattering at sufficiently low daptomycin concns. to det. that the mols. are monomeric before membrane binding.  By careful CD analyses of daptomycin with Ca2+ and PG-contg. membranes, the authors found that there are only two states identifiable by CD, one before and another after membrane binding; all other CD spectra are linear combinations of the two.  Before membrane binding, the mol. state of daptomycin as defined by CD is the same with or without calcium ions.  The authors are able to det. the stoichiometric ratios of the membrane-binding reaction.  The stoichiometric ratio of daptomycin to calcium is 2:3.  The stoichiometric ratio of daptomycin to PG is ∼1:1 if only the PG lipids in the outer leaflets of membranes are accessible to daptomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR46iV-oX0W7Vg90H21EOLACvtfcHk0liCuG4YZzrkVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlSitro%253D&md5=c48a4046ffd79b9973b2cefd994e6cd8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2017.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2017.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-T.%26aulast%3DHung%26aufirst%3DW.-C.%26aulast%3DHsieh%26aufirst%3DM.-H.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.-Y.%26aulast%3DHuang%26aufirst%3DH.%2BW.%26atitle%3DMolecular%2520state%2520of%2520the%2520membrane-active%2520antibiotic%2520Daptomycin%26jtitle%3DBiophys.%2520J.%26date%3D2017%26volume%3D113%26spage%3D82%26epage%3D90%26doi%3D10.1016%2Fj.bpj.2017.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berditsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jäger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strempel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overhage, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, A. S.</span></span> <span> </span><span class="NLM_article-title">Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5288</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1128/aac.00682-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAAC.00682-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26077259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyit7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=5288-5296&author=M.+Berditschauthor=T.+J%C3%A4gerauthor=N.+Strempelauthor=T.+Schwartzauthor=J.+Overhageauthor=A.+S.+Ulrich&title=Synergistic+effect+of+membrane-active+peptides+polymyxin+B+and+gramicidin+S+on+multidrug-resistant+strains+and+biofilms+of+Pseudomonas+aeruginosa&doi=10.1128%2Faac.00682-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa</span></div><div class="casAuthors">Berditsch, Marina; Jaeger, Thomas; Strempel, Nikola; Schwartz, Thomas; Overhage, Joerg; Ulricha, Anne S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5288-5296</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Multidrug-resistant Pseudomonas aeruginosa is a major cause of severe hospital-acquired infections.  Currently, polymyxin B (PMB) is a last-resort antibiotic for the treatment of infections caused by Gram-neg. bacteria, despite its undesirable side effects.  The delivery of drug combinations has been shown to reduce the required therapeutic doses of antibacterial agents and thereby their toxicity if a synergistic effect is present.  In this study, the authors investigated the synergy between two cyclic antimicrobial peptides, PMB and gramicidin S (GS), against different P. aeruginosa isolates, using a quant. checkerboard assay with resazurin as a growth indicator.  Among the 28 strains that we studied, 20 strains showed a distinct synergistic effect, represented by a fractional inhibitory concn. index (FICI) of ≤0.5.  Remarkably, several clin. P. aeruginosa isolates that grew as small colony variants revealed a nonsynergistic effect, as indicated by FICIs between >0.5 and ≤0.70.  In addn. to inhibiting the growth of planktonic bacteria, the peptide combinations significantly decreased static biofilm growth compared with treatment with the individual peptides.  There was also a faster and more prolonged effect when the combination of PMB and GS was used compared with single-peptide treatments on the metabolic activity of pregrown biofilms.  The results of the present study define a synergistic interaction between two cyclic membrane-active peptides toward 17 multidrug-resistant P. aeruginosa and biofilms of P. aeruginosa strain PAO1.  Thus, the application of PMB and GS in combination is a promising option for a topical medication and in the prevention of acute and chronic infections caused by multidrug-resistant or biofilm-forming P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqijw44ZAF7LrVg90H21EOLACvtfcHk0liCuG4YZzrkVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyit7vN&md5=ae302e7ffc0edab83bf376efdfe23103</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FAAC.00682-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00682-15%26sid%3Dliteratum%253Aachs%26aulast%3DBerditsch%26aufirst%3DM.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DT.%26aulast%3DStrempel%26aufirst%3DN.%26aulast%3DSchwartz%26aufirst%3DT.%26aulast%3DOverhage%26aufirst%3DJ.%26aulast%3DUlrich%26aufirst%3DA.%2BS.%26atitle%3DSynergistic%2520effect%2520of%2520membrane-active%2520peptides%2520polymyxin%2520B%2520and%2520gramicidin%2520S%2520on%2520multidrug-resistant%2520strains%2520and%2520biofilms%2520of%2520Pseudomonas%2520aeruginosa%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D5288%26epage%3D5296%26doi%3D10.1128%2Faac.00682-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yahav, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farbman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibovici, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, M.</span></span> <span> </span><span class="NLM_article-title">Colistin: new lessons on an old antibiotic</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1111/j.1469-0691.2011.03734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1111%2Fj.1469-0691.2011.03734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=22168320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslyqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=18-29&author=D.+Yahavauthor=L.+Farbmanauthor=L.+Leiboviciauthor=M.+Paul&title=Colistin%3A+new+lessons+on+an+old+antibiotic&doi=10.1111%2Fj.1469-0691.2011.03734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Colistin: new lessons on an old antibiotic</span></div><div class="casAuthors">Yahav, D.; Farbman, L.; Leibovici, L.; Paul, M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-29</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Colistin has been re-introduced into clin. practice for the treatment of carbapenem-resistant Gram-neg. bacteria.  Studies in the last decade attempted to reconstruct the path that present-day medications undergo prior to clin. use.  In this review, we summarize the results of recent clin. studies.  Colistin was assocd. with lower mortality than no effective treatment and higher unadjusted mortality than β-lactams in non-randomized clin. studies.  However, it was administered to sicker patients with carabapenem-resistant bacteria.  Overall, nephrotoxicity rates were not higher with colistin in these studies, and colistin-induced nephrotoxicity is reversible in most patients.  The emergence of colistin resistance has been described in high-use settings.  Synergy with carbapenem, rifampin and other antibiotics has been reported in vitro.  Randomized controlled trials are ongoing or in planning to assess this and other aspects of colistin use in clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-f1voXWR2OrVg90H21EOLACvtfcHk0liCuG4YZzrkVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslyqsLw%253D&md5=d68fa79542339eefbc897ca95a95bb9b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2011.03734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2011.03734.x%26sid%3Dliteratum%253Aachs%26aulast%3DYahav%26aufirst%3DD.%26aulast%3DFarbman%26aufirst%3DL.%26aulast%3DLeibovici%26aufirst%3DL.%26aulast%3DPaul%26aufirst%3DM.%26atitle%3DColistin%253A%2520new%2520lessons%2520on%2520an%2520old%2520antibiotic%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2012%26volume%3D18%26spage%3D18%26epage%3D29%26doi%3D10.1111%2Fj.1469-0691.2011.03734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooderham, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R.</span></span> <span> </span><span class="NLM_article-title">Antibacterial peptides for therapeutic use: obstacles and realistic outlook</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.coph.2006.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=16890021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=468-472&author=A.+Marrauthor=W.+Gooderhamauthor=R.+Hancock&title=Antibacterial+peptides+for+therapeutic+use%3A+obstacles+and+realistic+outlook&doi=10.1016%2Fj.coph.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial peptides for therapeutic use: Obstacles and realistic outlook</span></div><div class="casAuthors">Marr, Alexandra K.; Gooderham, William J.; Hancock, Robert E. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">468-472</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cationic antimicrobial peptides are produced by almost all species of life as a component of their immediate non-specific defense against infections.  The assets of these peptides in clin. application include their potential for broad-spectrum activity, rapid bactericidal activity and low propensity for resistance development, whereas possible disadvantages include their high cost, limited stability (esp. when composed of L-amino acids), and unknown toxicol. and pharmacokinetics.  Initial barriers to their success are being increasingly overcome with the development of stable, more cost-effective and potent broad-spectrum synthetic peptides.  Thus, there is hope that they will spawn a new generation of antimicrobials with a broad range of topical and systemic applications against infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZe7bT4WbvLLVg90H21EOLACvtfcHk0lhJKf1js_wCSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWrs7s%253D&md5=3dfb70f1b93480ea8fb6c3b509168498</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DMarr%26aufirst%3DA.%26aulast%3DGooderham%26aufirst%3DW.%26aulast%3DHancock%26aufirst%3DR.%26atitle%3DAntibacterial%2520peptides%2520for%2520therapeutic%2520use%253A%2520obstacles%2520and%2520realistic%2520outlook%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D468%26epage%3D472%26doi%3D10.1016%2Fj.coph.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uppu, D. S. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baul, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siersma, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaddar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemparala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamoen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, J.</span></span> <span> </span><span class="NLM_article-title">Isosteric substitution in cationic-amphiphilic polymers reveals an important role for hydrogen bonding in bacterial membrane interactions</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4623</span>, <span class="refDoi"> DOI: 10.1039/c6sc00615a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1039%2FC6SC00615A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=30155109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1Kku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=4613-4623&author=D.+S.+S.+M.+Uppuauthor=M.+M.+Konaiauthor=U.+Baulauthor=P.+Singhauthor=T.+K.+Siersmaauthor=S.+Samaddarauthor=S.+Vemparalaauthor=L.+W.+Hamoenauthor=C.+Narayanaauthor=J.+Haldar&title=Isosteric+substitution+in+cationic-amphiphilic+polymers+reveals+an+important+role+for+hydrogen+bonding+in+bacterial+membrane+interactions&doi=10.1039%2Fc6sc00615a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Isosteric substitution in cationic-amphiphilic polymers reveals an important role for hydrogen bonding in bacterial membrane interactions</span></div><div class="casAuthors">Uppu, D. S. S. M.; Konai, M. M.; Baul, U.; Singh, P.; Siersma, T. K.; Samaddar, S.; Vemparala, S.; Hamoen, L. W.; Narayana, C.; Haldar, J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4613-4623</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Biomimetic antibacterial polymers, the functional mimics of antimicrobial peptides (AMPs), targeting the bacterial cell membrane have been developed to combat the problem of antibiotic resistance.  Amphiphilicity, a balance of cationic charge and hydrophobicity, in these polymers has been shown to be pivotal for their selective interactions with anionic lipid membranes of bacteria instead of zwitterionic mammalian (human erythrocyte) membranes.  However, it is unclear if and to what extent hydrogen bonding in amphiphilic antibacterial polymers contributes to this membrane binding specificity.  To address this, we employ isosteric substitution of ester with amide moieties that differ in their potency for hydrogen bonding in the side chains of N-alkyl maleimide based amphiphilic polymers.  Our studies reveal that amide polymer (AC3P) is a potent antibacterial agent with high membrane-disrupting properties compared to its ester counterpart (EC3P).  To understand these differences we performed bio-phys. expts. and mol. dynamics (MD) simulations which showed strong interactions of AC3P including hydrogen bonding with lipid head groups of bacterial model lipid bilayers, that are absent in EC3P, make them selective for bacterial membranes.  Mechanistic investigations of these polymers in bacteria revealed specific membrane disruptive activity leading to the delocalization of cell division related proteins.  This unprecedented and unique concept provides an understanding of bacterial membrane interactions highlighting the role of hydrogen bonding.  Thus, these findings will have significant implications in efficient design of potent membrane-active agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZpQ3SyiOjgLVg90H21EOLACvtfcHk0lhJKf1js_wCSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1Kku7c%253D&md5=eb844bdde33cb303db17cd788eb5006d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC6SC00615A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC00615A%26sid%3Dliteratum%253Aachs%26aulast%3DUppu%26aufirst%3DD.%2BS.%2BS.%2BM.%26aulast%3DKonai%26aufirst%3DM.%2BM.%26aulast%3DBaul%26aufirst%3DU.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DSiersma%26aufirst%3DT.%2BK.%26aulast%3DSamaddar%26aufirst%3DS.%26aulast%3DVemparala%26aufirst%3DS.%26aulast%3DHamoen%26aufirst%3DL.%2BW.%26aulast%3DNarayana%26aufirst%3DC.%26aulast%3DHaldar%26aufirst%3DJ.%26atitle%3DIsosteric%2520substitution%2520in%2520cationic-amphiphilic%2520polymers%2520reveals%2520an%2520important%2520role%2520for%2520hydrogen%2520bonding%2520in%2520bacterial%2520membrane%2520interactions%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26spage%3D4613%26epage%3D4623%26doi%3D10.1039%2Fc6sc00615a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.-Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and cancer cell growth inhibitory activity of icaritin derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.ejmech.2015.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26079090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=139-150&author=C.+Wangauthor=P.+Wuauthor=J.-F.+Shiauthor=Z.-H.+Jiangauthor=X.-Y.+Wei&title=Synthesis+and+cancer+cell+growth+inhibitory+activity+of+icaritin+derivatives&doi=10.1016%2Fj.ejmech.2015.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and cancer cell growth inhibitory activity of icaritin derivatives</span></div><div class="casAuthors">Wang, Chen; Wu, Ping; Shi, Jing-Fang; Jiang, Zi-Hua; Wei, Xiao-Yi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">139-150</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of icaritin derivs. bearing carboxylic acid or carboxylic ester groups are synthesized and their in vitro cytotoxic activity against three cancer cell lines, MCF-7, MDA-MB-435s and A549, are evaluated by MTT assay.  Several compds. show higher cytotoxic activity than the parent compd. icaritin against these cancer cell lines.  The compds. are even more cytotoxic to MCF-7 cells than the clinic drug tamoxifen.  Moreover, one compd. is found to be nontoxic to normal cells (Vero) and two compds. exhibit good selectivity towards estrogen receptor pos. MCF-7 breast cancer cells over estrogen receptor neg. MDA-MB-435s breast cancer cells.  The structure activity relationship anal. has revealed that mono-substitution at either a C-3 or a C-7 hydroxy group of icaritin could improve the cytotoxicity of icaritin, and the C-3 hydroxyl group may be a preferable site for chem. modification.  In addn., the length, the flexibility and the addnl. branching substituent group of the substitution chain(s) at both C-3 and C-7 hydroxyl groups can all affect the anti-cancer activity of these derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-9Kl4p9bPF7Vg90H21EOLACvtfcHk0lhJKf1js_wCSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltLnI&md5=04682c8199edad180b1e656848f1b428</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DJ.-F.%26aulast%3DJiang%26aufirst%3DZ.-H.%26aulast%3DWei%26aufirst%3DX.-Y.%26atitle%3DSynthesis%2520and%2520cancer%2520cell%2520growth%2520inhibitory%2520activity%2520of%2520icaritin%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D100%26spage%3D139%26epage%3D150%26doi%3D10.1016%2Fj.ejmech.2015.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salleh, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervushin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span> <span> </span><span class="NLM_article-title">Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1021/jm501285x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501285x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=739-752&author=J.-J.+Kohauthor=S.+Linauthor=T.+T.+Aungauthor=F.+Limauthor=H.+Zouauthor=Y.+Baiauthor=J.+Liauthor=H.+Linauthor=L.+M.+Pangauthor=W.+L.+Kohauthor=S.+M.+Sallehauthor=R.+Lakshminarayananauthor=L.+Zhouauthor=S.+Qiuauthor=K.+Pervushinauthor=C.+Vermaauthor=D.+T.+H.+Tanauthor=D.+Caoauthor=S.+Liuauthor=R.+W.+Beuerman&title=Amino+acid+modified+xanthone+derivatives%3A+novel%2C+highly+promising+membrane-active+antimicrobials+for+multidrug-resistant+Gram-positive+bacterial+infections&doi=10.1021%2Fjm501285x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Modified Xanthone Derivatives: Novel, Highly Promising Membrane-Active Antimicrobials for Multidrug-Resistant Gram-Positive Bacterial Infections</span></div><div class="casAuthors">Koh, Jun-Jie; Lin, Shuimu; Aung, Thet Tun; Lim, Fanghui; Zou, Hanxun; Bai, Yang; Li, Jianguo; Lin, Huifen; Pang, Li Mei; Koh, Wee Luan; Salleh, Shuhaida Mohamed; Lakshminarayanan, Rajamani; Zhou, Lei; Qiu, Shengxiang; Pervushin, Konstantin; Verma, Chandra; Tan, Donald T. H.; Cao, Derong; Liu, Shouping; Beuerman, Roger W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">739-752</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antibiotic resistance is a crit. global health care crisis requiring urgent action to develop more effective antibiotics.  Utilizing the hydrophobic scaffold of xanthone, we identified three components that mimicked the action of an antimicrobial cationic peptide to produce membrane-targeting antimicrobials.  Compds. 5c and 6, which contain a hydrophobic xanthone core, lipophilic chains, and cationic amino acids, displayed very promising antimicrobial activity against multidrug-resistant Gram-pos. bacteria, including MRSA and VRE, rapid time-kill, avoidance of antibiotic resistance, and low toxicity.  The bacterial membrane selectivity of these mols. was comparable to that of several membrane-targeting antibiotics in clin. trials. 5c and 6 were effective in a mouse model of corneal infection by S. aureus and MRSA.  Evidence is presented indicating that 5c and 6 target the neg. charged bacterial membrane via a combination of electrostatic and hydrophobic interactions.  These results suggest that 5c and 6 have significant promise for combating life-threatening infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWNgK4aLyoWrVg90H21EOLACvtfcHk0liHoerUXnQ0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegurnJ&md5=005cd4868c611bd6ae9a983821a99468</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm501285x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501285x%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DJ.-J.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DAung%26aufirst%3DT.%2BT.%26aulast%3DLim%26aufirst%3DF.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DL.%2BM.%26aulast%3DKoh%26aufirst%3DW.%2BL.%26aulast%3DSalleh%26aufirst%3DS.%2BM.%26aulast%3DLakshminarayanan%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DPervushin%26aufirst%3DK.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BH.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26atitle%3DAmino%2520acid%2520modified%2520xanthone%2520derivatives%253A%2520novel%252C%2520highly%2520promising%2520membrane-active%2520antimicrobials%2520for%2520multidrug-resistant%2520Gram-positive%2520bacterial%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D739%26epage%3D752%26doi%3D10.1021%2Fjm501285x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyrager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faissner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillancourt, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshavn, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamoorthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee Yong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stys, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storr, T.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer’s disease</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5636</span>– <span class="NLM_lpage">5643</span>, <span class="refDoi"> DOI: 10.1039/c7sc01269a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1039%2Fc7sc01269a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=28989601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1yitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=5636-5643&author=M.+R.+Jonesauthor=E.+Mathieuauthor=C.+Dyragerauthor=S.+Faissnerauthor=Z.+Vaillancourtauthor=K.+J.+Korshavnauthor=M.+H.+Limauthor=A.+Ramamoorthyauthor=V.+Wee+Yongauthor=S.+Tsutsuiauthor=P.+K.+Stysauthor=T.+Storr&title=Multi-target-directed+phenol-triazole+ligands+as+therapeutic+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc7sc01269a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease</span></div><div class="casAuthors">Jones, Michael R.; Mathieu, Emilie; Dyrager, Christine; Faissner, Simon; Vaillancourt, Zavier; Korshavn, Kyle J.; Lim, Mi Hee; Ramamoorthy, Ayyalusamy; Wee Yong, V.; Tsutsui, Shigeki; Stys, Peter K.; Storr, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5636-5643</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial disease that is characterized by the formation of intracellular neurofibrillary tangles and extracellular amyloid-β (Aβ) plaque deposits.  Increased oxidative stress, metal ion dysregulation, and the formation of toxic Aβ peptide oligomers are all considered to contribute to the etiol. of AD.  In this work we have developed a series of ligands that are multi-target-directed in order to address several disease properties. 2-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)phenol (POH), 2-(1-(2-morpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PMorph), and 2-(1-(2-thiomorpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PTMorph) have been synthesized and screened for their antioxidant capacity, Cu-binding affinity, interaction with the Aβ peptide and modulation of Aβ peptide aggregation, and the ability to limit Aβ1-42-induced neurotoxicity in human neuronal culture.  The synthetic protocol and structural variance incorporated via click chem., highlights the influence of R-group modification on ligand-Aβ interactions and neuroprotective effects.  Overall, this study demonstrates that the phenol-triazole ligand scaffold can target multiple factors assocd. with AD, thus warranting further therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv3gpDPj7eaLVg90H21EOLACvtfcHk0liHoerUXnQ0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1yitL0%253D&md5=c70d2f489b8d762cfc246c0dc1428f1a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2Fc7sc01269a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc7sc01269a%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DM.%2BR.%26aulast%3DMathieu%26aufirst%3DE.%26aulast%3DDyrager%26aufirst%3DC.%26aulast%3DFaissner%26aufirst%3DS.%26aulast%3DVaillancourt%26aufirst%3DZ.%26aulast%3DKorshavn%26aufirst%3DK.%2BJ.%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DRamamoorthy%26aufirst%3DA.%26aulast%3DWee%2BYong%26aufirst%3DV.%26aulast%3DTsutsui%26aufirst%3DS.%26aulast%3DStys%26aufirst%3DP.%2BK.%26aulast%3DStorr%26aufirst%3DT.%26atitle%3DMulti-target-directed%2520phenol-triazole%2520ligands%2520as%2520therapeutic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26spage%3D5636%26epage%3D5643%26doi%3D10.1039%2Fc7sc01269a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oae, S.</span></span> <span> </span><span class="NLM_article-title">Reaction of aromatic nitro compounds with elemental sulfur in liquid ammonia and amines</span>. <i>Phosphorus Sulfur</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1080/03086647908077473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1080%2F03086647908077473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADyaL3cXlsV2qs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1979&pages=229-234&author=R.+Satoauthor=S.+Takizawaauthor=S.+Oae&title=Reaction+of+aromatic+nitro+compounds+with+elemental+sulfur+in+liquid+ammonia+and+amines&doi=10.1080%2F03086647908077473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of aromatic nitro compounds with elemental sulfur in liquid ammonia and amines</span></div><div class="casAuthors">Sato, Ryu; Takizawa, Saburo; Oae, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus and Sulfur and the Related Elements</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-34</span>CODEN:
                <span class="NLM_cas:coden">PREEDF</span>;
        ISSN:<span class="NLM_cas:issn">0308-664X</span>.
    </div><div class="casAbstract">Arom. nitro compds. [PhNO2, 4-O2NC6H4OH, 4-O2NC6H4OMe, 4-O2NC6H4Me, 3-O2NC6H4Cl, 4-O2NC6H4CN] were reduced with elemental S in NH3(l) and in liq. amines [PrNH2, BuNH2, Et2NH, morpholine, piperidine], to give the corresponding anilines.  Introduction of a substituent on the benzene ring or variation of the amine changed the pattern of this reaction.  Thus, 4-nitrotoluene and 4-cyanonitrobenzene gave not only the corresponding reduced products but also 4,4'-dicyanodiphenyl disulfide and 4-cyanoaniline.  Probable mechanisms of these reactions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojfYGulk2Qx7Vg90H21EOLACvtfcHk0lg3DXqgmnOxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlsV2qs7g%253D&md5=134f93966aca755ab9db9ea0f223e7a4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1080%2F03086647908077473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03086647908077473%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DR.%26aulast%3DTakizawa%26aufirst%3DS.%26aulast%3DOae%26aufirst%3DS.%26atitle%3DReaction%2520of%2520aromatic%2520nitro%2520compounds%2520with%2520elemental%2520sulfur%2520in%2520liquid%2520ammonia%2520and%2520amines%26jtitle%3DPhosphorus%2520Sulfur%26date%3D1979%26volume%3D7%26spage%3D229%26epage%3D234%26doi%3D10.1080%2F03086647908077473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rathinakumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkenhorst, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimley, W. C.</span></span> <span> </span><span class="NLM_article-title">Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">7609</span>– <span class="NLM_lpage">7617</span>, <span class="refDoi"> DOI: 10.1021/ja8093247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja8093247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFOmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=7609-7617&author=R.+Rathinakumarauthor=W.+F.+Walkenhorstauthor=W.+C.+Wimley&title=Broad-spectrum+antimicrobial+peptides+by+rational+combinatorial+design+and+high-throughput+screening%3A+the+importance+of+interfacial+activity&doi=10.1021%2Fja8093247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Broad-Spectrum Antimicrobial Peptides by Rational Combinatorial Design and High-Throughput Screening: The Importance of Interfacial Activity</span></div><div class="casAuthors">Rathinakumar, Ramesh; Walkenhorst, William F.; Wimley, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7609-7617</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently described 10 peptides selected from a 16 384-member combinatorial library based on their ability to permeabilize synthetic lipid vesicles in vitro.  These peptides did not share a common sequence motif, length, or net charge; nonetheless, they shared a mechanism of action that is similar to the natural membrane permeabilizing antimicrobial peptides (AMP).  To characterize the selected peptides and to compare the activity of AMPs in vivo and in vitro, we report on the biol. activity of the same selected peptides in bacteria, fungi, and mammalian cells.  Each of the peptides has sterilizing activity against all classes of microbes tested, at 2-8 μM peptide, with only slight hemolytic or cytotoxicity against mammalian cells.  Similar to many natural AMPs, bacteria are killed within a few minutes of peptide addn., and the lethal step in vivo is membrane permeabilization.  Single D-amino acid substitutions eliminated or diminished the secondary structure of the peptides, and yet, they retained activity against some microbes.  Thus, secondary structure and biol. activity are not coupled, consistent with the hypothesis that AMPs do not form pores of well-defined structure in membranes but rather destabilize membranes by partitioning into membrane interfaces and disturbing the organization of the lipids, a property that we have called "interfacial activity".  The observation that broad-spectrum activity, but not all antimicrobial activity, is lost by small changes to the peptides suggests that the in vitro screen is specifically selecting for the rare peptides that have broad-spectrum activity.  We put forth the hypothesis that methods focusing on screening peptide libraries in vitro for members with the appropriate interfacial activity can enable the design, selection, and discovery of novel, potent, and broad-spectrum membrane-active antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_PuRl_scnlbVg90H21EOLACvtfcHk0lg3DXqgmnOxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFOmsro%253D&md5=9e58c4974aed1aac26cbe35b9441f887</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja8093247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja8093247%26sid%3Dliteratum%253Aachs%26aulast%3DRathinakumar%26aufirst%3DR.%26aulast%3DWalkenhorst%26aufirst%3DW.%2BF.%26aulast%3DWimley%26aufirst%3DW.%2BC.%26atitle%3DBroad-spectrum%2520antimicrobial%2520peptides%2520by%2520rational%2520combinatorial%2520design%2520and%2520high-throughput%2520screening%253A%2520the%2520importance%2520of%2520interfacial%2520activity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D7609%26epage%3D7617%26doi%3D10.1021%2Fja8093247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derebe, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callenberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Propheter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, L. V.</span></span> <span> </span><span class="NLM_article-title">Antibacterial membrane attack by a pore-forming intestinal C-type lectin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nature12729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnature12729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=24256734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ovVagsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=103-107&author=S.+Mukherjeeauthor=H.+Zhengauthor=M.+G.+Derebeauthor=K.+M.+Callenbergauthor=C.+L.+Partchauthor=D.+Rollinsauthor=D.+C.+Propheterauthor=J.+Rizoauthor=M.+Grabeauthor=Q.-X.+Jiangauthor=L.+V.+Hooper&title=Antibacterial+membrane+attack+by+a+pore-forming+intestinal+C-type+lectin&doi=10.1038%2Fnature12729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial membrane attack by a pore-forming intestinal C-type lectin</span></div><div class="casAuthors">Mukherjee Sohini; Derebe Mehabaw G; Rollins Darcy; Propheter Daniel C; Zheng Hui; Callenberg Keith M; Partch Carrie L; Rizo Josep; Grabe Michael; Jiang Qiu-Xing; Hooper Lora V</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">103-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human body-surface epithelia coexist in close association with complex bacterial communities and are protected by a variety of antibacterial proteins.  C-type lectins of the RegIII family are bactericidal proteins that limit direct contact between bacteria and the intestinal epithelium and thus promote tolerance to the intestinal microbiota.  RegIII lectins recognize their bacterial targets by binding peptidoglycan carbohydrate, but the mechanism by which they kill bacteria is unknown.  Here we elucidate the mechanistic basis for RegIII bactericidal activity.  We show that human RegIIIα (also known as HIP/PAP) binds membrane phospholipids and kills bacteria by forming a hexameric membrane-permeabilizing oligomeric pore.  We derive a three-dimensional model of the RegIIIα pore by docking the RegIIIα crystal structure into a cryo-electron microscopic map of the pore complex, and show that the model accords with experimentally determined properties of the pore.  Lipopolysaccharide inhibits RegIIIα pore-forming activity, explaining why RegIIIα is bactericidal for Gram-positive but not Gram-negative bacteria.  Our findings identify C-type lectins as mediators of membrane attack in the mucosal immune system, and provide detailed insight into an antibacterial mechanism that promotes mutualism with the resident microbiota.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKlyEjWbjBdyjiVMCqkKxVfW6udTcc2eadtu6OaFcb5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ovVagsg%253D%253D&md5=a6bcf611db65fec251706982bd3b0c21</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnature12729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12729%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DDerebe%26aufirst%3DM.%2BG.%26aulast%3DCallenberg%26aufirst%3DK.%2BM.%26aulast%3DPartch%26aufirst%3DC.%2BL.%26aulast%3DRollins%26aufirst%3DD.%26aulast%3DPropheter%26aufirst%3DD.%2BC.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DGrabe%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DQ.-X.%26aulast%3DHooper%26aufirst%3DL.%2BV.%26atitle%3DAntibacterial%2520membrane%2520attack%2520by%2520a%2520pore-forming%2520intestinal%2520C-type%2520lectin%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D103%26epage%3D107%26doi%3D10.1038%2Fnature12729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millard, P. J.</span></span> <span> </span><span class="NLM_article-title">Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2421</span>– <span class="NLM_lpage">2431</span>, <span class="refDoi"> DOI: 10.1128/aem.63.6.2421-2431.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAEM.63.6.2421-2431.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=9172364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFGisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=2421-2431&author=B.+L.+Rothauthor=M.+Pootauthor=S.+T.+Yueauthor=P.+J.+Millard&title=Bacterial+viability+and+antibiotic+susceptibility+testing+with+SYTOX+green+nucleic+acid+stain&doi=10.1128%2Faem.63.6.2421-2431.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain</span></div><div class="casAuthors">Roth, Bruce L.; Poot, Martin; Yue, Stephen T.; Millard, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2421-2431</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A fluorescent nucleic acid stain that does not penetrate living cells was used to assess the integrity of the plasma membranes of bacteria.  SYTOX Green nucleic acid stain is an unsym. cyanine dye with three pos. charges that is completely excluded from live eukaryotic and prokaryotic cells.  Binding of SYTOX Green stain to nucleic acids resulted in a >500-fold enhancement in fluorescence emission (absorption and emission maxima at 502 and 523 nm, resp.), rendering bacteria with compromised plasma membranes brightly green fluorescent.  SYTOX Green stain is readily excited by the 488-nm line of the argon ion laser.  The fluorescence signal from membrane-compromised bacteria labeled with SYTOX Green stain with typically >10-fold brighter than that from intact organisms.  Bacterial suspensions labeled with SYTOX Green stain emitted green fluorescence in proportion to the fraction of permeabilized cells in the population, which was quantified by microscopy, fluorometry, or flow cytometry.  Flow cytometric and fluorometric approaches were used to quantify the effect of β-lactam antibiotics on the cell membrane integrity of Escherichia coli.  Detection and discrimination of live and permeabilized cells labeled with SYTOX Green stain by flow cytometry was markedly improved over those by propidium iodide-based tests.  These studies showed that bacterial baleing with SYTOX Green stain is an effective alternative to conventional methods for measuring bacterial viability and antibiotic susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxkVUBxik7T7Vg90H21EOLACvtfcHk0lj5b83V-YOonw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFGisbk%253D&md5=174863923aaafd556aee6be6956077da</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FAEM.63.6.2421-2431.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.63.6.2421-2431.1997%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DPoot%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DS.%2BT.%26aulast%3DMillard%26aufirst%3DP.%2BJ.%26atitle%3DBacterial%2520viability%2520and%2520antibiotic%2520susceptibility%2520testing%2520with%2520SYTOX%2520green%2520nucleic%2520acid%2520stain%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D1997%26volume%3D63%26spage%3D2421%26epage%3D2431%26doi%3D10.1128%2Faem.63.6.2421-2431.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamrani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuerman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, E.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan Leong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Park, M. B.</span></span> <span> </span><span class="NLM_article-title">A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability</span>. <i>Nat. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/nmat2915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fnmat2915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=21151166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=149-156&author=P.+Liauthor=Y.+F.+Poonauthor=W.+Liauthor=H.-Y.+Zhuauthor=S.+H.+Yeapauthor=Y.+Caoauthor=X.+Qiauthor=C.+Zhouauthor=M.+Lamraniauthor=R.+W.+Beuermanauthor=E.-T.+Kangauthor=Y.+Muauthor=C.+M.+Liauthor=M.+W.+Changauthor=S.+S.+Jan+Leongauthor=M.+B.+Chan-Park&title=A+polycationic+antimicrobial+and+biocompatible+hydrogel+with+microbe+membrane+suctioning+ability&doi=10.1038%2Fnmat2915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability</span></div><div class="casAuthors">Li, Peng; Poon, Yin Fun; Li, Weifeng; Zhu, Hong-Yuan; Yeap, Siew Hooi; Cao, Ye; Qi, Xiaobao; Zhou, Chuncai; Lamrani, Mouad; Beuerman, Roger W.; Kang, En-Tang; Mu, Yuguang; Li, Chang Ming; Chang, Matthew W.; Leong, Susanna Su Jan; Chan-Park, Mary B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Materials</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-156</span>CODEN:
                <span class="NLM_cas:coden">NMAACR</span>;
        ISSN:<span class="NLM_cas:issn">1476-1122</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite advanced sterilization and aseptic techniques, infections assocd. with medical implants have not been eradicated.  Most present coatings cannot simultaneously fulfil the requirements of antibacterial and antifungal activity as well as biocompatibility and reusability.  Here, we report an antimicrobial hydrogel based on dimethyldecylammonium chitosan (with high quaternization)-graft-poly(ethylene glycol) methacrylate (DMDC-Q-g-EM) and poly(ethylene glycol) diacrylate, which has excellent antimicrobial efficacy against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus and Fusarium solani.  The proposed mechanism of the antimicrobial activity of the polycationic hydrogel is by attraction of sections of anionic microbial membrane into the internal nanopores of the hydrogel, like an 'anion sponge', leading to microbial membrane disruption and then microbe death.  We have also demonstrated a thin uniform adherent coating of the hydrogel by simple UV immobilization.  An animal study shows that DMDC-Q-g-EM hydrogel coating is biocompatible with rabbit conjunctiva and has no toxicity to the epithelial cells or the underlying stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRETRDXi5GKLVg90H21EOLACvtfcHk0lj5b83V-YOonw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovV2isQ%253D%253D&md5=18b8c0d55f18af86bd3e5de9d4a9dadd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnmat2915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmat2915%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DPoon%26aufirst%3DY.%2BF.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.-Y.%26aulast%3DYeap%26aufirst%3DS.%2BH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DLamrani%26aufirst%3DM.%26aulast%3DBeuerman%26aufirst%3DR.%2BW.%26aulast%3DKang%26aufirst%3DE.-T.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DChang%26aufirst%3DM.%2BW.%26aulast%3DJan%2BLeong%26aufirst%3DS.%2BS.%26aulast%3DChan-Park%26aufirst%3DM.%2BB.%26atitle%3DA%2520polycationic%2520antimicrobial%2520and%2520biocompatible%2520hydrogel%2520with%2520microbe%2520membrane%2520suctioning%2520ability%26jtitle%3DNat.%2520Mater.%26date%3D2011%26volume%3D10%26spage%3D149%26epage%3D156%26doi%3D10.1038%2Fnmat2915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosshard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weilenmann, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egli, T.</span></span> <span> </span><span class="NLM_article-title">Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight kit in combination with flow cytometry</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3283</span>– <span class="NLM_lpage">3290</span>, <span class="refDoi"> DOI: 10.1128/aem.02750-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1128%2FAEM.02750-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17384309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslSnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=3283-3290&author=M.+Berneyauthor=F.+Hammesauthor=F.+Bosshardauthor=H.-U.+Weilenmannauthor=T.+Egli&title=Assessment+and+interpretation+of+bacterial+viability+by+using+the+LIVE%2FDEAD+BacLight+kit+in+combination+with+flow+cytometry&doi=10.1128%2Faem.02750-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight kit in combination with flow cytometry</span></div><div class="casAuthors">Berney, Michael; Hammes, Frederik; Bosshard, Franziska; Weilenmann, Hans-Ulrich; Egli, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3283-3290</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The com. available LIVE/DEAD BacLight kit is enjoying increased popularity among researchers in various fields of microbiol.  Its use in combination with flow cytometry brought up new questions about how to interpret LIVE/DEAD staining results.  Intermediate states, normally difficult to detect with epifluorescence microscopy, are a common phenomenon when the assay is used in flow cytometry and still lack rationale.  It is shown here that the application of propidium iodide in combination with a green fluorescent total nucleic acid stain on UVA-irradiated cells of Escherichia coli, Salmonella enterica serovar Typhimurium, Shigella flexneri, and a community of freshwater bacteria resulted in a clear and distinctive flow cytometric staining pattern.  In the gram-neg. bacterium E. coli as well as in the two enteric pathogens, the pattern can be related to the presence of intermediate cellular states characterized by the degree of damage afflicted specifically on the bacterial outer membrane.  This hypothesis is supported by the fact that EDTA-treated nonirradiated cells exhibit the same staining properties.  On the contrary, this pattern was not obsd. in gram-pos. Enterococcus faecalis, which lacks an outer membrane.  Our observations add a new aspect to the LIVE/DEAD stain, which so far was believed to be dependent only on cytoplasmic membrane permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo37Tn6MrFabVg90H21EOLACvtfcHk0lj5b83V-YOonw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslSnu7o%253D&md5=a44bb8a22a9d26de6683699b075e5eb3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FAEM.02750-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.02750-06%26sid%3Dliteratum%253Aachs%26aulast%3DBerney%26aufirst%3DM.%26aulast%3DHammes%26aufirst%3DF.%26aulast%3DBosshard%26aufirst%3DF.%26aulast%3DWeilenmann%26aufirst%3DH.-U.%26aulast%3DEgli%26aufirst%3DT.%26atitle%3DAssessment%2520and%2520interpretation%2520of%2520bacterial%2520viability%2520by%2520using%2520the%2520LIVE%252FDEAD%2520BacLight%2520kit%2520in%2520combination%2520with%2520flow%2520cytometry%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2007%26volume%3D73%26spage%3D3283%26epage%3D3290%26doi%3D10.1128%2Faem.02750-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Sessions, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Periaswamy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. Y.</span></span> <span> </span><span class="NLM_article-title">A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">917</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03325-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1038%2Fs41467-018-03325-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=29500445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A280%3ADC%252BC1Mrnt1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=917&author=W.+Chinauthor=G.+Zhongauthor=Q.+Puauthor=C.+Yangauthor=W.+Louauthor=P.+F.+De+Sessionsauthor=B.+Periaswamyauthor=A.+Leeauthor=Z.+C.+Liangauthor=X.+Dingauthor=S.+Gaoauthor=C.+W.+Chuauthor=S.+Biancoauthor=C.+Baoauthor=Y.+W.+Tongauthor=W.+Fanauthor=M.+Wuauthor=J.+L.+Hedrickauthor=Y.+Y.+Yang&title=A+macromolecular+approach+to+eradicate+multidrug+resistant+bacterial+infections+while+mitigating+drug+resistance+onset&doi=10.1038%2Fs41467-018-03325-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset</span></div><div class="casAuthors">Chin Willy; Yang Chuan; Lee Ashlynn; Liang Zhen Chang; Ding Xin; Gao Shujun; Yang Yi Yan; Chin Willy; Zhong Guansheng; Lou Weiyang; Bao Chang; Fan Weimin; Pu Qinqin; Wu Min; De Sessions Paola Florez; Periaswamy Balamurugan; Chu Collins Wenhan; Bianco Simone; Hedrick James L; Tong Yen Wah</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">917</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Polymyxins remain the last line treatment for multidrug-resistant (MDR) infections.  As polymyxins resistance emerges, there is an urgent need to develop effective antimicrobial agents capable of mitigating MDR.  Here, we report biodegradable guanidinium-functionalized polycarbonates with a distinctive mechanism that does not induce drug resistance.  Unlike conventional antibiotics, repeated use of the polymers does not lead to drug resistance.  Transcriptomic analysis of bacteria further supports development of resistance to antibiotics but not to the macromolecules after 30 treatments.  Importantly, high in vivo treatment efficacy of the macromolecules is achieved in MDR A. baumannii-, E. coli-, K. pneumoniae-, methicillin-resistant S. aureus-, cecal ligation and puncture-induced polymicrobial peritonitis, and P. aeruginosa lung infection mouse models while remaining non-toxic (e.g., therapeutic index-ED50/LD50: 1473 for A. baumannii infection).  These biodegradable synthetic macromolecules have been demonstrated to have broad spectrum in vivo antimicrobial activity, and have excellent potential as systemic antimicrobials against MDR infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPzHSE9LOK2QyMywPm6HgQfW6udTcc2eY_AWLTfUG1srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mrnt1Kqtw%253D%253D&md5=69d579a0a7cd0a5e2e2c0aeba186f522</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03325-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03325-6%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DG.%26aulast%3DPu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLou%26aufirst%3DW.%26aulast%3DDe%2BSessions%26aufirst%3DP.%2BF.%26aulast%3DPeriaswamy%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DZ.%2BC.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DC.%2BW.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DY.%2BW.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DHedrick%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BY.%26atitle%3DA%2520macromolecular%2520approach%2520to%2520eradicate%2520multidrug%2520resistant%2520bacterial%2520infections%2520while%2520mitigating%2520drug%2520resistance%2520onset%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D917%26doi%3D10.1038%2Fs41467-018-03325-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vikesland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maile-Moskowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, N.</span></span> <span> </span><span class="NLM_article-title">Differential drivers of antimicrobial resistance across the world</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.8b00643</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.8b00643" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktlOqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=916-924&author=P.+Vikeslandauthor=E.+Garnerauthor=S.+Guptaauthor=S.+Kangauthor=A.+Maile-Moskowitzauthor=N.+Zhu&title=Differential+drivers+of+antimicrobial+resistance+across+the+world&doi=10.1021%2Facs.accounts.8b00643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Drivers of Antimicrobial Resistance across the World</span></div><div class="casAuthors">Vikesland, Peter; Garner, Emily; Gupta, Suraj; Kang, Seju; Maile-Moskowitz, Ayella; Zhu, Ni</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">916-924</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antimicrobial resistance (AMR) is one of the greatest threats faced by humankind.  The development of resistance in clin. and hospital settings has been well documented ever since the initial discovery of penicillin and the subsequent introduction of sulfonamides as clin. antibiotics.  In contrast, the environmental (i.e., community-acquired) dimensions of resistance dissemination have been only more recently delineated.  The global spread of antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARGs) between air, water, soil, and food is now well documented, while the factors that affect ARB and ARG dissemination (e.g., water and air quality, antibiotic fluxes, urbanization, sanitation practices) in these and other environmental matrixes are just now beginning to be more fully appreciated.In this Account, we discuss how the global perpetuation of resistance is dictated by highly interconnected socioeconomic risk factors and illustrate that development status should be more fully considered when developing global strategies to address AMR.  We first differentiate low to middle income countries (LMICs) and high-income countries (HICs), then we summarize the modes of action of com. available antibiotics, and then discuss the four primary mechanisms by which bacteria develop resistance to those antibiotics.  Resistance is disseminated via both vertical gene transfer (VGT; parent to offspring) as well as by horizontal gene transfer (HGT; cell to cell transference of genetic material).  A key challenge hindering attempts to control resistance dissemination is the presence of native, environmental bacteria that can harbor ARGs.  Such environmental "resistomes" have potential to transfer resistance to pathogens via HGT.  Of particular concern is the development of resistance to antibiotics of last-resort such as the cephalosporins, carbapenems, and polymyxins.We then illustrate how antibiotic use differs in LMICs relative to HICs in terms of the vols. of antibiotics used and their fate within local environments.  Antibiotic use in HICs has remained flat over the past 15 years, while in LMICs use over the same period has increased substantially as a result of economic improvements and changes in diet.  These use and fate differences impact local citizens and thus the local dissemination of AMR.  Various phys., social, and economic circumstances within LMICs potentially favor AMR dissemination.  We focus on three phys. factors: changing population d., sanitation infrastructure, and solid-waste disposal.  We show that high population densities in cities within LMICs that suffer from poor sanitation and solid-waste disposal can potentially impact the dissemination of resistance.  In the final section, we discuss potential monitoring approaches to quantify the spread of resistance both within LMICs as well as in HICs.  We posit that culture-based approaches, mol. approaches, and cutting-edge nanotechnol.-based methods for monitoring ARB and ARGs should be considered both within HICs and, as appropriate, within LMICs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRfuY4_Wvzk7Vg90H21EOLACvtfcHk0ljAqhAMEJbqcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktlOqsrs%253D&md5=bec2a3f62b68867760d6eee400681646</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.8b00643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.8b00643%26sid%3Dliteratum%253Aachs%26aulast%3DVikesland%26aufirst%3DP.%26aulast%3DGarner%26aufirst%3DE.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DMaile-Moskowitz%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DN.%26atitle%3DDifferential%2520drivers%2520of%2520antimicrobial%2520resistance%2520across%2520the%2520world%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2019%26volume%3D52%26spage%3D916%26epage%3D924%26doi%3D10.1021%2Facs.accounts.8b00643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel terminal bipheny-based diapophytoene desaturases (CrtN) inhibitors as anti-MRSA/VISR/LRSA agents with reduced hERG activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01300</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01300" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=224-250&author=B.+Liauthor=S.+Niauthor=F.+Maoauthor=F.+Chenauthor=Y.+Liuauthor=H.+Weiauthor=W.+Chenauthor=J.+Zhuauthor=L.+Lanauthor=J.+Li&title=Novel+terminal+bipheny-based+diapophytoene+desaturases+%28CrtN%29+inhibitors+as+anti-MRSA%2FVISR%2FLRSA+agents+with+reduced+hERG+activity&doi=10.1021%2Facs.jmedchem.7b01300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity</span></div><div class="casAuthors">Li, Baoli; Ni, Shuaishuai; Mao, Fei; Chen, Feifei; Liu, Yifu; Wei, Hanwen; Chen, Wenhua; Zhu, Jin; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224-250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections.  More than 100 new compds. were synthesized, which target the overwhelming the defects of the CrtN inhibitor 1 (I).  Analogs 23a ((E)-3-([1,1'-biphenyl]-4-yl)-N-(benzofuran-3-ylmethyl)-N-methylprop-2-en-1-amine hydrochloride) and 23b ((E)-N-((1H-indol-7-yl)methyl)-3-([1,1'-biphenyl]-4-yl)-N-methylprop-2-en-1-amine hydrochloride) demonstrated a significant activity against pigmented S. aureus Newman and 13 MRSA strains (IC50 = 0.02-10.5 nM), along with lower hERG inhibition (IC50 > 30 μM, ∼10-fold decrease in comparison with 1).  Furthermore, 23a and 23b were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid.  Remarkably, 23a could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that 23a has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rqm9J1xyJbVg90H21EOLACvtfcHk0ljAqhAMEJbqcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2gsLfF&md5=d92739f38cc85e69ca280dc62b198934</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01300%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DNi%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520terminal%2520bipheny-based%2520diapophytoene%2520desaturases%2520%2528CrtN%2529%2520inhibitors%2520as%2520anti-MRSA%252FVISR%252FLRSA%2520agents%2520with%2520reduced%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D224%26epage%3D250%26doi%3D10.1021%2Facs.jmedchem.7b01300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’onnell, K. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmond, G. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">10706</span>– <span class="NLM_lpage">10733</span>, <span class="refDoi"> DOI: 10.1002/anie.201209979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1002%2Fanie.201209979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=24038605" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10706-10733&author=K.+M.+G.+O%E2%80%99onnellauthor=J.+T.+Hodgkinsonauthor=H.+F.+Soreauthor=M.+Welchauthor=G.+P.+C.+Salmondauthor=D.+R.+Spring&title=Combating+multidrug-resistant+bacteria%3A+current+strategies+for+the+discovery+of+novel+antibacterials&doi=10.1002%2Fanie.201209979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.201209979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201209979%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599onnell%26aufirst%3DK.%2BM.%2BG.%26aulast%3DHodgkinson%26aufirst%3DJ.%2BT.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DSalmond%26aufirst%3DG.%2BP.%2BC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DCombating%2520multidrug-resistant%2520bacteria%253A%2520current%2520strategies%2520for%2520the%2520discovery%2520of%2520novel%2520antibacterials%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2013%26volume%3D52%26spage%3D10706%26epage%3D10733%26doi%3D10.1002%2Fanie.201209979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sani, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Separovic, F.</span></span> <span> </span><span class="NLM_article-title">How Membrane-active peptides cet into lipid membranes</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.6b00074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.6b00074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFeqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=1130-1138&author=M.-A.+Saniauthor=F.+Separovic&title=How+Membrane-active+peptides+cet+into+lipid+membranes&doi=10.1021%2Facs.accounts.6b00074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">How Membrane-Active Peptides Get into Lipid Membranes</span></div><div class="casAuthors">Sani, Marc-Antoine; Separovic, Frances</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1130-1138</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The structure-function relationship for a family of antimicrobial peptides (AMPs) from the skin of Australian tree frogs is discussed and compared with that of peptide toxins from bee and Australian scorpion venoms.  Although these membrane-active peptides induce a similar cellular fate by disrupting the lipid bilayer integrity, their lytic activity is achieved via different modes of action, which are investigated in relation to amino acid sequence, secondary structure, and membrane lipid compn.  In order to better understand what structural features govern the interaction between peptides and lipid membranes, cell-penetrating peptides (CPPs), which translocate through the membrane without compromising its integrity, are also discussed.AMPs possess membrane lytic activities that are naturally designed to target the cellular membrane of pathogens or competitors.  They are extremely diverse in amino acid compn. and often show specificity against a particular strain of microbe.  Since our antibiotic arsenal is declining precariously in the face of the rise in multiantibiotic resistance, AMPs increasingly are seen as a promising alternative.  In an effort to understand their mol. mechanism, biophys. studies of a myriad of AMPs have been reported, yet no unifying mechanism has emerged, rendering difficult the rational design of drug leads.  Similarly, a wide variety of cytotoxic peptides are found in venoms, the best known being melittin, yet again, predicting their activity based on a particular amino acid compn. or secondary structure remains elusive.  A common feature of these membrane-active peptides is their preference for the lipid environment.  Indeed, they are mainly unstructured in soln. and, in the presence of lipid membranes, quickly adsorb onto the surface, change their secondary structure, eventually insert into the hydrophobic core of the membrane bilayer, and finally disrupt the bilayer integrity.  These steps define the mol. mechanism by which these membrane-active peptides lyse membranes.  The last class of membrane-active peptides discussed are the CPPs, which translocate across the lipid bilayer without inducing severe disruption and have potential as drug vehicles.  CPPs are typically highly charged and can show antimicrobial activity by targeting an intracellular target rather than via a direct membrane lytic mechanism.A crit. aspect in the structure-function relationship of membrane-active peptides is their specific activity relative to the lipid membrane compn. of the cell target.  Cell membranes have a wide diversity of lipids, and those of eukaryotic and prokaryotic species differ greatly in compn. and structure.  The activity of AMPs from Australian tree frogs, toxins, and CPPs has been investigated within various lipid systems to assess whether a relationship between peptide and membrane compn. could be identified.  NMR spectroscopy techniques are being used to gain atomistic details of how these membrane-active peptides interact with model membranes and cells, and in particular, competitive assays demonstrate the difference between affinity and activity for a specific lipid environment.  Overall, the interactions between these relatively small sized peptides and various lipid bilayers give insight into how these peptides function at the membrane interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLQ9FWucXXbVg90H21EOLACvtfcHk0lgke2MCpbzTMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFeqs78%253D&md5=b7c94da7a365d90d40b5ba58dea51322</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.6b00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.6b00074%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.-A.%26aulast%3DSeparovic%26aufirst%3DF.%26atitle%3DHow%2520Membrane-active%2520peptides%2520cet%2520into%2520lipid%2520membranes%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2016%26volume%3D49%26spage%3D1130%26epage%3D1138%26doi%3D10.1021%2Facs.accounts.6b00074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thaker, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cankaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, G. N.</span></span> <span> </span><span class="NLM_article-title">Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with Gram-negative activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">485</span>, <span class="refDoi"> DOI: 10.1021/ml300307b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300307b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslahu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=481-485&author=H.+D.+Thakerauthor=A.+Cankayaauthor=R.+W.+Scottauthor=G.+N.+Tew&title=Role+of+amphiphilicity+in+the+design+of+synthetic+mimics+of+antimicrobial+peptides+with+Gram-negative+activity&doi=10.1021%2Fml300307b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with gram-negative activity</span></div><div class="casAuthors">Thaker, Hitesh D.; Cankaya, Alper; Scott, Richard W.; Tew, Gregory N.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-485</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two new series of aryl SMAMPs (synthetic mimics of antimicrobial peptides) with facially amphiphilic (FA) and disrupted amphiphilic (DA) topologies were designed and synthesized to directly assess the role of amphiphilicity on their antimicrobial activity against Gram-pos. and Gram-neg. bacteria in closely related structures.  The FA SMAMPs displayed broad spectrum antimicrobial activity against both Gram-pos. S. aureus and Gram-neg. E. coli, whereas the DA SMAMPs, which contained a polar amide bond in between the hydrophobic moieties, only exhibited activity toward S. aureus with increasing hydrophobicity.  The integy moment (IW) was used to quantify the amphiphilicity of the SMAMPs and confirmed that it is crit. for the design of SMAMPs with Gram-neg. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjC0kntuFqrVg90H21EOLACvtfcHk0lgke2MCpbzTMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslahu7o%253D&md5=8361bfc67f53d455f2323ca87d2a31e2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fml300307b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300307b%26sid%3Dliteratum%253Aachs%26aulast%3DThaker%26aufirst%3DH.%2BD.%26aulast%3DCankaya%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DTew%26aufirst%3DG.%2BN.%26atitle%3DRole%2520of%2520amphiphilicity%2520in%2520the%2520design%2520of%2520synthetic%2520mimics%2520of%2520antimicrobial%2520peptides%2520with%2520Gram-negative%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D481%26epage%3D485%26doi%3D10.1021%2Fml300307b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rotem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, A.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial peptide mimics for improved therapeutic properties</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1788</i></span>,  <span class="NLM_fpage">1582</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2008.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.bbamem.2008.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=19028449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1GhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1788&publication_year=2009&pages=1582-1592&author=S.+Rotemauthor=A.+Mor&title=Antimicrobial+peptide+mimics+for+improved+therapeutic+properties&doi=10.1016%2Fj.bbamem.2008.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial peptide mimics for improved therapeutic properties</span></div><div class="casAuthors">Rotem, Shahar; Mor, Amram</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1788</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1582-1592</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The relatively recent recognition of the major role played by antimicrobial peptides (AMPs) in sustaining an effective host response to immune challenges was greatly influenced by studies of amphibian peptides.  AMPs are also widely regarded as a potential source of future antibiotics owing to a remarkable set of advantageous properties ranging from mol. simplicity to low-resistance swift-kill of a broad range of microbial cells.  However, the peptide formula per se, represents less than ideal drug candidates, namely because of poor bioavailability issues, potential immunogenicity, optional toxicity and high prodn. costs.  To address these issues, synthetic peptides have been designed, reproducing the crit. peptide biophys. characteristic in unnatural sequence-specific oligomers.  Thus, the use of peptidomimetics to overcome the limitations inherent to peptides phys. characteristics is becoming an important and promising approach for improving the therapeutic potential of AMPs.  Here, we review most recent advances in the design strategies and the biophys. properties of the main classes of mimics to natural AMPs, emphasizing the importance of structure-activity relationship studies in fine-tuning of their physicochem. attributes for improved antimicrobial properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Fo1isOgcjbVg90H21EOLACvtfcHk0lgke2MCpbzTMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1GhtL4%253D&md5=dd1481ddd791081c51865b7f24569108</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2008.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2008.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DRotem%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DA.%26atitle%3DAntimicrobial%2520peptide%2520mimics%2520for%2520improved%2520therapeutic%2520properties%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1788%26spage%3D1582%26epage%3D1592%26doi%3D10.1016%2Fj.bbamem.2008.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lio, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, E. T.</span></span> <span> </span><span class="NLM_article-title">Topical antibacterial agents</span>. <i>Med. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1016/j.mcna.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1016%2Fj.mcna.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslSisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2011&pages=703-721&author=P.+A.+Lioauthor=E.+T.+Kaye&title=Topical+antibacterial+agents&doi=10.1016%2Fj.mcna.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Topical Antibacterial Agents</span></div><div class="casAuthors">Lio, Peter A.; Kaye, Elaine T.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Clinics of North America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">703-721</span>CODEN:
                <span class="NLM_cas:coden">MCNAA9</span>;
        ISSN:<span class="NLM_cas:issn">0025-7125</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Decreased systemic toxicity, ease of application, and increased concns. at the target site are some of the important advantages topical antibacterial agents offer.  This article reviews the literature on selected indications for these agents and provides in-depth examn. of specific agents for the prophylaxis and treatment of skin and wound infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdQzkvM5_dcLVg90H21EOLACvtfcHk0lgXch7PN_1YYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslSisLc%253D&md5=84488de6c8acc6abd917ae620514ffa2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DLio%26aufirst%3DP.%2BA.%26aulast%3DKaye%26aufirst%3DE.%2BT.%26atitle%3DTopical%2520antibacterial%2520agents%26jtitle%3DMed.%2520Clin.%26date%3D2011%26volume%3D95%26spage%3D703%26epage%3D721%26doi%3D10.1016%2Fj.mcna.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Budak, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baykara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivanc, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicek, S.</span></span> <span> </span><span class="NLM_article-title">Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis</span>. <i>Cutan. Ocul. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.3109/15569527.2015.1058273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.3109%2F15569527.2015.1058273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=26100380" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=126-130&author=B.+A.+Budakauthor=M.+Baykaraauthor=S.+A.+Kivancauthor=H.+Yilmazauthor=S.+Cicek&title=Comparing+the+ocular+surface+effects+of+topical+vancomycin+and+linezolid+for+treating+bacterial+keratitis&doi=10.3109%2F15569527.2015.1058273"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.3109%2F15569527.2015.1058273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15569527.2015.1058273%26sid%3Dliteratum%253Aachs%26aulast%3DBudak%26aufirst%3DB.%2BA.%26aulast%3DBaykara%26aufirst%3DM.%26aulast%3DKivanc%26aufirst%3DS.%2BA.%26aulast%3DYilmaz%26aufirst%3DH.%26aulast%3DCicek%26aufirst%3DS.%26atitle%3DComparing%2520the%2520ocular%2520surface%2520effects%2520of%2520topical%2520vancomycin%2520and%2520linezolid%2520for%2520treating%2520bacterial%2520keratitis%26jtitle%3DCutan.%2520Ocul.%2520Toxicol.%26date%3D2016%26volume%3D35%26spage%3D126%26epage%3D130%26doi%3D10.3109%2F15569527.2015.1058273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kollef, M. H.</span></span> <span> </span><span class="NLM_article-title">Limitations of vancomycin in the management of resistant staphylococcal infections</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">S191</span>– <span class="NLM_lpage">S195</span>, <span class="refDoi"> DOI: 10.1086/519470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=10.1086%2F519470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=17712746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=S191-S195&author=M.+H.+Kollef&title=Limitations+of+vancomycin+in+the+management+of+resistant+staphylococcal+infections&doi=10.1086%2F519470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Limitations of vancomycin in the management of resistant staphylococcal infections</span></div><div class="casAuthors">Kollef, Marin H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S191-S195</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Vancomycin is effective against methicillin-resistant Staphylococcus aureus and has been widely used in the past few years.  However, several recent reports have highlighted the limitations of vancomycin, and its role in the management of serious infections is now being reconsidered.  Vancomycin treatment failure rates are assocd. with an increase in the min. inhibitory concn. as well as a decrease in the rate of bacterial killing.  The intrinsic limitations of vancomycin also include poor tissue penetration, particularly in the lung; relatively slow bacterial killing; and the potential for toxicity.  In addn., intermediate-level vancomycin resistance has emerged among staphylococci, as have rare cases of fully resistant strains.  Because of these problems, when using vancomycin, it is probably prudent to carefully establish the diagnosis, test for antimicrobial susceptibility, and monitor serum trough concns. to ensure adequate dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBH-llmKSIY7Vg90H21EOLACvtfcHk0lgXch7PN_1YYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrrN&md5=a0dfef666bbe14e28f1d60a33e5a2b25</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1086%2F519470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F519470%26sid%3Dliteratum%253Aachs%26aulast%3DKollef%26aufirst%3DM.%2BH.%26atitle%3DLimitations%2520of%2520vancomycin%2520in%2520the%2520management%2520of%2520resistant%2520staphylococcal%2520infections%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2007%26volume%3D45%26spage%3DS191%26epage%3DS195%26doi%3D10.1086%2F519470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i81"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00053">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24734"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00053?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00053</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_001.csv">CSV</a>)</p></li><li><p class="inline">MIC values of amphiphilic kaempferol derivatives against various Gram-negative bacterial strains; fluorescence changes of compounds <b>45</b> and <b>52</b> without adding SYTOX Green; water solubility test; and HPLC traces of the final kaempferol compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_001.csv">jm0c00053_si_001.csv (5.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00053/suppl_file/jm0c00053_si_002.pdf">jm0c00053_si_002.pdf (1.17 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00053&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00053%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00053" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a4ea97e4c3dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
